The Antibiotic Resistance Growth Plate (ARGP) as an experimental evolution tool to explore the phenotypic and genotypic mutational pathways underlying the emergence

of antimicrobial resistance in 'Escherichia coli' by Cullen, Lucky Bonnie Lucia
  
Kingston University London 
 
The Antibiotic Resistance Growth Plate (ARGP) as an experimental evolution tool to 
explore the phenotypic and genotypic mutational pathways underlying the emergence 
of antimicrobial resistance in Escherichia coli. 
 
A thesis submitted in partial fulfilment for the degree of 
Doctor of Philosophy 
 
By  
Lucky Bonnie Lucia CULLEN  
 
 
Faculty of Science, Engineering and Computing 
 
February 2019
  
 
 i 
Declaration  
This thesis entitled ‘The Antibiotic Resistance Growth Plate (ARGP)’ as an 
experimental evolution tool to explore the phenotypic and genotypic mutational 
pathways underlying the emergence of antimicrobial resistance in Escherichia coli’ is 
based upon the work conducted in the Faculty of Science, Engineering and 
Computing at Kingston University London and in collaboration with Dr Philip Aldridge 
at Newcastle University and Katie Hopkins and Neil Woodford from Public Health 
England. All the work described is the candidate’s own original work unless otherwise 
stated. None of the work presented has been submitted for another degree internally 
or externally.   
 
  
  
 
 ii 
Acknowledgements 
At the start of this PhD I had a dream, a dream which could have never been 
accomplished without the support of many people. Firstly, I would like to express my 
sincere appreciation to my director of studies Professor Mark Fielder, your provision, 
guidance and unconditional belief in my potential has contributed significantly to the 
completion of this thesis. I would also like to acknowledge the overwhelming support 
received from, Dr Scott Lawton, Camilla Eldridge and Ben Jones, your wealth of 
knowledge and expertise in the field of evolutionary biology and bioinformatics has 
assisted greatly in concluding the work within this PhD. 
 
I would also like to praise the incredible multidisciplinary support received at Kingston 
University, specifically that from Dr Gary-Forster Wilkins, Dr Adam Le Gresley, Dr 
Brian Rooney, Dr James Denholm-Price and Richard Giddens. I would also like to 
extend my gratitude to all those in the Microbiology laboratory including my lovely 
friends and technicians, who have made this experience enjoyable.  A special thank 
you goes to Coral Brazier, from the Kingston University wellbeing team.  
 
Finally, I would like to thank my wonderful family and friends who have believed in me 
endlessly, thank you all for being a part of my journey.  To my sister Kaycee thank 
you for being my glimmer of sunshine during the darkest times. The greatest thank 
you goes to my mum, nobody knows how challenging this journey has been like you 
do and neither would this have been possible without you. Everything, I am and 
everything I aspire to be, I owe to you. Nanny Kathy although you will not remember, I 
dedicate this to you.  
  
 
 iii 
Publications  
 
Antibiotic Resistance Growth Plate (ARGP): A simple tool for exploring the 
evolution of antimicrobial resistance. 
Cullen LBL, Eldridge C, Forster-Wilkins G and Fielder MD (Article in preparation).  
 
Presentations 
Developing an experimental tool to explore the evolution of antimicrobial 
resistance? Oral presentation. Society for Applied Microbiology ECS Research 
Conference. The Royal Society of Medicine. October 2016.   
Exploring the evolutionary pathways to antimicrobial resistance using 
experimental evolution. Oral presentation. Society for Applied Microbiology 
Antimicrobial Resistance Conference. One Great George Street. November 2016.  
Characterising the emergence of antibiotic resistance through mutations using 
experimental evolution. Poster presentation. Science Engineering and Computing 
Conference. Kingston University London. April 2017.  
Characterising the emergence of antibiotic resistance: mutation mapping of the 
resistome. Oral presentation. American Society for Microbiology (ASM) Microbe 
Conference.  New Orleans. June 2017.  
An alternative approach to tackling the antibiotic resistance crisis. Oral 
presentation. Three Minute Thesis winner and national semi-finalist. Kingston 
University London. 2017.  
 
 
 
 
  
 
 iv 
List of Acronyms 
 
 
 
° Degree 
°C Degrees Centigrade 
μg Micrograms 
μl Microliter 
μM Micromolar 
 Nucleotide Diversity 
3’ 3 prime end 
5’ 5 prime end 
ABU Asymptomatic Bacteriuria  
AIC Akaike Information criterion 
ALE Adaptive Laboratory Evolution 
AACs Aminoglycoside Acetyltransferases 
AMEs Aminoglycoside Modifying Enzymes 
AMR Antimicrobial Resistance 
APHA Animal and Plant Health Agency 
ARGP Antibiotic Resistance Growth Plate 
ASM American Society for Microbiology  
BIC Bayesian Information Criterion 
BSAC British Society for Antimicrobial Chemotherapy 
CDC Centre for Disease Control and Prevention 
CDS Coding Sequence 
CFU/mL Colony Forming Units Per mL 
  
 
 v 
CLED Cysteine-Lactose-Electrolyte Deficient 
CPE Carbapenemase Producing Enterobacteria 
CRE Carbapenem-Resistant Enterobacteriaceae 
Cryo-EM Cryo-Electron Microscopy 
D2O Deuterium Oxide 
dH2O Distilled Water 
DMAB Dimethylaminobenzaldehyde 
dN/dS Non-synonymous/Synonymous 
dNTPs Fluorescently Tagged Nucleotides 
DT Decision Theory 
EARS-Net European Antimicrobial Resistance Surveillance Network 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic Acid 
EF-G Elongation Factor-G 
EF-Tu Elongation Factor-Tu 
EMBL-EBI European Bioinformatics Institute 
EPEC Enteropathogenic E. coli 
EUCAST European Committee on Antimicrobial Susceptibility Testing  
ExPEC Extraintestinal Pathogenic E. coli  
G. mellonella  Galleria mellonella  
GF-Score Goodness-of-Fit Score 
GMQE Global Model Quality Estimate 
GTP Guanosine Triphosphate 
HGT Horizontal Gene Transfer 
  
 
 vi 
-InL Likelihood 
ICL Imperial College London 
iNTPs Initiating Nucleoside Triphosphate 
IS Insertion Elements 
iTOL Interactive Tree of Life 
KU Kingston University 
LCBs Locally Collinear Blocks 
LC-MS Liquid Chromatography- Mass Spectroscopy 
MEA Maximum Expected Accuracy 
MEGA Molecular Evolutionary Genetics Analysis 
MFE Minimum Free Energy 
MH Mueller Hinton 
MIC Minimum Inhibitory Concentration 
ML Maximum Likelihood 
MLST Multilocus Sequence Typing 
mRNA Messenger Ribonucleic Acid 
MSW Mutant Selection Window 
MUSCLE Multiple Sequence Comparison Log-Expectation 
MVA Multivariate Analyses 
NCBI National Centre for Biotechnology 
NCTC National Collection of Type Cultures 
NJ Neighbour Joining 
NMR Nuclear Magnetic Resonance 
NNI Nearest-neighbour Interchange 
  
 
 vii 
nt Nucleotide 
NU Newcastle University 
OD Optical Density 
O/N Overnight 
OPG Osmoregulated Periplasmic Glucan 
OPLS-SA Orthogonal Partial Least Squares- Discriminant Analysis 
P. mirabilis  Proteus mirabilis 
PBS Phosphate Buffered Saline 
PCA Principal Component Analysis 
PCR Polymerase Chain Reaction 
PDB Protein Data Bank 
PHE Public Health England 
ppGpp Guanosine5’-diphosphate 3’-diphosphate 
QMEAN Quality Model Energy 
QSQE Quaternary Structure Quality Estimate 
RND Resistance-Nodulation-Division 
rrn Ribosomal RNA 
rRNA Ribosomal Ribonucleic Acid 
SAPS Statistical Analysis of Protein Sequences 
SEM Scanning Electron Microscopy 
SfAM Society for Applied Microbiology  
SMART Simple Modular Architecture Research Tool 
smFRET Single-Molecule Fluorescence Resonance Energy Transfer 
SNP Single Nucleotide Polymorphism 
  
 
 viii 
Spp. Species 
TBE Tris-Borate-EDTA 
TDR Totally Drug-Resistant 
TMS Tetramethylsilane 
trGTPases Translational GTPases 
TTC Triphenyltetrazolium Chloride 
VSEPR Valence Shell Electron Pair Repulsion  
WGS Whole Genome Sequencing 
WT Wild-Type 
 
 
  
  
 
 ix 
Table of Contents 
 
List of acronyms ............................................................................................. iv 
Table of contents ............................................................................................ ix 
Table of figures ............................................................................................... xx 
Table of tables ................................................................................................. xxx 
Abstract……………………………………………………………………………xxxiii 
Chapter 1: Introduction .................................................................................. 1 
 1.1 Antimicrobial resistance ............................................................................. 1 
      1.1.1 The antimicrobial resistance threat .................................................... 1 
      1.1.2 Antimicrobial resistance: a one health perspective ............................ 2 
      1.1.3 Mechanisms of antimicrobial resistance ............................................. 3 
            1.1.3.1 Intrinsic mechanisms of antimicrobial resistance  ..................... 4 
            1.1.3.2 Acquired mechanisms of antimicrobial resistance..................... 5  
            1.1.3.3 Acquired antimicrobial resistance through mutations ................ 5 
      1.1.4 The significance of Gram-negative bacteria ....................................... 7 
            1.1.4.1 Escherichia coli and its application as a model organism ......... 8 
            1.1.4.2 The importance of aminoglycoside antibiotics  .......................... 11 
 1.2 The history of microbial culture methods ................................................... 12 
      1.2.1 The application of adaptive laboratory evolution (ALE) in microbiology. 
 .......................................................................................................................... 12  
      1.2.2 Experimental approaches in the study of antimicrobial resistance ..... 13 
      1.2.3 The future of ALE studies ................................................................... 17 
 1.3 Fitness costs associated with resistance development .............................. 19  
 1.4 Phylogenetic interpretation of ALE findings ............................................... 20 
 1.5 Treatment strategies informed by ALE ....................................................... 20 
 1.6 Aims and objectives ................................................................................... 22 
Chapter 2: Materials and methods ................................................................ 24 
  2.1 Chemicals and reagents ........................................................................... 24 
  2.2 Bacterial strains ........................................................................................ 24 
  2.3 Bacterial cultures and inoculum preparation ............................................. 25 
       2.3.1 Preparation of bacterial stocks .......................................................... 27 
  
 
 x 
      2.3.2 Recovery of bacterial stocks .............................................................. 27 
 2.4 Preparation of antimicrobial stock solutions ............................................... 27 
      2.4.1 Antibiotic sensitivity testing methods .................................................. 29 
 2.5 Characterisation of bacterial strains ........................................................... 30 
      2.5.1 Catalase test ...................................................................................... 31 
      2.5.2 Oxidase test ....................................................................................... 32 
      2.5.3 Lactose fermentation.......................................................................... 32 
      2.5.4 Indole test .......................................................................................... 32 
      2.5.5 Urease test ......................................................................................... 33 
 2.6 Enumeration of bacteria ............................................................................. 34 
 2.7 Method development and optimisation ...................................................... 34 
     2.7.1 Preliminary experiment: production of Bioplates  ................................ 34 
           2.7.1.1 Preliminary diphasic plate experiment: MH agar ........................ 35 
     2.7.2 Preliminary filter tip experiment ........................................................... 36 
           2.7.2.1 Filter tip experiment .................................................................... 38 
     2.7.3 Triphasic circle plate experiment ......................................................... 40 
     2.7.4 Broth method serial passage  ............................................................. 42 
 2.8 Genome sequencing, assembly and alignment  ........................................ 44 
     2.8.1 Whole genome sequencing at Microbes NG ....................................... 44 
     2.8.2 Whole genome assembly CLC ............................................................ 47 
     2.8.3 Alignment of conserved genomic sequences with rearrangements  
using Mauve...................................................................................................... 49 
 2.9 Physiochemical analysis of mutagenesis ................................................... 50 
     2.9.1 RNA consensus secondary structure XRNA ....................................... 50 
     2.9.2 RNA secondary structure analysis using RNAfold  ............................. 50 
     2.9.3 Phylogenetic analysis using MEGA .................................................... 51 
     2.9.4 EMBL SAPS protein structure analysis ............................................... 51 
     2.9.5 TreeSAAP selection of amino acid properties  .................................... 52 
     2.9.6 Homology modelling of protein structure using Swiss Model .............. 53 
 2.10 Molecular genetics based on bioinformatics findings  .............................. 54 
     2.10.1 Primer design  ................................................................................... 54 
     2.10.2 DNA extraction .................................................................................. 55 
  
 
 xi 
     2.10.3 Polymerase chain reaction  ............................................................... 55 
     2.10.4 Agarose gel electrophoresis .............................................................. 58 
 2.11 Molecular docking analysis  ..................................................................... 59 
     2.11.1 Molecular structure analysis .............................................................. 59 
     2.11.2 Preparation of PDB files for Autodock ............................................... 59 
     2.11.3 Receptor preparation for docking  ..................................................... 60 
     2.11.4 Ligand preparation for docking  ......................................................... 61 
     2.11.5 Grid box preparation and docking with AutoDock ............................. 61 
     2.11.6 Single docking analysis and visualisation with PyMOL ..................... 62 
 2.12 The phylogenetic analysis of the fusA gene ............................................. 62 
     2.12.1 The evolutionary model selection using JModel  ............................... 62 
     2.12.2 Phylogenetic tree construction using PhyML .................................... 63 
 2.13 Analysis of bacterial fitness ...................................................................... 64 
     2.13.1 Manual growth curve ......................................................................... 64 
     2.13.2 Galleria mellonella virulence model  ................................................. 64 
     2.13.3 Scanning electron microscopy .......................................................... 68 
Chapter 3: Experimental evolution as a tool for exploring the evolution of 
antimicrobial resistance across an antibiotic landscape under laboratory 
conditions ........................................................................................................ 70 
 3.1 Introduction  ............................................................................................... 70 
 3.2 Materials and methods ............................................................................... 72 
    3.2.1 Preliminary diphasic plate experiment ................................................. 72 
          3.2.1.1 Preliminary diphasic plate experiment: semi-solid MH agar ........ 72 
          3.2.1.2 Preliminary diphasic plate experiment: M9 minimal media .......... 73 
    3.2.2 Preliminary triphasic plate experiment ................................................. 75 
          3.2.2.1 Preliminary triphasic plate experiment: semi-solid MH agar ........ 76 
          3.2.2.2 Preliminary diphasic plate experiment: agar slope ...................... 76 
    3.2.3 Preliminary filter tip experiment  ........................................................... 78 
          3.2.3.1 The filter tip experiment  .............................................................. 78 
          3.2.3.2 Quantification of the filter tip experiment ..................................... 78 
          3.2.3.3 The altered filter tip experiment ................................................... 79 
    3.2.4 The triphasic circle plate experiment  ................................................... 81 
  
 
 xii 
          3.2.4.1 The altered triphasic circle plate method ..................................... 81 
     3.2.5 Motility experiments ............................................................................ 82 
           3.2.5.1 Motility testing: stab test ............................................................. 82 
           3.2.5.2 Genomic analysis of bacterial motility  ....................................... 83 
                    3.2.5.2.1 DNA extraction for the analysis of bacterial motility  ...... 83 
                    3.2.5.2.2 PCR for the analysis of bacterial motility ........................ 84 
                    3.2.5.2.3 DreamTaq Polymerase PCR for the analysis of  
bacterial motility ................................................................................................ 84 
                    3.2.5.2.4 Gel electrophoresis for the analysis of bacterial motility.85  
           3.2.5.3 Motility testing: 6-well plate assay .............................................. 86 
    3.2.6 Finalised triphasic plate circle method renamed the Antibiotic Resistance 
Growth Plate (ARGP) ........................................................................................ 86 
    3.2.7 Quantification of antimicrobial diffusion and degradation  
within the ARGP ................................................................................................ 88 
           3.2.7.1 Quantification of antimicrobial diffusion and degradation using Nuclear 
Magnetic Resonance (NMR) ............................................................................. 88 
           3.2.7.2 Quantification of antimicrobial diffusion and degradation  
using LC-MS ..................................................................................................... 90 
    3.2.8 Serial passage ..................................................................................... 91 
 3.3 Experimental results  ................................................................................. 92 
    3.3.1 Antimicrobial susceptibility testing results  ........................................... 92 
    3.3.2 The preliminary diphasic plate experiment ........................................... 94 
          3.3.2.1 The production of Bioplates for the diphasic plat experiment ...... 94 
          3.3.2.2 The diphasic plate experiment: resistance evolution of laboratory strains 
of E. coli and P. mirabilis under chloramphenicol  
exposure on MH agar ....................................................................................... 94 
          3.3.2.3 The diphasic plate experiment: resistance evolution of laboratory strains 
of E. coli and P. mirabilis under chloramphenicol exposure on semi-solid MH agar
 .......................................................................................................................... 95 
          3.3.2.4 The diphasic plate experiment: resistance evolution of laboratory strains 
of E. coli and P. mirabilis under chloramphenicol exposure on M9 minimal  
media ................................................................................................................ 95 
  
 
 xiii 
    3.3.3 The triphasic plate experiment: resistance evolution of laboratory strains of E. 
coli and P. mirabilis under chloramphenicol exposure on MH agar................... 96 
          3.3.3.1 The triphasic plate experiment: resistance evolution of laboratory strains 
of E. coli and P. mirabilis under chloramphenicol exposure in  
semi-solid MH agar ........................................................................................... 97 
          3.3.3.2 The diphasic agar slope plate experiment: resistance evolution of 
laboratory strains of E. coli and P. mirabilis under  
chloramphenicol exposure ................................................................................ 98 
    3.3.4 The preliminary filter tip experimental results ....................................... 98  
          3.3.4.1 The filter tip experiment:  resistance evolution of laboratory strains of E. 
coli and P. mirabilis resistance under trimethoprim exposure ........................... 98 
          3.3.4.2 Quantification of the filter tip experiment: resistance evolution of a 
laboratory strain of E. coli under trimethoprim exposure ................................... 99 
          3.3.4.3 The altered filter tip experiment: resistance evolution of E. coli and P. 
mirabilis under trimethoprim exposure .............................................................. 101 
    3.3.5 The triphasic circle plate experiment: resistance evolution of E. coli under 
trimethoprim exposure ...................................................................................... 101 
          3.3.5.1 The altered triphasic circle plate experiment: resistance evolution of P. 
mirabilis under trimethoprim exposure .............................................................. 102 
          3.3.5.2 The altered triphasic circle plate experiment with M9 minimal media: 
resistance evolution of P. mirabilis and E. coli under  
trimethoprim exposure ...................................................................................... 103 
    3.3.6 Assessment of bacterial motility ........................................................... 104 
          3.3.6.1 The motility stab test ................................................................... 104 
          3.3.6.2 Genomic analysis of bacterial motility  ........................................ 105 
          3.3.6.3 Motility assay .............................................................................. 106 
    3.3.7 The triphasic circle plate experiment: ARGP with 0.3%  
motility layer ...................................................................................................... 106 
          3.3.7.1 The triphasic circle plate experiment: ARGP with 3%  
motility layer ...................................................................................................... 107 
    3.3.8 Assessment of antimicrobial degradation and diffusion within  
the ARGP .......................................................................................................... 109 
  
 
 xiv 
          3.3.8.1 NMR spectra of the selected antimicrobial agents and media utilised 
within this study ................................................................................................. 109 
          3.3.8.2 Quantification of antimicrobial diffusion and degradation using LC-MS
 .......................................................................................................................... 111 
    3.3.9 Serial passage: laboratory strain E. coli MG1655 ................................ 120 
          3.3.9.1 Serial passage: E. coli MG1655 under trimethoprim selection .... 123 
          3.3.9.2 Serial passage: uropathogenic clinical strains of E. coli .............. 125 
 3.4 Discussion .................................................................................................. 129 
    3.4.1 Experimental design and optimisation ................................................. 129 
    3.4.2 The analysis of bacterial motility .......................................................... 131 
    3.4.3 Quantification of antimicrobial degradation and diffusion ..................... 132 
    3.4.4 The traditional serial passage approach .............................................. 133 
    3.4.5 Conclusion ........................................................................................... 134 
Chapter 4:  Understanding the molecular mechanisms behind the evolution of 
aminoglycoside resistance in E. coli MG1655 .............................................. 135 
 4.1 Introduction ................................................................................................ 135 
 4.2 Materials and methods ............................................................................... 137 
    4.2.1 Whole genome sequencing at Microbes NG ........................................ 137 
    4.2.2 Whole genome assembly CLC ............................................................. 137 
    4.2.3 Identification of genes of interest ......................................................... 137 
    4.2.4 Genomic alignment using Mauve ......................................................... 138 
          4.2.4.1 SNP identification ........................................................................ 138 
    4.2.5 Proteome analysis using CD-HIT ......................................................... 142 
 4.3 Experimental results .................................................................................. 144 
    4.3.1 Whole genome sequencing .................................................................. 144 
    4.3.2 CLC Sequence quality and trimming .................................................... 145 
          4.3.2.1 Per sequence- length distribution analysis .................................. 145 
          4.3.2.2 Per sequence- GC content analysis ............................................ 147 
          4.3.2.3 Per sequence- quality distribution analysis ................................. 148 
          4.3.2.4 Per base- coverage analysis ....................................................... 149 
          4.3.2.5 Per base- nucleotide contribution analysis .................................. 150 
          4.3.2.6 Per base- GC content analysis ................................................... 151 
  
 
 xv 
          4.3.2.7 Per base- quality distribution analysis ......................................... 152 
          4.3.2.8 Over-representation enriched 5mers analysis ............................. 154 
    4.3.3 Identification of genes associated with aminoglycoside resistance ...... 155 
    4.3.4 Genome sequence alignment in Mauve ............................................... 161 
          4.3.4.1 Mauve SNP identification ............................................................ 166 
    4.3.5 Proteome analysis using CD-HIT ......................................................... 174 
 4.4 Discussion .................................................................................................. 185 
    4.4.1 Microbial genome sequencing, assembly and annotation .................... 185 
    4.4.2 Gentamicin targets and SNP detection ................................................ 187 
    4.4.3 Proteome analysis and contaminant identification ............................... 190 
    4.4.4 Conclusion ........................................................................................... 191 
Chapter 5:  Physiochemical analysis of the genes predicted to be involved in 
the evolution of gentamicin resistance in E. coli MG1655 .......................... 192 
 5.1 Introduction ................................................................................................ 192 
 5.2 Materials and methods ............................................................................... 195 
    5.2.1 RNA consensus secondary structure XRNA ........................................ 195 
    5.2.2 RNAfold secondary structure analysis ................................................. 195 
          5.2.2.1 Secondary structure analysis using Vienna ................................ 195 
    5.2.3 DNAsp sequence polymorphism analysis ............................................ 197 
    5.2.4 Phylogenetic analysis using MEGA ..................................................... 198 
    5.2.5 EMBL SAPS protein structure analysis ................................................ 198 
          5.2.5.1 TreeSAAP selection of amino acid properties ............................. 198 
          5.2.5.2 NCBI conserved domains analysis .............................................. 198 
    5.2.6 Homology modelling of protein structure: Swiss Model ........................ 199 
          5.2.6.1 Modelling of protein structure: Scigress ...................................... 199 
          5.2.6.2 Protein structure analysis: PyMOL molecular graphics system ... 199 
    5.2.7 Molecular analysis based on bioinformatics findings ........................... 200 
          5.2.7.1 Primer design and DNA extraction .............................................. 200 
          5.2.7.2 PCR and agarose gel electrophoresis ......................................... 201 
          5.2.7.3 Illumina sequencing at The Natural History Museum facility ....... 201 
 5.3 Experimental results  ................................................................................. 202 
     5.3.1 RNA consensus secondary structure .................................................. 202 
  
 
 xvi 
     5.3.2 RNA secondary structure predictions using RNAfold .......................... 205 
           5.3.2.1 RNA secondary structure analysis using Vienna........................ 211 
     5.3.3 RNA sequence polymorphism analysis using DNAsp ......................... 214 
     5.3.4 Phylogenetic analysis of the rRNA variants ........................................ 215 
     5.3.5 EMBL SAPS protein charge analysis .................................................. 220 
           5.3.5.1 TreeSAAP selection on amino acid properties ........................... 222 
5.3.5.2 Conserved protein domain analysis ........................................... 226 
    5.3.6 Protein modelling using Swiss Model ................................................... 228 
          5.3.6.1 Protein modelling using Scigress ................................................ 230 
          5.3.6.2 Functional analysis of EF-G using PyMOL  ................................. 232 
    5.3.7 PCR amplification and sequencing of genes with mutations ................ 238 
 5.4 Discussion .................................................................................................. 245 
    5.4.1 Transcriptional regulation and control of the rRNA operon .................. 245 
    5.4.2 Secondary structure modelling of the 16s rRNA mutations .................. 246 
    5.4.3 16s rRNA mutagenesis and aminoglycoside resistance ...................... 247 
    5.4.4 Functional analysis of the ribosomal protein EF-G ............................... 249 
    5.4.5 Conclusion ........................................................................................... 251 
Chapter 6:  In-silico molecular docking analysis illustrating the adaptive 
response to gentamicin resistance in E. coli MG1655 ................................. 252 
 6.1 Introduction ................................................................................................ 252 
 6.2 Materials and methods ............................................................................... 254 
    6.2.1 Molecular structure analysis ................................................................. 254 
    6.2.2 Preparation of PDB files for docking .................................................... 254 
    6.2.3 Preparation of receptor and ligand for docking .................................... 254 
    6.2.4 Grid box preparation and single docking analysis ................................ 254 
    6.2.5 Autodock modifications ........................................................................ 255 
 6.3 Experimental results .................................................................................. 256 
    6.3.1 The molecular structure analysis of gentamicin ................................... 256 
    6.3.2 Preparation of the gentamicin-ligand for molecular docking to the 30s-
ribosomal subunit protein S12........................................................................... 258 
    6.3.3 Ligand and grid-box preparation for the molecular docking simulation of 
gentamicin to the 30s-ribosomal subunit protein S12 ....................................... 259 
  
 
 xvii 
            6.3.3.1 Single docking analysis of gentamicin to the 30s-ribosomal subunit 
protein S12 ....................................................................................................... 261 
    6.3.4 Gentamicin docking analysis 70s-ribosomal complex .......................... 266 
          6.3.4.1 Receptor preparation of the 70s-ribosomal complex ................... 266 
          6.3.4.2 70s pre-ribosomal complex docking analysis pre-mutagenesis .. 267 
          6.3.4.3 70s post-ribosomal complex docking analysis pre-mutagenesis.273  
    6.3.5 Gentamicin docking analysis post-mutagenesis .................................. 277 
          6.3.5.1 70s pre-ribosomal complex docking analysis post-mutagenesis.277 
          6.3.5.2 70s post-ribosomal complex docking analysis post-mutagenesis.281 
    6.3.6 Comparative assessment of gentamicin docking ................................. 284 
          6.3.6.1 Gentamicin binding analysis 70s pre-ribosomal complex pre- and post- 
mutagenesis...................................................................................................... 284 
          6.3.6.2 Gentamicin binding analysis 70s post-ribosomal complex pre- and post- 
mutagenesis...................................................................................................... 286 
 6.4 Discussion .................................................................................................. 288 
    6.4.1 Aminoglycoside inhibition of ribosomal protein synthesis..................... 289 
    6.4.2 The 30s-ribosomal subunit protein S12 and EF-G ............................... 290 
Chapter 7: Phylogeny and evolution of EF-G: a phylogenetic  
perspective ...................................................................................................... 292 
 7.1 Introduction ................................................................................................ 292 
 7.2 Materials and methods ............................................................................... 296 
    7.2.1 Phylogenetic analysis of fusA using PhyML ......................................... 296 
    7.2.2 SMART structure analysis of EF-G ...................................................... 297 
    7.2.3 Phylogenetic analysis of the 16s rRNA ................................................ 297 
    7.2.4 Protein conservation analysis of EF-G ................................................. 299 
    7.2.5 Bioinformatic analysis of EF-G: Enterobacteriaceae database ............ 299 
 7.3 Experimental results .................................................................................. 300 
    7.3.1 Best fit model selection for the phylogenetic analysis of fusA .............. 300 
    7.3.2 Phylogenetic analysis of fusA in within the Escherichia genus ............ 301 
    7.3.3 Phylogenetic analysis of fusA amongst the  
Enterobacteriaceae family ................................................................................ 301 
  
 
 xviii 
          7.3.3.1 Phylogenetic analysis of fusA amongst distinct clades of the 
Enterobacteriaceae family ................................................................................ 304 
    7.3.4 Haplotype analysis of fusA within the Enterobacteriaceae family ........ 304 
    7.3.5 Phylogenetic analysis of the 16s rRNA genes amongst distinct clades of the 
Enterobacteriaceae family ................................................................................ 306 
    7.3.6 EF-G protein conservation analysis PRALINE ..................................... 308 
    7.3.7 Bioinformatic analysis of the fusA mutation at PHE ............................. 310 
 7.4 Discussion .................................................................................................. 310 
Chapter 8: The fitness costs associated with the acquisition of gentamicin 
resistance in E. coli MG1655 .......................................................................... 314 
 8.1 Introduction ................................................................................................ 314 
 8.2 Material and methods ................................................................................ 316 
    8.2.1 Manual growth curves .......................................................................... 316 
    8.2.2 Automated growth curves .................................................................... 316 
    8.2.3 Dose response analysis ....................................................................... 317 
    8.2.4 Galleria mellonella virulence model ..................................................... 317 
    8.2.5 Scanning electron microscopy ............................................................. 317 
 8.3 Experimental results .................................................................................. 318 
    8.3.1 Automated bacterial growth analysis  .................................................. 318 
8.3.1.1 Automated exponential phase growth analysis .......................... 328 
    8.3.2 Manual assessment of bacterial growth ............................................... 333 
8.3.2.1 Manual exponential phase growth analysis ................................ 338 
    8.3.3 Manual bacterial growth analysis bacterial enumeration ...................... 340 
8.3.3.1 Manual exponential growth analysis bacterial enumeration ....... 346 
    8.3.4 Bacterial dose response analysis ......................................................... 349 
    8.3.5 Bacterial virulence analysis .................................................................. 354 
    8.3.6 SEM bacterial morphology analysis ..................................................... 365 
          8.3.6.1 SEM morphological analysis of E. coli MG1655 WT Strain ......... 365 
          8.3.6.2 SEM morphological analysis of the gentamicin resistant E. coli MG1655 
strain ................................................................................................................. 367 
  8.4 Discussion ................................................................................................. 369 
     8.4.1 Fitness costs of antimicrobial resistance ............................................. 369 
  
 
 xix 
     8.4.2 The fitness costs associated with chromosomal mutations ................. 370 
     8.4.3 The fitness costs associated with rRNA mutation ............................... 371 
     8.4.4 Bacterial virulence and antimicrobial resistance ................................. 372 
     8.4.5 Morphological assessments using SEM.............................................. 373 
     8.4.6 Conclusion .......................................................................................... 373 
Chapter 9: General discussion and conclusions ......................................... 374 
 9.1 The ARGP experimental evolution model  ................................................. 374 
 9.2 Comparative genomic analysis through WGS ............................................ 376 
 9.3 Bioinformatic analysis: the functional consequences of mutagenesis ........ 376 
 9.4 Molecular docking analysis of gentamicin  ................................................. 377 
 9.5 Phylogenetic analysis of the fusA gene ..................................................... 378 
 9.6 The bacterial fitness costs of gentamicin resistance .................................. 379 
 9.7 Future work ................................................................................................ 379 
 9.8 Concluding remarks ................................................................................... 380 
Appendix ......................................................................................................... 382 
References....................................................................................................... 428 
 
 
  
  
 
 xx 
Table of Figures 
 
Figure 1.1 Bacterial antimicrobial resistance strategies .................................. 4 
Figure 1.2 Global epidemiology of the CTX-M genotypes ............................... 10 
Figure 1.3 The Morbidostat algorithm.............................................................. 15 
Figure 1.4 The MEGA-Plate experimental device ........................................... 16 
Figure 2.1 Template of the prototype Bioplates ............................................... 35 
Figure 2.2 The preliminary diphasic plate layout ............................................. 36 
Figure 2.3 The preliminary filter tip experiment with MacConkey agar ............ 38 
Figure 2.4 The modified filter tip experiment with antimicrobial agents ........... 39 
Figure 2.5 The triphasic circle plate ................................................................ 41 
Figure 2.6 The serial passage and antimicrobial control plate set-up ............. 42 
Figure 2.7 Overview of Illumina next-generation sequencing .......................... 46 
Figure 2.8 Whole genome assembly in CLC genomics workbench ................ 48 
Figure 2.9 The Galleria mellonella virulence model ........................................ 67 
Figure 3.1 The modified diphasic plate layout ................................................. 74 
Figure 3.2 The triphasic plate layout ............................................................... 75 
Figure 3.3 The diphasic slope plate layout ...................................................... 77 
Figure 3.4 Quantification of the filter tip experiment ........................................ 80 
Figure 3.5 The finalised ARGP set-up  ............................................................ 87 
Figure 3.6 Agar extraction mapping within the ARGP ..................................... 89 
Figure 3.7 The motility stab test ...................................................................... 105 
Figure 3.8 The ARGP 0.3% motility layer ........................................................ 107 
Figure 3.9 The ARGP 3% motility layer: E. coli MG1655 ................................ 108 
Figure 3.10 The ARGP 3% motility layer:  E. coli CFT073 .............................. 109 
Figure 3.11 One-dimensional (1D) 1H NMR spectra ....................................... 110 
Figure 3.12 Representative 1D 1H NMR spectra of the gentamicin  
 agar extracts .................................................................................................. 111 
Figure 3.13 2D molecular structure of the gentamicin complex ....................... 112 
Figure 3.14 The preliminary LC-MS chromatogram output of a series  
  of gentamicin agar extractions ...................................................................... 114 
Figure 3.15 LC-MS gentamicin agar extraction quantification ......................... 119 
  
 
 xxi 
Figure 3.16 Automated growth curve of E. coli MG1655 over 12-hours .......... 120 
Figure 3.17 Serial passage of E. coli MG1655 under gentamicin selection ..... 122 
Figure 3.18 Bacterial counts from the serial passage of E. coli MG1655  
  under gentamicin selection ............................................................................ 123 
Figure 3.19 Serial passage of E. coli MG1655 under trimethoprim selection .. 124 
Figure 3.20 Bacterial counts from the serial passage of E. coli MG1655  
  under trimethoprim selection ......................................................................... 125 
Figure 3.21 Manual growth curve of uropathogenic strains of E. coli over  
  12-hours ........................................................................................................ 126 
Figure 3.22 Serial passage of uropathogenic E. coli strains under  
  gentamicin selection ...................................................................................... 127 
Figure 3.23 Bacterial counts from the serial passage of uropathogenic  
  E. coli strains under gentamicin selection ..................................................... 128 
Figure 4.1 The node text file format required for the get_seq_go script .......... 139 
Figure 4.2 The node command executed when running the  
get_seq_go script ............................................................................................ 140 
Figure 4.3 The Exonerate command utilised to obtain the nucleotide  
  sequences of genes within the nodes of interest ........................................... 141 
Figure 4.4 The Transeq command utilised to translate the nucleotide  
  sequences ..................................................................................................... 141 
Figure 4.5 The command utilised to prepare proteome files for CD-HIT  
  analysis ......................................................................................................... 142 
Figure 4.6 CD-HIT command for the identification of novel proteins ............... 143 
Figure 4.7 CD-HIT command for the identification of novel proteins 
 with SNPs ....................................................................................................... 143 
Figure 4.8 Sequence read analysis of the sensitive and resistant E. coli  
  MG1655 genomes ......................................................................................... 145 
Figure 4.9 Length distribution analysis of the sensitive and resistant  
  E. coli MG1655 genomes .............................................................................. 146 
Figure 4.10 GC content analysis of the sensitive and resistant E. coli  
  MG1655 genomes ......................................................................................... 147 
  
 
 xxii 
Figure 4.11 Quality distribution analysis of the sensitive and resistant  
  E. coli MG1655 genomes .............................................................................. 148 
Figure 4.12 Coverage analysis of the sensitive and resistant E. coli  
  MG1655 genomes ......................................................................................... 149 
Figure 4.13 Nucleotide contribution analysis of the sensitive and resistant  
  E. coli MG1655 genomes. ............................................................................. 151 
Figure 4.14 GC content per base analysis of the sensitive and resistant  
  E. coli MG1655 genomes .............................................................................. 152 
Figure 4.15 Quality distribution per base analysis of the sensitive and resistant  
  E. coli MG1655 genomes .............................................................................. 153 
Figure 4.16 Over-representation analysis of the sensitive and resistant  
  E. coli MG1655 genomes .............................................................................. 155 
Figure 4.17 The ribosomal rna123 gene alignment ......................................... 157 
Figure 4.18 The ribosomal rna154 gene alignment ......................................... 158 
Figure 4.19 Schematic representation of the 30s-ribosomal subunit  
assembly ......................................................................................................... 160 
Figure 4.20 STRING protein association network of the rpsL gene  ............... 161 
Figure 4.21 Mauve alignment of the gentamicin sensitive E. coli MG1655  
  genome and the E. coli K-12 MG1655 reference genome ............................ 163 
Figure 4.22 Mauve alignment of the gentamicin resistant E. coli MG1655  
  genome and the E. coli K-12 MG1655 reference genome ............................ 164 
Figure 4.23 The progressive Mauve alignment of the gentamicin sensitive  
  and resistant E. coli MG1655 genomes ......................................................... 165 
Figure 4.24 The fusA gene alignment ............................................................. 169 
Figure 4.25 The pinR gene alignment ............................................................. 170 
Figure 4.26 STRING protein association network of the fusA gene ................ 172 
Figure 4.27 STRING protein association network of the pinR gene ................ 173 
Figure 4.28 Biological functions of the sensitive and resistant proteins of  
  E. coli MG1655 containing SNPs .................................................................. 183 
Figure 5.1 The RNAfold commands utilised in the production of the 16s  
  rRNA secondary structures within Vienna ..................................................... 196 
  
 
 xxiii 
Figure 5.2 The command utilised in the production of the 16s rRNA  
  secondary structure mountain plots within Vienna ........................................ 196 
Figure 5.3 The RNAplot command utilised in the production of the 16s  
  rRNA secondary structures with annotations within Vienna .......................... 197 
Figure 5.4 XRNA E. coli 16s rRNA secondary structure consensus  
  template ........................................................................................................ 203 
Figure 5.5 The 16s rRNA tertiary Interactions within the 30s-ribosomal  
  subunit ........................................................................................................... 204 
Figure 5.6 Secondary structure analysis of rRNA 123 using RNA fold ............ 207 
Figure 5.7 Secondary structure analysis of rRNA 154 using RNA fold ............ 210 
Figure 5.8 RNA secondary structure analysis of rRNA 123 using Vienna ....... 212 
Figure 5.9 RNA secondary structure analysis of rRNA 154 using Vienna ....... 213 
Figure 5.10 Nucleotide diversity of the 16s rRNA 123 and 154 genes ............ 214 
Figure 5.11 Molecular phylogenetic analysis of the 16s rRNA 154 gene ........ 216 
Figure 5.12 Molecular phylogenetic analysis of the 16s rRNA 123 gene ........ 218 
Figure 5.13 Charge distributional analysis of the fusA encoding EF-G  
protein ............................................................................................................. 220 
Figure 5.14 Charge distributional analysis of the pinR encoding  
  serine recombinase protein ........................................................................... 221 
Figure 5.15 Protein compressibility: protein property under positive  
  selection within EF-G. ................................................................................... 223 
Figure 5.16 The power to be at C-terminus: protein property under  
  positive selection within EF-G. ...................................................................... 224 
Figure 5.17 Isoelectric point: protein property under positive selection within  
  the pinR serine recombinase ......................................................................... 225 
Figure 5.18 Conserved domain analysis of the fusA encoding EF-G protein .. 226 
Figure 5.19 Conserved domain analysis of the pinR encoding serine  
  recombinase protein ...................................................................................... 227 
Figure 5.20 Protein homology modelling of EF-G ........................................... 228 
Figure 5.21 Protein homology modelling of Serine Recombinase pinR .......... 229 
Figure 5.22 Molecular modelling of EF-G ........................................................ 231 
Figure 5.23 Conformational changes of EF-G during ribosomal translocation.233 
  
 
 xxiv 
Figure 5.24 The conserved domains of EF-G ................................................. 234 
Figure 5.25 PyMOL mutagenesis of EF-G ...................................................... 236 
Figure 5.26 The amino acid alteration in the mutagenesis of EF-G ................ 237 
Figure 5.27 The resequenced ribosomal rna123 gene alignment ................... 239 
Figure 5.28 The resequenced ribosomal rna154 gene alignment ................... 241 
Figure 5.29 The resequenced ribosomal fusA gene alignment ....................... 244 
Figure 6.1 Molecular structures of gentamicin and the ribonucleotide and  
  amino acid binding structures ........................................................................ 257 
Figure 6.2 Preparation of the gentamicin ligand for docking in Autodock ........ 258 
Figure 6.3 The gentamicin ligand preparation docking summary .................... 259 
Figure 6.4 The grid box preparation for the 30s-ribsomomal subunit  
  protein S12 .................................................................................................... 260 
Figure 6.5 Binding energies of the gentamicin conformations obtained from  
  the docking simulation with the 30s-ribosomal subunit protein S12  
  with Autodock ................................................................................................ 262 
Figure 6.6 Superimposition of the gentamicin binding poses .......................... 262 
Figure 6.7 Docking simulation of all gentamicin poses to the  
  30s-ribsomomal subunit protein S12 ............................................................. 263 
Figure 6.8 Docking simulation of gentamicin to the 30s-ribsomomal  
  subunit protein S12 ....................................................................................... 264 
Figure 6.9 Preparation of the 70s-ribosomal complex receptor for docking  
  in Autodock ................................................................................................... 266 
Figure 6.10 The tertiary structure of the 70s pre-ribosomal complex .............. 267 
Figure 6.11 The grid box preparation for the 70s pre-ribosomal complex ....... 268 
Figure 6.12 Binding energies of the gentamicin conformations obtained from  
  the docking simulation with the 70s pre-ribosomal complex with Autodock .. 269 
Figure 6.13 Docking simulation of all gentamicin poses within the 70s  
  pre-ribosomal complex .................................................................................. 270 
Figure 6.14 Docking simulation of gentamicin to the 70s pre-ribosomal  
  complex ......................................................................................................... 272 
Figure 6.15 The tertiary structure of the 70s post-ribosomal complex. ............ 273 
  
 
 xxv 
Figure 6.16 Binding energies of the gentamicin conformations obtained  
  from the docking simulation with the 70s post-ribosomal complex  
  with Autodock ................................................................................................ 274 
Figure 6.17 Docking simulation of all gentamicin poses within the 70s  
  post-ribosomal complex ................................................................................ 275 
Figure 6.18 Docking simulation of gentamicin to the 70s post-ribosomal  
  complex ......................................................................................................... 276 
Figure 6.19 Binding energies of the gentamicin conformations obtained from  
  the docking simulation with the 70s pre-ribosomal complex  
  post-mutagenesis with Autodock ................................................................... 277 
Figure 6.20 Docking simulation of all gentamicin poses within the 70s  
  pre-ribosomal complex post-mutagenesis ..................................................... 279 
Figure 6.21 Docking simulation of gentamicin bound to the 70s  
  pre-ribosomal complex post-mutagenesis ..................................................... 280 
Figure 6.22 Binding energies of the gentamicin conformations obtained from  
  the docking simulation with the 70s post-ribosomal complex  
  post-mutagenesis with Autodock ................................................................... 281 
Figure 6.23 Docking simulation of all gentamicin poses within the 70s  
  post-ribosomal complex post-mutagenesis ................................................... 282 
Figure 6.24 Docking simulation of gentamicin bound to the 70s  
  post-ribosomal complex post-mutagenesis ................................................... 283 
Figure 6.25 Docking simulation comparison of gentamicin bound to the 70s  
  pre-ribosomal complex pre- and post-mutagenesis....................................... 285 
Figure 6.26 Docking simulation comparison of gentamicin bound to the 70s  
  post-ribosomal complex pre- and post-mutagenesis ..................................... 287 
Figure 7.1 The PhyML commands executed in the fusA ML tree  
  construction ................................................................................................... 296 
Figure 7.2 The TrimAl command executed for the removal of poorly  
  aligned regions of the 16s rRNA sequences ................................................. 298 
Figure 7.3 The PhyML command executed in the 16s rRNA ML tree  
  construction ................................................................................................... 298 
  
 
 xxvi 
Figure 7.4 Phylogenetic analysis of the fusA gene and EF-G within  
  the Enterobacteriaceae family ....................................................................... 303 
Figure 7.5 Phylogenetic analysis of the fusA within distantly related species of  
  the Enterobacteriaceae family ....................................................................... 305 
Figure 7.6 Phylogenetic analysis of the 16s rRNA genes within  
  the Enterobacteriaceae family ....................................................................... 307 
Figure 7.7 PRALINE protein conservation analysis of EF-G within  
  the Enterobacteriaceae family ....................................................................... 309 
Figure 8.1 Automated growth analysis of E. coli MG1655 WT strain .............. 319 
Figure 8.2 Automated growth analysis of E. coli MG1655 MIC strain ............. 321 
Figure 8.3 Automated growth analysis of E. coli MG1655 x10 MIC strain ....... 323 
Figure 8.4 Automated growth analysis of gentamicin sensitive and  
  resistant strains of E. coli MG1655 ................................................................ 325 
Figure 8.5 Normality tests for the statistical analysis of the automated  
  bacterial growth curves ................................................................................. 327 
Figure 8.6 Automated exponential growth analysis of E. coli MG1655 WT  
  strain ............................................................................................................. 328 
Figure 8.7 Automated exponential growth analysis of E. coli MG1655 MIC  
  strain ............................................................................................................. 329 
Figure 8.8 Automated exponential growth analysis of E. coli MG1655 X10  
  MIC strain ...................................................................................................... 330 
Figure 8.9 Automated exponential growth analysis of gentamicin sensitive  
  and resistant strains of E. coli MG1655 ......................................................... 332 
Figure 8.10 Manual growth analysis of E. coli MG1655 WT strain .................. 334 
Figure 8.11 Manual growth analysis of E. coli MG1655 MIC strain ................. 335 
Figure 8.12 Manual growth analysis of E. coli MG1655 X10 MIC strain .......... 336 
Figure 8.13 Manual growth analysis of gentamicin sensitive and resistant  
  strains of E. coli MG1655 .............................................................................. 337 
Figure 8.14 Manual exponential growth analysis of gentamicin sensitive  
  and resistant strains of E. coli MG1655 ......................................................... 339 
Figure 8.15 Manual growth analysis of E. coli MG1655 WT strain by  
  bacterial enumeration .................................................................................... 341 
  
 
 xxvii 
Figure 8.16 Manual growth analysis of E. coli MG1655 MIC strain by  
  bacterial enumeration .................................................................................... 342 
Figure 8.17 Manual growth analysis of E. coli MG1655 X10 MIC strain  
  by bacterial enumeration ............................................................................... 343 
Figure 8.18 Manual growth analysis of gentamicin sensitive and resistant  
  strains of E. coli MG1655 by bacterial enumeration ...................................... 345 
Figure 8.19 Manual exponential growth analysis of gentamicin sensitive  
  and resistant strains of E. coli MG1655 by bacterial enumeration ................. 348 
Figure 8.20 Manual dose response analysis of E. coli MG1655 WT strain ..... 350 
Figure 8.21 Manual dose response analysis of E. coli MG1655 MIC strain .... 351 
Figure 8.22 Manual dose response analysis of E. coli MG1655 X10 MIC  
  strain ............................................................................................................. 352 
Figure 8.23 Manual dose response analysis of gentamicin sensitive and  
  resistant strains of E. coli MG1655 ................................................................ 353 
Figure 8.24 Survival analysis of G. mellonella after E. coli MG1655 WT  
  infection ......................................................................................................... 356 
Figure 8.25 Survival analysis of G. mellonella after E. coli MG1655 MIC  
  infection ......................................................................................................... 358 
Figure 8.26 Survival analysis of G. mellonella after E. coli MG1655 X10  
  MIC infection ................................................................................................. 360 
Figure 8.27 Survival analysis of G. mellonella after infection with sensitive  
  and resistant strains of E. coli MG1655 ......................................................... 362 
Figure 8.28 Galleria mellonella infection with gentamicin sensitive and  
  resistant strains of E. coli MG1655 ................................................................ 364 
Figure 8.29 SEM of E. coli MG1655 WT strain ................................................ 366 
Figure 8.30 SEM of the gentamicin resistant E. coli MG1655 MIC strain ........ 368 
Figure A.1 The triphasic circle plate experiment: E. coli under  
  trimethoprim selection ................................................................................... 382 
Figure A.2 The triphasic circle plate experiment: P. mirabilis under  
  trimethoprim selection ................................................................................... 382 
Figure A.3 The triphasic circle plate experiment: E. coli under  
  trimethoprim selection over 2 weeks ............................................................. 383 
  
 
 xxviii 
Figure A.4 The triphasic circle plate experiment: E. coli and P. mirabilis  
  under trimethoprim selection in MH and M9 minimal media .......................... 384 
Figure A.5 Gel electrophoresis image of the genomic analysis of bacterial  
  motility ........................................................................................................... 385 
Figure A.6 The 0.3% 6-well plate motility assay .............................................. 386 
Figure A.7 LC-MS chromatogram 4mg/L gentamicin agar extraction .............. 387 
Figure A.8 LC-MS chromatogram 8mg/L gentamicin agar extraction .............. 388 
Figure A.9 LC-MS chromatogram 10mg/L gentamicin agar extraction ............ 389 
Figure A.10 LC-MS chromatogram 20mg/L gentamicin agar extraction .......... 390 
Figure A.11 LC-MS chromatogram 40mg/L gentamicin agar extraction .......... 391 
Figure A.12 Mountain plot representation of the rRNA secondary  
  structure analysis using RNA fold.................................................................. 406 
Figure A.13 Secondary structure analysis of rRNA 86 using RNA fold ........... 407 
Figure A.14 Secondary structure analysis of rRNA 3 using RNA fold ............. 408 
Figure A.15 Secondary structure analysis of rRNA 134 using RNA fold ......... 409 
Figure A.16 Secondary structure analysis of rRNA 146 using RNA fold ......... 410 
Figure A.17 Secondary structure analysis of rRNA 156 using RNA fold ......... 411 
Figure A.18 Gel electrophoresis image of the genomic analysis of genes  
  with mutations ............................................................................................... 412 
Figure A.19 Resequenced rRNA 123 gene alignment .................................... 413 
Figure A.20 Resequenced rRNA 154 gene alignment .................................... 414 
Figure A.21 Phylogenetic analysis of fusA within the Escherichia genus ........ 415 
Figure A.22 Haplotype analysis of the fusA gene within the  
  Enterobacteriaceae family ............................................................................. 416 
Figure A.23 Haplotype variation analysis of the fusA gene within  
  the Enterobacteriaceae family ....................................................................... 417 
Figure A.24 Normality tests for the statistical analysis of the manual  
  bacterial growth OD curves ........................................................................... 418 
Figure A.25 Manual exponential growth analysis of E. coli MG1655 WT  
strain ............................................................................................................... 419 
Figure A.26 Manual exponential growth analysis of E. coli MG1655 MIC  
strain ............................................................................................................... 420 
  
 
 xxix 
Figure A.27 Manual exponential growth analysis of E. coli MG1655 X10  
  MIC strain ...................................................................................................... 421 
Figure A.28 Normality tests for the statistical analysis of the manual  
  bacterial growth log10 CFU/mL curves ......................................................... 422 
Figure A.29 Manual exponential growth analysis of E. coli MG1655 WT strain  
  by bacterial enumeration ............................................................................... 423 
Figure A.30 Manual exponential growth analysis of E. coli MG1655 MIC strain  
  by bacterial enumeration ............................................................................... 424 
Figure A.31 Manual exponential growth analysis of E. coli MG1655 X10  
  MIC strain by bacterial enumeration .............................................................. 425 
Figure A.32 Normality tests for the statistical analysis of the dose response  
  OD curves ..................................................................................................... 426 
Figure A.33 Normality tests for the statistical analysis of the bacterial  
  virulence ........................................................................................................ 427 
 
 
  
  
 
 xxx 
Table of Tables 
 
Table 2.1 Bacterial strains used within this study ............................................ 24 
Table 2.2 Media used within this study............................................................ 26 
Table 2.3 Antimicrobial agents used within this study ..................................... 28 
Table 2.4 Calculation example for the preparation of antimicrobial stock  
  solutions ........................................................................................................ 28 
Table 2.5 Media and reagents used in bacterial identification ......................... 31 
Table 2.6 Bacterial identification techniques for E. coli and P. Mirabilis.   ....... 33 
Table 2.7 Primer Parameters .......................................................................... 54 
Table 2.8 PCR reaction mix components ........................................................ 56 
Table 2.9 Thermocycling PCR conditions for gradient PCR ............................ 56 
Table 2.10 Thermocycling conditions for PCR reactions ................................. 57 
Table 2.11 Buffers used for agarose gel electrophoresis  ............................... 58 
Table 3.1 Constituents of semi-solid MH agar ................................................. 72 
Table 3.2 M9 salt composition ......................................................................... 73 
Table 3.3 M9 minimal media composition ....................................................... 74 
Table 3.4 Semi-solid MH agar composition for the triphasic plate  
experiments ..................................................................................................... 76 
Table 3.5 Motility media components .............................................................. 83 
Table 3.6 Primer sequences used in the genomic analysis of bacterial  
motility  ............................................................................................................ 84 
Table 3.7 PCR reaction mix for the bacterial motility PCR reactions ............... 85 
Table 3.8 Thermocycling conditions used for the bacterial motility PCR  
  reactions ........................................................................................................ 85 
Table 3.9 EUCAST susceptibility breakpoint guidelines .................................. 93 
Table 3.10 Zone diameter breakpoints ............................................................ 93 
Table 3.11 The filter tip experimental results ................................................... 99 
Table 3.12 The quantification of the filter tip experiment ................................. 100 
Table 3.13 Gentamicin components and fragmentation for LC-MS ................. 112 
Table 3.14 LC-MS tabular output for a series of gentamicin agar extractions . 113 
Table 3.15 LC-MS tabular output of the 4mg/L gentamicin extract ................. 115 
  
 
 xxxi 
Table 3.16 LC-MS tabular output of the 8mg/L gentamicin extract ................. 116 
Table 3.17 LC-MS tabular output of the 10mg/L gentamicin extract ............... 116 
Table 3.18 LC-MS tabular output of the 20mg/L gentamicin extract ............... 117 
Table 3.19 LC-MS tabular output of the 40mg/L gentamicin extract ............... 118 
Table 4.1 Paired sequence read summary of the sensitive and resistant  
  E. coli MG1655 genomes .............................................................................. 144 
Table 4.2 Mauve node SNP summary............................................................. 167 
Table 4.3 The non-identical proteins within the proteome of the sensitive strain  
  of E. coli MG1655 .......................................................................................... 174 
Table 4.4 The non-identical proteins within the proteome of the resistant strain  
  of E. coli MG1655 .......................................................................................... 175 
Table 4.5 CD-HIT proteome analysis of the E. coli MG1655 sensitive vs  
  resistant swap ............................................................................................... 177 
Table 4.6 CD-HIT proteome analysis of the E. coli MG1655 resistant vs  
  sensitive swap ............................................................................................... 178 
Table 4.7 E. coli MG1655 sensitive proteome contaminants ........................... 179 
Table 4.8 E. coli MG1655 resistant proteome contaminants ........................... 180 
Table 4.9 Molecular functions of the novel proteins identified in the E. coli  
  MG1655 sensitive strain ................................................................................ 181 
Table 4.10 Molecular functions of the novel proteins identified in the E. coli  
  MG1655 resistant strain ................................................................................ 182 
Table 4.11 The sensitive and resistant E. coli MG1655 proteins containing  
  SNPs ............................................................................................................. 184 
Table 5.1 Primers used for the confirmatory PCR amplification of the  
  evolved gentamicin resistance genes............................................................ 200 
Table 5.2 Analysis of the E. coli strains which clustered with the  
  gentamicin resistant rna123 isolate ............................................................... 219 
Table 6.1 The 30s-ribsomomal subunit protein S12 grid box parameters for  
  the single molecular docking analysis ........................................................... 261 
Table 6.2 The 70s pre-ribosomal complex grid box parameters for the  
  molecular docking analysis ........................................................................... 269 
  
 
 xxxii 
Table 7.1 JModelTest2 model selection summary for the fusA nucleotide  
  sequence data within Enterobacteriaceae family .......................................... 300 
Table 7.2 JModelTest2 model selection summary for the fusA nucleotide  
  sequence data within distinct clades of the Enterobacteriaceae family ......... 301 
Table 8.1 TECAN Infinite M200 Pro plate reader conditions ........................... 316 
Table A.1 MAUVE SNP export ........................................................................ 392 
Table A.2 CD-Hit export non-identical proteins in the sensitive strain ............. 399 
Table A.3 CD-Hit export non-identical proteins in the resistant strain ............. 402 
 
 
  
  
 
 xxxiii 
Abstract  
The increasing threat of an antimicrobial resistance crisis is a significant global 
concern. Antimicrobial treatment failures are worsened by the rapid evolution of 
resistance amongst bacterial pathogens. Therefore, in addition to developing novel 
antimicrobial agents, there is growing interest in exploring the underlying genotypic 
factors of resistance evolution.  Traditionally, such studies have focused heavily on 
well-established mechanisms of acquired resistance involving horizontal gene 
transfer, yet the evolution of resistance through the acquisitions of mutations is yet to 
be fully elucidated.  
 
Adaptive laboratory evolution studies have provided insights into the genetic basis of 
adaptation through the direct observation of the evolutionary process. Experimental 
evolution has advanced from serial passage in well mixed systems to the 
incorporation of spatiotemporal antibiotic concentration gradients. During this study 
the Antibiotic Resistance Growth Plate (ARGP) was developed as a simple 
experimental tool to explore the ability of bacteria to evolve resistance across an 
antibiotic landscape. The device (90mm × 15mm) facilitates the direct observation of 
the evolutionary trajectories of mutational lineages within a circular format supporting 
the radial growth and the exploration of phenotypic space within bacterial populations. 
Whole genome sequencing of the evolved resistant strains, identified key mutations in 
the 16s rRNA genes and the fusA gene encoding elongation factor-G, specific to 
antimicrobial agent gentamicin. Additional gene sequencing revealed parallel 
gentamicin resistant bacterial populations, evolved identical mutations within the fusA 
gene. Combined bioinformatic, phylogenetic and molecular docking analysis 
  
 
 xxxiv 
uncovered the biological significance of the fusA gene in the mutational pathways of 
gentamicin resistance in E. coli MG1655 in vitro. In contrast, the observed biological   
fitness costs associated with the acquisition of resistance conferring mutations, 
emphasised why such costly resistant genotypes were unidentified in natural and 
clinical settings.  
 
This study has established an experimental evolution model to explore the mutational 
pathways underlying antimicrobial resistance development in vitro.  The ARGP offers 
a platform for the continued research into the acquisition of antimicrobial resistance 
through mutations, for more complex bacterial pathogens selected against a range of 
antimicrobial agents.  As a tool, the ARGP can be utilised to inform therapeutic 
decisions based on the evolutionary risk management, provide new opportunities 
within the field of drug development and holds scope for its application within an 
educational setting.  
  
 
 
1 
Chapter 1: General Introduction  
1.1 Antimicrobial resistance  
The development of antimicrobial agents was an eminent discovery of the last 
century; as their introduction saw a drastic reduction in morbidity and mortality 
(Davies, 2006). However, the rapid emergence of single and multi-drug-resistant 
bacterial strains has diminished our repertoire of effective antimicrobial agents 
available (Davies and Davies, 2010). Antimicrobial chemotherapy acts as a selective 
pressure driving the development of resistance, however preceding the therapeutic 
use of Penicillin, an enzyme capable of destroying it was identified (Abraham and 
Chain, 1940; Aminov, 2010). Following the widespread therapeutic application of 
penicillin, resistant strains of Staphylococcus aureus began to disseminate, not 
dissimilar to the heightened situation seen today (Lowy, 2003; Foster, 2017). The 
inevitable trend of antimicrobial discovery, and concomitant resistance development 
has caused an antimicrobial discovery void, where despite the alarming rates of 
resistance development, no novel classes of antimicrobial agents have been 
discovered (Payne et al., 2007; Silver, 2011; Brown, 2015).  
 
1.1.1 The antimicrobial resistance threat  
To appreciate the magnitude of the problem in regards to human health, in the year 
2015, the European Antimicrobial Resistance Surveillance Network (EARS-Net) 
estimated that, 33,110 deaths were attributable to antibiotic resistant infections 
(Cassini et al., 2019). Two years previous, the United States Centers for Disease 
Control and Prevention (CDC) projected that 2 million people developed drug 
resistant infections, which were expected to account for a minimum of 23,000 deaths 
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per year (CDC, 2013). Despite this, there are major inconsistencies in the global 
surveillance and reporting of antimicrobial resistant infections (Felmingham, 2002). 
Therefore, the extent of this global issue is likely to be more serious than the available 
data suggests (World Health Organisation, 2014). In fact, a review commissioned by 
the UK government on antimicrobial resistance, revealed that based on current trends 
the annual deaths caused by antimicrobial resistant infections could increase to 10 
million per year by 2050 (O’Neil, 2016).  
 
1.1.2 Antimicrobial resistance: a one health perspective 
The extensive misuse of antimicrobial agents in the environment, human medicine 
and animal husbandry is a predominant cause of the global rise of antimicrobial 
resistance (AMR) (Hollis and Ahmed, 2013). The concept of ‘One Health’ accurately 
portrays the issue of AMR, as it refers to the ecological relationships between human, 
animal and environmental health (American Veterinary Medical Association, 2008; 
Robinson et al., 2016). Therefore, tackling the multisectoral issue of AMR, requires 
interdisciplinary collaboration across a range of sectors including; human, animal, 
food, agriculture and pharmaceutics (Singh, 2017; WHO, 2018). This was 
acknowledged by the G20 health ministers in Berlin, who declared a commitment to 
develop future AMR actions plans, based on a one health approach (G20 Health 
Ministers Declaration, 2017).  
 
 
 
 
  
 
 
3 
1.1.3 Mechanisms of antimicrobial resistance  
Antimicrobial agents are characterised based on their mechanisms of action and 
exert their activity through the disruption of cellular processes or functions essential to 
bacterial cell growth (bacteriostatic antibiotics) or viability (bactericidal antibiotics) 
(Walsh, 2003).  The principal mechanisms of action include: inhibition of cell wall 
synthesis by -lactam antibiotics (Tomasz, 1979), interference of deoxyribonucleic 
acid (DNA) synthesis through double stranded DNA breaks by quinolones (Drlica et 
al., 2008), inhibition of ribosomal protein synthesis by a variety of antimicrobial agents 
including the aminoglycosides (Vakulenko and Mobashery, 2003) and the inhibition of 
metabolic pathways including folate synthesis by sulfonamides (Miller, Doukas and 
Seydel, 1972; Tenover, 2006). The antimicrobial mechanisms and drug-target 
interactions have been extensively reviewed by Kohanski, Dyer and Collins (2010). 
Microbial resistance has emerged through an abundance of mechanisms to 
overcome the antimicrobial actions of the various classes of antibiotics including; drug 
target modification, enzymatic modification, enzymatic degradation and active drug 
efflux (Wright, 2011), as illustrated in Figure (1.1).  
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Figure 1.1 Bacterial antimicrobial resistance strategies. The image displays some 
of the prevalent mechanisms utilised by bacteria to overcome antimicrobial selective 
pressures. Examples include: enzymatic inactivation, altered drug uptake, target 
modification and active drug efflux. Other mechanisms including target 
overproduction, target mimicry and enzymatic bypass of drug inhibition pathways 
have not been included in this image.  
 
 
1.1.3.1 Intrinsic mechanisms of antimicrobial resistance  
Intrinsic resistance indicates bacterial species which are inherently resistant to a 
variety of classes of antibiotics, independent of the antimicrobial selective pressure, 
this mechanism of resistance has been reviewed extensively by Cox and Wright 
(2013).  Intrinsic resistance is a growing concern in both clinical and environmental 
environments, owed to the prevalence of intrinsic resistance within multi-drug 
resistant (MDR) Gram-negative pathogens, and the abundance of intrinsically 
resistant organisms being isolated from soil samples (Nikaido, 1994; D’Costa et al., 
2006).  This has motivated efforts to inhibit the key targets of the intrinsic resistome, 
to impart antimicrobial sensitivity on inherently resistant microorganisms (Liu et al., 
2010).  
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1.1.3.2 Acquired mechanisms of antimicrobial resistance 
Antimicrobial resistance can be acquired by previously susceptible bacteria, through 
the horizontal acquisition of genetic material, referred to as horizontal gene transfer 
(HGT) (Davies, 1997). There are three mechanisms which facilitate HGT, which 
include: transduction, natural transformation and conjugation (Blakely, 2015; Sun, 
2018). Extracellular mobile genetic elements (MGEs) including integrons and 
transposons promote HGT by natural transformation (Domingues, Nielsen and da 
Silva, 2012).  Whereas, plasmids and bacteriophages which are widespread amongst 
bacterial populations, assist the process of HGT by conjugation and transduction 
respectively (Harrison et al., 2015; Lerminiaux and Cameron, 2018). As HGT can 
occur between closely related and phenotypically diverse organisms, HGT is widely 
considered as the mechanism accountable for the global dissemination of resistance 
genes (Wiedenbeck and Cohan, 2011; Johnston et al., 2014; von Wintersdorff et al., 
2016; Lerminiaux and Cameron, 2018).  
 
1.1.3.3 Acquired antimicrobial resistance through mutations  
In addition to the horizontal acquisition of resistance, bacteria can acquire resistance 
through spontaneous chromosomal mutations referred to as vertical evolution 
(Martinez and Baquero, 2000). The chromosomal resistance conferring mutations 
typically emerge within antimicrobial targets (Spratt, 1994). Although uncommon, a 
single mutation in a bacterial genome can significantly alter the susceptibility of an 
organism to antimicrobial agents, as demonstrated by the spontaneous mutations 
conferring clarithromycin resistance in Helicobacter pylori, rifampin resistance in 
Staphylococcus aureus and fluoroquinolone resistance in Campylobacter jejuni 
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(Aubry-Damon, Soussy and Courvalin, 1998; Engberg et al., 2001; Wang et al., 
2001). Nevertheless, the development of high levels of antimicrobial resistance, in the 
absence of plasmids, has been directly linked to a stepwise accumulation of multiple 
resistance conferring mutations (Levy and Marshall, 2004; Lozovsky et al., 2009).  
While advancements in laboratory evolution experiments, have suggested that the 
distinctive stepwise trend in mutational trajectories is highly dependent on the 
antimicrobial class (Toprak et al., 2011).  
 
To study the evolution of bacterial genomes through mutations, it is necessary to 
understand the determinants of spontaneous mutations. The greatest source of 
genetic variation within prokaryotic genomes occurs through DNA polymerase errors 
and through endogenous and exogenous DNA damage (Foster et al., 2015). 
Spontaneous mutation rates in the absence of exogenous DNA damaging agents 
such as antibiotics, can vary significantly between bacterial genomes (Drake et al., 
1998; Rosche and Foster, 2000).  The spontaneous mutation rates in the bacterium 
E. coli is estimated to be 1.0 x 10-3 per genome per generation; with a generation time 
of twenty minutes (Lee et al., 2012).  Antimicrobial agents are known to accelerate 
mutation rates in bacterial populations, however evolved mutations can have varying 
impacts depending on whether they are deleterious, neutral or beneficial to the 
organism (Denamur and Matic, 2006; Long et al., 2016). Therefore, it is unsurprising 
that bacterial hypermutators, which display elevated mutation rates have an 
increased frequency of resistance conferring mutations (Giraud et al., 2001). 
Typically, adaptive evolution is determined using likelihood estimates of non-
synonymous and synonymous substitution rates (dN/dS), however when very few 
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mutations are present in a small number of genes, the likelihood approach lacks 
statistical power (Yang and Nielsen, 1998).  Thus, in such cases, adaptive evolution 
is confirmed through sequencing parallel evolved bacterial strains for the existence of 
adaptive mutations (Palmer and Kishony, 2013). Sequentially, the functional impacts 
of the identified resistance conferring mutations are assessed based on positional 
conservation within the mutated gene, and any significant alterations in protein 
properties, structure and function (Toprak et al., 2011; Stucki and Gagneux, 2013; 
Baym et al., 2016b).  
 
1.1.4 The significance of Gram-negative bacteria  
The bacterial cell envelope differentiates Gram-positive and Gram-negative bacterial 
species (Gram, 1884). A unique feature of Gram-negative bacteria is the outer 
membrane, which decreases the permeability of the bacterial cell and is considered a 
causative factor of intrinsic bacterial resistance (Silhavy, Kahne and Walker, 2010). 
The outer membrane barrier is amongst several factors that has contributed to the 
lack of progress in the development of new antimicrobial agents effective against 
Gram-negative pathogens (Vaara, 1992; Livermore, 2011). This is of great concern, 
owing to the drastic increase in multidrug-resistant Gram-negative bacterial infections 
(Worthington and Melander, 2013; Exner et al., 2017).  As a result, previously 
withdrawn antimicrobial agents including the polymyxin colistin have re-emerged as 
therapeutic options (Stein and Raoult, 2002; Ouderkirk et al., 2003; Falagas and 
Kasiakou, 2005).  
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The Gram-negative, Enterobacteriaceae family, pose a significant threat as in 
addition, to the multi-drug resistance described above, enteric bacteria are emerging 
with extremely drug-resistant (XDR) and totally drug-resistant phenotypes (TDR) 
(Rossolini et al., 2014).  The prevalence of highly resistant phenotypes amongst 
Gram-negative bacteria including, Klebsiella pneumoniae, Pseudomonas aeruginosa 
and Enterobacter spp. is extremely alarming as these bacteria form part of the 
ESKAPE pathogens which are the leading cause of nosocomial infections worldwide 
(Pendleton, Gorman and Gilmore, 2013; Santajit and Indrawattana, 2016). The 
emergence of Carbapenem-resistant Enterobacteriaceae (CRE) presents a major 
public health crisis, as Carbapenemase producing Enterobacteria (CPE) infections 
are associated with mortality rates as high as 70% and almost all CPE infections are 
of the XDR phenotype (Tzouvelekis et al., 2012). The rapid evolution and 
dissemination of CPE, caused an international epidemic of colistin resistant Klebsiella 
pneumoniae carbapenemase (KPC) producing K. pneumoniae of the ST258 clonal 
lineage (Kitchel et al., 2009; Samuelsen et al., 2009; Bogdanovich et al., 2011).    
1.1.4.1 Escherichia coli and its application as a model organism  
Escherichia coli (E. coli) is a Gram-negative, rod-shaped bacterium, of the 
Enterobacteriaceae family (Li et al., 2013; Croxen et al., 2013).  The facultative 
anaerobe, is found commonly within the mammalian gastrointestinal tract, where it 
typically constitutes between 0.1%-5% of the gut microflora (Conway, Krogfelt and 
Cohen, 2004; Tenaillon et al., 2010; Conway and Cohen, 2015).  While commensal 
strains of E. coli are considered beneficial and generally harmless, pathogenic strains 
of E. coli contribute significantly to global morbidity and mortality (Moal Lievin-Le and 
Servin, 2006; Khalil et al., 2018). The pathogenic strains of E. coli are 
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phylogenetically diverse, and can cause a variety of enteric and extraintestinal 
infections in humans, which vary according to their pathogenicity profile or pathotype 
(Duriez et al., 2001; Kaper, Nataro and Mobley, 2004; Croxen and Finlay, 2009; 
Clements et al., 2012). The extraintestinal pathogenic E. coli (ExPEC), are the most 
frequently detected Gram-negative pathogens, and are associated with 
uropathogenic infections, systemic infections including septicaemia and neonatal 
meningitis (Johnson and Russo, 2002; Russo, and Johnson, 2003; Johnson et al., 
2003).  
 
Antimicrobial resistance in E. coli is a growing public health concern (Schwaber et al., 
2006). The management of hospital-acquired and community-onset ExPEC infections 
by -lactam antibiotics, has been compromised by the production of extended-
spectrum beta-lactamases (ESBLs) within the Enterobacteriaceae family (Livermore 
and Woodford, 2006; Pitout and Laupland, 2008). The widespread increase in CTX-M 
ESBL producing isolates of E. coli, is of major global concern seeing the CTX-M 
pandemic and the association of such strains with increased resistance to multiple 
classes of antibiotics (Canton and Coque, 2006; Pitout 2012; Woerther et al., 2013). 
The global dissemination of the CTX-M genotypes is displayed in figure (1.2) 
(Hawkey and Jones, 2009).  
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Figure 1.2 Global epidemiology of the CTX-M genotypes. The image displays the 
geographical locations of the most frequently isolated CTX-M genotypes worldwide. 
The CTX-M enzymes isolated from faecal samples are indicated using a star. 
Adapted from: Hawkey and Jones, 2009.  
 
Since the discovery of the bacterium in 1885, E. coli has become one of the most 
comprehensively studied bacterial species (Escherich, 1988). This was enhanced, 
through the completion of the K-12 MG1655 strain whole genome sequence, which 
led to prominent discoveries in genetic recombination (Lederberg and Tatum, 1946; 
Blattner et al., 1997; Riley et al., 2006). Subsequently, the E. coli K-12 MG1655 strain 
was adopted widely as the wild-type (WT) in laboratory experiments, and became the 
favoured bacterial model organism in experimental evolution studies (Kawecki et al., 
2012; Blount, 2015).  Consequently, the E. coli strain K-12 MG1655 was selected as 
the principle organism within this thesis.  
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1.1.4.2 The importance of aminoglycoside antibiotics  
The first aminoglycoside antibiotic discovered, was streptomycin, from Streptomyces 
griseus, in 1944 (Schatz, Bugle and Waksman, 1944). The aminoglycoside antibiotics 
were originally referred to as aminoglycosidic aminocyclitols, as they are 
characterised by amino sugars attached to an aminocyclitol by glycosidic linkages 
(Begg and Barclay, 1995). Aminoglycosides exert their antimicrobial activity through 
binding to the bacterial ribosome and inhibiting ribosomal protein synthesis 
(Vakulenko and Mobashery, 2003).  Additionally, they express synergistic bactericidal 
activity when in combination with antibiotics which inhibit cell wall synthesis (Iannini, 
Ehret and Eickhoff, 1976; Calderwood et al., 1977). Aminoglycosides have broad-
spectrum activity against a range of clinically significant bacterial pathogens including 
members of the Enterobacteriaceae family, P. aeruginosa and Mycobacterium spp. 
(Swenson et al., 1985; Aggen et al., 2010; Krause et al., 2016).  
 
The most recurrently administered aminoglycoside is gentamicin, which was derived 
from Micromonospora purpurea, in 1963 (Weinstein et al., 1963) and is used widely in 
the empirical treatment of severe Gram-negative pathogens within neonatal 
departments (Kumana and Yuen, 1994; Germovsek, Barker and Sharland, 2016). 
The therapeutic application of aminoglycosides within clinical practice, is heavily 
compromised by the development of aminoglycoside resistance (Garneau-Tsodikova 
and Labby, 2016; Doi, Wachino and Arakawa, 2016). This is worsened by the diverse 
mechanisms of resistance to aminoglycosides, which comprise: enzymatic drug 
modification through aminoglycoside-modifying enzymes (AMEs) including 
aminoglycoside N-acetyltransferases (AACs) (Ramirez and Tolmasky, 2010), active 
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efflux primarily through the multidrug transporter AcrAD, of the resistance-nodulation- 
division (RND) family of efflux pumps (Nikaido,1996), decreased permeability through  
modifications in the barrier properties of the bacterial outer membrane (Hancock, 
1981) and ribosomal/target site modification which could be enzymatic or mutational 
(Mingeot-Leclercq, Glupczynski and Tulkens 1999; Vakulenko and Mobashery, 2003; 
Krause et al., 2016; Doi, Wachino and Arakawa, 2017).  Consequently, the 
aminoglycoside gentamicin was the most extensively utilised antimicrobial agent 
within this thesis.  
 
1.2 The history of microbial culture methods  
Traditional bacterial culture methods were based on elective enrichment whereby 
favourable conditions were established to encourage the identification of naturally 
occurring organisms (van Niel, 1944).  Subsequent developments in bacterial 
cultivation methods, saw the introduction of selective enrichment techniques, 
including replica plating, where precise organisms were selected based on adaptive 
changes under specified conditions (Lederberg and Lederberg, 1952; Lagier et al., 
2015).  This direct method of selection, was used to demonstrate the development of 
resistance mutants to increased concentrations of penicillin (Eagle, Fleischman and 
Levy, 1951). 
 
1.2.1 The application of adaptive laboratory evolution (ALE) in microbiology  
Bacterial selection experiments, prompted the use of microorganisms in ecological 
studies of the evolutionary process of natural selection (Dykhuizen, 1990). 
Historically, this was inferred through the analysis of evolutionary outcomes, in 
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multicellular eukaryotic organisms (Darwin, 1859). Microorganisms are well-suited 
within this field, as the rapid-generation times allows researchers to explore evolution 
in action (Elena and Lenski, 2003).  This stimulated long-term evolution experiments 
investigating the phenotypic adaptations of bacterial populations over an infinite 
number of generations (Lenski, 2004; Barrick et al., 2009).  The recent advancements 
in genomic technologies have transformed the field of laboratory evolution, as 
bacterial populations can be comparatively monitored in highly controlled 
environments to decipher the genetic basis of adaptation (Herring et al., 2006; 
Hegreness and Kishony, 2007).  Despite the genomic technologies in place, the 
application of evolutionary studies within the field of microbiology has been limited 
due to the lack of experimental approaches available.   
 
1.2.2 Experimental approaches in the study of antimicrobial resistance  
The study of resistance traditionally relied upon the application of strong selective 
pressures, to determine bacterial survival under fixed antibiotic concentrations 
(Pankey and Sabath, 2004; Michel et al., 2008).  The study of drug resistance by agar 
selection or disc diffusion has permitted the selection of single step resistant 
mutations with large phenotypic effects (Palmer and Kishony, 2013). 
The implementation of laboratory evolution within this field, has provided valuable 
insights into the genetic mutations underpinning resistance development (Demerec, 
1945; Albert et al., 2005; Friedman, Alder and Silverman, 2006; Lee et al., 2010). 
These experiments typically utilised the Mutant Selection Window (MSW), which is 
relatively passive and excludes the multiple mutations which appear under sustained 
drug selection (Dong et al., 1999; Drlica, 2003; Toprak et al., 2013).  Whereby, when 
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a resistant mutation appears within a population, the selected antimicrobial 
concentration is no longer providing the selective pressures required to allow mutants 
to evolve higher levels of resistance (Toprak et al., 2013).  In addition, ALE 
experiments using serial passage, frequently include bottlenecks, which severely 
affect the evolutionary dynamics of bacterial populations (Wahl, Gerrish and Saika-
Voivod, 2002; Barrick and Lenski, 2013).  
To explore the multi-step evolution of antibiotic resistance, ALE experiments were 
adapted to incorporate continuous culture and spatial gradients (Palmer and Kishony, 
2013).  Continuous culture devices include, chemostats, which facilitate the external 
control of batch cultures, through the fixed addition of increased concentrations of 
antibiotics, to maintain the selective pressures on evolving bacterial populations 
(Dykhuizen and Hartl, 1983; Gresham and Hong, 2015).  The morbidostat developed 
by Toprak et al. (2013), is an innovative selection device, which regulates cell growth 
by automatically adjusting antibiotic concentrations, in response to antibiotic inhibition 
(Figure 1.3) (Toprak et al., 2013).  
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Figure 1.3 The Morbidostat algorithm. The process of bacterial growth inhibition of 
evolving bacterial populations within the morbidostat in response to resistance 
development through the external regulation of drug concentration. Image taken from: 
Toprak et al. (2013).  
 
In addition to continuous culture, selective pressures can be maintained in spatial 
gradients using microfluidic devices, which contain microenvironments of increased 
antibiotic concentrations (Zhang et al., 2011). Similarly, an experimental device 
known as the microbial evolution and growth arena (MEGA)-plate, permits the study 
of multi-step resistance evolution of distinct bacterial populations, using a highly 
structured spatiotemporal gradient of antibiotics (Figure 1.4) (Baym et al., 2016b).  
Although the laboratory evolution studies varied in experimental approach, the 
findings have suggested that the mutational pathways to antibiotic resistance are 
highly structured and reproducible (Zhang et al., 2011; Toprak et al., 2013; Baym et 
al., 2016b).  
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Figure 1.4 The MEGA-Plate experimental device. Displaying E. coli under 
trimethoprim selection over a period of 12-days, with time lapse imagining of the 
highlighted section. The coloured dots represent the sampling locations at given 
antimicrobial concentrations, connected by lines indicative of mutational ancestry. 
Image adapted from: Baym et al. (2016b). 
 
In modern medicine, combinational therapy has been highly effective, through 
employing various inhibition mechanisms, in the treatment of drug resistant infections 
(Rybak and McGrath, 1996).  Despite this success, the effects of chosen antibiotic 
combinations and their ensuing interactions on resistance evolution, remains unclear 
(Torella, Chait and Kishony, 2010).  ALE investigations into the cross resistance and 
epistatic interactions between synergistic and antagonistic drug pairs, revealed that 
for both E. coli and Staphylococcus aureus synergistic combinations which are 
preferred clinically, may favour resistance evolution (Michel et al., 2008; Hegreness et 
al., 2008).  Moreover, antagonistic interactions have been valued for their ability to 
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unfold biologically functions, and what holds even greater potential is their ability to 
offset the evolution of resistance (Yeh et al., 2010).  Further to combinational therapy, 
the intermittent rotation of drug treatments using alternative therapy, has been shown 
to constrain the evolution of resistance (Kim, Lieberman and Kishony, 2014). The 
findings from ALE experiments have challenged prescribing practices and have 
resulted in altered recommendations to slow resistance evolution (Jahn et al., 2017). 
1.2.3 The future of ALE Studies  
There is considerable debate regarding the translation of evolutionary findings from in 
vitro to in vivo, as the evolved mutations may differ when the host environment is 
accounted for (Yang et al., 2011).  The immune system plays an imperative role 
during antimicrobial therapy and it is sensed that in vitro ALE studies heavily 
underestimate the immune system involvement (Geli et al., 2012).  However, the 
advancements in Whole Genome Sequencing (WGS), have enabled researchers to 
monitor the genomic evolution of bacterial pathogens during endemic infections 
(Harris et al., 2010; Croucher et al., 2011; Kennemann et al., 2011).  A problem with 
this approach is that it becomes difficult to decipher the adaptive mutations, from 
neutral mutations which have been fixed within a population by genetic drift 
(Goodarzi, Hottes and Tavazoie, 2009).  To overcome this, comparative WGS has 
been combined with ALE experiments, to reveal the recurrent patterns of evolution 
implicated in resistance development in vivo, by sampling human subjects during 
infectious disease outbreaks and in the treatment of complicated bacterial infections 
(Mwangi et al., 2007; Howden et al., 2011; Lieberman et al., 2011; Comas et al., 
2012).  
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There are various challenges to modelling bacterial evolution in vivo (Metcalf et al., 
2015). The within-host interactions and increased bacterial genomic plasticity, can 
have considerable effects on bacterial adaptation (Geli et al., 2012; Woodcock et al., 
2017).  An in vivo study monitoring the genome evolution of a prototype 
asymptomatic bacteriuria (ABU) strain of E. coli following bladder colonisation, 
revealed the bacterial evolution was distinct for each subject, but followed key 
changes in genes involved in metabolism and virulence (Zdziarski et al., 2010). 
Studying the evolution of resistance in humans through the course of antimicrobial 
therapy, would provide invaluable information regarding the effects of host imprints on 
bacterial evolution, however ethical restrictions largely prevent such studies (Kouyos 
et al., 2014).  Moreover, there is a lack of a suitable animal model to explore the 
adaptive bacterial evolution in vivo (Giraud et al., 2001).  In antimalarial drug 
resistance studies, the Plasmodium chabaudi mouse malaria model, has provided 
valuable insights into the within host evolutionary dynamics during parasite co-
infection (Huijben et al., 2010). 
Mathematical models have played a crucial role in increasing our understanding of 
antimicrobial resistance (Opatowski et al., 2011).  One of the earliest models in this 
field was produced by Lipsitch and Levin (1997), which evaluated the bacterial 
population dynamics and the likelihood of resistance mutations arising during 
antibiotic treatment.  Since then, mathematical models have advanced significantly, 
and are now being used to investigate various aspects of AMR including: infection 
prevention and control, evolution, epidemiology and antimicrobial treatment protocols 
(Bonten, Austin and Lipsitch, 2001; Grundmann and Hellriegel, 2006; Consortium 
2007; Temime et al., 2008; Bonhoeffer, Liptsitch and Levin, 1997; D’Agata et al., 
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2007, 2008).  In the future, mathematical models could be combined with ALE, to 
interpret empirical laboratory observations and to assess how likely it is for a 
resistance mutation to occur, and whether the selected antimicrobial treatment 
regimen, minimises the risk of resistance evolution (Spicknall et al., 2013; Ankomah 
and Levin, 2014). 
1.3 Fitness costs associated with resistance development 
Antibiotic resistance is frequently associated with bacterial fitness costs (Vogwill and 
MacLean, 2015). These fitness costs frequently manifest as reductions in growth, 
virulence and competitiveness within environments free of antibiotics (Enne et al., 
2004; Binet and Maurelli, 2005; Johnson et al., 2005; Sjolund et al., 2005; Andersson, 
2006).  The antimicrobial fitness costs are central to the evolutionary dynamics of 
resistance, by contributing to the rate and spread of resistance in the presence of 
antibiotics, but also, the rate of clearance or persistence in their absence (Andersson 
and Levin, 1999).  Subsequently, fitness is used as a predictor of resistance 
development, as irrespective of rate, costly mutants will be selected against 
(Andersson, 2003). This was demonstrated in a study of rifampicin-resistance in 
Staphylococcus aureus, where the most frequently isolated resistant mutants in a 
clinical setting presented little or no fitness costs (O’Neil et al., 2006). Therefore, 
when utilising ALE models, it is necessary to define the genotypes underlying 
antimicrobial resistance development and measure the corresponding phenotypic 
effects on bacterial fitness (Andersson, 2006; Palmer and Kishony, 2013).  
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1.4 Phylogenetic interpretation of ALE findings  
Phylogenetic reconstruction can be performed alongside ALE studies, as the 
evolutionary history of a strain can provide valuable information regarding both the 
mutation and transmission events underlying resistance evolution (Baldauf, 2003; 
Palmer and Kishony, 2013). Traditionally in ALE the reoccurrence of a mutation in 
repeated experiments provides evidence of parallel evolution, however phylogenetics 
can be applied to determine strong signatures of adaptive evolution through the 
identification of mutations independently in related bacterial strains, this is referred to 
as evolutionary convergence (Didelot and Falush, 2007; Laehnemann et al., 2014).  
The phylogenetic differentiation of neutral mutations from true resistance conferring 
mutations, allows researchers to establish whether the identified laboratory evolved 
polymorphisms can be utilised as markers of antimicrobial resistance (Feuerriegel, 
Köser and Niemann, 2014).  
 
1.5 Treatment strategies informed by ALE  
The desired bacterial inhibitory effects of antimicrobial treatment routines are heavily 
compromised by the evolution of resistance, which has emphasised the requirement 
for techniques to control this evolutionary process (Baym, Stone and Kishony, 
2016a). ALE tools have provided great insights into the evolutionary dynamics of 
resistance during single, alternating and multi-drug environments, and have 
suggested the potential for the manipulation of these interactions to revert the 
evolution of resistance (Hegreness et al., 2008; Kim, Lieberman and Kishony, 2014; 
Baym, Stone and Kishony, 2016a). For this to be accomplished ALE must be coupled 
with WGS, to not only identify mutated genes which confer resistance, but to decipher 
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the adaptive mutational pathways to resistance for range of antimicrobial agents, 
independently and in combination (Jansen, Barbosa and Schulenburg, 2013; Palmer 
and Kishony, 2013). The simplest application of ALE models, is within diagnostic 
experimental evolution, where susceptible strains could be isolated from patients and 
evolved in real-time to predict the potential for resistance, and in cases where 
resistance has already emerged, ALE could inform treatment strategies which 
minimise subsequent evolution (Lieberman et al., 2011; Toprak et al., 2012; Palmer et 
al., 2015; Woods and Read, 2015). 
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1.6 Aims and objectives  
The prevalence of antimicrobial resistance is an ever-increasing global concern. 
Antimicrobial treatment failures are exacerbated by the rapid evolution of resistance 
amongst bacterial pathogens. Therefore, in addition to developing novel antimicrobial 
agents, there is increased interest in exploring the underlying genotypic and 
phenotypic factors of resistance evolution.  Several studies have suggested the 
potential of ALE, to uncover the adaptive mutational pathways to antimicrobial 
resistance.  ALE models can be used to monitor the evolutionary potential of bacterial 
strains, against a range of antimicrobial agents and inform therapeutic decisions 
based on evolutionary risk management.  In addition, the identification of underlying 
mutational mechanisms of resistance, will provide new opportunities for drug 
development.  The development of a simplified ALE approach, offers a unique 
opportunity for the application of such tools in scientific teaching laboratories to 
observe evolution in real-time.  
The aims of this study are:  
1. To develop a simplified ALE tool, to explore the evolution of antimicrobial 
resistance through mutations. 
2. Using comparative WGS, to identify SNPs associated with resistance 
development and through confirmatory PCR determine the reproducibility of 
the mutational pathways.  
3. Using bioinformatic analysis explore the functional impacts of the identified 
adaptive mutations and establish through molecular docking whether the 
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binding of antimicrobial agents to their given antimicrobial targets is disrupted.  
4. Explore the phylogeny of the mutated genes within the Enterobacteriaceae 
family and distinguish any signatures of convergent evolution.  
5. Determine the fitness costs associated with antimicrobial resistance 
development.  
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Chapter 2: Materials and methods  
2.1 Chemicals and reagents  
All chemicals and reagents used within the study were purchased from Sigma-
Aldrich, unless stated otherwise.  
 
2.2 Bacterial strains  
In this study, drug sensitive strains of E. coli (NCTC 11954) and Proteus mirabilis (P. 
mirabilis) (NCTC 13376) were used, as provided by Kingston University. The E. coli 
MG1655 strain was provided by Dr Nick Coldham from the Animal and Plant Health 
Agency (APHA). Motile clinical strains of E. coli and Enteropathogenic E. coli (EPEC) 
strains were kindly provided by Dr Philip Aldridge, Newcastle University (NU) and Dr 
Dan Brown, Imperial College London (ICL). Further Details of bacterial strains are 
provided in (Table 2.1).  
Table 2.1 Bacterial strains used within this study. Table showing the bacterial ID 
of the E. coli and P. mirabilis strains utilised within this study and information 
regarding the strain origin and source.  
 
Strain ID Strain Type Source 
Escherichia coli 11954 Laboratory Strain KU 
Proteus mirabilis 13376 Laboratory Strain KU 
Escherichia coli MG1655 Laboratory Strain APHA 
Escherichia coli UTI89 Clinical Strain Class 2 NU 
Escherichia coli CFT073 Clinical Strain Class 2 NU 
Escherichia coli TPA2743 Clinical Strain EPEC ICL 
Escherichia coli TPA4792 Clinical Strain EPEC ICL 
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2.3 Bacterial cultures and inoculum preparation  
Frozen stocks of P. mirabilis and E. coli were isolated and grown on brain heart 
infusion agar and were incubated overnight (O/N) aerobically at 37°C for 12 hours. To 
prepare the inoculum for use, the bacteria were suspended in phosphate buffered 
saline (PBS), to obtain a cell density equivalent to that of a 0.5 McFarland standard, 
with an approximate cell count of 1.50 x 108 colony forming units/mL (CFU/mL).  
Bacterial strains sourced from outside KU, were transported on Nutrient Agar Plates 
and upon arrival sub-cultured and incubated O/N aerobically at 37°C for 12 hours 
prior to cryopreservation (see below section 2.3.1). Details of the media utilised within 
this study are provided in table (2.2).  
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Table 2.2 Media used within this study. Table showing the media used within the 
study, their composition and the working concentrations of each component.  
 
Medium Composition Concentration (g/L) 
Mueller Hinton (MH) 
Agar  
Agar 
Beef Infusion Solids 
Casein Hydrolysate  
Starch  
17.0 
2.0 
17.5 
1.5  
Mueller Hinton Broth  Beef Infusion Solids 
Casein Hydrolysate 
Starch  
2.0 
17.5 
1.5 
M9 Minimal Medium  Na2HPO4 
KH2PO4 
NH4Cl 
NaCl  
D (+) -Glucose  
MgSO4 
CaCl2 
Thiamine  
33.9 
15.0 
5.0 
2.5 
4.0 (20mL of 20% 
Solution)  
0.2407 (2mL 1M Solution)  
0.011 (0.1mL 1M Solution) 
0.0005 (0.1mL 0.5% w/v 
Solution)  
M9 Minimal Medium 
Agar  
M9 Minimal Medium  
Bacteriological Agar 
 
30.0 
Motility Agar  
 
Pancreatic Digest of Casein 
NaCl 
Beef Extract 
Bacteriological Agar  
10.0 
5.0 
3.0 
4.0 
Motility Agar + 
Triphenyltetrazolium 
Chloride (TTC) 
Pancreatic Digest of Casein 
NaCl 
Beef Extract 
Bacteriological Agar 
TTC  
10.0 
5.0 
3.0 
4.0 
0.5 
Mueller Hinton Agar 
of Semi Solid 
Consistency (25%) 
Agar  
Beef Infusion Solids 
Casein Hydrolysate  
Starch 
4.25 
0.5 
4.375 
0.375 
Cysteine-Lactose-
Electrolyte Deficient 
(CLED) Agar  
Agar 
Beef Extract 
Bromo thymol blue 
Casein enzymatic hydrolysate 
L-cystine 
Lactose  
Peptic digest of animal tissue 
15.0 
3.0 
0.002 
4.0 
0.128 
10.0 
4.0 
Nutrient Agar  Agar  
Beef extract  
Peptic digest of animal tissue 
15.0 
3.0 
5.0 
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2.3.1 Preparation of bacterial stocks  
MicrobankTM vials (Pro-Lab diagnostics) facilitated the long-term storage and retrieval 
of bacterial cultures. For long term storage, bacterial strains were transferred to 
MicrobankTM vials and stored at -80°C.  E. coli strains were used to inoculate MH 
plates and were incubated at 37°C within a static incubator overnight for 18-24 hours. 
Single colonies of a pure culture were used to inoculate the cryopreservative fluid, to 
emulsify, the vial was then inverted 4-5 times and immediately stored at -80°C.  
 
2.3.2 Recovery of bacterial stocks  
The MicrobankTM vial containing the culture of interest was removed from storage at -
80°C. The cryovial was asceptically opened and using a sterile swab a sample of the 
culture was taken. The cryovial was then closed immediately and returned to storage 
at -80°C. The swab was then used to inoculate a fresh MH plate which was incubated 
at 37°C O/N aerobically within a static incubator. The culture was then passaged a 
further three times before being utilised within any experiment.  
 
2.4 Preparation of antimicrobial stock solutions 
The antimicrobial agents utilised within this study are detailed below (Table 2.3). 
Stock solutions of each antimicrobial agent were prepared as per Sigma Aldrich 
supplier guidelines. An example calculation used in the preparation of antimicrobial 
stock solutions is shown in table (2.4). 
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Table 2.3 Antimicrobial agents used within this study. Table showing the 
antimicrobial agents utilised within this study and information regarding the 
antimicrobial class and minimal inhibitory concentration.  
 
Antimicrobial Agent Class of Antimicrobial Minimal Inhibitory 
concentration (mg/L) 
 
Chloramphenicol Chloramphenicol 8 
Meropenem Carbapenem 2 
Trimethoprim Benzene and substituted 
derivative 
2 
Colistin Polypeptide 2 
Levofloxacin Quinolone 1 
Gentamicin Aminoglycoside 2 
 
 
Table 2.4 Calculation example for the preparation of antimicrobial stock 
solutions. Table showing an example calculation of the preparation of a 200mg/L 
trimethoprim stock solution.  
 
 
 
Antimicrobial Agent and Stock 
Concentration 
Stock Solution Calculation 
 
 
Trimethoprim  
(200mg/L) 
 
 
 
 
   
 
 
  
  
 
 
 
÷1000 
÷1000 
x10 
0.002g/mL 
0.0002g/mL 
0.20mg/mL 
200mg/L 
(Followed by a 1 in 10 dilution of the prepared solution) 
(X10 to allow a scalable reading on the weighing scales) 
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Once prepared, stock solutions were either stored at 4°C or -20°C in accordance to 
manufacturer guidelines. The required volume of antimicrobial stock solution to be 
added to the molten MH agar preparation was calculated using the formula 
C1V1=C2V2.   
 
2.4.1 Antibiotic sensitivity testing methods  
The first sensitivity test conducted was the disc diffusion method. MH plates were 
prepared and seeded with fresh cultures of both organisms with a cell density of 1.50 
x 108 CFU/mL. Commercially obtained discs with the standard concentration of each 
antimicrobial agent, were lightly pressed against the agar surface and incubated O/N 
aerobically at 37°C for 12 hours.  After incubation, the zones were measured and 
compared to the standard interpretation chart provided by the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST, 2018).  
To determine the minimum inhibitory concentration (MIC) the microbroth dilution 
method was conducted within a microtiter plate.  A total MH broth volume of 100µL 
was placed into used wells, with 200µL of the maximum concentration of antimicrobial 
agent placed into its corresponding well, to give a final concentration of 128mg/L. 
Subsequently, two-fold serial dilutions were performed to produce a series of 
concentrations of each given antimicrobial agent (0.25, 0.50, 1.0, 2.0, 4.0, 8.0, 16.0, 
32.0, 64.0 and 128mg/L).  MH broth containing no antibiotic was inoculated with the 
bacterial strains as the positive control and uninoculated MH broth as the   
negative control. The inoculum was prepared as stated above (2.3) and 100µL of 
each bacterium was added to the corresponding wells. The plates were then 
incubated aerobically at 37°C and the MIC was identified.  
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2.5 Characterisation of bacterial strains  
The initial confirmatory test for bacterial identification was a Gram-Stain.  This 
staining technique was used to differentiate between Gram-positive and Gram-
negative microorganisms and to provide further details regarding bacterial 
morphology (Gregersen, 1978). Here, bacterial colonies were heat fixed onto 
microscope slides followed by staining with a series of reagents using the traditional 
Gram-stain procedure outlined by Bartholomew and Mittwer (1952). All reagents were 
applied for a duration of one minute, excluding acetone which was left for ten 
seconds. Each stage of the staining process was followed by a wash step where 
slides were flooded with distilled water (dH2O). Subsequently, slides were blotted dry 
and analysed using light microscopy.   
 
In addition to the primary identification using the Gram procedure, differential tests 
were required to distinguish E. coli from P. mirabilis, and for the identification of 
potential contaminants.  Below is a description of the media and reagent components 
used for bacterial identification (Table 2.5). Details of the expected results are 
stipulated in table (2.6).  
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Table 2.5 Media and reagents used in bacterial identification. Table displaying 
the media and reagent components required for the bacterial identification tests 
utilised within this study.  
 
Bacterial 
Identification 
Test 
Reagents/Media Components 
Catalase Catalase Reagent Hydrogen Peroxide (H2O2) 
Oxidase Oxidase Reagent 0.01g Tetramethyl-p-phenylenediamine 
(TMPD) in aqueous dH2O 
Lactose 
Fermentation 
MacConkey Agar 17.0 g/L Peptone  
3.0g/L Proteose Peptone 
10.0g/L Lactose 
1.5g/L Bile Salts No. 3 5.0g/L Sodium 
Chloride (NaCl) 
13.5g/L Agar 
0.03g/L Neutral Red  
0.001g/L Crystal Violet 
Indole Test Tryptone Broth 
 
 
 
Kovacs Reagent 
10g Tryptone 
5g Sodium Chloride (NaCl) 
in aqueous dH2O 
 
150mL Amyl alcohol 
10g p-dimethylaminobenzaldehyde (DMAB) 
50mL Hydrogen Chloride (HCl) 
Urease test Urea Broth 9g/L Potassium dihydrogen orthophosphate 
(KH2PO4) 
0.100g/L Yeast Extract 
9.5g/L Anhydrous disodium hydrogen 
phosphate (Na2HPO4) 
20g/L Urea 
0.01g Phenol red 
 
2.5.1 Catalase test   
A catalase test is used predominantly in the identification of Enterobacteriaceae.  
Bacteria which possess the enzyme catalase can be identified using H2O2 and 
observing the formation of bubbles (Taylor and Achanzar, 1972). Bacterial colonies 
were transferred to a microscope slide using a sterile loop. A drop of 3% H2O2 was 
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added and apparent bubbling was indicative of a catalase positive organism.  
 
2.5.2 Oxidase test  
The oxidase test is a technique which works again through the identification of a 
bacterial enzyme, in this case Cytochrome C Oxidase which is essential during the 
final stage of aerobic respiration (Kovacs, 1956). The bacterial inoculum was obtained 
using Whatman filter paper, by scrapping bacterial colonies from a freshly prepared 
O/N culture. This was followed by the addition of a drop of 1% TMPD to the filter 
paper and the observation of a dark blue colour within ten seconds was indicative of 
an oxidase positive organism.    
 
2.5.3 Lactose fermentation  
Bacterial identification was also achieved using MacConkey agar which contains the 
pH indicator neutral red which turns red in acidic environments through lactose 
fermentation (MacConkey, 1905). Lactose fermenting organisms were identified as 
pink/red colonies on MacConkey agar following O/N aerobic incubation at 37°C for 12 
hours.  
 
2.5.4 Indole test  
Following the identification of lactose fermenting organisms on MacConkey agar.  
Gram-negative organisms were differentiated using an Indole test (Vracko and 
Sherris, 1963). Bacterial strains were inoculated in sterile tubes containing tryptone 
water and incubated O/N aerobically at 37°C for 12 hours. Following incubation, a 
drop of Kovac’s reagent was added (McWilliams, 2009). A positive result was indicted 
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by a red/pink alcohol layer on the surface of the solution.   
 
2.5.5 Urease test  
The final bacterial identification technique used within this study was the urease test, 
utilised explicitly for the identification of P. mirabilis (Christensen, 1946). Bacteria 
were inoculated in 10mL of urea broth containing the indicator phenol red and were 
incubated at 37°C. A positive result for Proteus spp. was identified by a rapid change 
in broth colour to bright pink, which can occur within 1-2 hours. 
 
Table 2.6 Bacterial identification techniques for E. coli and P. Mirabilis.  Table 
displaying the expected results from the bacterial identification tests to differentiate E. 
coli from P. mirabilis based upon several distinctive characteristics.   
 
 
Genotypic confirmation of bacterial strains was achieved through whole genome 
sequencing, discussed further in Chapter 3.  
 
 
 
Characteristic Escherichia coli Proteus mirabilis 
Gram  Negative Rod Negative Rod  
Catalase  Positive  Positive  
Oxidase  Negative  Negative  
Lactose  Positive  Negative  
Indole  Positive Negative 
Urease  Negative Positive  
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2.6 Enumeration of bacteria  
Bacterial enumeration was achieved through quantification using CFU/mL 
calculations. When enumeration was required, bacterial suspensions were transferred 
to a serial dilution plate containing PBS. Serial dilutions of the sample were prepared 
to produce a dilution series of 10-1 to 10-8.  Ten µL of diluted suspensions were then 
plated onto MH agar and incubated at 37°C O/N for 12 hours. Plates with dilutions 
containing 20-200 bacterial colonies were counted and the CFU/mL was determined 
using the formula: CFU/mL = (no. of colonies x dilution factor) x (1000 / volume plated 
on MH (µL)).  
 
2.7 Method development and optimisation  
2.7.1 Preliminary experiment: production of Bioplates  
The preliminary test was to devise a simple model, which allowed the study of the 
evolution of antimicrobial resistance under antimicrobial exposure. To do this, 
diphasic plates were produced by the insertion of Bioplates (see two prototypes with 
dimensions below figure 2.1).   
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Figure 2.1 Template of the prototype Bioplates. Figure displaying the “Overhang” 
and “Slip” Bioplate templates with dimensions.  
 
 
2.7.1.1 Preliminary diphasic plate experiment: MH agar 
Diphasic plates were produced by the sterile insertion of autoclaved Bioplates, the 
experiment was repeated to test both the overhang and slip Bioplates. MH agar was 
prepared and autoclaved at 121ºC at 115psi for 15 minutes. Bioplates were sealed 
into place using sterilised MH agar and allowed to set. The two phases contained 
non-antibiotic and antibiotic containing agar at MIC concentration. The antibiotic was 
added to the media post-sterilisation. Once the two phases were poured and set, the 
Bioplates were aseptically removed. The gap was then filled using sterile MH agar. 
The bacteria were inoculated onto the non-antibiotic phase as 3 separate 10µL  
drops. The diphasic plates were then incubated at 37 ºC over a period of 7 days 
(Figure 2.2). Control plates containing MH agar plus the MIC concentration of the 
selected antimicrobial agent were produced and incubated over the duration of the 
study, to test the effectiveness of the antimicrobial agent.  
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Figure 2.2 The preliminary diphasic plate layout. Diagram displaying the plate set-
up used in the production of the diphasic plate. Plates were divided using Bioplates to 
produce a gradient of antimicrobial agent. Plates were inoculated with three 10μL 
(1.50 x 108 CFU/mL) drops of drug sensitive bacterial suspensions on the phase 
containing no antimicrobial agent.  
 
 
2.7.2 Preliminary filter tip experiment  
The filter tip experimental method was produced to explore the flow of 
microorganisms through a controlled laboratory system, to study the evolution of 
antimicrobial resistance. The initial experiments were conducted primarily to see 
whether organisms could flow through the filter tip. 
 
To prepare for the preliminary filter tip experiment P1000 micropipette tips and filter 
tips were sterilised within glass petri dishes.  The filter tips were divided into two 
separate dishes representing the two different types of agar.  The P1000 
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micropipettes were removed asceptically from the glass petri dish and placed within a 
micropipette tip box.  Nutrient and MacConkey Agar was poured over the filter tips in 
their respective glass petri dishes and the agar was left to set. Following on from this, 
600μL of Nutrient agar was used to plug the base of the micropipette tip. Once the 
plugged agar had set, sterile forceps were used to transfer the filter tips containing 
MacConkey agar to the micropipette tip, followed by the placement of the Nutrient 
agar filter tips directly on top. The remaining gap was filled with Nutrient agar using a 
Pasteur pipette (Figure 2.3).  Bacterial suspensions were produced as described in 
(2.3), and 10μL (1.50 x 108 CFU/mL) of each suspension was used to inoculate the 
surface of tip via a stab culture. Micropipette tip boxes were then placed within a 
Tupperware box, which had been layered with a water covered absorbent pad. The 
lid of the box contained two 0.2μM filters, inserted to facilitate the passage of sterile 
air, the box was then placed in the static aerobic incubator at 37ºC and analysed daily 
for a period of 7 days. To confirm the presence of bacteria, filter tips were aseptically 
removed and dotted onto Nutrient and CLED agar. 
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Figure 2.3 The preliminary filter tip experiment with MacConkey agar. Diagram 
showing the set-up of the filter tip experiment with MacConkey agar. P1000 
micropipette tips were sealed with autoclave tape and sterilised. The micropipette tips 
were then plugged with Nutrient agar. Filter tips were covered in both MacConkey 
and Nutrient agar and allowed to solidify. The filter tips were then asceptically 
transferred to the micropipette tips. Nutrient agar was then used to fill the remainder 
of the micropipette tip.  The micropipette tip was then inoculated with 10μL (1.50 x 108 
CFU/mL) of bacterial suspension. 
 
2.7.2.1 Filter tip experiment  
The experiment described in (2.7.2) was repeated with the inclusion of MH agar. Here 
the filter tips were divided into two separate dishes representing the differing 
antimicrobial concentrations.  Agar containing both the MIC of the selected antibiotic 
and MH with no antibiotic was poured over the filter tips respectively. The P1000 
micropipette tips were plugged and any remaining gaps were filled with MH agar 
(Figure 2.4).  
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Figure 2.4 The modified filter tip experiment with antimicrobial agents. Diagram 
displaying the set-up of the filter tip experiment with antimicrobial agents. P1000 
micropipette tips were sealed with autoclave tape and sterilised. The micropipette tips 
were then plugged with MH agar. Filter tips were covered in both MH agar and MH 
agar plus antimicrobial agent and allowed to solidify. The filter tips were then 
asceptically transferred to the micropipette tips. MH agar was then used to fill the 
remainder of the micropipette tip. The micropipette tip was then inoculated with 10μL 
(1.50 x 108 CFU/mL) of drug sensitive bacterial suspension. 
 
 
 
Following incubation, daily triplicates were removed and analysed over a period of 
seven days. The analysis involved the aseptic removal of filter tips, the initial MH tip 
was discarded into a Virkon waste pot and the tip containing the antimicrobial agent 
and thus any potentially resistant organisms was plated onto MH agar plates of the 
selected antimicrobial concentration to maintain the selective pressure. After O/N 
incubation at 37ºC plates were analysed for growth, providing growth and 
confirmation of phenotypic resistance, isolates were cryopreserved.  
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2.7.3 Triphasic circle plate experiment  
To facilitate the radial growth of the organisms the triphasic circle plate method was 
developed. Here within a glass petri-dish using concentric rings of different sizes, a 
concentration gradient of three phases of antimicrobial agent was produced 
representing: zero, MIC and x10 MIC.  The bacteria were inoculated in the inner zone 
containing no antibiotic and plates were observed daily to see whether growth would 
proceed to the outer phases containing increasing concentrations of a selected 
antibiotic. To achieve this, a thin layer of Mueller Hinton agar was poured and two 
concentric rings were placed into the agar and allowed to set. Antimicrobial agents 
were added to the media once cooled and phases were poured from the inside out, 
with the final step being the removal of the rings. Plates were then inoculated with 
10μL of a 0.5 McFarland standard of bacteria (1.50 x 108 CFU/mL) as described in 
(2.3) (Figure 2.5). Control plates were produced using the antibiotic containing media 
used in the preparation of the triphasic circle plate, which were tested daily over the 
experimental course. When a potentially resistant organism arises, samples were 
taken and plated onto MH plates of the selective antibiotic concentration and 
cryopreserved once resistance had been confirmed.  
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Figure 2.5 The triphasic circle plate. Diagram displaying the triphasic circle plate 
set-up and the concentric rings used to produce the antibiotic phases. The concentric 
rings were added to the triphasic plate to produce a three-phase antimicrobial 
gradient raging from zero to x10 the MIC of a given antimicrobial agent. The triphasic 
circle plates were inoculated with a 10μL (1.50 x 108 CFU/mL) drop of a drug sensitive 
bacterial suspension in the central phase containing no antimicrobial agent.  
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2.7.4 Broth method serial passage  
 
Alongside the evolutionary experiments carried out using spatial temporal gradients, 
comparative experiments were conducted using serial passage. Here, MH broth was 
prepared and 4.5mL was transferred to wells of a 12-well Nunc Multidish 
(ThermoFisher Scientific) in triplicate, and plates were inoculated with 500μL of drug 
sensitive E. coli standardised to an OD600 of 0.5 OD units (1.50 x 108 CFU/mL). The 
plates were then covered with a breath-easier plate sealer and incubated aerobically 
O/N at 37ºC. Daily negative and positive controls were included, see plate set-up 
figure (2.6).  
Figure 2.6 The serial passage and antimicrobial control plate set-up. Diagram 
showing the set-up of the two plates utilised within the broth method. The serial 
passage plate contains three replicates of isogenic bacterial populations of either 
drug sensitive E. coli or P. mirabilis and a positive control containing MH broth. 
Bacterial populations were inoculated originally into MH broth containing no antibiotic, 
and following O/N growth 500µL of each culture was transferred to increased 
antimicrobial concentrations. The antimicrobial concentrations followed the sequential 
doubling of the MIC for a given antimicrobial agent. The antibiotic control plate 
provided the experimental negative control. Each antimicrobial broth concentration 
prepared was inoculated with the originally sensitive bacterial replicates and was 
monitored for growth following O/N incubation.  
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Providing growth following O/N incubation, MH broth was prepared with the addition 
of selected antimicrobial agents, the initial antimicrobial concentration was pre-
determined from the MIC microbroth dilution experiments described in section (2.4.1). 
Then 500µL of bacteria from the previous wells was serially transferred to the freshly 
prepared broth containing the MIC of the given antimicrobial. This passaging process 
was repeated every 24 hours with doubling antimicrobial concentrations. To confirm 
phenotypic resistance 10μL of daily broth cultures was transferred to MH agar plates 
of the selected antimicrobial concentration, and incubated O/N at 37ºC. Quantification 
was achieved by daily OD600 measurements and CFU/mL calculations.  
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2.8 Genome sequencing, assembly and alignment   
2.8.1 Whole genome sequencing at Microbes NG  
Whole genome sequencing was provided by Microbes NG 
(http://www.microbesng.uk) which is supported by the Biotechnology and Biological 
Sciences Research Council (BBSRC) (grant number BB/L024209/1). Strains for 
whole genome sequencing were placed into pre-barcoded bead tubes and were 
returned to Microbes NG sequencing facility at Birmingham University. Genomic DNA 
was extracted and purified before being transferred to a Hamilton Microlab STAR 
automated liquid handling systems for quantification using the Quantit dsDNA HS 
assay and genomic DNA library preparation using Nextera XT Library Prep Kit 
(Illumina, San Diego, USA). The pooled library DNA was then quantified prior to 
sequencing using the Kapa Biosystems Library Quantification Kit for Illumina on a 
Roche light cycle 96 qPCR machine (https://microbesng.uk/microbesng-faq/). Whole 
genome sequencing was carried out using Illumina HiSeq or MiSeq using 250bp 
paired end.  
 
Figure (2.7) displays the four main stages behind the chemistry of illumina 
sequencing. The initial sample preparation step involves the fragmentation of 
genomic DNA, followed by the addition of adapters and supplementary motifs which 
are then thermally amplified and transferred to a flow cell. The templates are then 
simultaneously amplified by bridge amplification to form clusters. Sequencing by 
synthesis follows with the addition of fluorescently tagged nucleotides (dNTPs) 
alongside revisable terminators. After the addition of each nucleotide the clusters are 
excited and the signal emitted determines the base called. The samples are then 
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clustered based on sequence similarity and forward and reverse sequences are 
paired to form contiguous sequences for bioinformatic analysis using an automated 
pipeline (Illumina, 2018).   
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Figure 2.7 Overview of Illumina Next-Generation Sequencing. The image displays 
the four steps of illumina sequencing: (A) Library Sample Preparation. Here the 
genomic DNA is fragmented and ligated using specialised adapters. (B) Cluster 
Generation. The library generated in step 1 is loaded onto a flow cell and the 
fragments and hybridized into clusters using bridge amplification. (C) Sequencing. 
Fluorescently labelled nucleotides are added and the emission wavelength and 
intensity from each cluster is recorded throughout the sequencing cycle. (D) Data 
Analysis. Reads are then aligned to a reference genome and analysed using various 
bioinformatics software. The illumina MiSeq and HiSeq Series platform images (D) 
were obtained from Illumina. (2018).   
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2.8.2 Whole genome assembly CLC  
Whole genome sequencing data retrieved from Microbes NG sequencing facility was 
analysed using CLC genomics workbench 7.7.5. Sequence data was imported into 
CLC in Genbank (. gbk) format and saved as DNA sequences. Quality reports were 
used to assess the quality of the sequences, and failed reads were removed 
accordingly. The remaining poor quality reads were trimmed based on quality (0.01), 
ambiguities (0) and length (<50) using the automated trimming tool to ensure 
consistency between sequences. After each stage during the whole genome 
assembly in CLC workbench a quality report was produced. Once sequences were 
refined to meet quality standards, sequence reads were assembled to the E. coli K-12 
MG1655 reference genome (NP_CP027060.1). The reference sequence was 
assembled in contigs, and sequences were analysed for SNP variation amongst 
closely related strains of bacteria. The workflow utilised during whole genome 
assembly within CLC genomics workbench is detailed in figure (2.8). 
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Figure 2.8 Whole genome assembly in CLC genomics workbench. Image 
detailing the workflow utilised to assembly the whole genome sequences obtained 
from microbes NG and the given parameters used during the quality control 
procedure.  
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2.8.3 Alignment of conserved genomic sequences with rearrangements using 
Mauve 
 
Genomes sequencing data retrieved from microbes MG sequencing facility was of 
draft quality and therefore it was necessary to reorder contigs prior to alignment. 
Reordering was achieved using a mauve algorithm known as Mauve Contig Mover 
(MCM), by ordering contigs from each genome independently to the E. coli K-12 
MG1655 reference genome and subsequently outputting multiple mauve alignments 
files reflecting stages within the reordering process (Rissman et al., 2009).  Genomes 
were aligned with progressive mauve under default parameters and visualised within 
the mauve alignment display. To identify the presence of single nucleotide 
polymorphisms on a genome-wide scale and to eliminate any uncertainty surrounding 
missed mutations using the antimicrobial target search approach within CLC 
workbench, the SNP export function within mauve was utilised. 
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2.9 Physiochemical analysis of mutagenesis  
2.9.1 RNA consensus secondary structure XRNA 
Initially to determine the generalised locality of all the mutations observed within two 
ribosomal ribonucleic acid (rRNA) variants, a consensus 16s RNA secondary 
structure was used to represent all seven rrn operons within E. coli. The XRNA java 
based suite version 1.2.0 (beta) was downloaded from 
http://rna.ucsc.edu/rnacenter/xrna/xrna.html [accessed July 17, 2018]. Following this 
the E. coli 16s.xrna secondary structure was exported 
http://rna.ucsc.edu/rnacenter/xrna/xrna_download.html [accessed July 18, 2018]. and 
viewed within xRNA. The 16s-secondary structure was then annotated to highlight the 
mutation positions and visualised in adobe illustrator version 22.1.0.  
2.9.2 RNA secondary structure analysis using RNAfold 
The folding of RNA molecules plays an important role in the determination of function 
(Mohsen et al., 2009). Thus, it was necessary to identify whether the observed rRNA 
mutagenesis resulted in alterations in rna secondary structure. RNAfold (Gruber et 
al., 2008 available at: http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi 
[accessed September 3, 2018] was used for the computational prediction and 
graphical representation of rRNA secondary structures.  Ribonucleic Acid (RNA) fold 
algorithmically predicts the optimal secondary structure based on the given nucleotide 
sequence using the dynamic programming technique (Lorenz et al., 2016). The rRNA 
sequences were uploaded independently to RNAfold in Fasta format and secondary 
structures prediction were calculated using default parameters.  Results including 
graphical outputs and predictions plots were downloaded from the RNAfold 
webserver.  Direct visual comparisons were then made between the Minimum Free 
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Energy (MFE) and Centroid structures produced for the seven E. coli rRNA variants 
between the sensitive and resistant strains.  
2.9.3 Phylogenetic analysis using MEGA 
The phylogenies of the fusA and ribosomal RNA nucleotide sequences were resolved 
by comparing the sensitive and resistant sequences of the experimental strains to 
that of the corresponding E. coli sequences collected from the National Centre for 
Biotechnology (NCBI) available at: https://blast.ncbi.nlm.nih.gov/Blast.cgi [accessed 
October 19, 2017]. The fasta aligned sequences were then imported into MEGA 
version 7.0 (Tamura et al., 2016), for the construction of Maximum Likelihood (ML) 
Trees. Once the sequences were uploaded into MEGA a local alignment was carried 
out using the integrated alignment tool; Multiple Sequence Comparison Log-
Expectation (MUSCLE) (Edgar, 2004).  Using the Molecular Evolutionary Genetics 
Analysis (MEGA) alignment explorer, sequences were analysed to determine the 
presence of incomplete genomic sequences and to identify sequences which required 
reverse complementation prior to tree construction. Sequences were then realigned 
prior to model selection analysis, to determine the best fit DNA model for the given 
sequence data set. Following model selection, ML trees were constructed with a 
bootstrap of 1000.  
 
2.9.4 EMBL SAPS protein structure analysis  
The computational analysis tool for the Statistical Analysis of Protein Sequences 
(SAPS) provided by the European Bioinformatics Institute (EMBL-EBI), was used to 
evaluate the protein sequences to determine any alterations in the functional 
properties of proteins relating specifically to the amino acid type and charge 
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distribution observed at the site of mutagenesis. This is achieved through the 
clustering of negative, positive and mixed charged clusters relative to the overall 
charge of the protein (Brendel et al., 1992). Protein sequences were uploaded into 
SAPS, E. coli K-12 was selected as the species and under defaults settings lysine 
and arginine was selected as positively charged prior to submission.  
 
2.9.5 TreeSAAP selection of amino acid properties  
To assess the effects of positive selection on the molecular evolutional of the 
functional domains of the fusA gene, it was necessary to determine any significant 
changes in the physiochemical properties of the amino acids within the protein 
Elongation Factor G. TreeSAAP (Woolley et al., 2003) was used to analyse 31 
structural and biochemical amino acid properties of Elongation Factor G from both the 
sensitive and resistant strains of E. coli. A prerequisite of TreeSAAP is the 
construction of a tree for phylogenetic analysis and this was achieved through the 
alignment of sequences followed by the production of a Neighbour joining (NJ) tree. 
As there was only a direct comparison being made between two sequence it was 
necessary to duplicate each sequence to avoid forcing tree topology. Input nucleotide 
sequences was compiled in NEXUS format and loaded into  
TreeSAAP for analysis. The number of magnitude categories was set to eight with a 
sliding window of 15 with a step of one as per developer guidelines. In addition, the 
bacterial genetic code 11 was selected.  The magnitude categories are hierarchical 
with the lowest category depicting non-synonymous mutations which conserve an 
amino acid property through to eight where the alteration causes a radical change in 
property (Datta et al., 2010).  Consequently, only highly significant results (p<0.001) 
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from categories six to eight were further analysed due to likely impact of the 
physiochemical change of an amino acid on protein function and thus could be 
associated to adaption. This value is determined by a goodness-of-fit score (GF-
score) and a series of z-scores where a higher score is reflective of the intensity of 
selection (McClellan and McCracken, 2001). An identical analysis was performed on 
all genes with non-synonymous mutations identified between the sensitive and 
resistant strains of E. coli MG1655.    
 
2.9.6 Homology modelling of protein structure using Swiss Model 
Protein modelling was initially carried out using Swiss-Model available at: 
https://swissmodel.expasy.org [accessed August 26, 2018] as its automated ease 
requires no user participation apart from the submission of an initial input sequence 
(Guex and Peitsch, 1997). Swiss Model enabled the modelling of the experimentally 
determined sensitive and resistant protein structures based on templates of known 
evolutionary related protein structures (Waterhouse et al., 2018). Fasta sequences 
were imported into Swiss Model and a subsequent search was carried out to identify 
a template, prior to modelling. Template results are ranked based on the expected 
model quality which is assessed by Global Model Quality Estimate (GMQE) and 
Quaternary Structure Quality Estimate (QSQE) scores. In addition to these two 
values, templates were selected based on their protein coverage and identity to the 
submitted sequences. The selected template was then used to build the protein 
models of protein sequences of interest. Once complete, the best quality models were 
chosen based on the Quality Model Energy Analysis (QMEAN) value which is a 
statistical potential score of the nativeness of structures centred around geometric 
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descriptors (Benkert et al., 2007). Resulting, Protein Data Bank (PDB) files and model 
reports were downloaded and protein homology was compared.  
 
2.10 Molecular genetics based on bioinformatics findings  
2.10.1 Primer design  
Primer sets specific to the intended fusA gene and ribosomal RNA targets were 
generated using Primer-Blast which employs both Primer3 and BLAST available at: 
https://www.ncbi.nlm.nih.gov/tools/primer-blast/ [accessed July 23, 2018] (Ye et al., 
2012). 
 
The PCR template was inputted as a DNA Sequence complied in FASTA format for 
the fusA gene and ribosomal RNA 123 and 154 respectively and the user adjustable 
parameters were modified accordingly indicated in table (2.7). To ensure the 
designed primers flanked the regions containing the SNPs, the sequence ranges 
were adapted.  
 
Table 2.7 Primer parameters. Table detailing the primer parameters selected within 
Primer-Blast specific to the PCR template.  
 
Primer Parameter  Selection  
Database  nr 
Organism  Escherichia (Taxid: 561)  
Max Tm difference  5 
Minimum primer melting temperature 50  
Optimum primer melting temperature 55 
Maximum primer melting temperature 60 
Max target size 4000 
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2.10.2 DNA extraction  
The bacterial DNA of E. coli MG1655 resistant and sensitive isolates was extracted 
through thermal lysis. Five individual colonies of overnight growth of gentamicin 
resistant and sensitive E. coli MG1655 were picked from MH agar plates. The 
individual colonies were transferred to sterile Eppendorf tubes containing 100μL of 
DNase/RNase free water, to obtain a suspension of bacterial cells approximately 1-2 
x 109 cells ml-1. The Eppendorf tubes were then placed in a heat block pre-set to 95C 
for 10 minutes lyse the bacterial cells. Following lysis, the extracted bacterial DNA 
was immediately cooled on ice before being processed by Polymerase Chain 
Reaction (PCR).  
 
2.10.3 Polymerase chain reaction  
PCR was performed on all DNA samples extracted using the thermal lysis technique 
described above. Using gene specific primers (table 5.1) generated using Primer-
Blast (Section 2.10.1), PCR reactions were conducted to amplify the specific gene 
sequences with the forward and reverse primer sets incorporating the mutated 
regions of the genes respectively.  Primarily, a gradient PCR reaction was carried out 
to determine the optimal annealing temperature for all three primer sets used in the 
PCR reaction. Two microliters of bacterial template DNA was transferred to PCR 
reaction tubes containing 23 microliters of pre-aliquoted PCR reaction mix. The PCR 
reaction mix components and the corresponding quantities used for all PCR reactions 
are presented in table (2.8). The thermocycling conditions and the resultant durations 
of the PCR steps are shown in table (2.9). Through use of the gradient function on the 
thermocycler, an annealing gradient of 52-57C was set. After identifying the optimal 
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annealing temperature, subsequent PCR reactions were conducted using conditions 
shown in table (2.10).  
 
Table 2.8 PCR reaction mix components.  Table displaying the PCR reaction mix 
components and the corresponding quantities and concentrations used.  
 
Component Volume 
(µL) 
Concentration 
Master Mix  
Dream Taq 
12.5 2X 
Forward primer 1.5 1 μM 
Backwards primer 1.5 1 μM 
Template DNA 2.0 ~100 ng 
Nuclease free water 7.5 - 
Total volume (µL) 25 - 
 
 
Table 2.9 Thermocycling PCR conditions for gradient PCR. Table displaying the 
thermocycling conditions used for all three primer sets in the initial gradient PCR 
reaction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step Temperature 
(°C) 
Time 
(mins) 
No. of 
Cycles 
Initial Denaturation 94 3.0 1 
Denaturation 95 0.5  
35 Annealing 52,53,54,55,56,57 0.5 
Extension 72 2.0 
Final Extension  72 10.0 1 
  
 
 
57 
Table 2.10 Thermocycling conditions for PCR reactions. Table displaying the 
thermocycling conditions used for all three primer sets, following the identification of 
the optimal annealing temperature using gradient PCR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step Temperature 
(°C) 
Time 
(mins) 
No. of 
Cycles 
Initial Denaturation 94 3.0 1 
Denaturation 95 0.5  
35 Annealing 54 0.5 
Extension 72 2.0 
Final Extension  72 10.0 1 
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2.10.4 Agarose gel electrophoresis  
Agarose gel electrophoresis was used to analyse the resultant PCR amplicons prior 
to sequencing.  All bacterial DNA and RNA samples were analysed on a 2% w/v Top 
Vision Agarose gel (Thermoscientific) with the addition of the nucleic acid stain Gel 
Red (Cambridge Bioscience) in 1 x Tris-Borate-EDTA (TBE) buffer (table 2.11). DNA 
gel loading dye (ThermoFisher) was added to each DNA sample for the visual 
tracking of samples within the gel during electrophoresis at a 1:5 ratio of loading dye 
to DNA. The DNA samples were then added to well of the agarose gel together with 
2kb hyper ladder 2 50bp-2kb (FisherScientific) as a marker of molecular weight. 
Agarose gels were run at 80v (BIO-RAD Power-Pac 300) for 45 minutes in a gel 
electrophoresis flow chamber (Flowgen) filled with 1x TBE as the running buffer. Gels 
were then visualised and imaged using the G: Box Chemi XRQ (Syngene) gel 
documentation imaging system. 
 
Table 2.11 Buffers used for agarose gel electrophoresis. Table showing the 
materials used for agarose gel electrophoresis. 1 x TBE was used as a runner buffer 
to make a 1% w/v agarose gel. DNA gel loading dye was added to the DNA samples 
at a ratio of 1:5.   
 
Buffer Composition  Concentration 
 
1x TBE 
Tris base 
Boric acid 
EDTA 
HCl  
89mM 
89mM 
2mM 
pH 8.3 
 
DNA Gel Loading Dye 
Tris 
Bromophenol blue 
Xylene cyanol FF 
Glycerol 
Ethylenediaminetetraacetic Acid 
(EDTA) (pH 7.6 adjusted with 
Sodium Hydroxide (NaOH)) 
10mM 
0.03% 
0.03% 
60% 
60mM 
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2.11 Molecular docking analysis  
2.11.1 Molecular structure analysis 
The molecular drawing tool MoleculeSketch version 2.0 (download from the Apple 
App Store) was used to sketch the structures of the molecules which played an 
essential role in the antimicrobial docking of gentamicin to the 30s-ribosomal subunit. 
Molecular structures were drawn for the gentamicin complex, as well as the predicted 
binding sites which include single ribonucleotide bases of the 16s rRNA and the 
amino acid lysine residue of the 30s-ribosomal protein S12.  
 
2.11.2 Preparation of PDB files for AutoDock  
Computational protein-ligand docking and virtual drug screening was achieved using 
the AutoDock suite. Before docking the freely available open-source software 
AutoDock 4.2 and MGLTools 1.5.6 must be downloaded and installed (Morris et al., 
2009). In addition, coordinate files for both the receptor and ligands must be obtained 
from the PDB or any other database or server providing experimental coordinates in a 
variety of formats including pdb, mol2, cif or sdf. As the protein complex required for 
this protein-ligand docking experiment was not available on the routine databases, 
the PDB files for the Pre-and Post 70s-ribosomal complex in combination with 
Elongation Factor G were supplied by Professor Jinzhong Lin at the State Key 
Laboratory of Genetic Engineering at Fudan University in Shanghai, China. 
The ribosomal complexes were formed as previously described by Gagnon et al. 
(2012) with some additional modifications (Lin et al., 2015). X-ray diffraction data 
were collected from the ribosome crystals prepared by Lin et al. (2015) at beamlines 
X25 at Brookhaven National Laboratory and 24-ID-C at the Advanced Photon Source 
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at Argonne National Laboratory using 0.2 or 0.3 oscillations. Data were integrated 
and scaled using the XDS programme package (Kabsch, 1993). All crystals belong to 
orthorhombic P212121 space group and all ligands were removed as a starting 
model. A summary of the crystal parameters and statics of data collection and 
refinement are detailed in the supplementary material of the Lin et al. (2015) paper. 
The two ribosomal structures provided were resolved at 50 – 2.8 Å and the Rwork/Rfree 
values were 20.2/25.2% and 22.1/26.6% for the pre- and post- ribosomal complexes 
respectively. The final step before starting Autodock tools was to collate all Autodock 
related files into a folder, including the pdb and Autodock and Autogrid .exe files.  
 
2.11.3 Receptor preparation for docking  
Once Autodock tools was opened, using preferences the Autodock tools folder was 
selected as the start-up directory and this was made default. The protein for docking 
was inputted using read molecule and selecting the receptor.pdb file. It is here error 
messages can be encountered due to input file formatting issues particularly 
concerning the spacing within a pdb file containing metal ions (magnesium and zinc). 
The next steps involved editing the receptor to ensure compatibility for docking, the 
first step being involved deleting water residues, followed by inspection of the 
hydrogens by adding hydrogens to polar atoms. The next step included the 
assignment of charges, to do this Gasteiger Charges were computed and the 
correctness of the assignment was checked and the deficit was spread across 
residues if necessary. The final step in the preparation of the receptor for docking was 
to merge the non-polar hydrogens.  
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2.11.4 Ligand preparation for docking  
To prepare the ligand for docking firstly the receptor was hidden from view and the 
corresponding ligand.pdb was opened. Once the ligand has been opened in 
AutoDock several steps were followed to prepare a PDBQT file for docking. The first 
being to detect the root or the centre of the ligand which was determined by selecting 
torsion tree followed by detect root. In addition to the root detection, the next step was 
to choose torsions which displayed the number of fixed and rotatable bonds, and it 
was essential at this stage that all amide bonds were made rotatable. The final stage 
in the ligand preparation involved saving the ligand output file in PDBQT format.  
 
2.11.5 Grid box preparation and docking with AutoDock  
The final step before the docking simulation experiment within AutoDock was to 
generate the receptor coordinate file, by selecting the receptor as the macromolecule 
using the grid settings. The ligand PDBQT file previously prepared was selected as 
the ligand using the set map type option. Once the formatting of the receptor and 
ligand was completed the grid box was defined. The grid box centre was defined by 
providing explicit coordinates selected based on known binding regions for the 
designated the ligand, the grid output was then saved with a gpf extension.  The grid 
map for the 70s pre-and post- ribosomal complex were of dimensions 60 x 60 x 60 
points with a spacing of 0.465 Å, yielding a cylindrical box with a size of 1.5. The grid 
parameters were altered for docking stimulations for the ribosomal protein S12, with 
grid map dimensions of 40 x 40 x 40 points with a spacing of 0.375 Å. 
Command line was then used to run Autogrid, by ensuring both Autogrid executable 
and autogrid4 were located within the same directory. Prior to running Autodock, 
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using the docking function, the macromolecule receptor pdbqt file and the ligand were 
selected and outputted with Lamarkian GA type with a dpf extension. Subsequently, 
autodock can was launched by selecting the newly generated dpf file, and upon 
completion a log file with a dlg extension was produced.  
 
2.11.6 Single docking analysis and visualisation with PyMOL 
Once autodock has completed its run, all posed docking was visualised by selecting 
the log generated files, the docked conformations were clustered using a tolerance of 
2. All poses were saved in pdb. format and figures were generated using PyMOL.  
 
2.12 The phylogenetic analysis of the fusA gene  
To resolve the phylogeny of the fusA gene both within the Escherichia taxid and 
Enterobacteriaceae family, Maximum Likelihood trees were constructed. The 
sequences of the fusA gene were collected using a Nucleotide BLAST search of the 
sensitive E. coli MG1655 query sequence optimised for somewhat similar sequences 
with a maximum number of target sequences set to 500. The DNA sequence 
alignments for 100% query cover were downloaded from NCBI and aligned using 
MUSCLE (Edgar, 2004). The sequences were compiled with the fusA gene 
sequences of the experimental strains exploited in this study followed by a further 
realignment using MUSCLE. 
 
2.12.1 The evolutionary model selection using JModel  
The software JModelTest2 version 2.1.10 was used for the statistical selection of 
model based on the aligned fusA nucleotide sequences. The DNA alignment file was 
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loaded into JModel and the likelihood scores were computed using the following 
settings:  Bayesian Information Criterion (BIC) clustering heuristics, base frequencies 
(+F) and rate variation (+I and +G). The number of processes requested within the 
search was 4 with 203 substitution schemes, giving a total of 1624 models for the 
comparison of best fit. The ML optimised option was selected as the base tree for 
likelihood calculations and the base tree search was Nearest-neighbour Interchange 
(NNI). Following the analysis of likelihood Akaike Information Criterion (AIC) and BIC 
calculations were computed under default settings (Guindon and Gascuel, 2003; 
Darriba et al., 2012).  
 
2.12.2 Phylogenetic tree construction using PhyML  
PHYML version 3.1 was downloaded from: www.atgc-
montpellier.fr/download/binaries/phyml/PhyML-3.1.zip and was compiled using the 
command-line interface. The DNA alignment file was converted to the PhyML 
supported Phylip format (interleaved or non-interleaved) using EMBOSS Seqret 
available at: https://www.ebi.ac.uk/Tools/sfc/emboss_seqret/ [accessed July 2, 2018].  
Following reformatting, the parameters for the phylogenetic analysis were 
determined. The selection of substitution model was predetermined using JModel_2.0 
(Section 2.12.1).  For all ML trees generated in PhyML, invariable sites models were 
utilised with fixed topology. The final selection parameter was the number of 
bootstraps and to increase the statistical reliability of the ML trees, the maximum 
number of bootstraps was selected (1000). The final step involved the configuration of 
a command line string to execute the phylogenetic ML tree construction within 
PhyML. The string included the number of bootstraps (–b), the model (-m), the input 
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file (-i) and finally the data type (-d) (Guindon et al., 2010). The output text file from 
the phylogenetic analysis using PHYML was then viewed and annotated using the 
online tree viewer iTOL (Interactive Tree of Life) version 4.2 available at: 
https://itol.embl.de [accessed October 4, 2018].  
 
2.13 Analysis of bacterial fitness  
2.13.1 Manual growth curve  
To compare the growth of the sensitive and resistant E. coli MG1655 strains, manual 
growth curves were conducted. Initially, O/N cultures of sensitive and resistant strains 
were used to inoculate 50mL falcon tubes containing 20mL of MH broth, in triplicate. 
Broth cultures were incubated O/N aerobically at 37ºC 100 rpm. Following incubation, 
cultures were centrifuged at 4,500 x g for 5 minutes, and bacterial cell populations were 
set to a starting OD of 0.2 at 600nm. Next, 1mL of standardised cultures were 
transferred to pre-warmed conical flasks containing 100mL of MH broth, to achieve a 
starting OD600 of 0.002 OD units, corresponding to approximately 104-106 CFU/mL. 
Conical flasks including MH broth controls were incubated aerobically at 37ºC 100 rpm 
for the experimental course. The OD600 was monitored every 30 minutes for 12 hours 
using 1cm path length cuvettes in an Eppendorf Biophotometer. In addition, at each 
time point quantification was achieved through serial dilutions and later CFU/mL 
calculations, described previously in section (2.6).  
 
2.13.2 Galleria mellonella virulence model  
The Galleria mellonella (G. mellonella) toxicity model was used to assess bacterial 
virulence. This was achieved through cultivating the resistant and sensitive cultures 
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from frozen as previously described section (2.3.2) before use within the Galleria 
toxicity model. The resistant bacteria and sensitive control were transferred into 
universal tubes containing 20mL of MH broth and the cultures were incubated 
aerobically at 37°C shaking at 100 rpm (Heidolph Unimax 110).  
 
Following overnight incubation, 1mL of each culture was used to inoculate pre-
warmed Erlenmeyer flasks containing 100mL MH broth. The freshly inoculated broths 
were then transferred into the shaking incubator at 37°C 100 rpm for 240 minutes 
(exponential phase of growth). Subsequently, a 1mL aliquot from each Erlenmeyer 
flasks (duplicated) was transferred to a sterile Eppendorf and using a centrifuge 
(Eppendorf Minispin), the aliquot was centrifuged for 2 minutes at 13,000 x g. The 
supernatant was then discarded and the pellet was resuspended in 1mL sterile PBS. 
The cells were washed a further two times, before a final resuspension in 1mL PBS.  
 
Assuming the duplicates are identical, 1mL of each test sample was transferred to a 
plastic cuvette and using a spectrophotometer (Thermo Spectronic Helios) the OD at 
600nm was recorded. To achieve the desired starting OD600 of 0.8 OD units, either 
PBS was added to dilute the sample or alternatively to achieve a higher OD the 
samples were re-centrifuged and suspended in smaller volume of PBS.  
 
A total of 60 Galleria larvae (Chessington Garden Centre, Surrey) were utilised within 
the toxicity model experiments. The larvae were divided into 6 control and 
experimental groups, with 10 larvae per group. The groups comprised: the non-
injected control, the PBS control, the sensitive control, MIC resistant cultures, x10 
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MIC resistant cultures and x100 MIC resistant cultures. A syringe (Hamilton 700 
series, bevelled tip) was used to inject each group, excluding the non-injected control. 
The syringe was sterilised between each inoculation using Industrial Methylated Spirit 
(IMS) followed by a final rinse with sterile PBS. 
 
The G. mellonella were injected with 10μL of bacterial suspension (106-108 CFU/mL), 
through the last left pro-leg. The larvae were placed between the thumb and 
forefinger and held in place while injecting, the larvae were cautiously removed from 
the needle and placed into the respective petri dishes.  Following inoculation, plates 
were placed in the static aerobic incubator at 37°C to mimic the mammalian 
environment for a period of 5 days (Figure 2.9).  
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Figure 2.9 The Galleria mellonella virulence model. The image outlines the three 
steps in the preparation of the galleria larvae for use within the toxicity model: (A) 
Bacterial sample preparation. (B) Injection procedure. The Hamilton syringe utilised 
within the study was flushed with ethanol followed by dH2O, prior to the inoculation of 
the injected larvae groups with 10μL of standardised bacterial samples or MH broth. 
The larvae were then placed within the respective petri dishes and incubated at 37°C. 
 
The Galleria larvae were analysed daily for mortality.  The larvae were assessed 
based on observations of mobility, melanisation and survival. The larvae were 
considered dead when inert and completely melanised, appearing black in colour.  
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2.13.3 Scanning electron microscopy 
Scanning Electron Microscopy (SEM) was used to determine any morphological 
differences in E. coli MG1655 due to the acquisition of gentamicin resistance. 
Gentamicin sensitive and MIC resistant strains were cultivated from frozen as 
described in section (2.3.2).  
 
Prior to biofixation, 12mm round coverslips were immersed in 100% ethanol overnight 
to ensure sterility, and left to air dry.  Next, to facilitate the adherence of bacterial 
cells, a 10L drop of dH2O was placed on the coverslip. Single bacterial colonies 
were isolated and smeared onto the cover slip, forming a thin layer of bacterial cells, 
which were fixed by the succinctly passing through a Bunsen Burner flame.   
 
The coverslips containing the fixed resistant and sensitive bacterial cells, were 
transferred to designated wells within a six-well polystyrene plate and covered with 
0.1 M phosphate buffer. Unless otherwise stated, subsequent sample preparation 
was performed in a class two biosafety cabinet. Once in the fume hood, the 
phosphate buffer was removed and immediately replaced with 2.5% glutaraldehyde 
for two hours. After the primary fixation, bacterial samples were washed with 
phosphate buffer for 15 minutes and this is repeated four times.  
 
Following washing, bacterial cells were secondary fixed with 1% osmium tetroxide for 
one hour. Ensuing secondary fixation, bacterial cells were dehydrated through a 
graded series of 50, 70, 80, 90 and 90% ethanol in increasing concentration, for a 
period of twenty minutes within each concentration. The final dehydration step 
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involved the emersion of bacterial cells in 100% ethanol for three successive periods 
of twenty minutes. Bacterial cells were dried by immersion in hexamethyledisilizane 
for five minutes, with plates covered, then allowed to air dry for 24 hours within the 
biosafety cabinet. During the sample preparation procedure, it was imperative to 
ensure that the coverslips were always in solution, and this was achieved by quickly 
decanting and replacing reagents.  
 
The coverslips containing the fixed bacterial cells, were then placed on carbon discs 
of appropriate width, and mounted onto an aluminium stub. Flash dry silver paint, was 
placed on each of the four corners, to create contact between the filter and the stub. 
The samples were then transferred to Quorum (Quorum Technologies, East Sussex 
UK) and nano coated via sputtering with a conductive medium of Gold/Palladium 
alloy. The sample was pumped down, purged with argon and sputtered with gold for 
120 seconds on a rotating stage. Once removed from the sputter coater it was 
essential that the samples were not touched, and non-conductive tape was added to 
secure the sample in place prior to analysis.  
 
All samples were imaged in a JCM-5700 Scanning Electron Microscope contained 
inside a mobile biological containment enclosure. The gold coated specimens were 
imaged under a high vacuum at 6kV, with an 8mm working distance and a 30m 
objective lens aperture. Images were collected using a secondary electron detector, 
with an acquisition time per image of 160 seconds and each image was 2560 x 1920 
pixels. SEM images were recorded at magnifications ranging from 3,000x to 19,000x.  
 
  
 
 
70 
Chapter 3: Experimental evolution as a tool for exploring the evolution of 
antimicrobial resistance across an antibiotic landscape under laboratory 
conditions. 
 
3.1 Introduction 
Experimental evolution studies have facilitated the analysis of key evolutionary 
processes, under experimentally determined conditions, allowing the direct 
visualisation of the evolutionary process (Kawecki et al., 2012). The employment of 
microorganisms to experimental evolution studies is permitted by the rapid generation 
times and mutation rates observed within bacterial populations (Elena and Lenski, 
2003). However, the true potential of experimental evolution studies was uncovered 
when utilised together with WGS techniques (Barrick and Lenski, 2013). The 
sequencing of bacterial genomes allows the genotypic pathways underlying the 
evolutionary changes to be determined (Conrad, Lewis and Palsson, 2011).  
 
Experimental evolution studies have been applied within the field of antimicrobial 
resistance, because in addition to characterising known resistance mechanisms such 
as the horizontal acquisition of resistance genes, it is essential to understand how 
resistance evolves through mutations (Lukacisinova and Bollenbach, 2017). This will 
not improve the understanding of the evolution of antimicrobial resistance within 
bacteria, but will provide insights into whether the genomic basis of adaptation can be 
quantitatively predicted (Furusawa, 2017).  
 
An initial approach used to explore the evolution of antimicrobial resistance was 
through serial passage, where experiments were conducted for extensive periods 
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over a given number of generations (Lenski et al.,1991).  Advancements within the 
field has seen the introduction of microbial selection devices which allowed the 
dynamic regulation of the experimental conditions influential to resistance evolution. 
Such studies have included distinct microenvironments, reflective of natural bacterial 
niches (Zhang et al., 2010) and sustained antimicrobial selection, whereby evolving 
bacterial populations are continuously challenged through the external regulation of 
antibiotic concentration in response to bacterial growth and nutrient utilisation (Toprak 
et al., 2011).  
 
A limitation of serial passage systems and fluidic selection devices, is the capacity to 
explore the ability of bacterial populations to migrate between spatially distinct 
regions, essential within the natural environment (Matinez, 2009). Therefore, 
experimental evolution approaches were developed which incorporated spatial 
temporal antibiotic concentration gradients. Grounded previous work conducted by 
the Kishony Lab at Harvard University, saw the introduction of the Microbial Evolution 
Growth Arena, denoted the MEGA plate reflecting its large size (120×60cm) facilitated 
the study of microbial evolution over an antibiotic landscape (Baym et al., 2016b). 
Owing to the success of the MEGA plate there was a need for similar more simplified 
approaches to facilitate the high throughput study of microbial evolution. 
 
This chapter is non-hypothesis driven as it is based upon method development and 
optimisation. The aim of this chapter is to develop a simple reproducible tool to 
explore the evolution of antimicrobial resistance over a spatial concentration gradient 
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of antimicrobial agents.  A comparative assessment will also be conducted with the 
more traditional evolutionary approach of serial passage.  
 
3.2 Materials and methods  
3.2.1 Preliminary diphasic plate experiment 
The initial stage in the development of a model to explore the evolution of antibiotic 
resistance, was to devise a diphasic agar plate. Diphasic plates were produced using 
bioplates which allowed the generation of two phases of MH agar with and 
without antibiotic supplementation. Details of the production of bioplates and 
preliminary diphasic experiments are detailed in chapter 2 (Section 2.7.1).  
 
3.2.1.1 Preliminary diphasic plate experiment: semi-solid MH agar 
The protocol described in (2.7.1.2) was repeated with the following adaptation. The 
consistency of the MH agar was altered to produce semi-solid consistencies of 75% 
and 50% (See table 3.1).  
 
Table 3.1 Constituents of semi-solid MH agar.  Table showing the formulation used 
to produce semi-solid MH agar of 50% and 75% consistencies for use within the 
diphasic plate experiments. 
  
Consistency Phase MH Broth (g) Volume of dH20 
(mL) 
Bacteriological 
Agar (g) 
50% 1 2.6250 125.00 1.3125 
2 2.5988 123.75 1.2994 
75% 1 2.6250 125.00 1.9688 
2 2.5988 123.75 1.9491 
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3.2.1.2 Preliminary diphasic plate experiment: M9 minimal media 
The protocol described in (2.7.1.2) was repeated with the following modifications.  
The nutrient availability within the agar was reduced, by use of minimal media. Initially 
the first step was to make the M9 salts, which were to be added to the media post 
sterilisation (Table 3.2). Subsequently, the agar was prepared by sterilising 700mL 
dH2O with 1.5% w/v bacteriological agar. The components added post sterilisation are 
detailed in table (3.3).  Plates were inoculated with one 10μL drop of bacterial 
suspension (1.5 x 108 CFU/mL), which was streaked using a sterile swab (Figure 3.1).   
 
Table 3.2 M9 salt composition. Table displaying the components required to 
produce M9 salts to be added post sterilisation for the preparation of M9 minimal 
media.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M9 salts 
Components Weight (g) 
Na2HPO4-7H2O 64 
KH2PO4 15 
NaCl 2.5 
NH4Cl 5.0 
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Table 3.3 M9 minimal media composition. Table displaying the components 
required to be added post sterilisation for the preparation of M9 minimal media, with 
the inclusion of the M9 salts detailed previously in table 3.2.  
 
Minimal media  
Components Volume (mL) 
M9 salts 200 
1M MgSO4 2 
20% glucose 20 
1M CaCl2 0.1 
Figure 3.1 The modified diphasic plate layout. Diagram displaying the plate set-up 
used in the production of the modified diphasic plate. Plates were divided into two 
phases using the bioplates to produce a gradient of antimicrobial agent. Plates were 
then inoculated with a single 10μL (1.5 x 108 CFU/mL) drop of sensitive bacterial 
suspension on the phase containing no antimicrobial agents, which was streaked 
horizontally using a sterile swab.  
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3.2.2 Preliminary triphasic plate experiment  
The experimental procedure described in (2.7.1.2) was repeated on a larger scale in 
a sterile plate with Teflon coating and dimensions of 24cmx24cmx5cm.  Indentations 
were made in the plate to facilitate the insertion of the larger overhang bioplates. The 
larger dimensions of the plate enabled the set up shown in figure (3.2). Here the plate 
was sterilised and the two outer zones were poured first, followed by the removal of 
bioplates and finally the filling of the inner zone. The triphasic plates were inoculated 
with three 100μL (1.5 x 108 CFU/mL) drops of drug-sensitive bacterial suspension.  
 
Figure 3.2 The triphasic plate layout. Diagram displaying the triphasic plate set-up. 
The plate was divided into three sections by inducing slots for the insertions of the 
overhang bioplates. This facilitated the production of a three-phase antimicrobial 
concentration gradient ranging from zero to x10 the MIC of a given antimicrobial 
agent. The triphasic plate diagram does not include bacterial inoculation.   
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3.2.2.1 Preliminary triphasic plate experiment: semi-solid MH agar  
As described in (3.2.1) the experimental procedure was repeated with the inclusion of 
semi-solid media. Consistencies of 60% and 75% MH agar were tested (Table 3.4).  
 
Table 3.4 Semi-solid MH agar composition for the triphasic plate experiments. 
Table showing the formulation used to produce semi-solid MH agar of 60% and 75% 
consistencies for the three phases within the triphasic plate experiments. 
 
 
 
3.2.2.2 Preliminary diphasic plate experiment: agar slope  
 
To explore the trickling effects of antimicrobial agents, as opposed to the effect of a 
set concentration gradient in previous methods a slope gradient was produced. Here 
the tray was sterilised and placed on a block, initially the second phase was poured 
containing the antimicrobial agent and allowed to set. Following on from this the block 
was removed and MH agar containing no antimicrobial agent was poured and allowed 
to set (Figure 3.3). The same method of inoculation was used as described in section 
(3.2.2).  
 
 
Consistency Phase MH Broth (g) Bacteriological 
Agar (g) 
60% 
 
1 21.00 12.60 
2 20.79 12.47 
3 18.90 11.34 
75% 
1 21.00 15.75 
2 20.79 15.59 
3 18.90 14.18 
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Figure 3.3 The diphasic slope plate layout. Diagram displaying the diphasic slope 
plate. The plate was divided into two antibiotic phases comprising zero antibiotic and 
the MIC of a selected antimicrobial agent. The concentration gradient slope was 
produced by pouring the antimicrobial containing media and placing the diphasic 
slope plate on a block whilst the media solidified. The block was subsequently 
removed and the media containing no antibiotic was poured. The diphasic slope plate 
was then inoculated with three separate 100μL drops of drug-sensitive bacterial 
suspension.  
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3.2.3 Preliminary filter tip experiment  
The filter tip experiment was devised to see the flow of bacteria through a controlled 
system as an evolutionary model of antimicrobial resistance. To be able to observe 
this flow of organisms through the filter tips; two filter tips were used which had been 
impregnated in two different agars; nutrient agar and the semi-selective MacConkey 
agar (Figure 2.3). Therefore, the migration of the bacteria was identifiable by a media 
colour change. Details of the preliminary filter tip experiment are described in chapter 
2 (Section 2.7.2).  
 
3.2.3.1 The filter tip experiment  
Once the flow of microorganisms through the filter tip system, had been confirmed. 
The experimental protocol described in (Section 2.7.2), was repeated with the 
inclusion of MH agar and filter tips were supplemented with antimicrobial agents. 
Experimental details are provided in (Section 2.7.2.1), with supplementary steps for 
the isolation of the potentially resistant organisms.  
 
3.2.3.2 Quantification of the filter tip experiment  
To quantify the filter tip experiment the experimental procedure described in section 
(3.2.3.1) was repeated, but here, the antimicrobial impregnated filter tip was used to 
perform colony counts. Samples were taken from the antibiotic containing tips via 
wooden swabs, which were immediately transferred to PBS and vortexed for 10 
seconds to isolate the potentially resistant organisms.  Two hundred microliters of the 
suspension was transferred to a 96-well plate and a total of six serial dilutions were 
performed per isolate. Subsequently, 10μL of each dilution was plated and incubated 
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aerobically O/N at 37ºC. Post incubation colonies were counted and CFU/mL were 
calculated (Figure 3.4).  
 
3.2.3.3 The altered filter tip experiment  
The method described in (3.2.3.2) was repeated with minor modifications. The P1000 
micropipette tips were cut at the base to enlarge the exit hole prior to sterilisation. The 
media used to plug the tip, was change to antibiotic containing agar with a 
concentration of the MIC of the given antimicrobial agent; Chloramphenicol (MIC 
8mg/L) and Trimethoprim (MIC 2mg/L).  After incubation, instead of removing the 
tips using sterile forceps, here forceps are used to push the media through the 
micropipette tube. Thus, the sterile wooden swab is used here to sample the antibiotic 
containing agar as opposed to the tips, to obtain the potentially drug resistant 
microorganisms. Once in the PBS, the suspensions can be used to inoculate 
antibiotic agar plates or perform serial dilutions to quantify viable counts of potentially 
drug resistant organisms.  
 
 
 
  
 
 
80  
F
ig
u
re
 3
.4
 Q
u
a
n
ti
fi
c
a
ti
o
n
 o
f 
th
e
 f
il
te
r 
ti
p
 e
x
p
e
ri
m
e
n
t.
 D
ia
g
ra
m
 s
h
o
w
in
g
 t
h
e
 m
e
th
o
d
 u
s
e
d
 f
o
r 
th
e
 q
u
a
n
ti
fi
c
a
ti
o
n
 o
f 
th
e
 f
ilt
e
r 
ti
p
 
e
x
p
e
ri
m
e
n
t.
 T
h
e
 P
1
0
0
0
 m
ic
ro
p
ip
e
tt
e
 t
ip
s
 w
e
re
 p
re
p
a
re
d
 u
s
in
g
 f
ilt
e
r 
ti
p
s
 w
h
ic
h
 w
e
re
 i
m
p
re
g
n
a
te
d
 w
it
h
 b
o
th
 M
H
 a
g
a
r 
a
n
d
 M
H
 p
lu
s
 
th
e
 M
IC
 o
f 
th
e
 s
e
le
c
te
d
 a
n
ti
m
ic
ro
b
ia
l 
a
g
e
n
t.
 T
h
e
 m
ic
ro
p
ip
e
tt
e
 t
ip
s
 w
e
re
 t
h
e
n
 i
n
o
c
u
la
te
d
 w
it
h
 1
0
μ
L
 o
f 
a
 d
ru
g
 s
e
n
s
it
iv
e
 b
a
c
te
ri
a
l 
s
u
s
p
e
n
s
io
n
. 
F
o
llo
w
in
g
 i
n
c
u
b
a
ti
o
n
, 
th
e
 f
ilt
e
r 
ti
p
 c
o
n
ta
in
in
g
 a
n
ti
m
ic
ro
b
ia
l 
a
g
e
n
t 
w
a
s
 a
s
c
e
p
ti
c
a
lly
 r
e
m
o
v
e
d
 f
ro
m
 t
h
e
 m
ic
ro
p
ip
e
tt
e
 t
ip
 
u
s
in
g
 t
w
e
e
z
e
rs
. 
T
h
e
 f
ilt
e
r 
ti
p
 w
a
s
 t
h
e
n
 s
w
a
b
b
e
d
 u
s
in
g
 a
 s
te
ri
le
 c
o
tt
o
n
 s
w
a
b
, 
w
h
ic
h
 w
a
s
 b
ro
k
e
n
 i
n
to
 a
 s
te
ri
le
 b
ijo
u
 c
o
n
ta
in
in
g
 P
B
S
 
a
n
d
 v
o
rt
e
x
e
d
 f
o
r 
1
0
 s
e
c
o
n
d
s
. 
T
h
e
 b
a
c
te
ri
a
l 
s
u
s
p
e
n
s
io
n
 w
a
s
 t
h
e
n
 t
ra
n
s
fe
rr
e
d
 t
o
 a
 9
6
-w
e
ll 
p
la
te
 a
n
d
 s
e
ri
a
l 
d
ilu
ti
o
n
s
 w
e
re
 
p
e
rf
o
rm
e
d
 b
e
fo
re
 p
la
ti
n
g
 1
0
μ
L
 o
f 
e
a
c
h
 d
ilu
ti
o
n
 o
n
to
 M
H
 p
la
te
s
 f
o
r 
C
F
U
/m
L
 c
a
lc
u
la
ti
o
n
s
. 
 
  
 
 
81 
3.2.4 The triphasic circle plate experiment 
The Triphasic plate method was modified to facilitate the radial growth of 
microorganisms, which was hindered within original rectangular format.  This revised 
method was named the Triphasic Circle Plate, and a comprehensive description of 
the protocol used in the production of the circular plate can be found in chapter 2 
section (2.7.3).   
 
3.2.4.1 The altered triphasic circle plate method  
The Triphasic Circle Plate experimental procedure was repeated with a slight 
alteration. The method was prepared as described in (2.7.3), but modifications 
followed the initial pouring of a thin layer of Mueller Hinton agar to the base of the 
plate. After this the outer phase ring was positioned and the x10 MIC segment was 
poured and allowed to set. Subsequently the inner phase ring was placed in position 
and the outer ring was removed, followed by the pouring of the second phase 
containing MIC of the antimicrobial agent. Finally, the inner ring was removed and the 
primary phase was poured containing zero antimicrobial agent. Plates were placed 
inside a plastic box containing an absorbent pad covered in autoclaved water; the lid 
of the box contained two 0.2μM filters to facilitate the sterile passage of air.  The 
boxes were then placed in the incubator at 37ºC, and observed daily for bacterial 
growth.  
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3.2.5 Motility experiments  
An impeding factor concerning all the spatial temporal models described previously 
within this chapter, is the motility requirement. To explore the motility of the 
microorganisms further, both phenotypic and genotypic experiments were conducted.   
 
3.2.5.1 Motility testing: stab test   
The initial phenotypic motility test conducted was the motility stab test.  Motility Media 
components (Table 3.5), was made up to 1 liter with dH2O and heated by boiling to 
melt the agar. Post boiling 5mL of 1% v/v Triphenyl tetrazolium chloride (TTC) 
solution was added, to improve the visibility of diffusion which is facilitated by the 
bacterial reduction of TTC to form a red colour (Kelly and MacDonald, 1952). 
Following sterilisation, 5mL aliquots of media were decanted into 15mL falcon tubes, 
which were cooled upright within a tube racks.  To test for motility a sterile needle was 
used to pick an isolated colony from an O/N MH plate, which was then stabbed into 
the motility agar to within 1 cm of the bottom of the falcon tube. After inoculation, 
racks were incubated at 35°C for 18 hours or until growth is evident. A positive 
motility test is confirmed by a red turbid area extending outwards into the media from 
the line of inoculation.  
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Table 3.5 Motility media components.  Table displaying the components required to 
produce motility media for the stab test in the assessment of bacterial motility.  
 
Motility Media  
Components Weight (g) 
Beef Extract 3.0 
Pancreatic digest of casein  10 
Sodium Chloride 5.0 
Agar  4.0 
 
3.2.5.2 Genomic analysis of bacterial motility  
As well as the phenotypic tests described above, motility can be assessed genotypically. 
Motility within E. coli is largely dependent on the production of flagella, which is initiated 
by the activation of transcription factors flhD and flhC, referred to as the flhDC complex 
(Wang et al., 2015).  As the expression levels of flhDC plus the number of insertion (IS) 
elements, have been directly linked to motility in E. coli K-12, PCR reactions for flhD 
and yecG was conducted on all E. coli strains used within this study (Fahrner and Berg, 
2015).  
 
3.2.5.2.1 DNA extraction for the analysis of bacterial motility 
DNA extraction was completed using the Gentra Puregene Yeast/Bacteria Kit. As per 
kit protocol. To prepare for DNA extraction isolates were inoculated into MH Broth for 
24hrs at 37°C 100RPM in a shaking incubator, after revival from cryovials. Optical 
densities were taken at 600nm on spectrophotometer and bacterial numbers were 
confirmed via serial dilution. The overnight culture must contain approximately 1-2 x 
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108 cells. After extraction, DNA was incubated at room temperature (15-25°C) overnight 
with gentle shaking or stored at -20°C after concentration and purity checks were 
completed using the NanoVue. 
 
3.2.5.2.2 PCR for the analysis of bacterial motility 
Primer sets specific to the intended flhD and yecG gene targets (Table 3.6) were 
generated using Primer-Blast available at: https://www.ncbi.nlm.nih.gov/tools/primer-
blast/ [accessed June 18, 2018]. The primer design parameters are detailed in 
chapter 2 (Table 2.7). The primer sets were tested against five different isolates of E. 
coli (UTI89, CFT073, TPA4792, TPA2743 and MG1655) in the assessment of 
bacterial motility.  
 
Table 3.6 Primer sequences used in the genomic analysis of bacterial motility. 
Table displaying the forward primer sequences of the flhD and yecG primers used in 
the genomic assessment of bacterial motility. 
 
 
3.2.5.2.3 DreamTaq Polymerase PCR for the analysis of bacterial motility 
PCR was completed using DreamTaq DNA Polymerase (Thermoscientific). The PCR 
reaction mix components and corresponding quantities used for the motility PCR 
reactions are presented in table (3.7). The thermocycling conditions and durations are 
detailed in table (3.8). An annealing temperature of 54ºC was used here, with a 2-10-
minute amplification time depending on the number of IS elements.  
Primer 
Target  
 Forward Sequence (5’-3’) Reverse Sequence (3’-5’) 
flhD TGTTTCAGCAACTCGGAGGTATGC 
 
GCATACCTCCGAGTTGCTGAAACA 
yecG CAGCGACAAGAATATTGCTATAGC GCTATAGCAATATTCTTGTCGCTG 
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Table 3.7 PCR reaction mix for the bacterial motility PCR reactions. Table 
displaying the PCR reaction mix components and the corresponding quantities and 
concentrations used in the PCR reactions for the assessment of bacterial motility.  
 
 
 
 
 
 
 
 
 
 
 
Table 3.8 Thermocycling conditions used for the bacterial motility PCR 
reactions. Table displaying the thermocycling conditions and the corresponding 
durations used in the PCR reactions in the assessment of bacterial motility.  
 
 
 
 
 
 
 
 
3.2.5.2.4 Gel electrophoresis for the analysis of bacterial motility  
PCR products were determined using Gel Electrophoresis. 2% w/v agarose gel stained 
with SYBR safe (Invitrogen, S33102). PCR products were loaded with loading buffer 
together with the GeneRuler 2Kb DNA ladder (Thermoscientific).  
 
 
 
 
Component Volume (µL) Concentration 
Dream Taq 25 2X 
Forward primer 2 1M 
Backward primer 2 1M 
Template DNA 1 ~ 100 ng 
Nuclease free water 20 - 
Total volume (µL) 50 - 
Step Temperature 
(°C) 
Time 
(mins) 
No. of 
Cycles 
Initial 
Denaturation 
95 1.5 1 
Denaturation 95 0.5 30 
Annealing 54 0.5 
Extension 72 0.5 
Final 
Extension 
72 2-10 1 
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3.2.5.3 Motility testing: 6-well plate assay    
In addition to the phenotypic stab test described above, a secondary phenotypic test 
was used to explore swimming motility using semi-solid motility agar, which would 
later be applied within the Triphasic Circle Plate Method. Here both tryptone and MH 
broth were prepared and solidified with 0.3% w/v bacteriological agar (Barker et al., 
2004). The semi-solid agars were then added to wells of a 6-well Multidish and 
inoculated with 2 μL of an O/N broth culture standardised to an OD of 0.5. Stationary 
semi-solid cultures were then incubated at 37°C and swarm diameters visually 
observed.  
 
3.2.6 Finalised triphasic plate circle method renamed the Antibiotic Resistance 
Growth Plate (ARGP) 
 
To provide a simple reproducible approach for studying bacterial evolution, the 
triphasic circle plate described in chapter 2 (Section 2.7.3) was downscaled to a 
polystyrene petri dish with dimensions of 90mm × 15mm, and the finalised 
experimental evolution model was named the ARGP. Here, the same experimental 
approach was followed as described in (Section 3.2.4.1), with an additional step.  
After the spatially distinct regions had been filled with molten agar of increasing 
antibiotic concentrations, this was overlaid by a layer of semi-solid agar, to enhance 
bacterial motility (Figure 3.5). The motility layer was prepared as described in 
(3.2.5.3), but here MH broth was solidified with 0.3% w/v to 3% w/v bacteriological 
agar to determine the optimal consistency. ARGP plates were inoculated and sealed, 
followed by upright aerobic incubation at 37ºC. Daily observations were captured 
using the G-Box Imaging system. 
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Figure 3.5 The finalised ARGP set-up. Diagram displaying the three-step 
antimicrobial concentration gradient utilised within the ARGP with antimicrobial 
concentration increasing exponentially by a factor of 10 of the MIC of the selected 
antimicrobial agent from the centre of the plate outwards. This was then covered with 
a thin motility layer and plates were inoculated in the central drug free region of the 
plate. Daily images are taken using the G-Box imaging system. 
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3.2.7 Quantification of antimicrobial diffusion and degradation within the ARGP 
 
To investigate the extent of antimicrobial diffusion and degradation occurring within 
the ARGP, it was necessary to assess the effect of MH agar on antimicrobial diffusion 
by NMR spectroscopy. Aside from depicting how the agar composition will affect the 
diffusion kinetics, it was essential to decipher the concentration of antimicrobial agent 
present within each phase over the experimental course. The different behaviour of 
classes of antimicrobial agents within bacteriological agar, is largely dependent on the 
agar composition. The predominant antimicrobial used within this study is 
Gentamicin, and aminoglycosides are known to be heavily influenced by variations in 
chemical groups within agar matrices of which magnesium, acid sulphate and calcium 
are attributable to the greatest antibiotic interactions.  
 
3.2.7.1 Quantification of antimicrobial diffusion and degradation using Nuclear 
Magnetic Resonance (NMR)  
 
All antimicrobials employed within this study were high performance liquid 
chromatography (HPLC) grade.  Gentamicin stock solutions of 2000mg/L were 
prepared using bidistilled water, and stored within a freezer at -20C. MH agar was 
prepared per guidelines, as previously described, to a pH of 7.3 +/- 0.1.  The varying 
gentamicin agar concentrations, were utilised to produce the antibiotic phases within 
the ARGP.  Gentamicin agar extraction from the ARGP was achieved by harvesting 
agar cylinders (1-5L) using calibrated glass microcapillaries, containing 
approximately 150mg per sample.  Cylinders were removed at set time points over a 
given period of aerobic incubation at 37C: 0, 0.5, 1, 2, 4, 6, 8, 16, 24, 48 and 72 
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hours. The extraction mapping trajectories within the ARGP for the NMR analysis of 
antimicrobial diffusion and degradation are shown in figure (3.6).   
Figure 3.6 Agar extraction mapping within the ARGP. The diagram displays the 
ARGP set-up with the extraction mapping trajectories representing the extraction time 
points: 0, 0.5, 1, 2, 4, 6, 8, 16, 24, 48 and 72 hours. Agar extracts were harvested by 
agar cylinders using calibrated glass microcapillaries.  
 
 
Derivatisation follows to improve the analytical capabilities of the agar gentamicin 
matrix. The agar cylinder removed at the given time point was placed in glass beaker 
with 20mL dH2O and was boiled until the agar had dissolved.  Samples were cooled, 
transferred to Eppendorf tubes and frozen at -20ºC until analysed using NMR. Prior to 
NMR analysis, 200µl of solution was taken up in 3mL NMR tubes. Followed by the 
addition of 5µl of 68mM Trimethylsilyl propionate (TSP), as the internal reference 
standard for quantification. NMR tubes were then placed in the 400MHz NMR 
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Machine, accounting for both the presence salt and water and 256 scans were 
performed. 
 
The linearity of the method was tested in aqueous working solutions of the 
antimicrobial agent gentamicin, obtained by diluting the 2000mg/L antibiotic stock 
(0.5,1, 2, 4, 8, 16, 32 and 40mg/L). A slight modification was made to the 
derivatization method, in that 12l of working solutions was placed in Eppendorf 
tubes; the subsequent steps were identical. Linearity of the agar extracts was 
evaluated by preparing plates (in triplicate) with known homogenous concentrations 
of gentamicin (2, 4, 8, 16, 32 and 40mg/L), agar cylinders were treated as previously 
described. Linear regression analysis was used to calculate the slope of the 
calibration curve, by plotting gentamicin area vs. agar concentration. The antibiotic 
diffusion was studied in agar as a function of time since the start of incubation (0, 0.5, 
1, 2, 4, 6, 8, 16, 24, 48 and 72 hours). Agar samples were taken from the central 
region of each zone (approximately 3mm). Kinetics were performed in triplicate.  
 
3.2.7.2 Quantification of antimicrobial diffusion and degradation using LC-MS  
The gentamicin extraction and derivatisation steps described above (section 3.2.7.1) 
were repeated, followed by analysis using Liquid Chromatography-Mass 
Spectroscopy (LC-MS), to increase the sensitivity of the method with lower detection 
limits. Initial experiments were conducted to produce a calibration curve, with agar 
extracts comprising 1, 4, 10, 20 and 40mg/L gentamicin using the API 3000 (Applied 
Biosystems, Analytical Technologies) and the Analyst Classic Algorithm.  
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The quantitative analysis of gentamicin using LC-MS presented several challenges as 
gentamicin contains several components which lack chromophoric groups to facilitate 
spectroscopic detection (Heller et al., 2005). Additionally, gentamicin has both 
hydrophilic and hydrophobic properties and thus cannot be retained by a conventional 
C18 column (Blanchaert et al., 2017). Subsequently, to avoid extensive column 
optimisation and incorporating a cleaning phase during the agar extraction process, a 
more expensive fusion column was utilised.  The Synergi 4µm Fusion-RP 80 Å, LC 
Column (100mm x 2mm) selectivity permitted balanced polar and hydrophobic 
compound retention and resolution. The stationary phase consisted of polar 
embedded C18 with Tetramethylsilane (TMS) endcapping with a porous silica solid 
support. The mobile phase was composed of water-acetonitrile (70:30) with a flow 
rate of 1mL/min and a detection wavelength of 281nm.  
 
3.2.8 Serial passage  
Alongside the spatial temporal models proposed within this chapter, the traditional 
experimental evolution method of serial passage was included as a comparative 
assessment of resistance evolution within a well-mixed system and solid bacterial 
growth media. The protocol used for serial passage was described in chapter 2 
(Section 2.7.4) and no modifications to the original method were necessary.  
 
 
 
 
 
 
  
 
 
92 
3.3 Experimental Results  
3.3.1 Antimicrobial susceptibility testing results  
The initial antimicrobial agent used within the study was chloramphenicol which was 
then followed by trimethoprim. The antimicrobial agents colistin, gentamicin, 
levofloxacin and meropenem was used in subsequent experiments following the 
optimisation of experimental methods.  
 
The initial susceptibility test carried out was the disc diffusion method described in 
chapter 2 (Section 2.4.1). The zone diameter breakpoints for the Enterobacteriaceae 
to the given antimicrobials agents utilised within this study were obtained from 
EUCAST (Table 3.9). The zone diameter breakpoint results from the susceptibility 
testing of E. coli and P. mirabilis against the antimicrobials; chloramphenicol and 
trimethoprim are shown in table (3.10).  
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Table 3.9 EUCAST susceptibility breakpoint guidelines. The EUCAST breakpoint 
table displays both the MIC and zone diameter breakpoints for the antimicrobial agents 
utilised within this study for the Enterobacteriaceae including E. coli and P. mirabilis.  
 
 
 
Table 3.10 Zone diameter breakpoints. Table displaying the zone diameter 
breakpoints (mm) for E. coli and P. mirabilis observed during the disc diffusion 
experiments with the antimicrobials chloramphenicol and trimethoprim.  
 
Antimicrobial 
Agent 
Disc Content 
(μg) 
Zone Diameter Breakpoint (mm) 
E. coli P. mirabilis 
Chloramphenicol  30 21 20 
Trimethoprim  25 34 25 
 
 
 
 
 
EUCAST Susceptibility Testing: Enterobacteriaceae 
Antimicrobial 
Agent 
MIC Breakpoint  
(mg/L) 
Zone Diameter Breakpoint 
(mm) 
S I R S I R 
Chloramphenicol  8 - 8 21 - 20 
Trimethoprim 2 4 4 17 14-16 13 
Colistin 2 - 2 - - - 
Gentamicin  4 4 2 16 17-19 20 
Levofloxacin 1 2 2 17 14-16 13 
Meropenem  2 4-8 8 27 20-26 19 
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The results confirmed the susceptibility of E. coli and P. mirabilis laboratory strains to 
both chloramphenicol and trimethoprim.  This was further supported by the results 
from the microbroth dilution assay where after 24 hours of incubation at 37 ºC the 
MIC breakpoints of chloramphenicol and trimethoprim were 8mg/L and 2mg/L 
respectively, which according to table (3.9) is indicative of bacterial susceptibility to 
the given antimicrobial agents. The results generated from both susceptibility tests, 
indicate that chloramphenicol and trimethoprim could be utilised within this the study.   
 
3.3.2 The preliminary diphasic plate experiment   
3.3.2.1 The production of Bioplates for the diphasic plate experiment  
Prior to experimentation, it was hypothesised that the ‘Overhang Bioplate’ would be 
the most suitable Bioplate for use within this diphasic plate experiments, as it would 
produce a tighter fit within the plate, and the hang would facilitate an easier removal. 
The results however, disproved the initial hypothesis as a greater amount of 
contamination was observed with the overhang Bioplate and the agar was disrupted 
upon removal. This result meant the ‘Slip Bioplate’ was used in subsequent 
experiments.  
 
3.3.2.2 The diphasic plate experiment: resistance evolution of laboratory strains 
of E. coli and P. mirabilis under chloramphenicol exposure on MH agar 
 
The initial experiment was subject to contamination, which was identified as normal 
skin flora. In addition to this, the added step of removing the Slip Bioplate and the 
subsequent filling with non-antibiotic media resulted in contamination along the 
division line of the two phases within the diphasic plate. Asides from contamination, 
the 10μL drop of bacterial suspension failed to migrate within the proposed method. 
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3.3.2.3 The diphasic plate experiment: resistance evolution of laboratory strains 
of E. coli and P. mirabilis under chloramphenicol exposure on semi-solid MH 
agar 
 
To increase the bacterial migratory rates, the consistency of the agar was modified to 
produce MH agar with consistencies of 50% w/v and 75% w/v.  The semi-solid agar 
with a consistency of 50% w/v was too aqueous. After incubation, the bacteria 
produced a covering on the surface of the agar, and the antimicrobial agent had 
precipitated from the media. The semi-solid agar with a consistency of 75% w/v 
worked best, the streak was effective but care must be taken to avoid tearing of the 
agar. Again, precipitation of the antimicrobial agent was observed along with 
contamination. However, filling the divide with agar containing chloramphenicol, 
significantly reduced the amount of contamination present.   
 
3.3.2.4 The diphasic plate experiment: resistance evolution of laboratory strains 
of E. coli and P. mirabilis under chloramphenicol exposure on M9 minimal 
media  
 
Furthermore, M9 Minimal Media was tested to increase the migratory rates of the 
bacterial populations. After 24 hours incubation at 37C the growth of both E. coli and 
P. mirabilis was insignificant, thus the media appeared to be having an adverse effect 
on the growth of the two organisms. There were contaminants present within the 
media, which indicated that a component of the minimal media was contaminated. 
Each component added post-sterilisation was tested and the contaminant identified 
was the 20% v/v glucose solution.  Due to the restricted growth of the organism, M9 
Minimal media was not used in subsequent diphasic plate experiments.  
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3.3.3 The triphasic plate experiment: resistance evolution of laboratory strains 
of E. coli and P. mirabilis under chloramphenicol exposure on MH agar  
 
After one day of incubation at 37C P. mirabilis had migrated across the entire first 
phase containing no antimicrobial agent. After two-days incubation, there was a slight 
discoloration of the agar within the second phase, suggestive of bacterial growth. To 
examine this further, three samples were taken from the triphasic plate (labelled A, B, 
C) and were plated onto MH plates containing the MIC of trimethoprim, which 
maintains the antimicrobial selective pressure whilst selecting for the growth of 
potential resistant organisms. The mass growth on the antimicrobial plates suggests 
the growth of potentially resistant organisms within the second phase of the triphasic 
plate. After one-week incubation, P. mirabilis had migrated across all three phases 
within the triphasic and evolved resistance to x10 the MIC of chloramphenicol, again 
signified by discoloration of the MH agar containing the antimicrobial agent. Again, 
three samples were taken and plated onto selective media with a concentration of x10 
MIC. After O/N incubation growth was present indicating potentially resistant 
organisms. There was no contamination present on the triphasic plate after one-week 
incubation.  
 
The growth of E. coli was much slower than that of P. mirabilis and the pattern of 
growth was significantly different. Here the inoculum appeared to bud out of the initial 
point of inoculation. After one week, the size of the initial inoculum had grown 
significantly within the initial phase, however the growth proceeded backwards and 
migration did not occur past the first boundary. After two weeks incubation, the three 
evolving populations had budded through phase one into the second phase 
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containing the MIC of chloramphenicol.  Samples were obtained from the triphasic 
plate and cultured onto selective media containing MIC of the antimicrobial agent to 
maintain the selective pressure. However, following sampling of the triphasic plate a 
contaminant was identified within the MIC phase. To comprehend the duration for E. 
coli to migrate across the triphasic plate, the experiment was left to proceed. After two 
weeks incubation, the contaminant had increased in size and was gram stained for 
bacterial identification. Gram staining revealed a Gram-positive filamentous rod with 
spores, suggestive of the bacillus bacterial genus, which are known environmental 
contaminants.  
 
3.3.3.1 The triphasic plate experiment: resistance evolution of laboratory 
strains of E. coli and P. mirabilis under chloramphenicol exposure in semi-solid 
MH agar  
 
Due to the increased surface area of the triphasic plate and the large volumes of 
media required. It was extremely difficult to control contamination during this 
experimental procedure. As previously discussed in section (3.3.2.3), the reduced 
agar content failed to increase the migratory rates of the evolving bacterial 
populations. Moreover, the slime layer produced from the 50% w/v MH experiment 
was detrimental here as it covered the surface of all three phases, on the sterile tray. 
Here contamination was identified as Gram-positive rod, with the same morphology 
as the contaminant described in section (3.3.3).  Comparable to findings that 
observed in section (3.3.2.3), where semi-solid media with a 75% w/v consistency 
was most effective but due to slow growth and contamination observed, semi-solid 
agar will not be used within the triphasic plate method.  
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3.3.3.2 The diphasic agar slope plate experiment: resistance evolution of 
laboratory strains of E. coli and P. mirabilis under chloramphenicol exposure  
 
In theory studying the trickling effect of antimicrobial agents on the growth of an 
organism was very promising, however the large triphasic plate did not facilitate this. 
Again, as seen with the results obtained in section (3.3.3), the repeated occurrence of 
contaminants within the proposed experimental evolution models was a major issue.  
 
3.3.4 The preliminary filter tip experimental results  
The use of MacConkey agar permitted the differentiation of Gram-negative bacteria 
that ferment lactose to those that do not. The flow of organism was detected visibly 
within the micropipette tip, as E. coli is a lactose fermenter and appeared pink, 
whereas P. mirabilis is not and appeared colourless within the tip.  The presence of 
growth was confirmed for all replicate samples obtained from filter tips within the 
micropipette tip for both organisms.  
 
 3.3.4.1 The filter tip experiment:  resistance evolution of laboratory strains of E. 
coli and P. mirabilis resistance under trimethoprim exposure 
 
After seven days, filter tips were removed and selectively sub cultured onto 
trimethoprim plates with a concentration of 2mg/L for each of the six replicates (Table 
3.11). The confirmed resistant cultures were then cryopreserved and stored at -80C.  
 
 
 
 
  
 
 
99 
Table 3.11 The filter tip experimental results.  The table displays the presence or 
absence of growth of six replicates of E. coli and P. mirabilis obtained after one-week 
incubation within the filter tip experiment.  
 
 
The results shown here, identified the presence or absence of potential resistant 
organisms after one-week incubation within the filter tip experiment. However, as the 
resistance evolution of bacterial populations can fluctuate daily, it was of interest to 
quantify the bacterial growth by performing CFU/mL calculations daily within the filter 
tip experiment. 
 
3.3.4.2 Quantification of the filter tip experiment: resistance evolution of a 
laboratory strain of E. coli under trimethoprim exposure 
 
The quantified filter tip experiment was arduous in terms of the materials and the pre-
experimental preparation required, thus the experimental procedure was initially 
downscaled by using E. coli as the primary organism and the experiments were 
performed in duplicate.  An observation was made on day 6 that the agar had 
desiccated within the P1000 micropipette, leaving the filter tip isolated at the top of 
the micropipette tip. This meant that the bacterial colony counts were not performed 
Replicate Potential Rx E. coli  Potential Rx P. mirabilis 
1 Mass Growth  Mass Growth 
2 Mass Growth Mass Growth 
3 Minimal Growth Mass Growth 
4 No Growth Mass Growth 
5 No Growth Mass Growth 
6 Minimal Growth  Mass Growth 
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on day 7 of the filter tip experiment. The daily CFU/mL counts for the two parallel 
populations of E. coli are shown below (Table 3.12).   
 
Table 3.12 The quantification of the filter tip experiment. The table displays the 
daily colony-forming unit counts of two replicates of E. coli (A and B) under 
trimethoprim selection over a period of six days within the quantified filter tip 
experiment.   
 
Day 1  Colony Counts 
(CFU/mL) 
E. coli A 4.30 x 105 
E. coli B 5.20 x 105 
Day 2  
E. coli A 9.80 x 105 
E. coli B  1.10 x 106 
Day 3  
E. coli A 6.80 x 106 
E. coli B  3.20 x 107 
Day 4  
E. coli A 8.20 x 106 
E. coli B 5.40 x 106 
Day 5  
E. coli A 9.10 x 106 
E. coli B  2.30 x 106 
Day 6  
E. coli A 15.60 x 106 
E. coli B  8.90 x 106 
  
 
 
101 
The results presented in table (3.12), suggested apparent fluctuations between the 
bacterial colony counts of the duplicate populations of E. coli.  This could be due to 
compensated growth as a bacterial fitness cost associated with the acquisition of 
antimicrobial resistance or because of a fault within the experimental design. 
Irrespective of the potential cause of this, the experimental procedure must be 
repeated with the inclusion of a greater number of parallel evolving populations.  
 
3.3.4.3 The altered filter tip experiment: resistance evolution of E. coli and P. 
mirabilis under trimethoprim exposure 
 
Due to the fluctuations observed within table (3.12), the experimental method was 
scrutinised to identify potential caveats. The method of filter tip removal described in 
section (3.2.3) was identified as possible cause for such variability.  When removing 
the filter tip from the micropipette tip the abrasion against the micropipette tip walls 
could result in the removal of resistant organisms and or the replacement of resistant 
organisms with susceptible bacterial populations. This altered method was 
implemented, however due to unsuccessful experimental controls the filter tip 
experiments were terminated.  
 
3.3.5 The triphasic circle plate experiment: resistance evolution of E. coli under 
trimethoprim exposure     
 
The preliminary triphasic circle plate experiment was conducted with E. coli only.  
Bacterial contamination was detected within the outer phase after one day of 
incubation and after day 3 significant dehydration was observed within the outer 
phase of the triphasic circle plate (Appendix Figure A.1). The small sized triphasic 
circle plate experiment was subject to substantial contamination, condensation and 
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agar separation within a condensed space, thus it was decided to repeat the 
experiment with the inclusion of the organism P. mirabilis within a bigger triphasic 
circle plate format.  
 
3.3.5.1 The altered triphasic circle plate experiment: resistance evolution of P. 
mirabilis under trimethoprim exposure     
 
The bacterium P. mirabilis was utilised within the altered triphasic plate experiment, 
as the swarming capabilities of Proteus spp. was expected to promote faster bacterial 
migration. After one day of incubation P. mirabilis had migrated and covered the 
whole of the first segment containing no antimicrobial agent. After two days of 
incubation, P. mirabilis had budded from a point around the circumference of the 
inner zone containing the MIC of the given antimicrobial agent. Within a total of three 
days P. mirabilis had grown across the surface of all three zones of the triphasic circle 
plate. The bacterial growth was made evident by a clear decolourisation of the media 
when the triphasic circle plate was positioned against a light box (Appendix Figure 
A.2). 
 
The rates of resistance evolution appeared to differ significantly based on the 
organism utilised within the proposed experimental evolution model. After one day 
incubation E. coli, had migrated 25mm, and the daily growth of the bacterium within 
the triphasic circle plate was almost immeasurable. After two weeks, E. coli had 
migrated a total of 37mm within the initial phase containing no antibiotic. In addition, 
the growth of E. coli was morphologically dissimilar to that observed for P. mirabilis 
with sporadic growth within initial zone of the triphasic circle plate (Appendix Figure 
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A.3). Interestingly, no contamination was observed within the altered triphasic circle 
plate method for the two organisms. 
 
3.3.5.2 The altered triphasic circle plate experiment with M9 minimal media: 
resistance evolution of P. mirabilis and E. coli under trimethoprim exposure     
 
As with the previous methods detailed within this chapter, it was decided to repeat the 
experiment with the inclusion of M9 minimal media alongside MH agar. The results 
uncovered comparable results with that observed in section (3.3.5.1) using MH agar.  
Following day one of incubation E. coli had migrated 31mm within the initial phase of 
the plate containing no antimicrobial agent. Conversely, zonal separation was 
observed on day one, where the phases moved upon manipulation. This resulted in 
the termination of the experiment following day two of incubation.  After two days, E. 
coli had migrated a further 1mm within the initial zone. In contrast, ensuing one-day 
incubation P. mirabilis had migrated 51mm within the initial zone containing no 
antimicrobial agent. After day two the P. mirabilis had evolved resistance to 
trimethoprim, through migrating 80mm and encompassing the entire phase containing 
the MIC of the antimicrobial agent.  
 
In comparison to the triphasic circle plate experiments utilising M9 minimal media, 
after day one of incubation, the plates appeared moist and it was difficult to visualise 
the growth of the inoculum for both E. coli and P. mirabilis. The plates were 
subsequently placed against a light source and the outline of the bacterial inoculum 
was marked. Analysis of the control plates revealed no bacterial growth on the plates 
containing no antimicrobial agent. Therefore, it was concluded that the original growth 
marked on the triphasic circle plate, was likely to be a watermark and not bacterial 
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growth.  Subsequently, the M9 minimal media triphasic circle plate experiments were 
terminated. A comparison of the bacterial growth of the two organisms on both MH 
and M9 minimal media within the triphasic circle plate over the two-day period of 
incubation can be found in the appendix (Figure A.4).  
The triphasic circle method was amended to decrease the amount of agar separation 
between zones, which was impeding bacterial migration. The alterations made to the 
triphasic circle plate experiment described in section (3.2.4.1) was successful as 
zonal separation was not observed during a two-week trial experiment. Despite, the 
effective alteration in experimental approach, there was concerns regarding the 
requirement of bacterial motility within the proposed model.   
 
3.3.6 Assessment of bacterial motility  
3.3.6.1 The motility stab test  
The motility stab test results indicated E. coli MG1655 is weakly motile (Figure 3.7), 
as shown by the marginal swarming from the initial line of inoculation into the 
surrounding media. This motile organism P. mirabilis was utilised within the motility 
test as the positive control. The results confirmed that E. coli MG1655 was 
considerably less motile than P. mirabilis, illustrated by the extensive diffusion 
throughout the medium by the motile organism. This provided a further explanation 
for the increased migratory rates of P. mirabilis observed within the triphasic circle 
plate experiments. Moreover, this result indicated that measures should be explored 
to enhance the bacterial motility of E. coli MG1655 for its application within the 
proposed experimental evolution model.  
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Figure 3.7 The motility stab test.  The image shows the motility stab test results for 
both E. coli (left) and P. mirabilis (right). A positive motility test result was indicated by 
the diffusion of bacterial growth from the initial point of inoculation into the 
surrounding media. P. mirabilis was used in this test as the positive control. 
 
 
3.3.6.2 Genomic analysis of motility  
The genomic analysis of motility was conducted primarily to screen for the presence 
of IS elements within the flhD promoter region of the flhD operon. The expected sizes 
of the PCR products when IS elements were present within the flhDC promoter region 
was 0.85kb. Gel electrophoresis of the five strains of E. coli indicated prominent flhDC 
expression in E. coli strains; CFT073, TPA2743 and TPA4792 (Appendix Figure A.5). 
However, under the selected PCR thermocycling conditions IS elements were not 
detected, as no bands were identified between 0.75 and 1.0kb.  This genomic results 
also suggested low expression of the flhDC operon within the E. coli strains MG1655 
and UTI89 as no bands were present at 0.75kb. Therefore, the reduced motility 
observed in E. coli MG1655, may be attributable to low levels of flhDC expression, 
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essential to the initiation of flagellar synthesis. To increase the likelihood of IS 
element detection, PCR reactions were repeated with an increased amplification time 
of ten minutes. The extended amplification time facilitated the identification of IS 
elements for the E. coli strains CFT073, TPA2743 and TPA4792. Similarly, the 
repeated PCR experiments revealed undetectable levels of flhDC expression within 
E. coli MG1655 again supporting the previous results of reduced motility within the 
proposed evolutionary models.  
 
3.3.6.3 Motility assay  
When analysing the literature for studies investigating the genomics of bacterial   
motility, it was noticed that phenotypic motility assays were conducted using broth 
solidified with bacteriological agar raging from 0.1-3% w/v. The qualitative results 
from the motility assays suggested that motility layers containing 0.3%-3% w/v agar 
could be utilised within the Triphasic circle method to increase motility of the weakly 
motile strains of E. coli (Appendix Figure A.6). 
 
3.3.7 The triphasic circle plate experiment: ARGP with 0.3% motility layer 
 
The Triphasic plate experiment was modified through the addition of a motility layer, 
and renamed the ARGP. The preliminary ARGP experiments were conducted on the 
E. coli strain MG1655 under gentamicin selection.  Initially a motility layer of 0.3% w/v 
agar was tested see below (Figure 3.8), however the liquid consistency made 
inoculation and incubator transfer extremely difficult. Following O/N incubation, the 
plates were concealed in bacterial growth, which reflected the consistency of the 
motility layer as opposed to the evolution of potentially drug resistant organisms. This 
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was confirmed by sampling organisms from the ARGP onto agar plates containing the 
MIC of gentamicin.  
 
 
Figure 3.8 The ARGP 0.3% motility layer. Figure displaying three replicates of  
E. coli MG1655 under gentamicin section following O/N incubation on the ARGP 
using a 3% motility layer. Images were taken using the G-Box imaging system.  
 
3.3.7.1 The triphasic circle plate experiment: ARGP with 3% Motility Layer 
To overcome the issues faced above (Section 3.3.7), the consistency of the motility 
layer was increased to 3% w/v agar. The consistency of this layer facilitated the 
precise inoculation of the initial zone containing no antibiotic. Following O/N 
incubation, the clear budding of bacterial colonies from the central zone into the 
phase containing the MIC was evident. Following day two of incubation the bacteria 
had migrated into the third phase containing x10 the MIC of gentamicin. The 0.3% w/v 
motility layer, therefore successfully permitted the visualisation of the evolution of 
bacterial resistance across an antibiotic landscape (Figure 3.9).  The distinct buds of 
bacterial colonies, were sampled daily and cryopreserved for later genomic analysis.  
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Figure 3.9 The ARGP 3% motility layer: E. coli MG1655. G–Box images taken 
displaying the resistance evolution of E. coli MG1665 under gentamicin selection in 
the ARGP over a period of three days. The contrast in these images has been slightly 
adjusted to improve visualisation but otherwise remain unedited.  
 
 
To further test the consistency of the motility layer, the experiment was repeated with 
the inclusion of the uropathogenic strains of E. coli (UTI89, CFT073, TPA4792 and 
TPA2743). Prior to experimentation within the ARGP, antimicrobial susceptibility tests 
were conducted on all strains using the microbroth dilution assay (Section 2.4.1). The 
MIC of all four uropathogenic strains of E. coli under gentamicin selection was 
confirmed as 4mg/L.   
The antimicrobial concentrations within the phases of the ARGP were modified 
accordingly, before experiments were repeated with the inclusion of the 3% w/v 
motility layer.  The results confirmed that the 3% w/v agar consistency, enhanced 
bacterial motility and enabled the visualisation of resistance evolution. This can be 
seen below (Figure 3.10), where the uropathogenic strain of E. coli CFT073 evolved 
resistance to x10 the MIC of gentamicin in a period of two days as seen with E. coli 
MG1665. However, there are clear distinctions between the two bacterial strains in 
the patterns of resistance evolution across the antimicrobial landscape.  
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Figure 3.10 The ARGP 3% motility layer: E. coli CFT073. G–Box images taken 
displaying the resistance evolution of the uropathogenic strain of E. coli CFT073 
under gentamicin selection in the ARGP over a period of three days. The contrast in 
these images has been slightly adjusted to improve visualisation but otherwise remain 
unedited. 
 
 
 
3.3.8 Assessment of antimicrobial degradation and diffusion within the ARGP 
 
3.3.8.1 NMR spectra of the selected antimicrobial agents and media utilised 
within this study  
 
NMR was evaluated as a method to detect the presence of antimicrobial agents 
within the ARGP and to account for the degree of diffusion and degradation over the 
experimental time course. Initial NMR experiments were conducted on a range of 
antimicrobial agents and agarose in powdered form. Through the visual inspection of 
the stacked plot, the results were encouraging as distinctive peaks were observed 
specific to the given class of antimicrobial agents (Figure 3.11).  
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Figure 3.11 One-dimensional (1D) 1H NMR spectra. Image displaying the stack plot 
representative of the one-dimensional (1D) 1H NMR spectra of the antimicrobial 
agents: meropenem (purple), levofloxacin (green), gentamicin (red) and the agarose 
media (yellow) utilised within the study.  
 
Following the successful detection of the independent antimicrobial agents and 
agarose media using NMR, it was of interest to repeat the analysis to determine 
whether the principal antimicrobial agent gentamicin could be identified within MH 
agar samples at varying antibiotic concentrations. This was achieved using the boiling 
method. The (1D) 1H NMR Spectra below (Figure 3.12) displays three concentrations 
of gentamicin (0, MIC and x10 MIC), utilised within the ARGP model. When 
comparing the NMR spectra of gentamicin shown in blue within figure (3.11), to the 
spectra obtained in figure (3.12), there is a clear reduction in PPM when the 
antimicrobial agent is added to the agarose containing bacteriological growth media. 
The result suggested that the detection limits of NMR were not feasible for the 
identification and quantification of antimicrobial agents within agar samples.  
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Therefore, it was decided to implement another analytical approach which may 
provide greater sensitivity.  
 
 
Figure 3.12 Representative 1D 1H NMR spectra of the gentamicin agar extracts. 
Image displaying the stack plot representative of the one-dimensional (1D) 1H NMR 
spectra of the gentamicin MH agar extracts. The examined gentamicin agar extract 
concentrations included:  No antibiotic (0mg/L) (green), MIC (2mg/L) (blue) and X10 
MIC (20mg/L) (red).  
 
 
3.3.8.2 Quantification of antimicrobial diffusion and degradation using LC-MS 
 
Further investigation into the analytical approaches for aminoglycoside detection, 
revealed complications with the antimicrobial agent gentamicin. Gentamicin as a 
complex consists as four major components, denoted C1, C1a and C2, C2a which 
can be separated into three distinct groups (1-3) (Figure 3.13) (Heller et al., 2005). 
The importance of each component was uncovered when LC-MS was employed in 
the quantification of gentamicin as the four components had three different   
 molecular weights (Table 3.13). 
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Figure 3.13 2D molecular structure of the gentamicin complex.  Figure display 
the 2D structure of the gentamicin complex. The three sections labelled 1, 2 and 3 
represent the three major components C1, C1a and C2.  
 
 
Table 3.13 Gentamicin components and fragmentation for LC-MS. Table 
displaying the main mass spectrometric fragmentation pathways of the 
aminoglycoside gentamicin complex using LC-MS.  
 
Gentamicin Component m/Z of MH +Ion 
1 C2, C2a 464 
2 C1a 450 
3 C1 478 
 
 
The initial LC-MS method was developed primarily to determine whether LC-MS 
could be utilised as an analytical approach for the detection of antimicrobials within 
agar extracts of varying antibiotic concentrations. The LC-MS tabular and 
chromatogram output, suggested the presence of the gentamicin within the agar 
extracts (Figure 3.14). However, the calculated antimicrobial concentration values 
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were not as predicted, with the gentamicin concentrations being overestimated for all 
extracts except 40mg/L (Cal 5 40mg/L) (Table 3.14). Nonetheless, as a valid 
antimicrobial internal reference standard was not included in the initial analysis and 
that only one component of the gentamicin complex was considered, the calculated 
gentamicin concentrations were disregarded.  
 
Table 3.14 LC-MS tabular output for a series of gentamicin agar extractions. 
Table showing the LC-MS output following gentamicin agar extraction of a series of 
target antibiotic concentrations (1mg/L, 4mg/L, 10mg/L, 20mg/L and 40mg/L) and the 
corresponding calculated concentration value based on the LC-MS output.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Name Sample Type Area (cps) RT (min) Target 
[Conc]. 
(mg/L) 
Calculated 
[Conc]. 
(mg/L) 
Cal 1 1mg/l Standard 1.080e+04 2.09 1.00 N/A 
Cal 2 4mg/l Standard 1.810e+04 2.12 4.00 10.9 
Cal 3 10mg/l Standard 4.400e+04 2.09 10.0 14.4 
Cal 4 20mg/l Standard 2.230e+04 2.07 20.0 26.1 
Cal 5 40mg/l Standard 1.150e+04 2.12 40.0 35.5 
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Figure 3.14 The preliminary LC-MS chromatogram output of a series of 
gentamicin agar extractions. LC-MC chromatogram curves displaying the 
calculated concentrations of the antimicrobial agent gentamicin from the MH agar 
extracts.  
 
Following the qualitative assessment of gentamicin using LC-MS, kanamycin was 
added as an internal reference standard to facilitate the quantification of the 
gentamicin agar extracts.  Kanamycin was selected as the internal reference standard 
as it is an aminoglycoside antimicrobial agent of similar molecular weight to 
gentamicin.   
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The LC-MS quantification of gentamicin by LC-MS was performed on agar extracts of 
a series of gentamicin concentrations (4mg/L, 8mg/L, 10mg/L, 20mg/L and 40mg/L) 
spiked with 1mg/L of kanamycin. The LC-MS tabular output for the selected 
concentrations are discussed independently below, and the LC-MS chromatograms 
for the agar extractions can be found in the appendix (A.7-A.11).  
 
The LC-MS results for the 4mg/L gentamicin agar extracts (Table 3.15), indicated 
fairly accurate predictions of retention time. Though, inconsistencies were raised 
when looking at the area counts and predicted gentamicin concentrations. Like that 
seen previously, predicted concentrations were significantly higher than the expected 
4mg/L, with m/z 464 and 450 concentrations increased by fourfold.   
 
Table 3.15 LC-MS tabular output of the 4mg/L gentamicin extract. Displaying the 
LC-MS output of the three components of the gentamicin complex following the 
4mg/L gentamicin agar extraction. 
 
 
The LC-MS results for the 8mg/L gentamicin agar extracts (Table 3.16), were 
comparable to the 4mg/L agar extracts in terms of the predicted retention times. 
However, the ITSD area counts for all three gentamicin components were equal and 
the expected concentrations were in this case lower than the expected 8mg/L.  
4mg/L Gentamicin MH Agar Extract 
Compound Name Gentamicin 1 
(464.292/322.300) 
Gentamicin 2 
(450.317/322.200) 
Gentamicin 3 
(478.325/322.200) 
Expected RT 1.91 1.98 2.15 
Actual RT 1.93 1.95 2.12 
Area Counts  33200 64100 79000 
ITSD Area Counts 9430 9430 9430 
Amount (mg/L) 16.4 16.0 12.1 
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Table 3.16 LC-MS tabular output of the 8mg/L gentamicin extract. Displaying the 
LC-MS output of the three components of the gentamicin complex following the 
8mg/L gentamicin agar extraction. 
 
 
The LC-MS results for the 10mg/L gentamicin agar extracts (Table 3.17), were 
comparable to the 8mg/L agar extracts with equal ITSD area counts for all three 
gentamicin components and lower than the expected concentrations than 10mg/L.  
 
Table 3.17 LC-MS tabular output of the 10mg/L gentamicin extract. Displaying 
the LC-MS output of the three components of the gentamicin complex following the 
10mg/L gentamicin agar extraction. 
 
10mg/L Gentamicin Mueller Hinton Agar Extract 
Compound Name Gent 1 
(464.292/322.300) 
Gent 2 
(450.317/322.200) 
Gent 3 
(478.325/322.200) 
Expected RT 1.91 1.98 2.15 
Actual RT 2.04 2.08 2.21 
Area Counts 17300 37100 48900 
ITSD Area Counts 10400 10400 10400 
Amount (mg/L) 7.80 8.42 6.83 
 
 
The LC-MS results for the 20mg/L gentamicin agar extracts (Table 3.18), again had 
equal ITSD area counts for all three gentamicin components with even lower than the 
expected concentrations than that seen with the 10mg/L extracts.  
 
8mg/L Gentamicin Mueller Hinton Agar Extract 
Compound Name Gent 1 
(464.292/322.300) 
Gent 2 
(450.317/322.200) 
Gent 3 
(478.325/322.200) 
Expected RT 1.86 1.93 2.10 
Actual RT 1.96 1.93 2.10 
Area Counts  234000 46700 53800 
ITSD Area Counts 19700 19700 19700 
Amount (mg/L) 5.53 5.58 3.95 
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Table 3.18 LC-MS tabular output of the 20mg/L gentamicin extract. Displaying 
the LC-MS output of the three components of the gentamicin complex following the 
20mg/L gentamicin agar extraction. 
 
The LC-MS results for the 40mg/L gentamicin agar extracts, again had equal ITSD 
area counts for all three gentamicin components, and surprisingly all three 
components displayed the lowest predicted concentrations of all tested gentamicin 
agar extracts.  
 
 
 
 
 
 
 
 
 
 
 
 
20mg/L Gentamicin Mueller Hinton Agar Extract 
Compound Name Gent 1 
(464.292/322.300) 
Gent 2 
(450.317/322.200) 
Gent 3 
(478.325/322.200) 
Expected RT 1.97 2.05 2.22 
Actual RT 2.01 2.04 2.17 
Area Counts  19600 36400 71600 
ITSD Area Counts 15700 15700 15700 
Amount (mg/L) 5.83 5.47 6.61 
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Table 3.19 LC-MS tabular output of the 40mg/L gentamicin extract. Displaying 
the LC-MS output of the three components of the gentamicin complex following the 
40mg/L gentamicin agar extraction. 
 
 
 
The results indicated variable responses for m/z 478, 464 and 450 (C1, C2+C2a and 
C1a), within samples of the same antimicrobial concentration. This strongly suggests 
inconsistencies within the gentamicin extraction method. Of the three components, it 
seems m/z 478 would be most appropriate in the detection of gentamicin within the 
agar extracts.  
Looking at the graph (Figure 3.15) of all three components of the gentamicin complex, 
an inverse relationship is seen between antimicrobial concentration and peak area, 
again supporting the evidence that the extraction method requires optimisation prior 
to accurate quantification of gentamicin within the ARGP. 
 
40mg/L Gentamicin Mueller Hinton Agar Extract 
Compound Name Gent 1 
(464.292/322.300) 
Gent 2 
(450.317/322.200) 
Gent 3 
(478.325/322.200) 
Expected RT 1.90 1.97 2.14 
Actual RT 2.02 1.99 2.43 
Area Counts  24500 48500 65300 
ITSD Area Counts 30800 30800 30800 
Amount (mg/L) 3.71 3.71 3.07 
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Figure 3.15 LC-MS gentamicin agar extraction quantification. Graph showing the 
LC-MS output of the five different concentrations of the gentamicin agar extracts for 
the all three major components of the gentamicin complex: GEN 1 (464.292) (blue), 
GEN 2 (450.317) (orange) and GEN 3 (478.325) (grey).  
 
To conclude, having assessed all the LC-MS results, there was enough evidence to 
assume the presence of gentamicin within all MH agar extracts attained from the 
ARGP experiments. However, until the extraction protocol has been fully optimised, 
quantification of the antimicrobial concentrations within the agar extracts could not be 
accurately calculated using LC-MS.  
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3.3.9 Serial passage: laboratory strain E. coli MG1655 
To determine the optimal duration of incubation prior to serial transfer an automated 
12-hour growth curve was conducted in MH broth. As the mid-late exponential phase 
of bacterial growth is desirable, the results from the graph below indicate that serial 
transfer should occur after 4 hours incubation at 37C (Figure 3.16). It is important to 
acknowledge that as growth rate of E. coli MG1655 is inhibited under antimicrobial 
selection, the duration of incubation was increased where appropriate.  
 
Figure 3.16 Automated growth curve of E. coli MG1655 over 12-hours. Graph 
showing the OD600 values of six parallel evolving populations of E. coli MG1655 
during a 12-hour growth curve using the TECAN automated plate reader to determine 
the optimal time-period of incubation prior to broth transfer within the serial passage 
system.  
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The serial passage results for E. coli MG1655 were quantified by both OD 
measurements and CFU/mL calculations under antimicrobial selection with 
gentamicin and trimethoprim.  
 
The serial passage experiments were conducted with 3 parallel evolving populations 
of E. coli in triplicate (E1-E9) over a series of increasing antimicrobial concentrations.  
The results from the graph below displaying the OD measurements of E. coli MG1655 
under gentamicin selection, revealed similar trends for all 9 parallel evolving 
populations at most of selected antimicrobial concentrations. What is evident is the 
fluctuations in OD which occur between transfer (Figure 3.17). The OD values appear 
to rapidly increase followed by periods of rapid decline, which may reflect the 
population bottlenecks which arise during serial passage. To comprehend this further 
bacterial counts were performed and CFU/mL were calculated at each of the 
antimicrobial concentrations.  
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Figure 3.17 Serial passage of E. coli MG1655 under gentamicin selection. Graph 
displaying the evolution of gentamicin resistance for three parallel evolving 
populations of E. coli in triplicate (E1-E9) measuring the OD600 over increased 
concentrations of gentamicin within a serial passage system.  
 
Consistent with the results obtained from the OD measurements, comparable trends 
are seen with the log10 CFU/mL calculations, with parallel populations displaying 
similar phenotypic trajectories (Figure 3.18). Repeatedly, periods of rapid bacterial 
growth are followed by significant log reductions. This is demonstrated at 160mg/L of 
gentamicin where all parallel evolving strains appear to be non-growing, until serial 
transfer into a higher antimicrobial concentration where growth rapidly resumes. This 
could be attributable to mutagenesis events.  
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Figure 3.18 Bacterial counts from the serial passage of E. coli MG1655 under 
gentamicin selection. Graph displaying the evolution of gentamicin resistance for 
three parallel evolving populations of E. coli in triplicate (E1-E9) measuring the 
bacterial colony counts (log10 CFU/mL) over increased concentrations of gentamicin 
within a serial passage system.  
 
 
3.3.9.1 Serial passage: E. coli MG1655 under trimethoprim selection   
 
Serial passage experiments were repeated with the inclusion of the antimicrobial 
agent trimethoprim. The OD measurements unlike that for E. coli under gentamicin 
selection, showed inconsistencies between the 9 parallel evolving populations at the 
lower antimicrobial concentrations, apparent at 10 and 12mg/L (Figure 3.19). 
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Figure 3.19 Serial passage of E. coli MG1655 under trimethoprim selection. 
Graph displaying the evolution of trimethoprim resistance for three parallel evolving 
populations of E. coli in triplicate (E1-E9) measuring the OD600 over increased 
concentrations of trimethoprim within a serial passage system.  
 
 
The results from the log10 CFU/mL calculations showed less fluctuations in terms of 
the periods where rapid bacterial growth followed rapid decline, yet this trend was 
seen at the two extremes of the selected trimethoprim concentrations, particularly 10-
12mg/L and 160-360mg/L (Figure 3.20).  
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Figure 3.20 Bacterial counts from the serial passage of E. coli MG1655 under 
trimethoprim selection. Graph displaying the evolution of trimethoprim resistance 
for three parallel evolving populations of E. coli in triplicate (E1-E9) measuring the 
bacterial colony counts (log10 CFU/mL) over increased concentrations of 
trimethoprim within a serial passage system.  
 
3.3.9.2 Serial passage: uropathogenic clinical strains of E. coli  
In agreement with the previous antimicrobial susceptibility results for the motile 
clinical strains of Escherichia coli UTI89, CFT073, TPA2743 and TPA4792. Serial 
passage experiments were not performed using the antibiotic Trimethoprim and 
experiments with clinical strains were repeated solely under gentamicin selection.  
 
Prior to serial passage experiments, a manual growth curve was conducted on the 
four new clinical strains to determine the optimal period of incubation prior to transfer 
(Figure 3.21). As expected, there are clear discrepancies between the OD 
measurements for the four strains over the 12-hour period. Here when looking at the 
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averaged OD measurements, the mid-late exponential phase of growth for all four 
clinical strains appears to occur later than that seen with E. coli MG1655 at around 
the 7-hour time point.  
 
 
Figure 3.21 Manual growth curve of uropathogenic strains of E. coli over 12-
hours. Graph showing the averaged OD600 values of four uropathogenic strains of E. 
coli (UTI89, CFT073, TPA2743 and TPA4792) over a 12-hour growth curve, to 
determine the optimal time-period of incubation prior to broth transfer within the serial 
passage system.  
 
The serial passage experiments for the four clinical strains were conducted with 3 
parallel evolving populations per strain (E1-E3).  The graph displaying the averaged 
OD of the four strains showed a rapid reduction upon the first transfer into a broth 
containing antimicrobial agent (Figure 3.22). This was then followed by bacterial 
growth recovery and maintenance with fluctuations occurring between OD600 of 0.6 
and 1 OD units. When comparing these results to that of E. coli MG1655 there is a 
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clear difference in the magnitude of growth fluctuations observed, with the most 
pronounced reduction here being for the CFT073 strain at 40mg/L gentamicin. 
 
 
Figure 3.22 Serial passage of uropathogenic E. coli strains under gentamicin 
selection. Graph displaying the evolution of gentamicin resistance for four parallel 
evolving populations of uropathogenic strains of E. coli (UTI89, CFT073, TPA2743 
and TPA4792), measuring the averaged OD600 over increased concentrations of 
gentamicin within a serial passage system.  
 
 
When comparing the serial passage OD results of the clinical strains to that of the 
log10 CFU/mL calculations, the results are highly comparable (Figure 3.23).  
Similarly, there is rapid log reduction in growth upon first transfer, this may 
attributable to bacterial stress responses. The bacterial growth of all strains is then 
recovered and keep relatively constant, until the rapid reduction in growth of strain 
CFT073 at 40mg/L.  In addition, these results can imply that under gentamicin 
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selection the four clinical strains of E. coli produce similar phenotypic responses, 
potentially indicating a degree of predictability.  
 
 
Figure 3.23 Bacterial counts from the serial passage of uropathogenic E. coli 
strains under gentamicin selection. Graph displaying the evolution of gentamicin 
resistance for four parallel evolving populations of uropathogenic strains of E. coli 
(UTI89, CFT073, TPA2743 and TPA4792) measuring the averaged bacterial colony 
counts (log10 CFU/mL) over increased concentrations of gentamicin within a serial 
passage system.  
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3.4 Discussion  
 
The chapter aims and objectives described in section (3.1) have been met as follows. 
After extensive provisional method development and optimisation, a finalised tool to 
explore the evolution of antimicrobial resistance over a spatial temporal antibiotic 
concentration gradient was established.  The application of this experimental 
evolution tool was directly compared to the traditional experimental evolution 
approach of serial passage.  
 
3.4.1 Experimental design and optimisation  
A major issue experienced with the initial experimental design, was the failed 
migration of the selected model organism E. coli. In regards to bacterial motility, two 
main processes can occur following the inoculation of bacteria onto agar, one being 
growth due to nutrient availability and secondly dispersion by cause of chemotaxis, 
which is dependent on a range of factors (Harshey, 2003). The first of these factors 
considered, was the inclusion of semi solid media. It is well established that  
surface motility is dependent on the moisture availability, and that the swarming of 
bacterial populations is enhanced at agar concentrations of 0.5%-0.7% w/v and 
compromised at concentrations exceeding 1% w/v (Wolfe and Berg, 1989; Croze et 
al., 2011). However, despite the alteration in agar consistency there was no 
significant improvement in the migration of the laboratory strain of E. coli.  
 
Ensuing the modifications in agar concentration, nutrient availability within the media 
was revised through the inclusion of M9 minimal media. The way in which bacterial 
populations respond to nutrient limitation can fluctuate significantly between 
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organisms (Martinez, Torello and Kolter, 1999; Toguchi et al., 2000). An initial 
assumption was made that following utilisation of inadequate nutrients within the zone 
of inoculation, bacterial populations would migrate towards a nutrient source in 
response to starvation, as seen with the intracellular signalling and subsequent 
fruiting body formation in Myxococcus xanthus (Shimkets, 1999). However, minimal 
media failed to support the swarming of E. coli within the proposed model (Section 
3.3.2.4), and instead swarming appeared to be restricted to the area of inoculation, a 
behaviour previously described by Harshey and Matsuyama (1994).   
 
Independent of the media condition and the corresponding effects on bacterial 
surface motility, the force of the antimicrobial selective pressure within the 
experimental model was considered. Bacterial adaptation can be hindered through 
the application of strong selective pressures to evolving bacterial populations (Baym 
et al., 2017). Further to the addition of an intermediate concentration forming the 
triphasic plate (Section 3.2.2), diphasic antimicrobial slopes were prepared (Section 
3.2.2.2), to reduce selective pressures and encourage bacterial adaptation. It was 
presumed that the gentle diffusion of antimicrobial agents at concentrations ≤MIC 
along an antimicrobial dose gradient, would replicate the selection of resistant 
bacteria in natural environments (Gullberg et al., 2011; Harmand et al., 2018).  
Despite these amendments, the suggested model was unsuccessful in the selection 
of antibiotic resistant bacteria.    
 
Considering the challenges faced above in the development of a spatial temporal 
gradient model, the filter tip method was introduced (Section 3.2.3).  The 
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experimental method proposed was subject to scrutiny as the oxygen availability 
within the system was unknown. E. coli is a facultative anaerobe, so although its does 
not require oxygen for growth, it preferentially utilises oxygen over the reduction of 
other compounds in its absence (Spiro and Guest, 1991). Oxygen availability has also 
been closely associated with bacterial motility in E. coli (Alder and Templeton, 1967; 
Douarche et al., 2012). This model effectively facilitated the vertical migration of 
bacterial populations by chemotaxis through the experimental system (Wang and 
Ford, 2010). However, concerns over oxygen availability and inconsistencies in the 
bacterial enumeration from tips presented more questions than answers.  
 
3.4.2 The analysis of bacterial motility  
The methods described in (Section 3.2.4) were enhanced through the inclusion of the 
E. coli strain MG1655, frequently employed in experimental evolution under controlled 
laboratory conditions to address a range of evolutionary questions (Marietou et al., 
2015; Fong, Joyce and Palsson, 2018; Knöppel et al., 2018). Despite the observed 
increase in motility of E. coli MG1655 when compared to other E. coli strains (Wood, 
2006), the E. coli MG1655 strain failed to migrate across the spatial temporal 
antibiotic gradient within the proposed model (Section 3.3.5). A key observation 
following the inclusion of E. coli MG1655, was the swarming of bacterial cells within 
the initial inoculum extending radially within the plate. The outward propelling motion 
of bacterial cells within the inoculum at the edge of the swarm, appeared to be 
inhibited at the boundaries of the Triphasic plate (Darnton et al., 2010). Based on 
these finding the model was altered to a circular format.  
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The motility of strains was investigated further following the inclusion of 
uropathogenic motile strains of E. coli (UTI89, CFT073, TPA2743 and TPA4792). 
Bacterial swimming motility was primarily investigated through the preparation of 
motility agar, by solidifying broth with 0.3-3% w/v bacteriological agar. The motility 
agar augmented the swimming motility for all E. coli strains and was therefore 
implemented into the ARGP model. The motility of strains was assessed more closely 
through genomic analysis.  Motility in E. coli is controlled through a master regulator 
known as the flhDC operon (Liu and Matsumura, 1994). The motility of E. coli strains 
can vary significantly, depending on the integration of insertion elements within the 
flhD operon (Blattner et al., 1997).  The results from the genomic analysis suggest no 
insertion elements within the version of E. coli MG1655 used within this study. Similar 
findings were identified by Barker, Pruß and Matsumura (2004), where strains of 
MG1655 lacking IS elements were poorly motile. The same study suggested that 
extended incubation of weakly motile strains in motility agar, can reveal motile 
subpopulations, which should be recommended for future experiments.  
3.4.3 Quantification of antimicrobial degradation and diffusion  
To validate the ARGP as a tool for exploring the evolution of antibiotic resistance, 
techniques should be in place to assess the extent of degradation and diffusion of 
antimicrobial agents (Bonev, Hooper and Parisot, 2008). This is essential as 
incubation conditions affect the stability of antimicrobial agents during in vitro 
Microbiological testing (Marchbanks, Yost and White, 1987). In addition, the decrease 
in antimicrobial activity due to degradation can compromise antimicrobial 
susceptibility results (Lallemand et al., 2016).  The concentration gradient present 
within ARGP, facilitates the diffusion of antimicrobial agents through the agar matrix 
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(Koch, 1999). The diffusion kinetics of antimicrobial agents within agar matrices is 
dependent on a range of factors including agar composition and the antimicrobial 
agent of choice (Kronvall,1983).  
The quantification of aminoglycosides by analytical techniques is difficult, owing to 
their highly polar nature and absence of strong chromophores for chromatographic 
detection (Lecároz et al., 2006). This was demonstrated with the complications faced 
in the detection of gentamicin within an agar matrix using NMR. As gentamicin, had 
been previously quantified in Mueller-Hinton agar by HPLC (Arcelloni et al., 2001), it 
was decided that liquid chromatography would be combined with mass spectroscopy 
to increase the sensitivity of the analytical approach (McGlinchey et al., 2008). The 
detection limits within LC-MS, allowed the detection of gentamicin at all selected 
concentrations. However, for the accurate quantification of gentamicin, the extraction 
procedure must be optimised to account for antibiotic loss during extraction which can 
be a very time-consuming process.  
3.4.4 The traditional serial passage approach  
Traditional experimental evolution approaches were based on serial passage in well 
mixed systems (Lenski et al., 1991). Serial passage is well-known for producing 
population bottlenecks, through the intermittent reduction in bacterial population size 
during transfer (Wahl, Gerrish and Voivod, 2002). This approach has been criticised 
for solely permitting the identification of single step resistant mutants, which can 
survive a given antimicrobial selective pressure (Palmer and Kishony, 2013). This 
approach has been included in this study for direct comparison with the ARGP, which 
facilitates the multi-step adaptive evolution of resistance over a spatial concentration 
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gradient of antibiotics.  
The comparative findings, support the accelerated resistance evolution within spatial 
concentration gradients (Zhang et al., 2011; Baym et al., 2016b). Nevertheless, the 
serial passage results presented some interesting findings. There were significant 
fluctuations in the growth of bacterial populations following transfer into increasing 
concentrations of antibiotics, where periods of drastically reduced growth followed 
rapid resistance development (section 3.3.9).  The phenotypic variants detected 
which displayed reduced growth and the ability to survive antimicrobial treatment, 
have been previously defined bacterial persisters (Orman and Brynildsen, 2016).  
Similar findings were observed by Levin-Reisman (2017), which suggested the 
incessant survival of sub-populations of bacterial persisters, permitted the 
establishment of highly resistance bacterial populations.  These findings signify the 
importance of antimicrobial tolerance in resistance evolution.  
3.4.5 Conclusion 
To conclude, after extensive modification the ARGP facilitates the visualisation of 
resistance evolution over a spatial gradient of antibiotics, which can be compared to 
traditional established evolutionary methods. However, the potential applications of 
this model will only be uncovered following the genomic analysis of the resistant 
evolved strains.  
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Chapter 4: Understanding the molecular mechanisms behind the evolution of 
aminoglycoside resistance in E. coli MG1655. 
 
4.1 Introduction  
From the development of sequencing methods in 1977 (Sanger, Nicklen and 
Coulson,1977; Maxam and Gilbert, 1977), to the first sequence of the human genome 
in 2001 (Venter et al., 2001), whole genome sequencing (WGS) technologies have 
revolutionised the field of genomics (van Dijk et al., 2014). With the increasing 
popularity of WGS, advancements have seen significant reductions in costs and WGS 
at unprecedented speeds with second and third generation sequencing technologies 
(Ambardar et al., 2016; Pareek, Smoczynski and Tretyn, 2011). The application of 
WGS technologies within the field of microbiology, has completely transformed the 
clinical diagnostic paradigm through improved clinical detection, drug susceptibility 
testing and epidemiological typing (Köser et al., 2012; Reuter et al., 2018; Fournier, 
Dubourg and Raoult, 2014).   
 
In addition, NGS technologies have facilitated the study of whole genome sequence 
variation, to provide insights into the adaptive evolution of bacterial populations 
(Bryant, Chewapreecha and Bentley, 2012). Such approaches have been utilised in 
the investigation of antimicrobial resistance, through the identification of resistance 
genes (Yoshida et al., 1990; Wang et al., 2016) and from a surveillance perspective 
to predict resistance using gene expression profiles (Bradley et al., 2015; Suzuki, 
Horinouchi and Furusawa, 2014).  
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Further to the horizontal acquisition of resistant genes, bacteria can evolve resistance 
through the acquisition mutations (Baquero and Blázquez, 1997; Woodford and 
Ellington, 2007). This is particularly pertinent in a time where sustained antimicrobial 
selective pressures are being placed upon bacterial populations (Alonso, Campanario 
E and Martínez JL, 1999). NGS permits the rapid detection of single nucleotide 
variants within bacterial populations, and through comparative genomics insights can 
be provided into molecular mechanisms underlying resistance development 
(Ramanathan et al., 2017).  
 
It is hypothesised that through comparative analysis SNPs will be identified which are 
unique to the gentamicin resistance isolate. It is also predicted that the likely locations 
of these SNPs will be within or associated with the antimicrobial target. The aim of 
this chapter is to genome sequence the sensitive and resistant isolates and through 
comparative genomics identify SNPs associated with the acquisition of gentamicin 
resistance. If gentamicin associated SNPs are identified it is likely these SNPs could 
be applied as markers for aminoglycoside resistance.  
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4.2 Materials and methods  
4.2.1 Whole genome sequencing at Microbes NG  
Genotypic analysis of both the sensitive and confirmed resistant bacterial isolates 
obtained from the ARGP, was achieved through WGS provided by Microbes NG. 
Here, sensitivity is defined as the inhibition of bacterial growth by a given 
concentration of antimicrobial agent. Details of the sequencing protocol and the 
principles behind illumina sequencing can be found in section (2.8.1).  
 
4.2.2 Whole genome assembly CLC  
The bacterial genomes were assembled in CLC genomics workbench 7.7.5. A full 
description of the assembly protocol is provided in section (2.8.2).  The newly 
assembled genomes were examined and genes interest were retrieved, these 
included known antimicrobial drug targets as well as genes associated with 
antimicrobial resistance. The genes of interest for both the sensitive and resistant 
genomes were exported and analysed using the alignment viewer aliview. 
 
4.2.3 Identification of genes of interest  
A preliminary search of the gentamicin antimicrobial drug targets was carried out 
using the bioinformatic and cheminformatic database DrugBank version 5.1.1 
(Wishart et al., 2018), and information regarding the pharmacodynamics and 
mechanism of action was obtained. Following this a more detailed search of the 
identified target genes was achieved using the database website EcoGene 
http://ecogene.org [accessed October 13, 2017] which dedicates itself to the 
improved functional annotation of the E. coli K-12 MG1655 genome and subsequently 
provided genomic and proteomic details (Zhou and Rudd, 2012). Using the proteomic 
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information obtained from EcoGene a final analysis was carried out using the online 
database STRING version 10.5 http://string-db.org [accessed July 30, 2018] to 
identify proteins forming functional interactions with the antimicrobial targets (Mering 
et al., 2003). This was achieved simply by supplying the protein name and the 
organism of interest.  
 
 
4.2.4 Genomic alignment using Mauve 
 
As previously described (Section 4.2.2) CLC workbench was used in the alignment 
and assembly of bacterial genomes to identify small-scale evolutionary changes 
including single nucleotide polymorphisms within known antimicrobial targets. In 
addition to these local changes, evolving bacterial populations can undergo more 
large-scale genome wide rearrangements, which were investigated using Mauve 
available at: http://gel.ahabs.wisc.edu/mauve [accessed August 18, 2018]. Mauve as 
a comparative genomics platform facilitates the investigation of all scales of 
evolutionary change which occur within bacterial genomes, through integrating large-
scale genomic analysis with multiple sequence alignment using locally collinear 
blocks (LCBs) (Darling et al., 2004). Details of the Mauve protocol utilised within this 
study can be found in section (2.8.3).  
 
4.2.4.1 SNP Identification 
The SNP export file produced by Mauve contained a list of node ID’s, SNP positions 
and the corresponding coding sequence (CDS) positions for both the sensitive and 
resistant genomes. Prior to analysis of SNPs, it was necessary to account for the 
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discrepancies in the annotations of the two genomes specifically the SNP position in 
relation to the designated scaffold or node ID.  
To obtain the nodal information and to ensure that the SNPs observed were located 
within coding regions of the genomes a python script named get_seq_go was used 
(Eldridge C, 2017). To execute the script, a text file was made containing a list of the 
node IDs for the two genomes and it is important to note that if duplicate IDs are 
present they must be formatted underneath each other within the file. An example of 
the format used in the node txt. file is presented below (Figure 4.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 The node text file format required for the get_seq_go script. An 
example of the format required for the execution of the get_seq_go script to obtain 
the nodal information from the two bacterial genomes. Information regarding the node 
number, length and coverage must be provided and node IDs must be formatted 
beneath each other.  
 
Subsequently, all script files must be located and placed within the same folder as the 
newly created node txt. file or alternatively a path must be written. Once terminal is 
opened the written command must be replicated per node for all genes indicating the 
presence of a SNP and their sensitive or resistant counterparts for comparison. Below 
is an example of the command used for the SNP indicated within node 38 of resistant 
genome (Figure 4.2).  
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Figure 4.2 The node command executed when running the get_seq_go script. 
An example of the command utilised when running the get_seq_go script for 
obtaining node 38 from the gentamicin resistant genome. The command must contain 
the relevant folder or path, the python script and the .txt file created in figure 4.1. The 
command was repeated for all nodes of interest indicated with SNPs for both the 
gentamicin sensitive and resistant E. coli MG1655 genomes.  
 
 
As previously stated, once the nodal information had been obtained using 
get_seq_go, it was necessary to retrieve the nucleotide sequences of the genes with 
SNPs from the corresponding nodes. This was achieved through use of the Genbank 
files to locate the Uniprot IDs (https://www.uniprot.org) and consequently retrieve the 
protein sequences of the SNP containing genes. The aligned protein sequences were 
then saved individually in fasta format. The sequence alignment tool Exonerate 
version 2.2 was downloaded from EMBL-EBI https://www.ebi.ac.uk/about/vertebrate-
genomics/software/exonerate [accessed October 30, 2018], to facilitate the mapping 
of protein coding genes within the genomic sequences contained within each node. 
To obtain the nucleotide sequences using the exonerate pairwise comparison model 
‘protein to genome’ both the query protein sequence and the target node sequence 
are required.  Below is an example of the command used to obtain the nucleotide 
sequence of the protein encoding clsC gene which was located within node 14 
(Figure 4.3).  
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Figure 4.3 The Exonerate command utilised to obtain the nucleotide sequences 
of genes within the nodes of interest.  An example of Exonerate command utilised 
to obtain the clsC gene sequence from node 14 of the gentamicin sensitive E. coli 
MG1655 genome. The command must contain the relevant folder or path, the nodal 
information obtain in figure 4.2, the clsC encoding protein sequence in. fasta format 
and the bacterial genetic code table 11 must be specified. The command was 
repeated for all genes with SNPs contained within the formerly obtained nodes.  
The final stage in the SNP identification process was to translate the retrieved 
nucleotide sequences from exonerate, to determine whether the single nucleotide 
changes observed result in alterations in amino acids. This was conducted within 
terminal using Transeq using all 6 open reading frames and the bacterial code 11. 
Below is an example of the command used to translate the nucleotide sequence of 
the clsC gene (Figure 4.4). The frame was the then selected with the longest open 
frame and the fewest stop codons and saved in fasta format for comparative analysis 
in an alignment viewer.  
 
 
Figure 4.4 The Transeq command utilised to translate the nucleotide 
sequences. An example of the command used to translate the clsC nucleotide 
sequence obtained from figure 4.3 to identify whether the SNPs were synonymous or 
non-synonymous. The command must contain the nucleotide sequence in. fasta 
format and the maximal number of reading frames (6) and the bacterial translation 
table (11) must be specified.  The command was repeated for all gene sequences 
identified with SNPs. 
 
 
 
 
 
 
  
 
 
142 
 
4.2.5 Proteome analysis using CD-HIT 
 
All protein annotations from the genbank files were extracted into one proteome file 
and subject to clustering, using a custom script available at: 
https://github.com/camilla-eldridge [accessed March 26, 2018]. CD-HIT was used to 
cluster and compare the sequences from the sensitive and resistant datasets, to 
reduce redundancy and improve subsequent bioinformatic analysis (Huang et al., 
2010). The programme cd-hit-2d which forms part of the CD-HIT package, allows the 
direct comparison of the two protein sequences facilitating the identification of novel 
proteins and thus allowing the elimination of contaminated proteins early in the 
bioinformatic analysis of sequences. Prior to running cd-hit-2d it was necessary to 
add unique headers and combine the sensitive and resistant proteomes for analysis. 
The executed commands used are shown below (Figure 4.5). 
 
 
Figure 4.5 The command utilised to prepare proteome files for the CD-HIT 
analysis.  The command utilised to add the appropriate headers to the gentamicin 
sensitive and resistant E. coli MG1655 proteome files, before combining the 
proteomes to a single file for the analysis within CD-HIT.   
 
Once the cd-hit directory was launched the preliminary step involves the identification 
of novel resistant proteins which are not present in the sensitive proteomes (1) and to 
identify the novel sensitive proteins which are not found in the resistant proteomes (2) 
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for the initial analysis clustering was achieved using default parameters with a 
sequence identity threshold (–c) of 1 for 100% ID (Figure 4.6).  
 
Figure 4.6 CD-HIT command for the identification of novel proteins. The 
command utilised to identify the novel sensitive proteins which are not found within 
the resistant proteome (1) and the novel resistant proteins not found in the sensitive 
proteome (2) using cd-hit-2d with a sequence identity threshold (–c) of 1 indicative of 
100% ID match.  
 
The outputs from the above commands were then used to detect the sensitive 
proteins which have not been identified in the resistant novel proteins (3) and 
secondly to identify the resistant proteins which are not found in the unique sensitive 
proteins (4) (Figure 4.7). This was achieved by clustering the outputs at 95% (-c = 
0.95), to enable the identification of nucleotide polymorphisms and to assist in the 
removal of potential contaminants.  
 
 
 
Figure 4.7 CD-HIT command for the identification of novel proteins with SNPs. 
The command utilised to identify the novel sensitive proteins which are not found 
within the resistant proteome (3) and the novel resistant proteins not found in the 
sensitive proteome (4) using cd-hit-2d with a sequence identity threshold (–c) of 0.95 
indicative of 95% ID match. 
 
The final stage in the proteome analysis using CD-HIT was to upload the identified 
novel protein variants from the sensitive and resistant datasets into NCBI: Protein 
BLAST and perform a standard blast search of the non-redundant protein sequence 
database. For the identification of protein contaminants, the organism was not 
specified.  
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4.3 Experimental results  
 
4.3.1 Whole genome sequencing  
 
WGS data obtained from Microbes NG revealed E. coli MG1655 resistant strain had a 
greater number of paired reads both before and after trimming within CLC, when 
compared to the E. coli MG1655 sensitive counterpart (Table 4.1). Despite the 
variations in coverage of the two sequenced genomes, strains were trimmed by 
90.54% and 89.47%, resulting in similar averaged lengths of 168.5 and 166.6 for the 
sensitive and resistant strains respectively (Figure 4.8). 
 
Table 4.1 Paired sequence read summary of the sensitive and resistant E. coli 
MG1655 genomes. Paired sequence read comparison for E. coli MG1655 sensitive 
and resistant genomes before and after trimming.  
 
E. coli MG1655 Sensitive Resistant 
Before Trim After Trim Before Trim After Trim 
Number of Reads 1,460,808 1,322,568 5,345,144 4,782,297 
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Figure 4.8 Sequence read analysis of the sensitive and resistant E. coli MG1655 
genomes. Graphical summary of E. coli MG1655 sensitive (A) and resistant (B) 
genome read length before and after trimming.  
 
 
 
4.3.2 CLC Sequence quality and trimming   
 
The sequences were then evaluated further by a range of analyses examining the 
genomes per sequence, per base and by assessing over representation. These 
analyses were conducted to ultimately improve sequence quality and will be 
discussed sequentially.  
 
4.3.2.1 Per sequence- length distribution analysis  
The length distribution analysis summarises the frequencies of observed sequence 
lengths, by considering the number of sequences occurring at the specific sequence 
length and comparing this to the total number of sequences to obtain a percentage. 
The results show for the two strains of E. coli MG1655, similar sequence lengths 
discussed above (Section 4.3.1), with sequences covering 38-254 base pairs before 
A B 
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being trimmed. Following trimming, no sequences were preserved below 50 and 
above 229 base pairs for the two genomes respectively.  Further, the distribution of 
most of the sequences for the two genomes post trimming, were above 204 base 
pairs (Figure 4.9).  
 
 
Figure 4.9 Length distribution analysis of the sensitive and resistant E. coli 
MG1655 genomes. The distribution of sequence length of the sensitive and resistant 
strains of E. coli MG1655 produced by illumina sequencing, before and after 
trimming.  
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4.3.2.2 Per sequence- GC content analysis  
The GC-content analysis summarises the distribution of GC bases compared to all 
other bases within the genomes, including those that are considered ambiguous. The 
results show similar GC-content for the two genomes before and after trimming 
(Figure 4.10). The GC contents of the two sequences ranged from approximately 
25% to 70%, with GC-contents peaking at 50%. This value correlates with the 
accepted GC content of 50.8% for E. coli K12.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 GC content analysis of the sensitive and resistant E. coli MG1655 
genomes. The GC content length for the sensitive and resistant strains of E. coli 
MG1655 produced by illumina sequencing, before and after trimming.  
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4.3.2.3 Per sequence- quality distribution analysis  
The quality distribution analysis summarises the distribution of averaged sequence 
quality scores using the arithmetic mean of its base qualities. Prior to trimming the 
phred score for the sensitive and resistant genomes ranged from 20 to 40 and 23 to 
40 respectively (Figure 4.11). Post trimming, the sensitive genome had quality scores 
between 27 to 40, with 87% of sequences scoring between 35 and 40.  When 
comparing this to the resistant genome after trimming had quality scores ranging 
between 28 to 40, with 91% of sequences scoring between 35 and 40.  
 
 
Figure 4.11 Quality distribution analysis of the sensitive and resistant E. coli 
MG1655 genomes. The averaged PHRED score for the sensitive and resistant 
strains of E. coli MG1655 produced by illumina sequencing, before and after 
trimming.  
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Resistant  
  
 
 
149 
4.3.2.4 Per base- coverage analysis  
The per base coverage analysis summarises the number of sequences which cover 
the individual base positions within the genomes. For the two genomes, the base 
coverage is similar pre- and post-trimming with a higher percentage coverage for 
base positions lower than 100 (Figure 4.12).   
 
 
 
Figure 4.12 Coverage analysis of the sensitive and resistant E. coli MG1655 
genomes. The percentage coverage per base position for the sensitive and resistant 
strains of E. coli MG1655 produced by illumina sequencing, before and after 
trimming.  
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4.3.2.5 Per base- nucleotide contribution analysis  
The nucleotide contribution analysis summarises the coverage of all four DNA 
nucleotides and ambiguous bases at the individual base positions across the 
genomes. The nucleotide contributions prior to trimming showed great fluctuations 
ranging from approximately 12-40% for all nucleotides for the first 20 bases, for both 
the sensitive and resistant genomes (Figure 4.13). Fluctuations were also present at 
a later base position 240, with a peak in the contribution of the nucleotide adenine 
and a reduction in nucleotide cytosine within both genomes.  
 
 
Following trimming, nucleotide contributions for both sequence had levelled however, 
there were slight differences observed between the two genomes. Within the 
sensitive genome nucleotide contributions were even at 25% across all base 
positions. Whereas, within the resistant genome the nucleotide contributions were 
even at 26% for nucleotides Guanine and cytosine, and even at a slightly lower 24% 
for thymine and adenine (Figure 4.13).  
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Figure 4.13 Nucleotide contribution analysis of the sensitive and resistant E. 
coli MG1655 genomes. The nucleotide contributions per base position for the 
sensitive and resistant strains of E. coli MG1655 produced by illumina sequencing, 
before and after trimming.  
 
 
4.3.2.6 Per base- GC content analysis 
 
The GC content analysis summarises the cumulative coverage of G and C bases, but 
in this instance per base across the two genomes.  As seen above with the nucleotide 
contribution, prior to trimming fluctuations are present between the two sequences 
ranging from approximately 30-70% GC contents for the first 20 base positions 
(Figure 4.14).  Following trimming, the GC contents had levelled between 50 and 51% 
over the 240 base positions for the two genomes respectively. This value again 
correlates with the accepted 50.8% GC content for E. coli K12 (Figure 4.14).   
Before Trimming  
Resistant  
Sensitive  
After Trimming  
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Figure 4.14 GC content per base analysis of the sensitive and resistant E. coli 
MG1655 genomes. The GC content per base position for the sensitive and resistant 
strains of E. coli MG1655 produced by illumina sequencing, before and after 
trimming. 
 
 
4.3.2.7 Per base- quality distribution analysis 
 
The quality distribution analysis summarises base quality along the base positions of 
the two genomes. The phred score quality distributions were very similar for the two 
genomes, with values ranging from 26-40 and 27-40 for the first 100 base positions 
for the sensitive and resistant genomes respectively, prior to trimming. Similarly, at 
base positions exceeding 100, there was a clear reduction in quality distribution for 
the 5%ile, with phred score values as low as 12 for the two genomes before trimming 
(Figure 4.15). Following trimming, the overall quality distribution was enhanced with 
Before Trimming  After Trimming  
Sensitive  
Resistant   
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phred score values of 35-40.  Improvements were also evident within the 5%ile where 
phred scores increased to >20 across all base positions for the two genomes (Figure 
4.15). 
 
 
 
 
Figure 4.15 Quality distribution per base analysis of the sensitive and resistant 
E. coli MG1655 genomes. The quality distribution analysis per base position for the 
sensitive and resistant strains of E. coli MG1655 produced by illumina sequencing, 
before and after trimming. 
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4.3.2.8 Over-representation enriched 5mers analysis  
 
The Enriched 5mers Analysis summarises the ratios of the observed and expected 
5mers along base positions across the two genomes. Before trimming, there was 
substantial fluctuation in the contributions of all 5mers with coverages ranging from 0-
0.55 and 0-0.57 for the first 20 base positions for the sensitive and resistant genomes 
respectively (Figure 4.16). At base positions between 20 to 240, 5mers were equably 
represented with coverages ranging between 0.2 and 0.3%, with a slight under 
representation of AAAAA for the two genomes. At base positions exceeding 240, 
there was an over representation of AAAAA and an under representation of TGGCG 
for the two genomes.  
 
Following trimming, the overall representation of 5mers had been reduced to between 
0.2-0.3% for the two genomes across all base positions. Consistent to the findings of 
the nucleotide distribution analysis, within the resistant genome there is a distinct 
separation, in this case of 5mers TTTTT and AAAAA with coverages ranging between 
0.22-0.25% and 5mers GCTGG and CCAGC with a coverage of 0.3% (Figure 4.16). 
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Figure 4.16 Over-representation analysis of the sensitive and resistant E. coli 
MG1655 genomes. The enriched 5mers analysis for the sensitive and resistant 
strains of E. coli MG1655 produced by illumina sequencing, before and after 
trimming. 
 
4.3.3 Identification of genes associated with aminoglycoside resistance  
Having assembled the two bacterial genomes to a high quality. CLC was used to 
perform a preliminary search of the antimicrobial drug targets. The aminoglycoside 
gentamicin provided the antimicrobial selective pressure in the sequenced resistant 
strain of E. coli MG1655. Aminoglycosides exert their activity, by binding to specific 
regions of the 70s-bacterial ribosome, principally through precise interactions with the 
16s rRNA at the decoding region of the A-site tRNA, which interrupts ribosomal 
protein synthesis (Wong et al., 1998). Further structural studies, have revealed 
gentamicin forms precise interactions within the binding pocket of the major grove of 
the A-site tRNA and through lateral proximity with the ribosomal subunit protein S12 
Before Trimming  After Trimming  
Sensitive   
Resistant    
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(Yoshizawa et al., 1988 and Demirci et al., 2013). Supported by the gentamicin drug 
target information obtained, an initial CLC search was performed on the 16s rRNA 
genes, of which there are seven variants in E. coli and the 30s-ribosomal subunit 
protein S12, encoded by the rpsL gene. 
 
The preliminary CLC search revealed no mutations within the rpsL gene, however 
mutations were found in two of the seven 16s rRNA genes; rna123 and rna154. The 
precise locations of the single nucleotide changes within the 16s rRNA genes are 
presented as alignment images obtained from Aliview. There were five mutations 
identified within the rna123 gene, ranging from base positions 208 to 273 (Figure 
4.17). When comparing this to the mutations found within the rna154 gene, there 
were a total of six mutations, but in two separate locations. Five of the six rna154 
mutations were identified at base positions between 79 to 93, and one mutation was 
found at position 226 (Figure 4.18). Interestingly, the mutation at position 226 was 
identified in both the rna123 and rna154 genes independently.  
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To broaden the search further, and to identify other genes potentially associated with 
the acquisition of gentamicin resistance, it was necessary to understand the highly 
coordinated 30s-ribosomal subunit assembly in greater detail. Particularly, with 
regards to the interactions of the 16s rRNA with the twenty 30s-ribosomal subunit 
proteins (Figure 4.19).  The assembly can be split into three based on the proteins 
which associate with the 16s rRNA in the early, mid or late stages of assembly 
(Holmes and Culver, 2005).  Highlighted in green is the gentamicin 30s-ribosomal 
subunit target protein S12, which associates early in the 30s-ribosomal subunit 
assembly with the16s rRNA in the body formation.  The interaction analysis of S12, 
revealed key associations with the primary binding proteins S5 and S17. Based on 
this, both the rpsE and the rpsQ genes which encode the S5 and S17 protein 
respectively, were searched within CLC however, no mutations were identified.  
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Figure 4.19 Schematic representation of the 30s-ribosomal subunit assembly. 
Diagram displaying the interactions between the 16s rRNA domains and the 30s 
ribosomal subunit proteins in the 30s-ribosomal subunit assembly. The arrows 
represent the hierarchical binding of the r-proteins which can be characterised into 
early, mid or late binding proteins depending on how early the r-proteins associate 
with the 16s rRNA domains in the 30s-ribosomal subunit assembly.  The ribosomal 
protein S12 has been highlighted as it is a gentamicin target protein.  
 
 
Subsequently, STRING was used to predict any additional protein interactions of the 
rpsL gene. The rpsL network identified using STRING, contained 11 nodes and 55 
edges, with a PPI enrichment p-value of 3.26e-13. All 11 proteins formed structural 
constituents of the ribosome playing key roles in the biological processes of gene 
expression and translation (Figure 4.20). A presumptive search of the 11 proteins was 
conducted in CLC, together with the remaining 8 30s-ribosomal subunit proteins, and 
again no mutations were identified.  
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Figure 4.20 STRING protein association network of the rpsL gene. Image 
displaying the predicted interactions of the ribosomal subunit protein S12 encoded by 
the rpsL gene. The coloured nodes represent the first shell of protein interactors with 
predicted 3D structures available. The edges or lines between the proteins are 
coloured based on type of interaction: gene neighbourhood (green), gene fusions 
(red), gene co-occurrence (dark blue). The thickness of the lines relates to the data or 
evidence available in support of the predicted interaction.   
 
 
 
4.3.4 Genome sequence alignment in Mauve 
 
Mauve was then used to Identify any large scale evolutionary events, between the 
sensitive and resistant genomes.  Firstly, the sensitive and resistant genomes were 
independently aligned to the E. coli K-12 MG1655 reference genome.  
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The initial alignment and movement of contigs of the sensitive strain to the reference 
genome, revealed a total of four LCBs, with a minimum weight of 1809. The total LCB 
length was 1173254 weighing 1182222 (Figure 4.21). Further assessment of LCBs 
revealed regions within the blocks which were not entirely coloured. The alignment 
was then magnified in order to examine the annotated CDS features, and segments 
of missing DNA were identified. On closer inspection, most gaps within the alignment 
were for genes encoding transposases. 
 
When comparing this to the alignment of the resistant strain against the reference 
genome. There was a total of two LCBs with a minimum weight of 15511. The total 
LCB length was 4542957 weighing 4584001 (Figure 4.22). The central region of the 
LCB was connected by a single line indicative of homologous regions the genome. As 
seen with the sensitive genome gaps were identified within transposase encoding 
genes.  
 
The final stage after the alignment and movement of contigs to the E. coli reference 
genome, was to align the sensitive and resistant genomes independently. A total of 
one LCB was identified, with a LCB length of 4574064 weighing 4577513 (Figure 
4.23). There was a drastic reduction in the number of genomics gaps identified, with 
conserved segments free of rearrangements or large scale evolutionary events.  To 
assess the small scale evolutionary events, single nucleotide changes between the 
two genomes were exported.  
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4.3.4.1 Mauve SNP identification  
 
After the successful alignment of the sensitive and resistant genomes within Mauve. 
The SNP export function was utilised, to identify the single nucleotide changes 
observed within the two genomes. A total of 1,166 SNPs were identified, with equal 
representation of 583 SNPs per genome. Following SNP identification, scripts were 
used to examine the SNP raw export file, to identify the SNPs which occur within 
coding regions of the genomes (Appendix table A.1). Confirmatory manual checks of 
SNP export files were also conducted. A total of 143 SNPs were identified between 
the sensitive and resistant genomes.  
 
Following the identification of the nodes containing SNPs within the coding regions of 
the genomes, it was necessary to identify the genes present within each node 
containing the SNPs for the both the sensitive and resistant genomes (Table 4.2).   
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Table 4.2 Mauve node SNP summary.  Table displaying the nodes containing genes 
with SNPs and the corresponding CDS positions within the gentamicin sensitive and 
resistant genomes of E. coli MG1655.  
 
Strain Node Gene CDS Position 
 
 
 
 
Sensitive 
2 yjeO 112915 
113217 
20 ldrD_2 59566 59673 
57 spoIIIE 1114 2310 
15 fusA 333 2447 
59 pinR 673 1263 
14 mdoG 98749 100251 
 
Resistant 
16 mdoC 98976 100133 
15 fusA 333 2447 
58 spoIIIE 1307 2089 
59 pinR 673 1263 
 
Once the genes containing SNPs had been identified, it was essential to obtain the 
nucleotide sequences. This was achieved using the script get_seq_go.py, first by 
obtaining the nodes containing the SNPs and secondly using the CDS positions 
retrieving the sequences.  
 
A subsequent BLAST search of all sequences, revealed that the SpoIIIE gene which 
encodes a DNA translocase was a contaminant from organism Bacillus subtilis. The 
remaining nucleotide sequences were translated in order to eliminate synonymous 
mutations, leaving only those non-synonymous mutations which cause alterations in 
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the amino acid sequence of proteins. Two of the genes identified; the ldrD_2 small 
toxic polypeptide encoding gene and the yjeO inner membrane protein encoding gene 
contained synonymous mutations, resulting in no alterations in amino acid sequence. 
The mdoC and mdoG genes were ignored as there were different annotations for the 
same gene, which might be representative of misannotation and neither genes have 
an amino acid change. Leaving the fusA and pinR genes which contained non-
synonymous mutations.  
 
The fusA gene is 2113 nucleotides in length and encodes the protein Elongation 
Factor G.  The fusA gene was identified with one SNP at position 1828, here the 
nucleotide cytosine (C) was mutated to adenine (A) in the resistant strain (Figure 4.24 
A). The given mutation identified resulted in an amino acid change at position 610 
from a proline (P) to a threonine (T) residue respectively (Figure 4.24 B).  
 
The pinR gene is 591 nucleotides in length, and encodes the protein Serine 
Recombinase.  The pinR gene was identified with one SNP at position 8, here the 
nucleotide Guanine (G) was mutated to adenine (A) in the resistant strain (Figure 
4.25 A). This mutation resulted in an amino acid change at position 3 from an arginine 
(R) to a Glutamine (Q) residue respectively (Figure 4.25 B).  
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To determine any functional interactions between the mutated fusA and pinR genes, 
STRING was utilised.  The precise interactions of the proteins containing SNPs could 
be indicative of key pathways associated with gentamicin resistance.  
 
The fusA network contained a total of 11 nodes plus 55 edges with a PPI enrichment 
p-value of 6.27e-11. All the 10 identified proteins within the fusA network formed 
structural constituents of the ribosome and were involved in the biological processes 
of gene expression and translation (Figure 4.26). The network comprised of ribosomal 
proteins for the small 30s and large 50s ribosomal subunits encoded by the rps and 
rpl genes respectively. Of significant importance, is the evidence suggesting a 
functional link between fusA and the rpsL gene, a known gentamicin target. The two 
genes have an intergenic distance of 664bp (score 0.535), are both involved in RNA 
binding and have fundamental roles during translation.  
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Figure 4.26 STRING protein association network of the fusA gene. Image 
displaying the predicted functional interactions of the ribosomal protein EF-G encoded 
by the fusA gene. The coloured filled nodes indicate the primary protein interactors 
with known 3D structures. The lines or edges represent the known or predicted 
interactions and the line thickness correlates to the evidence available in support of 
the specific interaction.  
 
The pinR network contained a total of 8 nodes plus 18 edges with a PPI enrichment 
p-value of 0.000835. This indicated that the network had significantly more 
interactions than expected (Figure 4.27). The network identified the pinR gene as a 
Rac Prophage with both recombinase and resolvase activity. The majority of proteins 
connections within the network comprised of prophages (pinQ, tfaR, tfaQ and YnaK) 
or prophage components (ynaE and rzoR). An additional experimentally determined 
interaction of pinR was with the polA gene a fused DNA polymerase with exonuclease 
activity (Score 0.460).  
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Figure 4.27 STRING protein association network of the pinR gene. Image 
displaying the predicted interactions of the putative serine recombinase PinR. Empty 
coloured nodes represent query proteins and first shell interaction proteins with 
unknown 3D structures.  The lines or edges can be coloured based on other 
interactions in addition to those which or known or predicted. The yellow/green line 
represents text mining evidence and the black line suggests evidence of 
coexpression.  
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4.3.5 Proteome analysis using CD-HIT  
 
Proteome analysis using CD-Hit was used as a confirmatory test for the identification 
of mutated proteins within the sensitive and resistant proteomes, but also to analyse 
the extent of contamination for the improvement of subsequent bioinformatic 
analyses.  
 
The initial analysis within CD-Hit was conducted to identify any novel proteins which 
were not 100% identical for the sensitive and resistant proteomes.  The analysis 
revealed 13 novel proteins within the sensitive strain (Table 4.3) and 30 novel 
proteins within the resistant strain (Table 4.4).  
 
Table 4.3 The non-identical proteins within the proteome of the sensitive strain 
of E. coli MG1655. Summary of the non-identical proteins identified in the proteome 
of the gentamicin sensitive E. coli MG1655 strain. 
 
CD-Hit Non-Identical Proteins Sensitive Strain 
1 sensitive_hypothetical protein 
2 sensitive_hypothetical protein 
3 sensitive_hypothetical protein 
4 sensitive_putative deoxyribonuclease RhsB 
5 sensitive_Putative deoxyribonuclease RhsC 
6 sensitive_ATP synthase gamma chain 
7 sensitive_putative major fimbrial subunit LpfA 
8 sensitive_hypothetical protein 
9 sensitive_Small toxic polypeptide LdrD 
10 sensitive_hypothetical protein 
11 sensitive_hypothetical protein 
12 sensitive_hypothetical protein 
13 sensitive_HTH-type transcriptional regulator ArcR 
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Table 4.4 The non-identical proteins within the proteome of the resistant strain 
of E. coli MG1655. Summary of the non-identical proteins identified in the proteome 
of the gentamicin resistant E. coli MG1655 strain. 
 
CD-Hit Non-Identical Proteins Resistant Strain 
1 resistant_Putative deoxyribonuclease RhsC 
2 resistant_Ethanolamine utilization protein EutM 
3 resistant_Putative deoxyribonuclease RhsC 
4 resistant_ATP synthase gamma chain 
5 resistant_Maltodextrin glucosidase 
6 resistant_Elongation factor G 
7 resistant_DNA-binding transcriptional repressor YiaJ 
8 resistant_Galactoside O-acetyltransferase 
9 resistant_Putative deoxyribonuclease RhsC 
10 resistant_DNA translocase SpoIIIE 
11 resistant_Serine recombinase PinR 
12 resistant_hypothetical protein 
13 resistant_hypothetical protein 
14 resistant_hypothetical protein 
15 resistant_hypothetical protein 
16 resistant_hypothetical protein 
17 resistant_Putative deoxyribonuclease RhsC 
18 resistant_hypothetical protein 
19 resistant_hypothetical protein 
20 resistant_hypothetical protein 
21 resistant_hypothetical protein 
22 resistant_hypothetical protein 
23 resistant_hypothetical protein 
24 resistant_PTS system fructose-specific EIIB component 
25 resistant_UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
26 resistant_hypothetical protein 
27 resistant_hypothetical protein 
28 resistant_NADP-dependent alcohol dehydrogenase C 
29 resistant_hypothetical protein 
30 resistant_Lactose operon repressor 
 
 
The identified proteins were then further clustered at 95% similarity, to identify the 
sensitive proteins which are not in the identified resistant novel proteins, and the 
resistant proteins which are not present in the sensitive novel proteins. This allows 
the identification of altered proteins as a result of nucleotide polymorphisms  
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assists in the removal of contamination.  
 
Following, the sensitive vs resistant cluster swap at 95%, seven proteins were 
identified with nucleotide changes between both the sensitive and resistant 
proteomes (Table 4.5). In addition, 15 proteins were identified exclusively within the 
sensitive proteome, which could be either novel proteins or contaminants.    
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Table 4.5 CD-HIT proteome analysis of the E. coli MG1655 sensitive vs resistant 
swap. Summary of the CD-Hit analysis of the gentamicin sensitive proteins clustered 
at 95% similarity. The black outlined regions of the table indicate clusters of interest 
with proteins containing nucleotide polymorphisms. Asterisks (*) indicate 100% 
similarity.  
 
Sensitive Vs Resistant Swap Cluster 
Cluster Amino Acids (aa) Predicted Protein % Similarity 
0 105 
309 
Sens_Putative 
Res_Putative 
* 
99.68 
1 1032 
289 
Sens_Putative 
Res_Putative 
* 
99.65 
2 704 
704 
Sens_Elongation 
Res_Elongation 
* 
99.86 
3 477 
311 
Sens_Putative 
Res_Putative 
* 
99.68 
4 398 
260 
Sens_DNA 
Res_DNA 
* 
99.23 
5 287 
258 
Sens_ATP 
Res_ATP 
* 
95.35 
6 262 Sens_Hypothetical * 
7 196 
196 
Sens_Serine 
Res_Serine 
* 
99.49 
8 167 Sens_Hypothetical * 
9 165 Sens_Putative * 
10 125 Sens_Hypothetical * 
11 125 Sens_Hypothetical * 
12 125 Sens_Hypothetical * 
13 113 Sens_Hypothetical * 
14 110 Sens_Carboxylestera * 
15 97 Sens_HTH-type * 
16 91 Sens_Hypothetical * 
17 91 Sens_Hypothetical * 
18 91 Sens_Hypothetical * 
19 84 Sens_Hypothetical * 
20 82 Sens_Oxygen-depende * 
21 35 Sens_Small * 
 
Succeeding, the resistant vs sensitive cluster swap at 95%, two proteins were 
recognised with nucleotide changes common to both the sensitive and resistant 
proteomes. Furthermore, 29 proteins were identified within the resistant proteome 
independently (Table 4.6). This suggested greater contamination within the resistant 
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proteome.  
 
Table 4.6 CD-HIT proteome analysis of the E. coli MG1655 resistant vs sensitive 
swap. Summary of the CD-Hit analysis of the gentamicin resistant proteins clustered 
at 95% similarity. The black outlined regions of the table indicate clusters of interest 
with proteins containing nucleotide polymorphisms. Asterisks (*) indicate 100% 
similarity. 
 
Resistant Vs Sensitive Cluster  
Cluster Amino Acids (aa) Predicted Protein % Similarity 
0 704 
704 
Res_Elongation 
Sens_Elongation 
* 
99.86 
1 605 Res_Maltodextrin * 
2 322 Res_Putative * 
3 315 Res_DNA-binding * 
4 311 Res_Putative * 
5 309 Res_Putative * 
6 289 Res_Putative * 
7 260 Res_DNA * 
8 258 Res_ATP * 
9 203 Res_Galactoside * 
10 196 
196 
Res_Serine 
Sens_Serine 
* 
99.49 
11 188 Res_Hypothetical * 
12 177 Res_Hypothetical * 
13 148 Res_Hypothetical * 
14 138 Res_Hypothetical * 
15 123 Res_Hypothetical * 
16 113 Res_PTS * 
17 111 Res_Ethanolamine * 
18 109 Res_Hypothetical * 
19 107 Res_UDP-N-acetylglu * 
20 104 Res_Hypothetical * 
21 103 Res_Hypothetical * 
22 91 Res_Lactose * 
23 88 Res_Hypothetical * 
24 86 Res_Hypothetical * 
25 85 Res_Hypothetical * 
26 84 Res_Hypothetical * 
27 80 Res_Hypothetical * 
28 80 Res_Hypothetical * 
29 74 Res_Hypothetical * 
30 63 Res_NADP-dependent * 
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The protein sequences of the non-identical proteins for both the sensitive and 
resistant proteomes (Appendix tables A.2 and A.3) were submitted to BLASTp, to 
isolate the contaminated proteins. A total of four contaminated proteins were 
identified within the sensitive proteome from Shigella and staphylococcus origin 
(Table 4.7).  
 
Table 4.7 E. coli MG1655 sensitive proteome contaminants. Summary of the 
contaminants identified in the proteome of the gentamicin sensitive E. coli MG1655 
strain. 
 
Contaminants Sensitive Strain Proteome 
Predicted Protein Amino Acid Length Predicted Organism 
Sensitive_Hypothetical 
Protein (IS1 family 
transposase) 
125 Shigella dysenteriae 
Sensitive_Hypothetical 
Protein (IS1 transposase) 
125 Shigella sonnei 
Sensitive_Hypothetical 
Protein (IS1 ORF2) 
125 Shigella sonnei 
Sensitive_ HTH-type 
transcriptional regulator ArcR 
97 Staphylococcus 
epidermidis 
 
As formerly predicted, there was a greater number of contaminated proteins identified 
within the resistant proteome. A total of 17 contaminated proteins were classified, 
from a range of organisms from uncommon sources (Table 4.8). It is therefore 
probable, that based on the source variability of the predicted proteins that the 
contaminants were likely introduced during the DNA extraction or genome 
sequencing process.  
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Table 4.8 E. coli MG1655 resistant proteome contaminants. Summary of the 
contaminants identified in the proteome of the gentamicin resistant E. coli MG1655 
strain. 
 
Contaminants Resistant Strain Proteome 
Predicted Protein Amino Acid Length Predicted Organism 
DNA Translocase SpoIIIE 260 Staphylococcus pasteuri 
Resistant_Hypothetical 
Protein 
177 Staphylococcus 
Resistant_Hypothetical 
Protein 
123 Bacilli 
Resistant_Hypothetical 
Protein 
103 Streptococcus 
pneumoniae 
Resistant_Hypothetical 
Protein 
148 Bacilli 
Resistant_Hypothetical 
Protein 
85 Stenotrophomonas 
maltophilia 
Resistant_Hypothetical 
Protein 
109 Rhodospirillaceae 
bacterium 
Resistant_Hypothetical 
Protein 
80 Ralstonia 
Resistant_Hypothetical 
Protein 
84 Stenotrophomonas 
maltophilia 
Resistant_Hypothetical 
Protein 
88 Stenotrophomonas 
maltophilia 
Resistant_PTS system 
fructose-specific EIIB 
component 
113 Klebsiella pneumoniae 
Resistant_UDP-N-
acetylglucosamine 1-
carboxyvinyltransferase 
107 Stenotrophomonas 
maltophillia 
Resistant_Hypothetical 
Protein 
86 Pseudomonas syringae 
Resistant_Hypothetical 
Protein 
73 Staphylococcus 
nepalensis 
Resistant_NADP-dependent 
alcohol dehydrogenase adhC 
62 Mycobacterium 
tuberculosis 
Resistant_Hypothetical 
Protein 
104 Nocardia niwae 
Resistant_Lactose Operon 
Repressor 
91 Klebsiella pneumoniae 
 
 
 
  
 
 
181 
Proceeding, the removal of contaminated proteins from the sensitive and resistant 
proteomes. The novel proteins were assessed further to determine their molecular 
functions. When looking at the novel proteins within the sensitive proteomes, there 
was an equal representation of proteins with mutations involved in DNA binding and 
self-proteolysis (Table 4.9).  
 
Table 4.9 Molecular functions of the novel proteins identified in the E. coli 
MG1655 sensitive strain. Summary of the molecular functions of the novel proteins 
identified in the proteome of the gentamicin sensitive E. coli MG1655 strain. 
 
Sensitive Proteins Identified with SNPs 
Sequence ID Protein Molecular Function 
KDU50036.1 Putative transposase DNA Binding 
Transposase Activity 
STM57295.1 IS1 orfA DNA Binding 
Transposase Activity 
OKV47142.1 Type IV secretion protein Rhs Self Proteolysis 
SQK58704.1 rhsC element core protein 
RshC 
Self Proteolysis 
WP_083584225.1 Type IV secretion protein Rhs Self Proteolysis 
EFK13670.1 ATP synthase F1, gamma 
subunit 
ATP production 
WP_000554707.1 Tail fiber Protein Mediated Virion 
Attachment 
KQB23928.1 Toxin Ldr, type I toxin-
antitoxin system family protein 
Cell Death 
STM57295.1 IS1 orfA DNA Binding 
Transposase Activity 
 
 
When comparing this to the novel proteins identified within the resistant proteomes. 
There was a greater number of proteins identified with unknown functions (Table 
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4.10). In addition, proteins were identified with diverse biological functions involving 
ligand binding and sugar metabolism.  
 
Table 4.10 Molecular functions of the novel proteins identified in the E. coli 
MG1655 resistant strain. Summary of the molecular functions of the novel proteins 
identified in the proteome of the gentamicin resistant E. coli MG1655 strain.  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
Resistant Proteins Identified with SNPs 
Sequence ID Proteins Function 
WP_062894316.1 RHS repeat protein Ligand Binding 
WP_001014241.1 Ethanolamine utilization 
microcompartment protein 
EutM 
Structural Activity 
Ethanolamine Catabolism   
STJ77837.1 RhsA core protein Self Proteolysis 
STM79647.1 Membrane-bound ATP 
synthase F1 sector gamma-
subunit 
ATP production 
SQR79350.1 Maltodextrin glucosidase Maltotriose Regulation 
Hydrolytic Activity  
WP_053272490.1 Elongation factor G GTPase Activity 
Translation Elongation  
WP_001310587.1 DNA-binding transcriptional 
activator MhpR 
DNA Binding 
Transcription Factor 
Activity   
Aromatic Catabolism  
WP_001335915.1 Galactoside O-
acetyltransferase 
Galactoside O-
acetyltransferase Activity 
Lactose Biosynthesis  
OZY07411.1 hypothetical protein 
CIJ89_20860 
Unknown 
SQK46172.1 YD repeat-containing protein Self Proteolysis 
WP_000078178.1 DNA invertase DNA binding  
Recombinase Activity  
SRB28838.1 Uncharacterised protein Unknown 
SQN38131.1 Uncharacterised protein Unknown 
WP_112044739.1 RHS repeat Ligand Binding 
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When directly assessing the biological functions of the novel sensitive and resistant 
proteins (Figure 4.28). Proteins were identified within the resistant and sensitive 
proteins with shared biological functions including ATP production and self-
proteolysis. Time permitting, it would be of interest to have analysed the individual 
proteins identified within the two proteomes further.  
 
Figure 4.28 Biological functions of the sensitive and resistant proteins of E. coli 
MG1655 containing SNPs. Graph displaying the biological function of the novel 
proteins identified with mutations in the gentamicin sensitive and resistant strains of 
E. coli MG1655. The numbers on the graph indicate the total number of proteins 
within the two bacterial strains which contain mutated proteins of a precise biological 
function.  
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Conclusively, the evidence from the proteome analysis suggest the Mauve SNP 
export results were correct, with non-synonymous mutations identified in proteins; 
Elongation Factor G and Serine Recombinase, encoded by the fusA and pinR genes 
respectively (Table 4.11).  
 
Table 4.11 The sensitive and resistant E. coli MG1655 proteins containing 
SNPs. Summary of the protein encoding genes containing non-synonymous SNPs 
present in the proteomes of both the gentamicin sensitive and resistant strains of E. 
coli MG1655. Asterisks (*) indicate 100% similarity. 
 
Proteins with SNPs within the Sensitive and Resistant Proteomes 
Cluster Amino Acids (aa) Predicted Protein % Similarity 
0 704 
704 
Res_Elongation 
Sens_Elongation 
* 
99.86 
2 704 
704 
Sens_Elongation 
Res_Elongation 
* 
99.86 
10 196 
196 
Res_Serine 
Sens_Serine 
* 
99.49 
7 196 
196 
Sens_Serine 
Res_Serine 
* 
99.49 
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4.4 Discussion  
Whole genome sequencing successfully facilitated the identification of SNPs unique 
to the gentamicin resistant isolate of E. coli MG165. The location of SNPs predicted to 
be related to gentamicin resistance were not disclosed to target genes, instead it 
emerged resistance conferring mutations could appear in genes more distantly 
involved in the known molecular action of gentamicin.   
 
4.4.1 Microbial genome sequencing, assembly and annotation  
The expansion of NGS technologies has permitted high throughput sequencing and 
increased data generation, while compromising sequence quality (Utturkar et al., 
2014). Demonstrated by the growing number of draft genomes being submitted to the 
sequence database (Chain et al., 2009). Moreover, it is approximated that 
sequencing platform errors are accountable for 0.1-1% of bases being miscalled (Fox 
et al., 2015). Despite the concerns surrounding the accuracy of sequencing 
technologies, illumina based platforms have predominated within the field due to cost 
effectiveness and the reduction in the number of missed gene sequences 
(Mavromatis et al., 2012).   
 
Illumina sequencing of the resistant genome produced the widest coverage with a 
greater number of paired reads sequenced when compared to the sensitive genome. 
There was substantial variation in the number of reads from the two genomes; 
Sensitive: 1,460,808 Resistant: 5,345,144 this was unexpected as the resistant 
genome is a product of the evolution of its sensitive counterpart. This could suggest a 
reduced quality of DNA extracted from the sensitive genome or sequencing errors.  
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The Illumina platform is recognised as a short read sequencing technology, owing to 
the number of short reads and paired end reads produced following sequencing 
(Illumina, 2018). The rapid increase in the number of short reads generated from 
NGS technologies, has meant a greater emphasis has been placed upon assembly 
techniques for the successful reconstruction and annotation of genomes (Nagarajan 
and Pop, 2013). Nevertheless, the assembly of short reads is a complex process 
which is further complicated by the presence of repeat regions of DNA within 
genomes (Alkan, Sajjadian and Eichler, 2011; Treangen and Salzberg, 2013). 
Despite such challenges, there are currently no consensus assembly tools available 
(Alhakami, Mirebrahim and Lonardi, 2017).   
 
The raw data obtained from illumina sequencing at MicrobesNG was analysed using 
CLC Genomics workbench. An initial pre-processing step was conducted where raw 
sequence reads were trimmed to discard sequences of partial or poor quality, which 
can negatively impact the reliability of both genome assembly and SNP detection 
(Fabbro et al., 2013). Following trimming the ambiguities in sequence read lengths 
were resolved, with comparable averaged lengths of 168.5 and 166.6 for the sensitive 
and resistant genomes respectively. A series of quality control steps were introduced 
at this stage, to minimise errors when independently mapping reads to the reference 
genomes, a process integral for downstream analyses and accurate variant detection 
(DePristo et al., 2011).  
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4.4.2 Gentamicin targets and SNP detection    
Following the high-quality genome assembly, known antimicrobial targets were 
examined for variant detection. The aminoglycoside gentamicin functions through its 
precise interactions with the 30s-ribosomal subunit, a complex composed of 16s 
rRNA and 30s ribonucleoproteins (Green and Noller, 1997; Carter et al., 2000). 
Acquired resistance to aminoglycosides occurs frequently due to mutations within 
antimicrobial targets, demonstrated by the presence of rpsL and 16s rRNA mutations 
conferring streptomycin resistance in E. coli (Toivonen, Boocock and Jacobs, 1999; 
Springer et al., 2001). The inspection of antimicrobial targets revealed no mutations 
within the rpsL gene encoding the ribosomal protein S12, but mutations were present 
in the 16s rRNA.  Nevertheless, due to the presence of multiple copies of rRNA 
operons within E. coli, it is difficult to suggest that resistance is mediated exclusively 
by this mechanism (Lambert, 2012). In addition, aminoglycoside resistance conferring 
mutations have been identified in several of the ribonucleoproteins (DeWilde and 
Wittmann-Liebold, 1973; Wilcox, Cavey and Pearson, 2001; Kirthi et al., 2006). 
Despite a broader search directed by STRING of associated proteins, no variation 
was discovered.  
 
As gentamicin is a broad spectrum antimicrobial agent, it was not feasible to carry out 
individual CLC searches of known targets and associated proteins, as the likelihood 
of missing mutations with this approach is extremely high. Therefore, Mauve was 
employed to identify any major genome rearrangements and for the exportation of 
SNPs. Using Mauve, 143 SNPs were identified independently within the coding 
regions of the resistant and sensitive bacterial genomes, through the visual analysis 
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of the SNP export file which was then verified using a script. Further sequence 
analysis revealed, the presence of a contaminated gene SpoIIIE from the organism B. 
subtilis, encoding a membrane bound DNA translocase which plays an essential role 
in chromosomal segregation during sporulation (Wu and Errington, 1994; Kaimer, 
González-Pastor and Graumann, 2009). It is probable that the B. subtilis contaminant 
was introduced during the DNA extraction or sequencing process at MicrobesNG. In 
addition, the paralogous genes MdoG and MdoC required for the synthesis of the 
Osmoregulated Periplasmic Glucan (OPG) backbone were misannotated (Lacroix et 
al., 1999; Lequette et al., 2004). This occurs commonly in whole genome assembly 
where paralogous genes, due to their highly similar sequences, fail to be assembled 
into separate loci (Vinson et al., 2005). 
 
In this study, synonymous SNPs were considered inconsequential, as an assumption 
was made that these mutations are selectively neutral and result in no alteration in 
phenotype (Hunt et al., 2009). However, there has been growing emphasis on 
experimental evolution approaches aimed at exploring the adaptive consequences of 
synonymous mutations (Zwart et al., 2018). Such experimental evolution studies 
have been conducted on the TEM-1 β-lactamase encoding gene, which have linked 
synonymous mutations with alterations in gene expression, protein folding and 
fitness (Salverda et al., 2011; Firnberg et al., 2014). This suggests that when 
investigating the evolutionary dynamics of resistance, all genetic variants should be 
accounted for.  
 
After discounting the synonymous mutations within the two genomes, a total of two 
non-synonymous polymorphisms were identified in the fusA and pinR genes.  The 
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pinR gene encodes a putative DNA invertase/site-specific recombinase, which has 
been closely associated with the lambdoid prophage RAC in the E. coli K-12 
genome (Mehta, Casjens and Krishnaswamy, 2004). Serine recombinases are 
frequently identified as having >30% sequence similarity, across the highly 
conserved catalytic domains, however the precise DNA inversion reactions are not 
well characterised (Johnson, 2015). Whereas, the fusA gene encodes the protein 
EF-G essential to ribosomal protein synthesis, providing a well-defined link to the 
antimicrobial mechanism of action (Agrawal et al., 1998). This is consistent with 
previous findings, where bacterial populations can survive selective pressures 
providing the presence of at least one large effect beneficial mutation (Dijk Van et 
al., 2017).   
 
Previous experimental evolution studies, exploring the evolutionary trajectories of 
aminoglycoside resistance in E. coli have identified mutations in similar positions 
within the fusA gene (Mogre et al., 2014, Mogre et al., 2017 and Ibacache-Quiroga et 
al., 2018). Genomic analysis from an in-vitro laboratory evolution study investigating 
the concentration dependent evolution of kanamycin resistance through serial 
passage, identified multiple kanamycin resistant mutations in the C-terminal end of 
domain 4 of EF-G (Mogre et al., 2014). Significantly, at sublethal concentrations of 
kanamycin the fusA (P610T) was identified, while at higher sublethal concentrations 
two further fusA mutations were discovered; fusA (P610L) and fusA (A608E) (Mogre 
et al., 2017). In a separate study, using gentamicin as a model to explore the 
mutational pathways to aminoglycoside resistance in both normo and hypermutable 
strains of E. coli, identified diverse mutations in all gentamicin resistant derivative 
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including a fusA (F593L) substitution in domain 4 of EF-G (Ibacache-Quiroga et al., 
2018). The findings from the laboratory evolution studies described, indicate that 
despite the experimental approach utilised, aminoglycoside antibiotics elicit a similar 
adaptive response within the fusA gene encoding EF-G. Additionally, these findings 
emphasise the functional significance of the C-terminal end of domain 4 of EF-G.  
4.4.3 Proteome analysis and contaminant identification  
The SNPs detected using Mauve were validated using CD-HIT-2D protein sequence 
analysis, which provides an alternative approach to analysing sequencing data 
through assigning proteins into clusters based on similarity (Li and Godzik, 2006). 
CD-HIT-2D facilitated the rapid identification of contaminated proteins and permitted 
the characterisation of genomic gaps corresponding to previously unidentified protein 
coding genes (Mavromatis et al., 2012). Interestingly, unlike the consistency seen 
with the number of SNPs identified between the two genomes using Mauve, there 
was a greater number of non-identical or contaminated proteins found within the 
resistant strain than its sensitive counterpart. This increase in the number of divergent 
proteins present within the resistant dataset, may reflect the differentiating number of 
sequence reads between the two genomes following illumina sequencing (Olson ND 
et al., 2012). Following a tblastn search of the non-identical sequences, proteins were 
detected within the sensitive and resistant strains from a diverse range of species 
including Ralstonia, a common contaminant of ultrapure water systems in NGS 
technologies (Lawrence, Hatzis and Brash, 2014). The identification and removal of 
contaminants introduced during the DNA extraction or sequencing process is 
essential for downstream analysis and the accurate interpretation of results (Sheik et 
al., 2018). Consistent to the findings from mauve, polymorphisms were confirmed 
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within the EF-G and Serine Recombinase proteins encoded by fusA and pinR genes 
respectively.  
 
4.4.4 Conclusion 
In conclusion, of the SNPs identified, those present in the 16s rRNA and fusA genes 
are most likely to be associated with the acquisition of gentamicin resistance. Further 
analysis will reveal the functional consequences of these SNPs and their potential to 
be utilised as markers for aminoglycoside resistance. 
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Chapter 5: Physiochemical analysis of the genes predicted to be involved in the 
evolution of gentamicin resistance in E. coli MG1655.  
 
5.1 Introduction 
The evolution of antimicrobial resistance occurs through the process of natural 
selection, following the emergence of mutations within a bacterial genome. The 
acquisitions of mutations within a genome is complex and dependent on a range of 
factors including the genomic stability and mutability of organisms (Martinez and 
Baquero, 2000; Matic, Taddei and Radman, 2004; Chopra, O’Neil and Miller, 2003).  
Furthermore, genomic adaptation is known to be induced in response to stress 
(Galhardo, Hastings and Rosenberg, 2007).  
 
Antimicrobial agents drive resistance evolution in bacteria, however the fixation of 
resistant conferring mutations is dependent on the site of mutagenesis and whether 
the mutation confers a selective advantage (Long et al., 2016; Schenk and de Visser, 
2013; Bamshad and Wooding, 2003). Thus, the first aim of this chapter is to analyse 
the mutations identified within chapter 4, and to determine the functionally 
consequences of these mutations relative to the acquisition of gentamicin resistance.  
 
The rRNA within the 70s ribosomal complex is essential for the functioning of the 
ribosome, this becomes more evident when the ribosome is targeted by antimicrobial 
agents which directly interfere with the ribosomal function during protein synthesis 
(Brodersen et al., 2000).  The genetic and functional analysis of the mutations 
identified within the rRNA is challenging due to the multiple copies of the rRNA genes 
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within E. coli, as the phenotypic expression of these mutations may be altered by the 
presence of sensitive to resistant ribosome variants (Lee, Holland-Staley and 
Cunningham, 2001). As rRNA mutations do not encode protein it is fundamental to 
assess the effect of single nucleotide mutations on the conformational 
rearrangements of the secondary structures of the mutated rRNA variants. 
Mutagenesis within the 16s rRNA could lead to alterations in both the free energy and 
the conformations of the secondary structure motifs, which are key in the 
maintenance of ribosomal function (Barash and Churkin, 2010).  
 
SNP are the most common form of genetic variation; therefore, it is necessary to 
determine which SNPs lead to amino acid substitutions in protein encoding genes, 
which could potentially alter protein function (Clifford et al., 2004; Ng and Henikoff, 
2003). The position of the amino acid substitutions is significant, particularly if the 
non-synonymous mutations are located within conserved proteins or domains which 
are most likely to be under positive selection (Choi et al., 2012). In addition, the 
specific amino acid substitutions which arise as a result of mutagenesis are significant 
due to the variable physical properties of amino acids and the effects this can have on 
protein function (Kidera et al., 1985). Furthermore, the effects of mutations can often 
be identified through protein structure analysis, which can often be used to explain 
the alterations in function (Chasman and Adams, 2001). 
 
As a result of the sequence variation and the potential for wrongly called bases 
through NGS techniques, it is necessary to validate the SNPs identified which are 
most likely to be attributable to the acquisition of gentamicin resistance.  SNP 
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validation can be achieved a variety of methods including bi-parental segregating 
population, but in this chapter the validity of SNPs will be assessed through 
confirmatory PCR and resequencing (Kumar, Banks and Cloutier, 2012; Li et al., 
2009). The SNPs were considered valid based on the recurrence of identical SNPs 
within the fusA and 16s rRNA genes of parallel evolved gentamicin resistant 
populations of E. coli MG1655, using confirmatory PCR and resequencing.   
 
It is hypothesised that there will be physiochemical variations present because of the 
evolved mutations in genes specific to the function of gentamicin or the associated 
antimicrobial pathways. Further to this, the mutations identified through WGS will be 
validated by their presence in other resistant strains isolated from the ARGP.  
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5.2 Materials and methods  
5.2.1 RNA consensus secondary structure XRNA 
The consensus secondary structure of the 16s rRNA within E. coli, was stipulated 
using XRNA to provided information regarding the locality of mutations. Further 
details of the protocol used within the XRNA suite can be found in section (2.9.1).   
5.2.2 RNAfold secondary structure analysis 
The initial RNA secondary structure predictions and analysis were carried out using 
RNAfold a stand-alone programme. Details of the RNAfold protocol are described in 
section (2.9.2).  
5.2.2.1 Secondary structure analysis using Vienna  
The secondary structure predictions provided by RNAfold did not facilitate the 
graphical representation of the specific single nucleotide changes which occur 
following mutagenesis. The ViennaRNA package 2.0 available at: 
http://www.tbi.univie.ac.at/RNA [accessed July 17, 2018], is an interactive command 
line tool which consists of a collection of RNA secondary structure programmes, with 
complementary utilities that assist in the graphical processing of secondary structures 
(Lorenz et al., 2011). After installation of the Vienna package, the preliminary steps 
repeated the secondary structure predictions calculated within RNAfold using the 
commands below. This commands were then repeated for all sensitive and resistance 
rRNA genes.  The output from the command is the MFE structure in dot bracket 
notation and its calculated free energy. The addition of options (–P) and (–MEA) to 
the command allows the calculations of partition function (-P) and maximum expected 
accuracy (MEA) respectively (Figure 5.1).  
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Figure 5.1 The RNAfold commands utilised in the production of the 16s rRNA 
secondary structures within Vienna. Displaying the RNAfold command utilised 
within the ViennaRNA packaged 2.0 to facilitate the centroid and MFE secondary 
structure predictions. 
 
In addition to using RNAfold within the Vienna package, an additional utility was 
required to allow the visual representation of secondary structure in the form of a 
mountain plot using the dp.ps output file from the RNAfold commands above. The 
mountain plot was previously produced using the RNAfold webserver and was 
repeated within Vienna using the command below (Figure 5.2).    
 
Figure 5.2 The command utilised in the production of the 16s rRNA secondary 
structure mountain plots within Vienna. Displaying the mountain Plot command 
utilised within ViennaRNA package 2.0.  
 
 
The results generated from RNAfold within Vienna can be obtained using the RNAfold 
webserver. However, the final application of Vienna and ultimate reason for its use, 
requires the .fold files which were generated from the commands shown in figure 
(5.1). The utility RNAplot was used to allow the graphical representations of the 
distinct regions containing the ribonucleotide mutations. This was achieved using the 
(cmark) which circles the base of interest followed by the coordinates of that base, 
which is then labelled using (label) and finally (omark) is used to stroke the segment 
by defining a width and a colour according the RGB code (Hofacker et al., 2017). This 
is then repeated for all the single ribonucleotide changes observed within the rRNA 
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sequence. See below (Figure 5.3) an example of the command used for the graphical 
representation of mutagenesis within rna154 resistant strain.  
Figure 5.3 The RNAplot command utilised in the production of the 16s rRNA 
secondary structures with annotations within Vienna. Displaying the RNAplot 
command utilised within the ViennaRNA packaged 2.0 to facilitate the graphical 
representation of ribonucleotide base mutagenesis within the RNA secondary 
structure.  
 
5.2.3 DNAsp sequence polymorphism analysis 
DNAsp version 5.1.0 http://www.ub.edu/dnasp/ [accessed November 28, 2017] was 
used in the analysis of sequence polymorphisms and divergence across the 16s 
rRNA genes for both the sensitive and resistant strains. DNAsp was not used in the 
analysis of diversity for the fusA gene, since there was only a single nucleotide 
polymorphism identified. DNAsp as a tool was used to provide evolutionary insights 
into the nucleotide diversity of the 16s rRNA gene and to understand the functional 
importance of genomic regions based on the locality of the polymorphisms observed 
(Librado and Rozas, 2009). Ribosomal rna sequence polymorphisms were measured 
using sliding window analysis of nucleotide diversity (π) across the length of the 16s 
rRNA 123 and 154 genes, with a sliding window of 1.  
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5.2.4 Phylogenetic analysis using MEGA 
To resolve the phylogeny of the mutated 16s rRNA sequences, maximum likelihood 
trees were constructed using MEGA against the Escherichia taxa specified in section 
(2.9.3).  
5.2.5 EMBL SAPS protein structure analysis  
The functional properties of the protein with mutations were assessed using EMBL 
SAPS, to determine any discrepancies in charge distribution across the protein 
sequence. The protocol for EMBL SAPS is described in section (2.9.4).  
 
5.2.5.1 TreeSAAP selection of amino acid properties  
Further physiochemical analysis of protein properties was conducted using 
TreeSAAP detailed in section (2.9.5).  
 
5.2.5.2 NCBI conserved domains analysis  
To understand the protein function in greater detail, NCBI was used to provide a 
summary of the conserved domains and functional sites of coding nucleotide 
sequences of the proteins of interest available at: 
https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi [accessed August 23, 2018]. A 
Blast search of the CDSEARCH/cdd v3.16 database was conducted using the default 
search parameter options, for fusA and pinR respectively. 
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5.2.6 Homology modelling of protein structure: Swiss Model 
The initial protein modelling was carried out using Swiss Model, to provide insights 
into the homology of mutated proteins between the sensitive and resistant strains of 
E. coli. Details of the Swiss Model methodology are provided in section (2.9.6).  
 
5.2.6.1 Modelling of protein structure: Scigress  
SCIGRESS (SCIGRESS, 2013) was used for the molecular modelling of the mutated 
protein structure further to the predicting the structural effects of mutagenesis. PDB 
files of both sensitive and resistant strains were imported into Scigress. For simplicity, 
the backbone of protein structures was changed to solid ribbon. To visualise the 
mutated residues within the protein structures, the sequences are displayed and 
observed as a three-letter code and the mutated amino acid residues were presented 
as ball and cylinders against the ribboned backbones ribbons of EF-G and pinR 
respectively. Models were comprehensively beatified and duplicate frames for the 
sensitive and resistant counterparts were exported and directly compared to identify 
any structural differences due to mutagenesis.  
 
5.2.6.2 Protein structure analysis: PyMOL molecular graphics system  
Conclusive structure analysis of the mutated proteins was completed using the 
molecular graphics system PyMOL (DeLano et al., 2002). Ensuing consistency, all 
protein PDB files used in this study were rendered using PyMOL with cartoon 
graphical representations http://www.pymol.org [accessed March 15, 2018]. Using the 
integrated python feature, protein domains and proteins within large complexes and 
be selected, highlighted and manipulated using command syntax and atom 
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selections. In addition, PyMOL was used for the graphical representation of in sillico 
mutagenesis using the PyMOL mutagenesis. The mutated amino acid residues of the 
resistant proteins were selected using sequence mode and modelled using wizard 
mutagenesis.  The amino acids residues pre- and post-mutagenesis were presented 
as sticks for visualisation and subsequent comparative analysis of secondary protein 
structures, supported by the export of the protein molecules as a multi-file.   
 
5.2.7 Molecular analysis based on bioinformatics findings 
5.2.7.1 Primer design and DNA extraction  
To determine whether the identified mutations were present in additional bacterial 
strains isolated from both the ARGP and serial passage systems, specific primer sets 
were designed as per protocol described in section (2.10.1). Details of the primer sets 
utilised in the PCR reactions are indicated in table (5.1). An alternative approach to 
DNA extraction was utilised here through thermal lysis, as detailed in section (2.10.2).   
 
Table 5.1 Primers used for the confirmatory PCR amplification of the evolved 
gentamicin resistance genes. Displaying the sequences and product sizes of the 
three primer sets: fusA, rna123 and rna154 designed using Primer BLAST.  
 
 
 
 
Primer Sequence (5’-3’) Gene Expected PCR 
Product Size 
fusA-1 5’-GTGTGGTTAACTCTGGTGAT-3’ fusA 1049 
fusA-2 5’-CGCTTCATCATACTTCAGGA-3’ 
rna123-1 5’-CTAACACATGCAAGTCGAAC-3’ rna123 1432 
rna123-2 5’-GAATCACAAAGTGGTAAGCG-3’ 
rna154-1 5’-AGAGTTTGATCATGGCTCAG-3’ rna154 964 
rna154-2 5’-CGTTGCATCGAATTAAACCA-3’ 
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5.2.7.2 PCR and agarose gel electrophoresis  
PCR reactions were executed on all bacterial DNA extracts, using the specific primers 
sets for the fusA and 16s rRNA genes. Details of the initial gradient PCR reactions 
and the subsequent thermocycling conditions used for the PCR reactions  
are available in section (2.10.3). All PCR reactions were analysed through gel 
electrophoresis using a 2% Top Vision agarose gel, detailed in section (2.10.4).  
 
5.2.7.3 Illumina sequencing at The Natural History Museum facility 
PCR products and original primer sets were submitted to the Natural History 
Museum, London, for sequencing using the Illumina MiSeq for next generation 
sequencing. The MiSeq platform uses non-targeted shot gun approach with 
fluorescent dye terminators (Illumina, 2018). Further details of the chemistry behind 
Illumina sequencing can be found in chapter 3.  Sequence files retrieved from the 
natural history museum were assessed for DNA sequencing quality by base calling 
from a raw chromatogram using Tracetuner 3.0.6 with the following parameters -Q 
3730 and -trim_threshold 20. Sequences were then trimmed based on quality and 
length ambiguities using a custom script available at: https://github.com/camilla-
eldridge [accessed May 18, 2018] before viewing in the alignment viewer aliview.  
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5.3 Experimental results  
 
5.3.1 RNA consensus secondary structure  
 
The E. coli 16s rRNA consensus secondary structure template was exported from 
XRNA and modified to illustrate the 16s rRNA structural domains and the locations of 
the identified mutations.  The template utilised is the consensus secondary structure 
model for all seven variants of the E. coli 16s rRNA, therefore both the rna123 and 
rna154 mutations have been included (Figure 5.4).  
 
Based on the results obtained in chapter 4, where the gentamicin ribosomal protein 
target S12, combines early with the 16s rRNA in the 30s-ribosomal subunit assembly. 
An assumption could be made that the 16s rRNA mutations will be identified within 
the first 5’ rRNA domain formed.  
 
As predicted, of the four 16s rRNA domains (body, platform, head and penultimate 
stem) the mutations were identified within the 5’ body domain (Figure 5.4 A). 
Following magnification of the body domain, the rna154 mutations occurred centrally 
within the structure within helix 6, whereas the rna123 mutations and the shared 
individual SNP occurred in the lower region of the body domain within helix 6, 7,10 
and 11 (Figure 5.4 B). Helix 44 was highlighted within figure (Figure 5.4 A), and its 
significance will be discussed later in this chapter. The locality of the mutations was 
further assessed based on the 16s rRNA tertiary interactions within the 30s-ribosomal 
subunit using PyMOL (Figure 5.5).   The rna154 mutations appeared to be situated 
towards the back of the ribosomal protein S12 (green), in close proximity to the 
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ribosomal protein S17 within the shoulder the 30s subunit. Whereas, the rna123 
mutations were predominantly positioned around domains 1 and 5 of EF-G.  
 
 
 
Figure 5.4 XRNA E. coli 16s rRNA secondary structure consensus template. (A) 
The four 16s rRNA domains; body (yellow), platform (blue), head (green) and 
penultimate stem (orange), in addition the position of helix 44 has been highlighted, 
for future reference. (B) Magnification of the body domain displaying the rna154 
mutations in green and the rna123 mutation in red. The shared mutation at position 
226 has been highlighted in blue. The 16s rRNA helices containing the mutations 
have been numbered in bold.  
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Figure 5.5 The 16s rRNA tertiary Interactions within the 30s-ribosomal subunit.   
Displaying the tertiary interactions of the 16s rRNA (dark grey) within the 30s-
ribosomal subunit (pre-complex). Also included within the image is 30s ribosomal 
proteins (light grey), the tRNA molecules A (blue), P (purple), E (pink), mRNA 
(orange), the gentamicin ribosomal binding proteins s12 (green) and s17 (yellow) and 
compacted EF-G (red). The locations of the 16s rRNA mutations were shown in light 
blue.  
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5.3.2 RNA secondary structure predictions using RNAfold  
 
Secondary structures of the individual 16s rRNA variants were obtained from 
RNAfold. Through the sequence submission, direct comparisons in the structural 
consequences of mutagenesis can be made between the sensitive and resistant 
strains of E. coli.  The RNAfold webserver results can be split into three sections 
which will be addressed accordingly for both rna123 and rna154.  
 
The results for rna123 based on the minimum free energy (MFE) prediction of the 
secondary structure, reveals a slight increase in the MFE of the resistant rna123 of -
583.40kcal/mol compared to -585.00kcal/mol. In addition, the thermodynamic 
ensemble prediction results, suggests an increase in the free energy of the ensemble 
from -609.25kcal/mol in the sensitive strain to -607.70kcal/mol in the resistant 
counterpart. The ensemble diversity of the two strains was 345.19 and 344.40 
respectively, indicating a small change in MFE.  When comparing this to the centroid 
MFE, there was a greater increase in free energy between the two strains, from -
474.17kcal/mol in the sensitive strain to -465.77kcal/mol in the resistant strain, 
suggestive of more apparent alterations in centroid structure.   
 
The final output from RNAfold, is in the form of graphical reports of secondary 
structure (Figure 5.6). Here secondary structures were coloured specifically, to 
encode base pair probabilities. When analysing the MFE images, which refers to the 
secondary structure which contributes minimally to the free energy, there are no 
visible alterations in structure (Zuker and Stiegler, 1981). When comparing this to the 
centroid images representative of the central tendencies of a data set, variations are 
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visible in seven regions of the secondary structure as highlighted using asterisks 
(Ding, Chan and Lawrence, 2005).   
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
207 
 
Figure 5.6 Secondary structure analysis of rRNA 123 using RNAfold. Displaying 
the MFE and Centroid structure images of the gentamicin sensitive (A) and resistant 
(B) strains of E. coli MG1655. The rRNA secondary structures are coloured by base-
pairing probabilities scored between 0-1. The structural variation  
observed between the sensitive and resistant centroid secondary structures have 
been indicated using an asterisk (*).  
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When analysing the RNAfold results for rRNA 154, comparable overall secondary 
structures were observed to that seen with rRNA 123 (Figure 5.7). Looking more 
closely at the results unlike that seen with rna123, the MFE secondary structure 
prediction was lower in the resistant strain compared to the sensitive, -583.40kcal/mol 
and -580.00kcal/mol respectively. The free energy values of the thermodynamic 
ensemble were similar -607.74kcal/mol for the sensitive strain compared to -
607.70kcal/mol for the resistant strain. A more substantial alteration was seen with 
ensemble diversity with a value of 381.71 for the sensitive strain, whereas the 
diversity value of the resistant strain was 344.40. As seen previously, there was a 
greater change when assessing the centroid MFE, here the sensitive strain had a 
higher MFE of -419.01kcal/mol compared with -465.77kcal/mol for the resistant strain.  
 
When assessing the graphical results, there were no apparent changes in the MFE 
secondary structure predictions, as seen with rna123 (Figure 5.6). Similarly, apparent 
changes were observed in the centroid images. Here a total of 8 regions showed 
modifications within secondary structure, of which an evident change being the 
collapse of the central loop in the rna154 resistant strain.  
 
An additional graphical report was produced in the form of mountain plots for rna123 
and rna154, which can be found in the appendix (Figure A.12). As there is 
speculation surrounding secondary structure modelling programmes, it was decided 
as a form of verification to predict the secondary structures of the remaining five 16s 
rRNA variants. This was based on the principle that given each variant contained 
identical rna sequences between the sensitive and resistant strains, the structures 
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therefore should be identical. This proved to be the case, but an interesting finding 
here was that some of the remaining variants, had dissimilar overall structures to that 
seen with rna123 and rna154 (Appendix A.13-A.17).  
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Figure 5.7 Secondary structure analysis of rRNA 154 using RNAfold. Displaying 
the MFE and Centroid structure images of the gentamicin sensitive (A) and resistant 
(B) strains of E. coli MG1655. The rRNA secondary structures are coloured by base-
pairing probabilities scored between 0-1. The structural variation  
observed between the sensitive and resistant centroid secondary structures have 
been indicated using an asterisk (*).  
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5.3.2.1 RNA Secondary Structure analysis using Vienna 
 
The Vienna RNA suite was used to comparatively asses the RNA secondary 
structures further, through the visualisation of the locality and the precise nucleotide 
changes which have arisen as a result of mutagenesis. In comparison to the results 
produced from RNAfold independently, distinct changes were identifiable from the 
MFE secondary structure images for both rna123 and rna154 post magnification 
(Figures 5.8 and 5.9).  
 
When looking at the Vienna analysis of rna123, the overall secondary structure 
appears highly conserved (Figure 5.8). However, following the magnification of the 
region containing the SNPs, alterations were recognised within two stems of the 
secondary structure. 
 
 
Similar results were seen with rna154 with highly comparable MFE structures prior to 
magnification for the sensitive and resistant strains (Figure 5.9). Following 
magnification, structural changes were observed predominantly within a single stem 
of the secondary structure. Intriguingly, the shared mutation at position 226 is found 
at identical locations within highly conserved secondary structures for the two rRNA 
variants. These results suggest that the specific mutation identified within two of the 
seven rRNA variants, may be significant in the acquisition of gentamicin resistance. 
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Figure 5.8 RNA secondary structure analysis of rRNA 123 using Vienna.  
Displaying the MFE secondary structures and magnifications of the rRNA 123 from 
the sensitive (left) and resistant (right) strains of E. coli MG1655. The Vienna package 
facilitates the identification of the predicted secondary structure alterations between 
the MFE structures and the annotation of both the mutational position and 
ribonucleotide base changes. The mutated ribonucleotide bases in the sensitive and 
resistant strains have been indicated in colour.  
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Figure 5.9 RNA secondary structure analysis of rRNA 154 using Vienna. 
Displaying the MFE secondary structures and magnifications of the rRNA 154 from 
the sensitive (left) and resistant (right) strains of E. coli MG1655. The Vienna package 
facilitates the identification of the predicted secondary structure alterations between 
the MFE structures and the annotation of both the mutational position and 
ribonucleotide base changes. The mutated ribonucleotide bases in the sensitive and 
resistant strains have been indicated in colour.  
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5.3.3 RNA sequence polymorphism analysis using DNAsp 
 
Additional rRNA polymorphism analysis was carried out within DNAsp, to assess the 
nucleotide diversity within the rRNA 123 and 154 genes. The remaining five rRNA 
were not included in the DNAsp analysis, as they were identical and had nucleotide 
diversity scores of 0 across the entire sequence length. The nucleotide diversity 
scores were either 0 or 1 depending on the presence or absence of a single 
nucleotide polymorphisms within the ribonucleotide sequences. The results suggest a 
high degree of conservation across the 16s rRNA sequences, with diversity 
constrained to early segments of the rRNA sequence for the two rRNA variants 
(Figure 5.10).  
 
Figure 5.10 Nucleotide diversity of the 16s rRNA 123 and 154 genes. Displaying 
the mean nucleotide diversity () of the 16s rRNA 123 (blue) and 154 (red) genes 
between the gentamicin sensitive and resistant strain of E. coli MG1655 using 
DNAsp.   
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5.3.4 Phylogenetic analysis of the rRNA variants 
 
To further assess rRNA conservation and to determine whether the identified rRNA 
mutations were present within other strains of E. coli, the phylogeny of the rna123 
and rna154 sensitive and resistant genes were resolved. Firstly, the phylogeny of the 
rna154 gene was resolved, revealing two clades with the rna154 resistant strain 
appearing as a lone outgroup within the ML tree (Figure 5.11). 
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Figure 5.11 Molecular phylogenetic analysis of the 16s rRNA 154 gene. 
Displaying the resolved phylogeny by maximum likelihood of the rna154 gene within 
the Escherichia taxa using MEGA. The gentamicin sensitive and resistant rna154 
isolates have been emphasised using an asterisk. 
* 
* 
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In comparison, the ML tree revealed similar tree topology for the rRNA 123 gene, with 
two discrete clades bootstrapped at 99%. There was a clear distinction between the 
rna123 sensitive and resistant gene sequences, clustering within two separate 
clades. However, an apparent difference between the rRNA 154 tree, was that the 
rRNA 123 resistant sequence does not appear as an outgroup, instead the sequence 
is clustered amongst other E. coli strains (Figure 5.12). Upon further inspection within 
NCBI of the strains which clustered with the resistant rna123 sequence, strains were 
found to be either genomically modified, or associated with antimicrobial tolerance 
and/or resistance (Table 5.2). This result indicates that the identified rRNA 123 
mutations could be markers associated with the acquisition of antimicrobial 
resistance.  
 
To conclude, the phylogenetic analysis shows high conservation for the two ML trees, 
with a single monophyletic unit split into two subgroups with a cladistics distinction of 
the presence of the resistant rRNA sequence. 
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Figure 5.12 Molecular phylogenetic analysis of the 16s rRNA 123 gene. 
Displaying the resolved phylogeny by maximum likelihood of the rna123 gene within 
the Escherichia taxa using MEGA. The gentamicin sensitive and resistant rna123 
isolates have been emphasised using an asterisk. 
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Table 5.2 Analysis of the E. coli strains which clustered with the gentamicin 
resistant rna123 isolate. Table displaying the details of the E. coli strains which 
clustered with the rna123 resistant isolate within the phylogenetic analysis.  
 
Strain  Strain ID  Description/Projects 
Escherichia coli strain 
MGY 
CP019629.1 Antimicrobial Tolerance/Resistance 
Evolution  
Escherichia coli strain 
RR1 
CP011113.2 Diagnosis and control of Antibiotic 
Resistant bacteria  
Escherichia coli strain 
Sanji 
CP011061.1 Antibiotic Resistant Strain  
Escherichia coli strain 
NCM3722 
CP011495.1 Metabolic Deficit Strain  
Escherichia coli strain 
SQ37 
CP011320.1 rRNA Operon Deletion Strain   
Escherichia coli strain 
ER3435 
CP010455.1 Genomically Recoded Strain 
Escherichia coli strain 
K12AG100 
LN832404.1 Sub-lethal Antimicrobial Selection 
Escherichia coli strain 
ER3413 
CP009789.1 Methyltransferase Deficient Strain  
Escherichia coli strain 
ER2796 
CP009644.1 Methyltransferase Deficient Strain 
Escherichia coli strain 
EcRV308 
LM995446.1 Monoisolate WGS  
Escherichia coli strain 
BW25113 
CP009273.1 Keio Collection Knockout Mutant (rRNA 
Deletion) 
Escherichia coli strain 
KLY 
CP008801.1 Antimicrobial Tolerance 
Escherichia coli strain 
C321 
CP006698.1 Evolution/Genetically Recoded Strain 
Escherichia coli strain 
BW2952 
CP001396.1 Strain malG-lacZ fusion/ 
Mutations/Recombination  
Escherichia coli strain 
DH10B 
CP000948.1 Common Laboratory Strain  
Escherichia coli strain 
AZ155 
CP019005.1 Global Surveillance of Antimicrobial 
Resistance 
 
 
Following the initial assessment of the rRNA mutations which form structural 
constituents of the ribosome, critical in the processing of genetic material and the 
production of proteins. The remainder of the results will be focused on the identified 
mutations within genes encoding proteins, for the fusA and pinR genes respectively.  
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5.3.5 EMBL SAPS protein charge analysis  
The first assessment of protein property was achieved using EMBL SAPS, to analyse 
the protein charge distribution following mutagenesis. The fusA results suggest that at 
the amino acid mutation position 610 there was no difference in charge pre-and post-
mutagenesis with both the amino acids proline and threonine being of neutral charge 
(Figure 5.13).  
Figure 5.13 Charge distributional analysis of the fusA encoding EF-G protein. 
Displaying the charge distribution analysis of the EF-G protein sequence between the 
gentamicin sensitive (A) and resistant (B) strains of E. coli MG1655 using EMBL 
SAPS. The amino acid mutational position is indicated using an asterisk. There is no 
difference in the charge distribution of the EF-G protein because of the mutation at 
the amino acid position 610.  
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When comprising this to the charge distribution of the pinR, a change in charge was 
identified at amino acid position 3. Here the amino acid arginine within the sensitive 
strain is positively changed and through mutagenesis is replaced with a glutamine 
residue of neutral charge (Figure 5.14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14 Charge distributional analysis of the pinR encoding serine 
recombinase protein. Displaying the charge distribution analysis of the serine 
recombinase protein sequence between the gentamicin sensitive (A) and resistant (B) 
strains of E. coli MG1655 using EMBL SAPS. The amino acid mutational position is 
indicated using an asterisk. The pinR mutagenesis has resulted in an alteration in the 
charge distribution at the amino acid position 3.  
 
 
The SAPS analysis of the two mutated proteins revealed no charge clusters, no high 
scoring uncharged segments and no unusual spacing within the amino acid 
sequences.   
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5.3.5.1 TreeSAAP selection on amino acid properties 
 
In addition to charge distribution the mutated proteins were analysed for alterations in 
physiochemical properties using TreeSAAP. The TreeSAAP analysis of the fusA gene 
showed significant results within two proteins properties; compressibility and power to 
be at C-terminus. There was a greater significance in the alteration of protein 
compressibility post mutagenesis, with a Z score within category 6 of 3.9*** (p<0.001) 
(Figure 5.15). When comparing this to power to be at C-terminus, there was a higher 
z-score of 4.028*** of equal significance (p<0.001). However, this score was obtained 
within magnitude category 5 (Figure 5.16).  These results suggest, the mutated amino 
acid is located at the C-terminus and causes significant alterations in the protein 
compressibility.  
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Figure 5.15 Protein compressibility: protein property under positive selection 
within EF-G. Figure displaying the TreeSAAP analysis of the fusA encoding EF-G 
protein of the drug sensitive and resistant E. coli MG1655 strains. The graph displays 
the frequency of a protein property under selection across the length of the protein 
sequence There was a significant alteration in protein property of protein 
compressibility at the mutation position with a Z score of 3.9 (p<0.001) within category 
6.  
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Figure 5.16 The power to be at C-terminus: protein property under positive 
selection within EF-G. Figure displaying the TreeSAAP analysis of the fusA 
encoding EF-G protein of the drug sensitive and resistant E. coli MG1655 strains. The 
graph displays the frequency of a protein property under selection across the length 
of the protein sequence. There was a significant alteration in protein property of 
power to be at C-terminus at the amino acid mutation position with a Z-score of 4.028 
(p<0.001) within category 5.  
 
 
The TreeSAAP analysis of the pinR gene showed a significant result with one protein 
property; isoelectric point. Post mutagenesis there was a significant change in the 
isoelectric point at the mutational position, with a Z score within category 7 of 2.876** 
(p<0.01) (Figure 5.17). This may reflect the alteration in charge identified previously 
using SAPS (Section 5.3.5).  The significance of the observed alteration in protein 
property within pinR was lower than seen for the two alterations in protein property 
within the fusA gene.  
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Figure 5.17 Isoelectric point: protein property under positive selection within 
the pinR serine recombinase. Figure displaying the TreeSAAP analysis of pinR 
serine recombinase protein of the drug sensitive and resistant E. coli MG1655 strains. 
The graph displays the frequency of a protein property under selection across the 
length of the protein sequence. There was a significant alteration in the proteins 
isoelectric point at the amino acid mutation position with a Z-score of 2.876 (P<0.01) 
in category 7. 
 
 
The observed alterations in protein properties are indicative of amino acid adaptation 
as a result of antimicrobial selection. Additional functional analysis conducted within 
this chapter will aim to characterise the extent of these adaptations, and their 
importance in the evolution of gentamicin resistance. 
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5.3.5.2 Conserved protein domain analysis  
 
The conserved domain analysis of the two mutated proteins was achieved using 
NCBI. The summary of the conserved domain analysis of the fusA sequence revealed 
3 superfamilies (Figure 5.18). The GTP-EFU superfamily spans the entire length of 
the fusA sequence (1-2112). The remaining 2 superfamilies include the P-
loop_NTPase superfamily and the EF-G_like_IV superfamily. The P-loop_NTPase 
superfamily is located at the nucleotide interval of 34-867 in the region of conserved 
functional sites including the GTP binding site. The EF-G_like_IV superfamily appears 
latter in the fusA sequence at an interval of 1495-1827. Together, GTP_EFTU and 
EF-G_like_IV form fundamental processes within ribosomal protein synthesis. Of 
particular importance is that the identified fusA mutation at the nucleotide interval 
1828, occurs at the terminal boundary of the conserved EF-G_like_IV superfamily.  
All the non-specific hits for the fusA nucleotide sequence can similarly be identified in 
figure (5.18).  
 
Figure 5.18 Conserved domain analysis of the fusA encoding EF-G protein. 
Displaying the graphical summary from the NCBI conserved domain analysis of the 
EF-G query sequence. The domains are colour coded per the assigned superfamilies. 
The functional sites of the protein are mapped to the query sequence and indicated 
as triangles of the same colour of the domain or superfamily providing the functional 
activity. The P-loop_NTPase superfamily comprises the functional sites of EF-G. The 
EF-G like_IV superfamily is of positional significance with regards fusA mutation.  
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In comparison to the conserved domain analysis within the pinR nucleotide sequence. 
In total one superfamily was identified; the Serine Recombinase superfamily, with a 
specific hit to PinE at an interval of 7-573 covering much of the nucleotide sequence 
(Figure 5.19). Further specific hits included SR_ResInv and Resolvase at an 
approximated interval of 10- 440 responsible for site specific recombination. The 
conserved domain analysis revealed that nucleotide position of the mutation within 
the pinR gene had a specific hit with PinE yet, was in a region containing no 
conserved functional sites. This result suggested that the identified mutation within 
pinR may be less relevant in the acquisition of gentamicin resistance than the 
mutation within the functional domain of fusA.  
 
Figure 5.19 Conserved domain analysis of the pinR encoding serine 
recombinase protein. Displaying the graphical summary from the NCBI conserved 
domain analysis of the serine recombinase query sequence. The domains are colour 
coded per the assigned superfamilies. The functional sites of the protein are mapped 
to the query sequence and indicated as triangles of the same colour of the domain or 
superfamily providing the functional activity. The functional sites of the pinR are 
sequence are annotated within the Ser_Recombinase superfamily.  
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5.3.6 Protein modelling using Swiss Model  
 
The best available template for the fusA gene sequence was the 4v7d.1 model, with a 
sequence identity of 100% for the sensitive strain (Figure 5.20 A). The resistant gene 
sequence in comparison had a sequence identity of 99.86% (Figure 5.20 B). Looking 
comparatively at the two models no obvious changes were present at the three 
magnifications, excluding the amino acid change at the point of mutagenesis.  
 
 
Figure 5.20 Protein homology modelling of EF-G. Displaying the protein models 
produced within Swiss Model of the EF-G protein within the sensitive (A) and resistant 
(B) strains of E. coli MG1655. The figure shows the overall structure of EF-G and a 
magnification of the protein model to facilitate the identification of the amino acids at 
the site of mutagenesis (circled in black).    
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When comparing this to the homology model for the pinR gene sequence. The best 
available template was the Igdt.1. E model with a sequence identity of 31.32% for 
both the sensitive and resistant pinR sequences, despite the presence of a non-
synonymous mutation. Upon closer inspection, all the available model templates for 
the pinR sequence within Swiss Model, did not comprise the first three amino acids 
and therefore any structural alterations were unidentifiable. There is an increasing 
number of incomplete crystal structures being deposited to the protein data bank, 
therefore missing N-terminal strings within a polypeptide chain of a putative protein is 
not unexpected (Djinovic-Carugo and Carugo, 2015). A single image was included 
representative of the general structure of the putative serine recombinase for both 
sequences (Figure 5.21).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.21 Protein homology modelling of Serine Recombinase pinR. 
Displaying the protein model produced within Swiss Model of the Serine 
Recombinase pinR protein within the sensitive strain of E. coli MG1655. The figure 
overall protein structure and a magnification of the protein model to facilitate the 
identification of the amino acid at the site of mutagenesis (circled in black). The 
protein model of the resistant E. coli MG1655 strain was not included in this image.  
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This concluded the functional analysis of the pinR encoding putative serine 
recombinase, in the interest of the fusA EF-G encoding mutation having greater 
involvement in the acquisition of gentamicin resistance.  
 
 
5.3.6.1 Protein modelling using Scigress  
 
The PDB molecules of the fusA encoding EF-G protein produced using Swiss Model, 
were imported into Scigress as chemical sample files (.csf), to geometrically optimise 
protein structures. The respective protein models were cleaned and beautified using 
the Valence Shell Electron Pair Repulsion (VSEPR) theory, prior to the visualisation 
of the mutated amino acid residue (Wong and Currie, 2012). 
 
When comparing the structural features of the geometrically optimised protein 
structures, there are evident differences between the sensitive (A) and resistant (B) 
models (Figure 5.22). This was originally identified when looking in the vicinity of the 
mutated amino acid residue.  Within the sensitive model a distinct coil was present 
adjacent to residue of interest, which was drastically loosened within the resistant 
model post mutagenesis. Subsequently, a comparative assessment of the overall 
tertiary structures revealed reduced compactness throughout the entire resistant 
model, which could reflect the reduction in protein compressibility identified using 
TreeSAAP.   
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Figure 5.22 Molecular modelling of EF-G. Displaying a comparison of the protein 
models of EF-G within the sensitive (A) and resistant (B) strains of E. coli MG1655 
using Scigress. The protein structures are shown in ribbon representation and the 
amino acids at the site of mutagenesis are represented using ball-and-stick. The 
image illustrates the alteration protein compressibility within the two protein 
structures.  
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5.3.6.2 Functional analysis of EF-G using PyMOL   
 
To comprehend the reduction in compressibility and alteration in tertiary protein 
structure, it was necessary to gain further insights into the biological function of EF-G 
within the 70s-ribosomal complex. The PDB files of EF-G bound to the 70s ribosomal 
complex were provided by Jinzhong Lin, and visualised within PyMOL. EF-G can be 
seen to undergo two conformational rearrangements during ribosomal translocation 
(Figure 5.23). For visual purposes EF-G has been presented both within the 70-s 
complex and independently. During the Pre–translocation state (A), EF-G is found in 
a compacted form, with unoccupied A (blue), P (purple) and E (pink) site tRNA’s. 
Post-translocation (B) EF-G undertakes a conformational change to its elongated 
state occupying the A site tRNA (Lin et al., 2014). The coordinated movement of the 
peptidyl tRNA from the A to the P site and the resultant movement of the mRNA 
initiated by EF-G, forms the basis of protein synthesis (Frank and Agrawal, 2000).  
 
The crystal structures of EF-G in complex with the ribosome provided by Lin et al. 
(2014) were utilised for both the protein modelling and molecular docking analysis 
within this thesis. As despite the availability of previously published cryo-electron 
microscopy (cryo-EM) and X-ray crystallography structures of ribosome complexes 
with EF-G (Brilot et al., 2013 and Pulk and Cate, 2013), the atomic resolution crystal 
structures detailed here, in both the pre- and post-translocational states, unveiled a 
previously unseen transient compact conformation during the pretranslocation 
complex, which suggested that EF-G exhibits greater conformational flexibility than 
previously observed (Lin et al., 2014).  Consequently, to determine the functional 
significance of fusA mutagenesis, structural analysis was conducted on the crystal 
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structures which provided the most recent insights into the conformational space 
occupied by EF-G during ribosomal translocation.  
 
Figure 5.23 Conformational changes of EF-G during ribosomal translocation.  
Displaying both the pre- (A) and post- (B) 70s-ribosomal complex and the 
corresponding conformational changes of EF-G from the compact form within the pre-
complex (C) to the elongated conformation in the post-complex (D). The 70s-
ribosomal subunit was presented in grey with the A-site (blue), P-site (purple) and E-
site (pink) TRNA’s. The two EF-G conformations were displayed multi-coloured to 
denote the five individual protein domains. 
 
Above (Figure 5.23), EF-G was presented as five individual segments of differing 
colours, representative of its five domains. The amino acid boundaries of each 
domain are shown in figure (5.24).  From the functional analysis it is evident that 
domains 3, 4 and 5 are key to the conformational change of EF-G during ribosomal 
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translocation. Out of the three domains, domain 4 undergoes the most extensive 
conformational change with its ‘swivel like’ motion.  This domain which was previously 
acknowledged as a superfamily within the conserved domain analysis. Moreover, the 
mutation identified is located at the boundary of domains 4 and 5 functioning as a 
hinge to facilitate the movement of domains.  
 
 
Figure 5.24 The conserved domains of EF-G. Pymol image displaying the five 
domains of EF-G (domain 1=pink, domain 2=yellow, domain 3=orange, domain 4=red 
and domain 5=blue) and the corresponding amino acid boundaries of each domain. 
Each of the five domains form a compact tertiary structure which contributes to the 
biological function or interaction of EF-G.  
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The PyMOL mutagenesis function was then used to indicate the position of the 
mutation, in relation to the domains of EF-G (Figure 5.25).  The results here further 
illustrated the significance of this mutation found at the hinge of domain 4, imperative 
to the conformational change of this domain during ribosomal translocation. No 
obvious alterations in the structure of EF-G were observed between the sensitive (A) 
and resistant (B) strains.  
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Figure 5.25 PyMOL mutagenesis of EF-G. Pymol image displaying a cartoon 
representation of the protein structures of the elongated conformation of EF-G within 
the sensitive (A) and resistant (B) strains of E. coli MG1655. The amino acid 
mutations were illustrated using the ball-stick-representation and the mutational 
position has been annotated. The five domains of EF-G (domain 1=pink, domain 
2=yellow, domain 3=orange, domain 4=red and domain 5=blue) have been 
highlighted to define the mutational domain. The amino acid mutation at 610 occurs at 
the boundary of domain 4 and 5 of EF-G.  
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Further Mutational analysis revealed that the specific amino acid at position 610 pre-
mutagenesis, was likely to be essential for the extreme conformational change of 
domain 4 during translocation (Figure 5.26).  Proline residues are referred to as Imino 
acids with a distinctive ability to associate with the protein backbone in two locations. 
This contrast to the other amino acids, means proline residues are often associated 
with polypeptide chains which require tight changes in direction (Barnes, 2003).  
Therefore, mutagenesis of a proline residue, which owing to its distinctive cyclic 
structure exhibits unique conformational rigidity, with an amino acid such as 
threonine, would hinder the structural rigidity at the molecular hinge of domain 4 of 
EF-G during the conformational transition from a compact to elongated state (Betts 
and Russell, 2003).  
 
Figure 5.26 The amino acid alteration in the mutagenesis of EF-G.   Displaying 
the 2D molecule sketch of the amino acid change from a proline to a threonine 
residue during mutagenesis of the fusA encoding EF-G. The nitrogen containing ring 
within the proline residue, is important for conformational changes within protein 
structures.  
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5.3.7 PCR amplification and sequencing of genes with mutations  
PCR reactions were conducted on the mutated genes most likely to be associated to 
the acquisition of gentamicin resistance which included both the rRNA genes and the 
EF-G encoding fusA gene. 
 
The initial PCR reactions were carried out on colonies selected at antimicrobial 
concentrations of 0, MIC and x10 MIC.  Colonies were selected at the three 
concentrations for all primer sets, and were successfully amplified by PCR (Appendix 
figure A.18) and sequenced at the Natural History Museum illumina sequencing 
facility.  
 
Successively, sequences were trimmed and aligned prior to analysis.  In addition to 
the sequenced data, comparable sequences of the rRNA and fusA genes were added 
to the alignment to ensure any variations observed were not due to sequencing 
errors. The analysis of the resequenced rRNA123 genes, displayed conservation 
across various nucleotide positions within the rRNA sequence. Of interest, the 
resistant associated mutations located at nucleotide positions 208, 250, 253 and 273, 
were observed in all resequenced rna123 strains at the two selected 
gentamicin concentrations (2mg/L and 20mg/L). Further to this, equivalent findings to 
the phylogenetic analysis of rna123 were observed, with identical polymorphisms 
being observed in a cluster of E. coli strains (Figure 5.27). 
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In addition, a single point mutation was found at the nucleotide position 1019 for 
colony 2 selected at 2mg/L gentamicin. Here, a nucleotide substitution from an 
adenine to a guanine was identified, which was not detected in any of the other 
strains of E. coli, suggestive of an error in sequencing. Moreover, resequencing data 
revealed substantial rRNA nucleotide discrepancies at positions 1117-1240 
(Appendix figure A.19).  
 
 
The resequencing results for the rRNA 154 genes displayed similarities with the 
rna123 sequences with high levels of rRNA conservation across the rna154 
sequences. The formerly identified mutation in the resistant strain of E. coli MG1655 
located at position 231, where the nucleotide guanine was substituted for an adenine, 
was not identified in any of the resequenced resistant strains of E. coli. In addition, a 
unique mutation at position 930 was discovered in colonies 1 and 4 selected at 2mg/L 
gentamicin, where again a guanine was substituted for adenine in the two resistant 
strains (Figure 5.28). These results support the findings from the phylogenetic 
analysis, as no resistant associated mutations were identified in comparable strains of 
E. coli.  
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There were nucleotide discrepancies evident in the region of positions 79-98 of the 
rna154 sequence (Appendix figure A.20). Mutations were formerly identified in this 
region, in the originally sequenced strain of E. coli MG1655. This suggests mutations 
within this locality despite the gaps within the alignment, may be associated with 
gentamicin resistance.  
 
In comparison to the resequenced fusA isolates, there was a high level of 
conservation observed, which was maintained across the entire sequence length.  An 
interesting finding here was that the fusA mutation at position 1834 was only 
observed within the 5 colonies selected at the highest antimicrobial concentration 
(Figure 5.29).  As the mutation was not identified within the MIC isolates, this could 
suggest antimicrobial tolerance at the lower antimicrobial concentration, with the 
resistant specific SNP only being fixed within the population at the higher 20mg/L 
concentration.  
 
To determine at what point the fusA mutation arises, PCR reactions were completed 
with colonies selected at intermediate antimicrobial concentrations of 4 and 8 mg/L. 
All 5 colonies selected at 8mg/L, were successfully amplified using PCR. Though, 2 
out of the 5 colonies selected at 4mg/L were unsuccessfully amplified.  When viewing 
the alignments of the intermediated sequences, mutations were identified surrounding 
the nucleotide position 1834, at positions 1815 and 1860 where in all but one case in 
both positions a guanine is substituted for an adenine (Figure 5.29). This implied that 
there are coexisting lineages with a region of mutation surrounding the resistant 
specific SNP. At position 1860, where guanine was substituted for an adenine, this 
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lead to no change in amino acid. Whereas, the SNPs located at position 1815 lead to 
an amino acid change from a glycine to a serine at amino acid position 605 which 
falls into domain 4. It is likely that the mutation present at 610, is more efficient in 
function, despite the increasing selective pressure.  
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5.4 Discussion  
 
The research hypothesis described in section (5.1) was supported by the 
experimental data presented within this chapter as follows. After extensive 
bioinformatic analysis physiochemical variations were identified in mutated rRNA 
genes and proteins which related specifically to the functional activity of the 
aminoglycoside gentamicin. Further to this confirmatory PCR and sequencing 
revealed the presence of the most significant most likely to be associated with the 
acquisition of gentamicin resistance in resistant strains, isolated separately within the 
proposed model and within the traditional serial passage system  
 
5.4.1 Transcriptional regulation and control of the rRNA operon 
In bacterial genomes, the rRNA genes are organised into operons, which present 
typically in several copies within prokaryotic organisms (Pei et al., 2010). The genome 
of the studied organism E. coli K-12 encodes seven copies of the rrn operon named 
rrnA to rrnH, (Kiss, Sain and Venetianer,1977; Ellwood and Nomura, 1981). It is 
generally assumed that the presence of multiple copies of the ribosomal RNA (rrn) 
operon within E. coli, is essential for rapid rates of growth (Condon et al., 1992). 
However, under favourable conditions the maximal growth rates of E. coli were 
maintained following the inactivation of two of the seven rrn operons (Condon et al., 
1995). This suggests the multiplicity of the rrn operon, is conserved not only to 
support maximal growth, but instead to allow bacterial populations to respond to 
changes in environmental conditions such as resource availability (Davis, Luger and 
Tai, 1986; Klappenbach, Dunbar and Schmidt, 2000). Therefore, assuming the 
mutations identified in the two rrn operons are inactivating, the bacterial growth 
response under selective pressures including antibiotics, could be compromised. 
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The transcription of rRNA genes is an essential rate-limiting step in ribosomal 
biosynthesis, and therefore is tightly regulated by several mechanisms to respond to 
the cellular demands during protein synthesis (Gourse et al., 1996). The initial control 
of rRNA synthesis is exerted at the level of transcription initiation, by the rrn promoter 
initiators ATP and GTP and the small molecule effectors initiating nucleoside 
triphosphate (iNTPs) and nucleotide guanosine5’-diphosphate 3’-diphosphate 
(ppGpp) which vary significantly in concentration in response to changes in nutritional 
conditions (Murray and Schneider and Gourse, 2003). The rRNA synthesis is also 
indirectly regulated through translational feedback from ribosomal protein synthesis, 
where whilst ribosomal proteins have a high affinity for rRNA to facilitate ribosomes 
assembly, in the presence of excess rRNA the ribosomal proteins act as repressor 
and bind to their own mRNA preventing protein synthesis (Burgos et al., 2017).  
 
5.4.2 Secondary structure modelling of the 16s rRNA mutations 
Computational modelling permitted the domain mapping of the rrn mutations to the 
secondary structure of the 16s rRNA, and the comparative analysis of conformational 
changes in secondary structure post-mutagenesis.  Increased knowledge of the 
interactions of the 16s rRNA domains with ribosomal components, has facilitated the 
identification of highly conserved regions and structural motifs which are essential to 
the function of the ribosome (O’Connor, Göringer and Dahlberg, 1992; Vila, Viril-
Farley and Tapprich, 1994; Santer et al., 1995; Van Ryk and Dahlberg, 1995).  
However, an examination of the 16s rRNA mutation database suggested the 
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identified mutations were not located within domains of high functional importance 
(Triman, 1996).   
Nevertheless, the association of the 16s rRNA with the ribosomal proteins is essential 
to the sequential assembly of the 30s-ribosomal subunit (Grondek and Culver, 2004). 
Studies have identified that mutations within conserved regions of the rRNA binding 
sites, which result in the conformational rearrangements of rRNA, impair ribosomal 
protein recognition and binding affinity in ribosomal proteins S7 and S8 (Allmang et 
al., 1994; Dragon, Payant and Brakier-Gingras, 1994). Therefore, according to 
secondary structure predictions and the tertiary interactions within the 30s ribosomal 
complex, the altered conformation of the body domain of rRNA 154 proximate to the 
ribosomal protein S17, could disrupt the initial assembly of the 30s ribosomal subunit. 
This is significant as the ribosomal protein S12 requires its primary binding protein 
S17 for its association with the 16s rRNA in the formation of the shoulder of the 30s 
subunit, which contains the aminoglycoside binding pocket (Jakob et al., 2012).   
 
Unfortunately, the PyMOL mutagenesis function does not operate on ribonucleic 
acids, and thus the conformational alterations in the tertiary structure of the 16s rRNA 
within the 30s subunit were unidentified.   
 
5.4.3 16s rRNA mutagenesis and aminoglycoside resistance 
In addition to the binding of 16s rRNA with the ribosomal proteins in the assembly of 
the 30s ribosomal-subunit, there are structural requirements of the 16s rRNA for 
ligand binding including aminoglycoside antibiotics (Cho, Hamasaki and Rando, 
1998). Footprinting studies have revealed a protective interaction between the 
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antimicrobial streptomycin and concise regions of the 16s rRNA at residues 913 and 
915, which when mutated gives rise to phenotypic resistance through the disruption of 
drug binding (Moazed and Noller, 1987; Leclerc, Melancon and Brakier-Gingras, 
1991). In like manner using a single rRNA allelic derivatives of the bacterium 
Mycobacterium smegmatis, hygromycin B resistant mutations were exclusively 
identified in residues within the helix 44 region of the 16s rRNA, local to the 
antimicrobial binding site (Pfister, Brodersen and Bottger, 2003). Hence, an 
assumption could be made that allosteric interactions occurring between the 16s 
rRNA mutations in helix 6 and the neighbouring helix 44, could disturb the  
gentamicin binding pocket and lead to phenotypic resistance.  
 
Further studies of the aminoglycoside tobramycin have revealed rRNA 
aminoglycoside binding, is determined by factors beyond a consensus recognition 
sequence, with greater emphasis on the folding behaviours and the distinct shapes 
produced by the 16s rRNA (Wang and Rando, 1995; Tor, Hermann and Westhof, 
1998). This suggests that the structural alterations observed within the 16s rRNA 
could have more profound effects on reducing the affinity of gentamicin to the binding 
pocket.  
 
Despite the fact previous studies have reported an association between 16s rRNA 
mutagenesis and resistance development, it is highly unlikely that resistance 
manifests exclusively due to an alteration within the rRNA target (Kotra, Haddad and 
Mobashery, 2000). This is predominantly due to the occurrence of multiple copies of 
the rrn operons which confer resistance in a recessive manner, and thus mutations 
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are often missed due to the dominance of sensitive rrn genes which contribute to a 
greater total number of ribosomes (Sigmund and Morgan, 1982). Therefore, it is 
unrealistic to assume that the acquisition of gentamicin resistance occurs exclusively 
as a result of the identified mutations within the two 16s rRNA operons. This was 
further supported through the confirmatory PCR and sequencing of the mutated 16s 
rRNA genes, which displayed irregularities in terms of the existence and locality of rrn 
mutations.   
 
5.4.4 Functional analysis of the ribosomal protein EF-G  
The functional analysis of the EF-G mutagenesis, holds great significance owing to its 
critical involvement during protein synthesis, through mediating the translocation of 
mRNA and tRNA’s through the ribosome (Ramrath et al., 2013). Over the last 15 
years, substantial insights have been provided into the dynamics of tRNA’s during 
translation (Blanchard et al., 2004; Ermolenko et al., 2007; Agirrezabala et al., 2008; 
Julian et al., 2008).  However, although EF-G is appreciated for its vital catalytic role, 
the molecular mechanism through which EF-G coordinates ribosomal translocation is 
not fully understood (Salsai et al., 2014).  
 
The elongation factor EF-G has considerable involvement in two independent phases 
of ribosomal translocation. The initial phase involves the spontaneous movement of 
tRNAs, between the ribosomal A- and P- sites relative to the 50s subunit, to form the 
classical and hybrid pre- translocational conformations (Kim, Puglisi and Chu, 2007; 
Munro et al., 2010). An important function of the binding of EF-G during this phase is 
to transiently stabilise the intermediate rotated hybrid state of the pre- translocation 
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ribosome (Spiegel, Ermolenko and Noller, 2007).  During the second phase, EF-G 
catalyses the movement of mRNA and tRNA combined with the reverse rotation of 
the 30s-ribosomal subunit (Savelsbergh et al., 2003; Ermolenko and Noller, 2011; 
Guo and Noller, 2012; Tourigny et al., 2013), which is said to be accelerated through 
GTP hydrolysis (Rodnina et al., 1997; Holtkamp et al., 2014).  
 
Early structural studies revealed EF-G contains five structurally defined domains, 
which are fundamental to understanding the molecular mechanisms behind ribosomal 
translocation (AEvarsson et al., 1994; Czworkowski 1994). EF-G domains 3, 4 and 5 
have combined functional significance, through the molecular mimicry of the 
aminoacyl-tRNA at the ribosomal A-site (Clark et al., 1999).  Domain 4 in its 
elongated state replicates the anticodon arm of the aa-tRNA and deletion of this 
domain results in diminished translocational activity (Martemyanov and 
Gudkov,1999). This is compelling evidence to suggest that the mutation identified in 
the boundary between EF-G domains 4 and 5, could result in altered binding of 
domain 4 to the ribosomal A site, and subsequently influence ribosomal translocation.  
 
Further structural investigations of the ribosome bound EF-G within the pre- and post 
translocation states, have indicated that EF-G must undergo substantial structural 
rearrangement in order to prevent the steric clash of domain 4 at the ribosomal A-site 
pre-translocation (Gao et al., 2009; Zhou et al., 2012; Brilot et al., 2013). This 
conformational variability displayed by EF-G in its bound form, is thought to be 
essential in promoting ribosomal translocation (Munro et al., 2010; Li et al., 2011). 
Such that, when the intramolecular mobility of EF-G is compromised through the 
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addition of disulfide crosslinks, EF-G is unable to facilitate ribosomal translocation 
despite the maintenance of GTPase activity (Peske et al., 2000). 
 
This is particularly meaningful as the non-synonymous mutation at position 610 
between the boundary of EF-G domains 4 and 5, leads to an amino acid substitution 
from a proline to a threonine residue. Proline residues have been recognised for their 
ability to form molecular hinges, which induce conformational changes within protein 
structures (Sansom and Weinstein, 2000). Consequently, the replacement of a 
proline residue at the domain 4 hinge with the amino acid threonine, could 
significantly effect the intrinsic flexibility of EF-G. This hypothesis was supported 
through the identification of mutation induced changes in protein compressibility, 
which is closely associated with modifications in the flexibility and overall functional 
dynamics of proteins (Gekko et al., 2000; Gekko et al., 2004). In addition, the 
presence of the EF-G mutation at position 610 in the resequenced resistant isolates, 
suggests fusA mutagenesis is fundamental to the acquisition of gentamicin resistance 
within the two models.  
 
5.4.5 Conclusion 
To conclude, it is therefore tempting to speculate that the combinatory effects of 16s 
rRNA and fusA mutations within the 70s-ribosomal complex, are the intrinsic 
genotypic adaptations governing gentamicin resistance within the experimental 
model. Nevertheless, it is currently unknown whether the observed mutations 
interfere with the antimicrobial binding, and this will be examined independently within 
chapter 6.   
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Chapter 6: In-silico molecular docking analysis illustrating the adaptive 
response to gentamicin resistance in E. coli MG1655.  
 
6.1 Introduction 
Molecular docking aims to predict the precise interactions between a ligand and a 
receptor using computational approaches (Meng et al., 2011). Such approaches have 
been fundamental in charactering the behaviours of small molecules and 
consequently have been applied as tools in molecular biology and computer assisted 
drug design (Morris and Lim-Wilby, 2008). Molecular docking is routinely used as a 
screening tool within modern drug design, to explore the drug receptor interactions of 
novel or synthesised derivatives of compounds (Vijesh et al., 2011).  
With the recent increase of antimicrobial resistance, there is an urgent need for 
approaches to combat this issue. Molecular docking has been utilised to provide 
insights into the known antimicrobial target mechanisms in the discovery of novel 
antimicrobial compounds of natural and synthetic origin (Alves et al., 2014; 
Rajasekaran and Rao, 2015; Gullapelli et al., 2017). In addition, docking can be 
applied in the study of existing antimicrobial agents to reveal the structural 
mechanisms of resistance following mutagenesis (Lee, Hong and Kim, 2018; Zhou et 
al., 2015).  
Owing to the application of gentamicin in this study, it was essential to comprehend 
the docking of antimicrobial agents which target the bacterial ribosome. Docking 
studies have revealed that mutations within both the ribosomal proteins and rRNA 
lead to target site perturbations which interfere with the binding of antimicrobial 
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agents (Long et al., 2009; Klitgaard et al., 2015). Ribosomal binding studies have also 
shown that in addition to mutations which directly interfere with the drug binding sites, 
mutations found at distant locations within the ribosome can result in antimicrobial 
resistance (Blaha et al., 2008).  
The structural basis for gentamicin inhibition of bacterial ribosomal protein synthesis 
in E. coli has been previously resolved by Borovinskaya et al. (2007), yet this high-
resolution structure only exists for EF-G in its elongated conformation of the post-
ribosome complex. Further cryo-EM reconstruction of EF-G in the pre-ribosomal 
complex, revealed small structural rearrangements of EF-G relative to the ribosome 
during translocation, which is trapped through the addition of the aminoglycoside 
viomycin (Brilot et al., 2013). Nevertheless, as this fails to demonstrate the 
conformational flexibility of EF-G between its compact and elongated states, the Lin 
et al. (2014) atomic resolution crystal structures were obtained for the in-silico 
molecular docking analysis of fusA mutagenesis in the gentamicin resistant strains of 
E. coli MG1655.  
The aim of this chapter is therefore to determine whether the binding of gentamicin to 
the molecular target is interrupted because of the ribosomal mutagenesis of the 16s 
rRNA genes and EF-G. It is hypothesised that as structural alterations have 
previously been identified post-mutagenesis, it is likely that the EF-G and rRNA 
mutations within the 70s-ribosomal complex will disrupt the binding of gentamicin. 
This would suggest that the identified mutations within this study, are responsible for 
the in-vitro acquisition of gentamicin resistance.  
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6.2 Materials and methods  
6.2.1 Molecular structure analysis 
The key components within the docking simulation experiments were sketched using 
MoleculeSketch, detailed in section (2.11.1).  
 
6.2.2 Preparation of PDB files for docking  
The computational ligand docking was achieved using AutoDock suite, a prerequisite 
of which is a correctly formatted PDB files. Details regarding the source of the  
PDB files and subsequent modifications for use within Autodock are provided in 
section (2.11.2).  
 
6.2.3 Preparation of receptor and ligand for docking  
The initial stage of molecular docking analysis involved the preparation of ligand and 
receptor files, which included root detection and computation of charges respectively. 
Further details of ligand and receptor preparation are specified in sections (2.11.3 and 
2.11.4). 
 
6.2.4 Grid box preparation and single docking analysis 
To ensure the correct binding of the ligand to the receptor, grid box parameters were 
specified and modified per docking analysis (Section 2.11.5). Following docking 
analysis all poses were visualised in PyMOL. Further details are available in section 
(2.11.6).  
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6.2.5 Autodock modifications   
An issue occurred within Autodock when reading the molecule, as the 70s complex 
exceeds the maximum number of atoms permitted. To overcome this the retain order 
was unset by compiling Autogrid and Autodock version 4.2 from source and editing 
the line in constants.h in the Autodock directory and line autogrid.h within Autogrid to 
define the max atoms and records to a number exceeding that of the 70s-ribosomal 
complex.  Before compiling, a new directory was made for the new build and ran 
using autoreconf –i and then built routinely using configure make. In addition to the 
atom size limit, discrepancies can be observed in molecules containing metal ions, 
including potassium and magnesium. This error was overcome by adding the 
following line: atom par K 3.81 0.035 12.000 -0.00110 0.0 0.0 0 -1 -1 1 to the file 
AD4_parameters.dat file in the Autodock subdirectory, which adds the given charges 
to the metal ion detailed. To ensure the changes are executed, after the gpf. and dpf. 
files are created the following line is added to the top of both files respectively: 
parameter_file AD4_parameters.dat.  
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6.3 Experimental results  
6.3.1 The molecular structure analysis of gentamicin  
The structural details of the aminoglycoside gentamicin were discussed previously in 
chapter 3 (Section 3.9.8.2). Gentamicin has two predominate targets within the 70s-
ribosomal complex, which include the 16s rRNA and the 30s-ribosomal subunit 
protein S12 (Section 4.3.3). Gentamicin has been found to bind to the 16s rRNA in 
two adjacent positions. Hydrogen bonds are formed between the nitrogen and 
guanine at position 1405 and between the oxygen and uracil at position 1406. In 
addition, gentamicin forms a hydrogen bond between the nitrogen and the lysine 
residue of S12 at position 42. The molecular structure of gentamicin and the 
corresponding ribonucleotides and the amino acid binding structures can be found 
below (Figure 6.1).  
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Figure 6.1 Molecular structures of gentamicin and the ribonucleotide and amino 
acid binding structures. Figure displaying the 2D molecular structure of the 
gentamicin complex with the three major components labelled 1, 2 and 3. The image 
also includes the structures of the gentamicin targets including the ribonucleotide 
bases uracil and guanine of the 16srRNA and the amino acid lysine in the 30s-
ribosomal subunit protein S12.  
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6.3.2 Preparation of the gentamicin-ligand for molecular docking to the 30s-
ribosomal subunit protein S12  
The primary docking experiments were conducted exclusively on the 30s-ribosomal 
subunit protein S12. The initial step involved the preparation of the ligand gentamicin. 
Here the antimicrobial root was detected and a total of 13 rotatable bonds were 
identified (Figure 6.2), this followed the computation gasteiger charges where a total 
of 5.0003 charges were added (Figure 6.3).  
 
Figure 6.2 Preparation of the gentamicin ligand for docking in Autodock.  
PyMOL image displaying the root detection of the gentamicin ligand. The root is 
determined as the fixed portion of the ligand closest to the molecule centre and is 
shown as a green sphere in both gentamicin structures. (A) Gentamicin structure 
displaying the root and the chemical composition of the ligand: nitrogen atoms (blue), 
oxygen atoms (red) and carbon atoms (grey). (B) Gentamicin structure displaying the 
detected root, the position of each atom and information regarding the rotatable 
bonds. The rotatable bonds are shown in green and the non-rotatable bonds are 
shown in red.  
 
 
A B 
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Figure 6.3 The gentamicin ligand preparation docking summary. The autodock 
output of the final stage in the ligand preparation, displaying the total number of 
gasteiger charges added the gentamicin ligand (5.003) and the ligand summary which 
includes the number of detected rotatable bonds (13) and number of merged non-
polar hydrogen atoms (27) for ligand docking.  
 
6.3.3 Ligand and grid-box preparation for the molecular docking simulation of 
gentamicin to the 30s-ribosomal subunit protein S12 
Subsequently, the grid box was prepared for the docking of the gentamicin ligand. As 
previously discussed (Section 6.3.1), gentamicin binds to the lysine residue at 
position 42 within S12 which was highlighted with yellow asterisks, to assist the grid 
box optimisation (Figure 6.4). The grid box was positioned directly surrounding the 
lysine residue and the finalised grid box parameters for docking are shown in table 
(6.1).  
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Figure 6.4 The grid box preparation for the 30s-ribsomomal subunit protein 
S12. PyMOL image displaying the structure of the 30s-ribsomomal subunit protein 
S12 in stick representation with colours determined by the atoms within the protein 
structure: carbon atoms (grey), nitrogen atoms (blue) and oxygen atoms (red). The 
grid box is positioned directly surrounding the lysine residue at position 42 of the 
ribosomal protein S12 to facilitate the site-specific docking of the ligand to the known 
binding sites within the protein structure.  
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Table 6.1 The 30s-ribsomomal subunit protein S12 grid box parameters for the 
single molecular docking analysis. Displaying the optimised grid box and centre 
grid box coordinates for the docking simulation of the gentamicin ligand to the 30s-
ribsomal subunit protein S12. 
  
 
 
 
 
 
 
 
6.3.3.1 Single docking analysis of gentamicin to the 30s-ribosomal subunit 
protein S12 
The docking analysis of gentamicin to the 30s-ribosomal protein S12 identified five 
possible antimicrobial conformations, varying in binding energies ranging from 5.48 to 
5.535 kcal/mol (Figure 6.5). All predicted gentamicin poses were visualised as sticks, 
and clear overlays in structures were observed (Figure 6.6).  
 
 
 
 
 
 
 
 
 
 
 
 
Current total grid points per map 6400 
Number of points in x-dimension 40 
Number of points in y-dimension 40 
Number of points in z-dimension 40 
Spacing (angstrom) 0.375 
Centre grid box 
X centre 19.806 
Y centre 11.306 
Z centre  -22.389 
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Figure 6.5 Binding energies of the gentamicin conformations obtained from the 
docking simulation with the 30s-ribosomal subunit protein S12 with Autodock. 
Graph showing the five predicted gentamicin conformations and the corresponding 
binding energies.  
 
 
 
 
 
 
 
 
Figure 6.6 Superimposition of the gentamicin binding poses.  PyMOL image 
displaying the structures of the five predicted gentamicin conformations illustrated 
using the stick model representation. All stick poses are differentiated by the colour of 
carbon backbone. The remaining elements of the ligand structure are coloured by 
atom:  nitrogen (blue) polar hydrogens (white) and oxygen (red). 
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Next, all predicted gentamicin conformations were docked to the 30s-ribosomal 
protein S12, and comparably the overlay in the gentamicin poses was observed as 
shown (Figure 6.6), with ligand binding appearing in close proximity to the lysine 
residue at position 42 (Figure 6.7).  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7 Docking simulation of all gentamicin poses to the 30s-ribsomomal 
subunit protein S12. PyMOL image displaying the single docking analysis image of 
all predicted gentamicin binding conformations illustrated using the stick model 
representation (circled in white) docked to the ribosomal subunit protein S12 (green) 
near the lysine residue at amino acid position 42.  
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As the binding of molecules is favourable in the lowest energy state, docking was 
conducted with the gentamicin conformation with a biding energy of 5.48 kcal/mol, 
using the space filling model (Figure 6.8). Within this model the nitrogen residue can 
be seen in binding in close proximity to the lysine residue at position 42, supporting 
the previous docking experiments.  
 
 
 
 
 
 
 
 
 
  
 
Figure 6.8 Docking simulation of gentamicin to the 30s-ribsomomal subunit 
protein S12. PyMOL image displaying the single docking analysis image of the 
lowest gentamicin binding energy conformation represented using the space filling 
model (circled in white) docked to the ribosomal subunit protein S12 (green) near the 
lysine residue at amino acid position 42.  
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To gain a comprehensive understanding of the interactions of the gentamicin ligand 
within the 30s-ribosomal subunit with both antimicrobial targets (ribosomal protein 
S12 and the 16s rRNA), docking experiments were repeated with the inclusion of the 
70s-ribosomal protein complex.  
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6.3.4 Gentamicin docking analysis 70s-ribosomal complex 
There were extensive modifications made to the PDB files of both the pre- and post 
70s-ribosomal complex with EF-G, prior to the successful upload into autodock.  
6.3.4.1 Receptor preparation of the 70s-ribosomal complex 
A primary stage in the receptor preparation, involved the computation of gasteiger 
charges. The total number of gasteiger charges added to the 70s-ribosomal complex 
was -2337.9281 (Figure 6.9).  
 
 
Figure 6.9 Preparation of the 70s-ribosomal complex receptor for docking in 
Autodock. Displaying the autodock output in the final stage of the 70s-ribosomal 
complex receptor preparation showing the total number of gasteiger charges added to 
the receptor macromolecule (-2337.9281).  
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6.3.4.2 70s pre-ribosomal complex docking analysis pre-mutagenesis  
Following receptor preparation, key components for gentamicin docking and 
ribosomal translocation were highlighted within PyMOL, and included the 30s-
ribosomal subunit protein S12, A, P and E site tRNAs, mRNA and EF-G (Figure 6.10).  
 
Figure 6.10 The tertiary structure of the 70s pre-ribosomal complex. PyMOL 
image displaying the 70s pre-ribosomal complex and the key components involved in 
the ribosomal translocation stage of protein synthesis: EF-G (red), mRNA (orange), 
A-site tRNA (blue), P-site tRNA (purple) and E-site tRNA (pink). The 30s and 50s 
ribosomal subunits are shown in light and dark grey respectively and the gentamicin 
30s-ribosomal subunit protein target S12 is depicted in green. EF-G (red) is found 
within its compact conformation within the 70s pre-ribosomal complex.  
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Successively, the grid box was prepared to encompass both ribosomal targets, 
comprising the lysine residue at position 42 and the two 16s rRNA positions. The grid 
box was further expanded to integrate sections of both the A-site tRNA and the 
mRNA (Figure 6.11). The optimised grid box parameters used in the docking 
experiments of the 70s-ribosomal complex, are provided in Table (6.2).  
 
Figure 6.11 The grid box preparation for the 70s pre-ribosomal complex. PyMOL 
image displaying the cartoon representation of the tertiary structure of the 70s pre-
ribosomal complex. The 30s-ribosomal subunit is shown in light grey, 50s-ribosomal 
subunit in dark grey, EF-G (red), mRNA (orange), A-site tRNA (blue), P-site tRNA 
(purple), E-site tRNA (pink) and the gentamicin 30s-ribosomal subunit protein target 
S12 is depicted in green. The grid box (yellow) is positioned proximal to the ribosomal 
subunit protein S12, A-site tRNA, mRNA and the neighbouring 16s rRNA.  
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Table 6.2 The 70s pre-ribosomal complex grid box parameters for the molecular 
docking analysis. Displaying the optimised grid box and centre grid box coordinates 
for the docking simulation of the gentamicin ligand to the 70s pre-ribosomal complex. 
 
Current total grid points per map 6400 
Number of points in x-dimension 60 
Number of points in y-dimension 60 
Number of points in z-dimension 60 
Spacing (angstrom) 0.465 
Centre grid box 
X centre 104.64 
Y centre 9.769 
Z centre  31.18 
 
Docking analysis of gentamicin to the 70s pre-ribosomal complex, revealed a total of 
8 gentamicin binding conformations, with binding energies ranging from 
approximately -108.2 to -105.6 kcal/mol (Figure 6.12).  
Figure 6.12 Binding energies of the gentamicin conformations obtained from 
the docking simulation with the 70s pre-ribosomal complex with Autodock. 
Graph showing the eight predicted gentamicin conformations and the corresponding 
binding energies. 
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All the 8 predicted gentamicin binding poses were shown within the 70s pre- 
ribosomal complex using the space filling model (Figure 6.13). From the figure, all the 
gentamicin conformations appeared to preferentially bind in closer proximity to the A- 
site tRNA and mRNA, and at a greater distance from the predicted binding site, the 
30s-ribosomal subunit protein S12.  
 
Figure 6.13 Docking simulation of all gentamicin poses within the 70s pre-
ribosomal complex. PyMOL image displaying the docking analysis image of all 
predicted gentamicin binding conformations illustrated using the space filling model 
representation (circled in white) docked to the 70s pre-ribosomal complex.  
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Afterwards, the docking results were amended to allow the visualisation of the 
gentamicin conformation with the lowest binding energy of -108.2 kcal/mol 
independently within the 70s pre-ribosomal complex (Figure 6.14). The figure below 
was magnified to determine the precise location of gentamicin within the ribosomal 
complex, relative to the key components previously described. The gentamicin 
molecule seemed to be equal distance from the A-site tRNA, mRNA, EF-G domain 4 
and the 30s-ribosomal subunit protein S12. It should be noted that the lysine residue 
at position 42 within the ribosomal protein S12 was highlighted in yellow, as the 
lowest bound energy conformation of gentamicin appeared in closer vicinity with S12 
than previously presumed.   
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Figure 6.14 Docking simulation of gentamicin to the 70s pre-ribosomal 
complex. Magnified PyMOL docking analysis image displaying the lowest gentamicin 
binding energy conformation depicted using a space filling model (circled in white) 
docked to the 70s pre-ribosomal complex. The gentamicin-ligand is bound to the 70s 
pre-ribosomal complex near the lysine residue at position 42 of the 30s-ribosomal 
subunit protein S12 (green), EF-G (red), A-site tRNA (blue) and mRNA (orange).   
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6.3.4.3 70s post-ribosomal complex docking analysis pre-mutagenesis 
The docking analysis was then repeated using identical grid box parameters, but in 
this case for the 70s post- ribosomal complex, where EF-G undergoes an extensive 
conformational change with domain 4 occupying the A-site tRNA (Figure 6.15). Again, 
the 30s-ribosomal subunit protein S12 was highlighted in green, as an indicator of the 
expected gentamicin target site.  
 
 
 
 
 
 
 
Figure 6.15 The tertiary structure of the 70s post-ribosomal complex. PyMOL 
image displaying the 70s post-ribosomal complex and the key components involved 
in the ribosomal translocation stage of protein synthesis: EF-G (red), mRNA (orange), 
P-site tRNA (purple) and E-site tRNA (pink). The 30s and 50s ribosomal subunits are 
shown in light and dark grey respectively and the gentamicin 30s-ribosomal subunit 
protein target S12 is depicted in green. EF-G (red) is found within its elongated 
conformation within the 70s pre-ribosomal complex. The EF-G domain 4 (circled in 
yellow) occupies the A-site tRNA within the 70s post-ribosomal complex.  
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Here, in comparison to the 8 predicted conformations for the 70s pre-ribosomal 
complex, there were a total of 9 gentamicin conformations predicted with binding 
energies ranging from -100.0 to -96.50 kcal/mol (Figure 6.16).  
 
Figure 6.16 Binding energies of the gentamicin conformations obtained from 
the docking simulation with the 70s post-ribosomal complex with Autodock. 
Graph showing the nine predicted gentamicin conformations and the corresponding 
binding energies. 
 
Following the docking predictions, all 9 gentamicin poses were visualised within the 
70s post-ribosomal complex (Figure 6.17). The docking analysis revealed 
discrepancies in the docking position of the antimicrobial gentamicin between the pre- 
and post- 70s ribosomal complex. Within the post ribosomal complex, all 9 gentamicin 
poses appeared behind domain 4 of EF-G, and distant from the 30s-ribosomal 
subunit protein S12.  
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Figure 6.17 Docking simulation of all gentamicin poses within the 70s post-
ribosomal complex. PyMOL image displaying the docking analysis image of all 
predicted gentamicin binding conformations illustrated using the space filling model 
representation (circled in white) docked to the 70s post-ribosomal complex. 
 
The docking results were then visualised exclusively for the gentamicin conformation 
with the lowest binding energy of approximately -100.00kcal/mol within the 70s post- 
ribosomal complex (Figure 6.18). The binding energy for the docking of gentamicin 
within the post complex was lower than the lowest binding energy of -108.2 kcal/mol 
within the 70s pre-ribosomal complex. As domain 4 of EF-G is known to occupy the 
A-site tRNA within the post complex, it can be assumed that as gentamicin appears 
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behind domain 4 it is within the vicinity of the A-site tRNA. However, its position 
seemed much higher relative to the 30s-subunit protein of S12 and the mRNA as 
seen in the 70s pre-complex.  
 
Figure 6.18 Docking simulation of gentamicin to the 70s post-ribosomal 
complex. Magnified PyMOL docking analysis image displaying the lowest gentamicin 
binding energy conformation depicted using a space filling model (circled in white) 
docked to the 70s post-ribosomal complex. The gentamicin-ligand is bound to the 70s 
post-ribosomal complex behind domain 4 of EF-G (red).  
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6.3.5 Gentamicin docking analysis post-mutagenesis  
Ensuing the docking analysis of gentamicin within the pre- and post 70s ribosomal 
complex, it was necessary to determine whether the mutagenesis observed within the 
16s rRNA and EF-G, affected gentamicin binding. Unfortunately, the 16s rRNA 
mutations were unable to be assessed using the PyMOL mutagenesis function, 
however the locality of these mutations were highlighted in yellow for all docking 
experiments post-mutagenesis.  
6.3.5.1 70s pre-ribosomal complex docking analysis post-mutagenesis 
Comparable to the docking analysis of gentamicin within the pre-ribosomal complex 
pre-mutagenesis 8 docking conformations were identified with almost 
undistinguishable binding energy profiles (Figure 6.19).  
 
Figure 6.19 Binding energies of the gentamicin conformations obtained from 
the docking simulation with the 70s pre-ribosomal complex post-mutagenesis 
with Autodock. Graph showing the eight predicted gentamicin conformations and the 
corresponding binding energies. 
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Although there were parallels between the conformational binding energies pre- and 
post-mutagenesis, such comparisons were not identified when visualising the 8 
docking poses within the 70s pre-ribosomal complex post mutagenesis (Figure 6.20). 
All the 8 gentamicin poses appeared higher than that seen pre-mutagenesis, residing 
within the A site-tRNA.  
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Figure 6.20 Docking simulation of all gentamicin poses within the 70s pre-
ribosomal complex post-mutagenesis. PyMOL image displaying the docking 
analysis image of all predicted gentamicin binding conformations illustrated using the 
space filling model representation (circled in white) docked to the 70s pre-ribosomal 
complex post-mutagenesis. The mutations within the 16srRNA of the 30s-ribosomal 
subunit (light grey) are depicted in yellow and the EF-G (red) mutation is illustrated 
using the stick model representation of the amino acid alteration at position 610 
(yellow).  
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The docking of gentamicin within the pre- complex post mutagenesis was then 
visualised singularly for the conformation with the lowest binding energy (-108.20 
kcal/mol) (Figure 6.21). This result clearly indicates an alteration in the docking 
position of gentamicin post-mutagenesis, which appears in a similar location to the 
docking results for the 70s post-ribosomal complex pre-mutagenesis (Figure 6.17).  
 
Figure 6.21 Docking simulation of gentamicin bound to the 70s pre-ribosomal 
complex post-mutagenesis. Magnified PyMOL docking analysis image displaying 
the lowest gentamicin binding energy conformation depicted using a space filling 
model (circled in white) docked to the 70s pre-ribosomal complex post-mutagenesis. 
The gentamicin-ligand is bound higher in the 70s pre-ribosomal complex structure in 
proximity to the A-site tRNA (blue) and of EF-G (red). 
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6.3.5.2 70s post-ribosomal complex docking analysis post-mutagenesis  
As seen with the predicted binding energies post mutagenesis for the 70s pre- 
ribosomal complex, corresponding binding energy profiles were observed. A total of 9 
conformations were predicted with binding energies ranging from -100.0 to -96.50 
kcal/mol (Figure 6.22).  
Figure 6.22 Binding energies of the gentamicin conformations obtained from 
the docking simulation with the 70s post-ribosomal complex post-mutagenesis 
with Autodock. Graph showing the nine predicted gentamicin conformations and the 
corresponding binding energies. 
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This similarity was reiterated when visualising the posed gentamicin docking positions 
within the 70s post-ribosomal complex post mutagenesis (Figure 6.23). Irrespective of 
the EF-G mutagenesis, gentamicin binds in precisely the same location within the 
post ribosomal complex, in the locality of domain 4 of EF-G.  
 
Figure 6.23 Docking simulation of all gentamicin poses within the 70s post-
ribosomal complex post-mutagenesis. PyMOL image displaying the docking 
analysis image of all predicted gentamicin binding conformations illustrated using the 
space filling model representation (circled in white) docked to the 70s post-ribosomal 
complex post-mutagenesis. The mutations within the 16s rRNA of the 30s-ribosomal 
subunit (light grey) are depicted in yellow and the EF-G (red) mutation is illustrated 
using the stick model representation of the amino acid alteration at position 610 
(yellow).  
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When viewing the specific docking pose of the lowest gentamicin binding 
conformation (-108.2 kcal/mol) within the 70s post-ribosomal complex post 
mutagenesis (Figure 6.24), the docking pose is indistinguishable from that observed 
pre-mutagenesis (Figure 6.20).  
 
Figure 6.24 Docking simulation of gentamicin bound to the 70s post-ribosomal 
complex post-mutagenesis. Magnified PyMOL docking analysis image displaying 
the lowest gentamicin binding energy conformation depicted using a space filling 
model (circled in white) docked to the 70s post-ribosomal complex post-mutagenesis. 
The gentamicin-ligand is bound to the 70s post-ribosomal complex behind domain 4 
of EF-G (red). 
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6.3.6 Comparative assessment of gentamicin docking  
6.3.6.1 Gentamicin binding analysis 70s pre-ribosomal complex pre- and post- 
mutagenesis 
 
To conclude the docking analysis, comparative visual assessments were made to 
determine the impact of the EF-G mutation on ribosomal translocation. There are 
apparent differences between the docking positions within the pre- ribosomal complex 
before and after mutagenesis (Figure 6.25).  
This result suggests that the mutation identified within EF-G, is culpable for the 
altered binding of gentamicin post mutagenesis. Functionally, this implies that if 
gentamicin is unable to bind in close proximity to the mRNA and the base of the A- 
site tRNA, it may no longer be able to interrupt the wobble base formation and 
consequentially lead to a disruption of protein synthesis. This would ultimately result 
in gentamicin resistance.  
 
 
 
 
 
 
 
 
 
 
  
 
 
285 
 
Figure 6.25 Docking simulation comparison of gentamicin bound to the 70s pre-
ribosomal complex pre- and post-mutagenesis. PyMOL docking analysis image 
displaying the lowest gentamicin binding energy conformation depicted using a space 
filling model (circled in white) docked to the 70s pre-ribosomal complex pre-
mutagenesis (A) and post-mutagenesis (B). The magnified docking images of 
gentamicin-ligand bound to the 70s pre-ribosomal complex pre-mutagenesis (C) and 
post-mutagenesis (D) demonstrate altered drug binding post-mutagenesis shown by 
the position of gentamicin in relation to the 30s-ribosomal subunit protein S12 (green), 
EF-G (red), A-site tRNA (blue) and mRNA (orange).   
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6.3.6.2 Gentamicin binding analysis 70s post-ribosomal complex pre- and post- 
mutagenesis 
When visually comparing the docking positions within the post ribosomal complex 
before and after mutagenesis, no differences were identified (Figure 6.26). This result 
suggests that for the antimicrobial gentamicin to be effective in its activity, it must 
dock to the 70s-ribosome within the pre- ribosomal complex. If gentamicin fails to 
dock within the pre-state, regardless of the presence of the EF-G mutation it will not 
successfully bind in a position which leads to the interruption of protein synthesis.  
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Figure 6.26 Docking simulation comparison of gentamicin bound to the 70s 
post-ribosomal complex pre- and post-mutagenesis. PyMOL docking analysis 
image displaying the lowest gentamicin binding energy conformation depicted using a 
space filling model (circled in white) docked to the 70s post-ribosomal complex pre-
mutagenesis (A) and post-mutagenesis (B). The magnified docking images of 
gentamicin-ligand bound to the 70s pre-ribosomal complex pre-mutagenesis (C) and 
post-mutagenesis (D) suggests no alterations in drug binding post-mutagenesis 
indicated by location of gentamicin behind domain 4 of EF-G in all four images. 
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6.4 Discussion 
The aim of this chapter described in section (6.1), was achieved through the 
identification of altered gentamicin binding to the 70s-ribosomal complex in its pre- 
translocation state, following fusA mutagenesis. The conclusions from the molecular 
docking analysis suggest that the mutation within EF-G, contributes significantly to 
the acquisition of gentamicin resistance within the proposed model.  
The sequential multistep process of ribosomal translocation, was described 
extensively within chapter 4. Although EF-G independent translocation has been 
observed in-vitro (Southworth, Brunelle and Green, 2002), it was revealed that the 
GTPase EF-G, was an essential requirement in the rapid response to the cellular 
demands during translation elongation (Voorhees and Ramakrishnan, 2013). Major 
advancements in understanding the complex mechanisms in which EF-G catalyses 
ribosomal translocation, have been provided through the addition of small molecules 
which inhibit the translocation stage of protein synthesis (Peske et al., 2004).  
The macrocyclic thiopeptide, thiostrepton is an antimicrobial agent which inhibits 
translation through directly interfering with the function of EF-G (Bowen et al., 2004). 
Interestingly, truncation of EF-G domains 4 and 5 permitted ribosomal translocation in 
the presence of thiostrepton (Walter et al., 2011). Therefore, it is plausible to suggest 
mutagenesis at the boundary of domains 4 and 5, could permit EF-G to induce 
translocation despite the presence of the aminoglycoside gentamicin.  
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6.4.1 Aminoglycoside inhibition of ribosomal protein synthesis 
Aminoglycoside antibiotics disrupt translation by inducing pleotropic effects on the 
ribosome in its pre-translocation complex, through diminishing the accuracy of tRNA 
selection at the decoding site and through the inhibition EF-G dependent 
translocation (Davies and Davies, 1967; Fredrick and Noller, 2003; Peske et al., 
2004). This confirms why no alterations were observed in the binding of gentamicin to 
the post-translocation complex ensuing mutagenesis, as aminoglycoside activity is 
dependent on drug binding to the ribosome in its pre- translocation state.  
The predominant binding site of aminoglycoside antibiotics is helix 44 of the 16s 
rRNA major groove, where precise interactions are made with the decoding bases 
A1492 and A1493 (Ogle, Carter and Ramakrishnan, 2003). The perturbations which 
arise following aminoglycoside binding to the decoding region, are thought to stabilise 
the classical state of the pre-translocation complex and increase the affinity of tRNAs 
to the A-site (Vaiana and Sanbonmatsu, 2009). Consequently, as gentamicin 
operates through classical state stabilisation, and post- mutagenesis is unable to bind 
to the decoding region of the pre-translocation complex, it is highly unlikely that 
ribosomal translocation will be inhibited (Feldman et al., 2010).  
Although the structural basis of aminoglycoside induced miscoding is well 
understood, high resolution crystallography and single-molecule fluorescence 
resonance energy transfer (smFRET) techniques have been applied to understand 
the molecular mechanisms behind the highly dynamic process of translation 
elongation inhibition (Tsai et al., 2013). Such studies have revealed secondary 
binding sites of aminoglycoside antibiotics including neomycin, which preferentially 
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binds to helix 69 of the 23s rRNA stabilising the hybrid state (P/E) position and 
consequently blocks the selection and translocation of aa-tRNA (Wang et al., 2012).  
6.4.2 The 30s-ribosomal subunit protein S12 and EF-G 
An independent docking analysis was conducted with the ribosomal protein S12 
owing to its involvement in the secondary binding interactions of gentamicin. The 
ribosomal protein S12 has been previously acknowledged for its functional role in the 
regulation of the pre-translocation state during aa-tRNA selection (Yates, 1979; 
Cukras et al., 2003). Further studies have suggested that upon codon recognition the 
ribosomal protein S12 is involved in the signalling between the 30s-ribosomal subunit 
and elongation factor-Tu (EF-Tu) (Gregory, Carr and Dahlberg, 2009). Functional 
insights into the interactions between the ribosomal protein S12 and EF-G have been 
provided by biochemical studies of the antibiotics dityromycin and GE82832, which 
through binding to S12 inhibit the EF-G dependent ribosomal translocation (Brandi et 
al., 2006; Buckley et al., 2014).  
The independent docking analysis, confirmed an interaction between gentamicin and 
the upper region of the ribosomal protein S12. This is significant as preceding the 
rotation of the 30s-subunit, the ribosomal protein S12 interacts with domain 3 of EF- 
G and blocks the conformational change from the compact to an elongated state, 
which becomes entirely inhibited in the presence of dityromycin (Lin et al., 2016).  
Therefore, based on the atomic resolution crystal structures of EF-G in complex with 
the 70s-ribosomal complex in the pre-translocation state, and through use of the 
PyMOL mutagenesis function, it is evident that the fusA mutation at the amino acid 
position 610 significantly effects the binding of gentamicin to the decoding region of 
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helix 44 near the ribosomal protein S12. This strongly indicates that the fusA 
mutagenesis, is the primary mechanism preventing the inhibition of ribosomal 
translocation by gentamicin within the resistant isolates of E. coli MG1655 obtained 
from the ARGP in vitro.  
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Chapter 7: Phylogeny and evolution of EF-G: a phylogenetic perspective 
7.1 Introduction  
In the previous chapters, WGS and subsequent bioinformatic analysis has suggested 
that the observed fusA mutation is strongly associated with the acquisition of 
gentamicin resistance. This SNP has not only been shown to alter the structure and 
physiochemical properties of the fusA encoding EF-G protein, but docking analysis 
has revealed the unsuccessful binding of gentamicin to the 70s-ribosome post 
mutagenesis in its pre-translocation state. Together, these results imply that if the 
fusA mutation was identified within other bacterial species under gentamicin 
selection, populations may resist the lethal action of aminoglycoside antibiotics. A 
mutation identified in a functional gene such as fusA could be used as a marker of 
resistance or assist in antimicrobial resistance surveillance. Phylogenetics, will be 
applied within this chapter to unravel the evolutionary information stored within the 
identified genes of interest, to gain better insights into the patterns and processes of 
molecular evolution (Soltis and Soltis, 2003).  
 
Phylogenetics has facilitated the study of patterns in the evolutionary conservation of 
genes across organisms (Bergmiller, Ackerman and Silander, 2012). This is 
significant, as orthologs of genes which are functionally essential and highly 
conserved, should remain essential across organisms of different bacterial taxa 
(Jordan et al., 2002). Relating specifically to selection, if orthologous genes are well 
conserved between organisms, this is indicative of purifying selection acting strongly 
on essential genes, manifesting in slow rates of evolution to maintain function 
(Silander and Ackerman, 2009).  The evolutionary conservation of an elongation 
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factor gene ‘tuf’ which encodes EF-Tu has been previously described (Isabel et al., 
2008). The EF-Tu gene is highly conserved, and has been used to resolve the 
phylogeny of the Enterobacteriaceae family, with better discrimination in bacterial 
classification than the 16s rRNA (Paradis et al., 2005).  
 
In addition to evolutionary conservation, phylogenetics enables the study of how 
genes evolve. Evolution occurs when the genetic composition of a population 
changes over a period time, and such variations can occur through a range of 
processes including natural selection, mutation and genetic drift (Lenski and Wiser, 
2009).   Adaptive evolution arises through the selection of mutations which are 
associated with enhancements of the fitness or survivability, in response to 
environmental conditions (Charlesworth, Barton and Charlesworth, 2017).  
Evolutionary adaptation is common amongst bacterial populations due to the frequent 
exposure to variable environments (Bennett and Lenski, 2007). However, the way in 
which organisms evolve in response to their environment can vary significantly. 
Stochastic processes such as mutation and drift lead to species divergence, whereas 
natural selection promotes convergence through similar adaptations in distantly 
related organisms (Deatherage et al., 2017).  
The adaptive evolution of bacterial populations has largely been explored through 
experimental evolution (Dettman et al., 2012).  Microorganisms are applicable for 
experimental evolution studies due to their rapid generation times and genetic 
adaptation when placed in varying environments (Elena and Lenski, 2003). The 
combination of laboratory evolution with comparative genomics, allows the direct 
observation of adaptive evolution within a laboratory timescales (Herring et al., 2006). 
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The highly controlled nature of experimental evolution studies facilitates the direct 
application of selective pressures to evolving populations to determine the underlying 
adaptive mutations leading to evolutionary change (Lang and Desai, 2014). 
Nevertheless, the short evolutionary timescales and regulation of selective pressures 
within experimental evolution studies, forces the selection of beneficial mutations, 
which may not present in natural environments (Hegreness and Kishony, 2007).  
Phylogenetic perspectives provide the basis for comparative genomics. 
Advancements in DNA sequencing technologies have facilitated an increase in the 
number of comparative genomic studies aimed at detecting sequence diversity 
amongst bacterial populations. Despite the success of comparative genomics, the 
identification of variants alone does not provide enough information regarding 
bacterial evolution, pathogenicity and epidemiology (Alland et al., 2003). Evolutionary 
events leave distinct patterns within bacterial populations which can be characterised 
through phylogenetic analysis (Guttman and Dykhuizen, 1994). Combined 
phylogenetics and comparative genomics reveals evolutionary relationships between 
bacterial strains, and allows the clustering of nucleotide polymorphisms of greater 
biological significance (Filliol et al., 2005).  
 
Combined phylogenetic analysis and comparative genomics has been applied in 
epidemiological studies of disease outbreaks, the classification of emerging bacterial 
pathogens and the identification of disease specific markers (Brenner et al., 2017; 
Kuroda et al., 2010; Gagneux and Small, 2007). Of significance, is the identification of 
phylogenetic markers associated with the acquisition of antimicrobial resistance 
(Feuerriegel, Köser and Niemann, 2014).  This has been decisive in the emergence 
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of resistance mutations among organisms of clinical significance such as 
carbapenemase producing Enterobacter spp. (Chavda et al., 2016).  
 
The initial aim of this chapter is to determine the level of gene conservation of fusA 
through the reconstruction of evolutionary relationships among the Escherichia taxa 
and Enterobacteriaceae family. Secondly, to establish how the fusA sequence 
evolves, explicitly whether the identified SNP is an adaptive response to the 
antimicrobial selective pressure, and thus convergence may have occurred within 
distantly related species within Enterobacteriaceae family. Finally, to discover 
whether the SNP identified, is found within the wild amongst clinically significant 
bacterial pathogens which pose a threat in the antimicrobial resistance crisis.  
 
It is hypothesised that the identified SNP within the fusA gene will remain unique to 
the experimentally evolved strain of E. coli MG1655 after screening distantly related 
strains within the Enterobacteriaceae family and strains of clinical significance.  
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7.2 Materials and methods 
7.2.1 Phylogenetic analysis of fusA using PhyML  
PHYML software version 3.1 was used for estimating maximum likelihood 
phylogenies, described previously in section (2.12).  Phylogenies of the fusA gene 
were resolved for the Enterobacteriaceae family. The optimal model for each of the 
data sets was determined using JModelTest2 (Section 2.12.1). Conclusively, PhyML 
was executed under the parameters outlined in section (2.12.2), for the construction 
of the phylogenetic trees. The PHYML command line strings used to construct the 
fusA ML trees, are shown below (Figure 7.1). All phylogenetic trees were visualised 
and annotated using iTOL.  
 
Figure 7.1 The PhyML commands executed in the fusA ML tree construction. 
Image displaying the PhyML commands utilised to construct the ML trees of the fusA 
gene within the Enterobacteriaceae family (1) and within distinct clades of the 
Enterobacteriaceae family (2). The command contains the PhyML execution followed 
by a list of parameters: number of bootstraps (-b), model (-m), alignment file (-i) and 
the data type (-d). The commands utilised the same model (011023), 1000 bootstraps 
and the data type was nucleotide (nt).  
 
  
 
 
 
 
 
 
 
 
1. MacBook-Pro:~ Lucky$ PhyML-3.1_macOS-MountainLion -b 1000 -m 011023 -i 
Desktop/Enterobacteriaceae_Tree.phylip -d nt  
2. MacBook-Pro:~ Lucky$ PhyML-3.1_macOS-MountainLion -b 1000 -m 011023 -i 
Desktop/Enterobacteriaceae_Distinct_Clade_Tree.phylp -d nt  
 
  
 
 
297 
7.2.2 SMART structure analysis of EF-G 
To identify any structural variants within the fusA encoding EF-G protein within the  
Enterobacteriaceae family, a Simple Modular Architecture Research Tool (SMART) 
was used available at: http://smart.embl-heidelberg.de [accessed October 4, 2018], to 
provide detailed annotations regarding the protein architecture and functionally 
important domains.  
 
7.2.3 Phylogenetic analysis of the 16s rRNA  
Escherichia coli ATCC 11775T strain 16s rRNA gene was used as the consensus 
gene sequence for the resultant 16s species tree for the Enterobacteriaceae family.  
A BLAST search was conducted as previously described in section (2.12) and 
downloaded from the NCBI database.  A total of 19 Enterobacteriaceae 16s rRNA 
genes along with the corresponding gene variants, which for most strains there was a 
total of seven 16s rRNA variants downloaded.  Ribonucleotide sequences were 
reverse complemented were necessary. Sequence files were then imported into 
EMBL: MUSCLE and progressively aligned.  
RNA alignment files were visualised using Aliview to assess the degree of gaps and 
sequence length discrepancies. TrimAl version 1.2 available at 
http://trimal.cgenomics.org [accessed August 29, 2018]. was used to remove all 
positions in the alignment with gaps in more than 10% of the sequences and prints 
the 60% best positions using the command below (Figure 7.2) and files were 
outputted in phylip format for direct manipulation in PhyML. 
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Figure 7.2 The TrimAl command executed for the removal of poorly aligned 
regions of the 16s rRNA sequences.  Image displaying the TrimAl command 
utilised to remove regions of the 16s rRNA sequences with gaps or sequence read 
discrepancies. The command contains the TrimAl execution followed by a series of 
parameters: input file (-in) in fasta format, output file (-out) in phylip format, gap 
threshold (-gt) and the minimum threshold of positions conserved within the original 
alignment (-cons). The command utilised specifies a gap threshold of 0.9 with a 60% 
sequence conservation threshold.  
 
Alongside this, the alignment file (fasta format) was imported directly into 
JModelTest2 to determine the best fit substitution model. Following the likelihood 
calculations, the model selection uncertainty was calculated for the three 
implemented information criteria models (AIC, BIC and decision theory (DT)), as per 
specifications described in section (2.12.1).  The rRNA alignment (phylip format) was 
used to construct a ML tree using PhyML with a bootstrap of 1000 using the model 
012342 as illustrated in the command below (Figure 7.3). The 16s rRNA species tree 
was visualised using iTOL. 
 
Figure 7.3 The PhyML command executed in the 16s rRNA ML tree 
construction. Image displaying the PhyML command utilised to construct the ML 
tree of the 16s rRNA gene within the Enterobacteriaceae family. The command 
contains the PhyML execution followed by a list of parameters: number of bootstraps 
(-b), model (-m), alignment file (-i) and the data type (-d). The command specifies 
1000 bootstraps, the 012342 model, the 16s-trimmed alignment file and the data type 
was nucleotide (nt).  
 
MacBook-Pro:~ Lucky$./trimal -in /Users/Lucky/Desktop/16s_New_3.fasta -out 
/Users/Lucky/Desktop/16s_Trimmed.phylip -gt 0.9 -cons 60 –phylip   
 
 MacBook-Pro:~ Lucky$ PhyML-3.1_macOS-MountainLion -b 1000 -m 012342 -i 
Desktop/16s_Trimmed.phylip -d nt.  
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7.2.4 Protein conservation analysis of EF-G 
Distinct Enterobacteriaceae sequences used for the construction of the fusA 
nucleotide tree, were used to assess the level of protein conservation for the fusA 
encoding protein Elongation Factor G. The fusA nucleic acid sequences were 
translated using EMBOSS Transeq available at: 
https://www.ebi.ac.uk/Tools/st/emboss_transeq/ [accessed August 20, 2018]. The 
selected parameters included the selection of the bacterial code 11 and all six frames. 
The translated sequences for the correct frame, were then downloaded and inputted 
into PRALINE, where in addition to a multi sequence alignment information can be 
obtained regarding the homology and amino acid conservation per residue of the 
given protein sequences. PRALINE was run under standard conditions, aside from 
the deselection of structural features which was not required.   
 
7.2.5 Bioinformatic analysis of EF-G: Enterobacteriaceae database  
The phylogeny of the E. coli MG1655 fusA gene was resolved by conducting a 
nucleotide BLAST search of the NCBI database repository as described in section 
(2.12). A further local alignment search was conducted at Public Health England 
(PHE), of the National Collection of Type Cultures (NCTC) culture collection in 
collaboration with Dr Katie Hopkins and Professor Neil Woodford. The fusA 
nucleotide sequence of the resistant strain of E. coli MG1655, was submitted to PHE 
and screened by the bioinformatician Dr Michel Doumith against a collection of 840 
carbapenemase-producing and 958 ESBL-producing E. coli genomes.  
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7.3 Experimental results 
 
7.3.1 Best fit model selection for the phylogenetic analysis of fusA 
Preceding the phylogenetic fusA nucleotide tree construction within PhyML, best fit 
models were selected based upon the likelihood (–InL) scores for the AIC, BIC and 
DT model criterion. The preferred model for the data sets used in the phylogenetic 
analysis of fusA amongst the Enterobacteriaceae family was 011023.  When looking 
more closely at the predicted scores generated using JModelTest2, all three of the 
selection criterion predicted models, 011020 and 011023 as best fitting for the two 
data sets (Tables 7.1 and 7.2).  
 
Table 7.1 JModelTest2 model selection summary for the fusA nucleotide 
sequence data within Enterobacteriaceae family. Displaying the selection of best 
fit model using the AIC, BIC and DT selection criterion. K indicates the number of 
parameters. Based on the JModel results summary, the 011023 model was selected 
as the best fit model. The best model was defined as the model with the lowest 
criterion value (-InL) indicated in bold.  
 
Model 
Selection 
Criterion  
Model Partition -InL K AIC/BIC/DT 
AIC1 011023+I+G+F 011023 5779.887 44 11647.775 
AIC2 011020+I+G 011020 5786.407 40 11652.813 
BIC1 011020+I+G 011020 5786.407 40 11879.029 
BIC2 011023+I+G 011023 5783.029 41 1879.928 
DT1 011020+I+G 011020 5786.407 40 0.008 
DT2 011023+I+G 011023 5783.029 41 0.008 
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Table 7.2 JModelTest2 model selection summary for the fusA nucleotide 
sequence data within distinct clades of the Enterobacteriaceae family. 
Displaying the selection of best fit model using the AIC, BIC and DT selection 
criterion. K indicates the number of parameters. Based on the JModel results 
summary, the 011023 model was selected as the best fit model. The best model was 
defined as the model with the lowest criterion value (-InL) indicated in bold.  
 
Model 
Selection 
Criterion  
Model Partition -InL K AIC/BIC/DT 
AIC1 011023+I+G+F 011023 5517.405 38 11110.809 
AIC2 011020+I+G 011020 5524.851 34 11117.701 
BIC1 011020+I+G 011020 5524.851 34 11309.984 
BIC2 011023+I+G 011023 5521.026 35 11309.990 
DT1 011020+I+G 011020 5524.851 34 11309.984 
DT2 011023+I+G 011023 5521.026 35 11309.990 
 
 
7.3.2 Phylogenetic analysis of fusA within the Escherichia genus 
 
The ML tree constructed for the analysis of fusA amongst the Escherichia genus has 
not been included here as all strains were monophyletic, and the slight topology 
evident was due to the inclusion of fusA sequences of the Shigella genus (Appendix 
A.21). Further haplotype analysis of fusA within the species E. coli (sensus stricto), 
revealed a total of two haplotypes, the resistant and the susceptible.  
 
7.3.3 Phylogenetic analysis of fusA amongst the Enterobacteriaceae family 
 
The resolved phylogeny of the fusA gene within the Enterobacteriaceae family 
demonstrated a high level of conservation amongst the Escherichia genus. Although 
the conservation of fusA within the Escherichia genus, is distributed amongst strains 
of the Shigella genus. The sensitive and resistant fusA sequences of the laboratory 
strains of Escherichia coli MG1655, have been highlighted in yellow and the observed 
distances between the two strains was likely reflective of the uncovered nucleotide 
polymorphism. There is slight topology evident within the ML tree, shown as an 
  
 
 
302 
outgroup comprising members of the Enterobacteriaceae family which do not fall into 
the Escherichia/Shigella genus. The tree topology is therefore suggestive of 
speciation or related to the taxonomic identification of bacteria (Figure 7.4 A).  
 
It is essential to identify whether the topological differences observed, are reflective of 
any structural alterations within the functional domains of EF-G. SMART analysis of 
the fusA encoding EF-G protein between distantly related species within the 
Enterobacteriaceae family, revealed identical EF-G protein structures with conserved 
functional domains (Figure 7.4 B). The conservation of the EF-G domains despite the 
observed tree topology, indicates the biological significance of EF-G and further 
suggests that the tree topology is related to speciation.  
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7.3.3.1 Phylogenetic analysis of fusA amongst distinct clades of the 
Enterobacteriaceae family  
 
To determine whether the evolution of the fusA gene suggests convergent evolution 
or speciation, a ML tree was constructed for the most distantly related species within 
the Enterobacteriaceae family and information was obtained regarding the strain 
source and locality (Figure 7.5). If convergent evolution of the fusA gene had 
occurred, it would be expected that strains would cluster based on source irrespective 
of the species. However, strains within the Enterobacteriaceae family which are 
classified as pathogenic are found disseminated throughout the tree and are largely 
clustered based on genus. However, supporting the previous findings again the fusA 
sequence is highly conserved amongst the Escherichia genus.  
 
7.3.4 Haplotype analysis of fusA within the Enterobacteriaceae family  
In addition to the phylogenetic analysis of fusA within the Enterobacteriaceae family, 
an examination of fusA haplotypes was completed. A total of 147 fusA sequences 
were examined, and 38 haplotypes were identified. Of the 38 haplotypes, 37 
haplotypes were species specific with one isolated haplotype specific to the fusA 
mutation in the resistant strain of E. coli MG1655 (Appendix Figure A.22). Looking 
more closely at the 37 species specific haplotypes there was significant variation 
within 340 independent nucleotide bases of the 2112 nucleotides of the fusA 
sequence (Appendix Figure A.23).  
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7.3.5 Phylogenetic analysis of the 16s rRNA genes amongst distinct clades of 
the Enterobacteriaceae family 
 
All the evidence gathered formerly suggests the evolution of fusA is directly related to 
speciation. To reaffirm the findings, a phylogenetic tree was constructed based on the 
16s rRNA sequences of the most distantly related species within the 
Enterobacteriaceae family. The 16s rRNA sequences are often used in the study of 
bacterial phylogeny and taxonomy, owing to the high conservation and slow evolution 
of the rRNA genes plus their high prevalence amongst bacterial species (Janda and 
Abbott, 2007). Members of the Enterobacteriaceae family were coloured based on 
species and numbered based on the rRNA gene variant (Figure 7.6). The tree 
suggests that the 16s rRNA sequences are clustered into phylogenetically groups 
based on species.  As previously described, there are deviations between the 
Escherichia and Shigella genus, shown by the intermittent strain highlighted in grey 
between the Escherichia strains coloured in red. Owing to the comparable clustering 
of sequences shown in figures (7.5 and 7.6), it can be interpreted that the evolution of 
fusA is species specific.  
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7.3.6 EF-G protein conservation analysis PRALINE 
 
The PRALINE protein conservation analysis of EF-G exposed a high degree of 
protein conservation across the entire protein sequence, with 4 being the lowest 
protein conservation score reported at a single amino acid position (Figure 7.7). 
There was complete conservation achieved for the first 150 amino acids, reflective of 
the conserved domain analysis (Section 7.3.3). Variations in amino acid conservation 
scores were detected between positions 150-250 and 400-500, with the lowest 
conservation score described at position 178 which falls within domain 1 of EF-G. 
When analysing the amino acid conservation at the point of mutagenesis (610), a 
conservation score of 9 was predicted with the only amino acid polymorphism being 
that of the evolved resistant strain of E. coli MG1655.  
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7.3.7 Bioinformatic analysis of the fusA mutation at PHE 
 
The fusA resistant nucleotide sequence was screened at PHE against a collection of 
carbapenemase and ESBL producing E. coli. This is relevant as mutations in fusA, a 
common cause of fusidic acid resistance, have been associated with multiple 
phenotypic characteristics including reduced growth rates, increased sensitivity to 
oxidative stress and hyper-susceptibility to various classes of antibiotics including B-
lactams (Macvanin et al., 2004 and Macvanin and Hughes, 2005). The search 
revealed that of the 840 carbapenemase-producing and 958 ESBL-producing E. 
coli genomes, there were no mutations identified at position 610 that could be 
associated with gentamicin resistance. 
 
7.4 Discussion  
 
The aims of this chapter described in section (7.1), were achieved as follows. The 
fusA gene was found to be highly conserved amongst the Escherichia taxa and 
Enterobacteriaceae family. Examination of the phylogenetic relationships of the fusA 
gene between distinct members of the Enterobacteriaceae revealed signatures of 
divergent evolution, which suggested a potential role for the fusA gene in bacterial 
phylogeny. Conclusively, as hypothesised the SNP within the fusA gene was 
unsuccessfully identified within the clinically significant bacterial pathogens.   
 
The elongation factor EF-G, is an important bacterial protein of the translational 
GTPases (trGTPases), which comprise the essential translation factors 
characteristically conserved across all domains of life (Atkinson, 2015). The main 
prokaryotic elongation factors are EF-Tu and EF-G, whilst independently involved 
  
 
 
311 
within two distinct phases of ribosomal translation, their mutual GTPase activity and 
structural similarities indicate they arose from a common ancestor (Laursen and 
Lawrence, 1978). The highly conserved EF-Tu, acts as an evolutionary marker in 
bacterial phylogeny, and has provided phenotypic details conventionally missed using 
16s rRNA (Kamla, Henrich and Hadding, 1996). More recently, the EF-G encoding 
fusA gene has been employed in Multilocus Sequence Typing (MLST), in the 
discrimination of diverse isolates within the Cronobacter bacterial genus (Joseph et 
al., 2012).  
 
Therefore, it is then unsurprising that the phylogenetic analysis of the fusA gene 
revealed monophyly within the Escherichia genus, owing to the highly conserved 
nature of the fusA gene and its application in the study of bacterial taxonomy. The 
observed overlay between the E. coli and Shigella species within the 
Enterobacteriaceae family phylogeny, further questions whether these closely related 
organisms should be reclassified as the same species (Chattaway et al., 2017). 
Furthermore, the highly conserved fusA gene performed similarly to the 16s rRNA 
genes in the classification of bacterial species within the Enterobacteriaceae family, 
which suggested that the fusA gene evolves through evolutionary divergence not 
convergence (Merhej et al., 2009; Wang and Huang, 2018).  
 
In addition to the phylogenetic analysis of the fusA gene, functional genomics was 
applied to provide a link between the protein sequence conservation and the function 
of EF-G (Benner et al., 2000). The protein conservation analysis uncovered  
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highly conserved regions within the EF-G protein sequence consistent across the 
Enterobacteriaceae family. This is likely to reflect the functional constraints on the 
divergent evolution of the elongation factor proteins, related to their essential roles 
during protein synthesis (Gaucher, Miyamoto and Benner, 2001). Therefore, it can be 
assumed that the amino acid variability detected within the non-conserved regions of 
EF-G, are species specific and do not lead to any significant alterations in protein 
structure or function (Chelvanayagam et al., 1997). Granting this the resistant 
mutation identified, was located within a functionally conserved region of EF-G, and 
thus any alteration is expected to drastically alter the protein function and the 
phenotype of the organism (Marini, Thomas and Rine, 2010).  
 
Despite all the evidence suggesting the mutation identified within the universally 
conserved elongation factor was of both functional and structural significance, the EF-
G mutation was restricted to the experimentally evolved strain of E. coli MG1655. The 
given outcome does not undermine the experimental findings but instead outlines the 
possible limitations of adaptive laboratory evolution. Here, within the proposed model 
bacterial populations are subject to an artificial highly controlled environment and 
driven to resistance through the application of an increasing antimicrobial selective 
pressure. Although antimicrobial concentration gradients have been employed to 
reflect the heterogeneity within natural environments, it is unlikely that in nature 
bacterial populations would be exposed to the elevated concentrations utilised within 
the model (Baquero and Negri, 2005; Ghaddar, Hashemidahaj and Findlay, 2018).  
Likewise, the evolutionary model does not represent all the selective pressures facing 
  
 
 
313 
bacterial populations in nature and clinical settings including; fluctuating 
environmental conditions, bacterial competition and the  
immune system involvement (Reznick and Ghalambor, 2005; Dragosits and 
Mattanovich, 2013).  
 
It is also important to acknowledge the mutational dynamics within bacterial 
populations, where beneficial mutations will be selected for, except when coexisting 
populations are present which harbour a substantial fitness advantage (Conrad, 
Lewis and Palsson, 2011). Consequently, it is feasible to suggest that the fusA 
mutation identified could have been eliminated from the population before reaching a 
detectable limit.  The fitness costs associated with the acquisition of gentamicin 
resistance will be discussed in detail within the next chapter. 
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Chapter 8: The fitness costs associated with the acquisition of gentamicin 
resistance in E. coli MG1655 
 
8.1 Introduction 
The emergence of antimicrobial resistance within bacterial populations is contingent 
upon several factors including: mutation rates, antibiotic administration patterns and 
the associated fitness costs (Andersson and Levin, 1999; Björkman and Andersson, 
2000; Lipsitch and Levin 1997). In general, it is commonly accepted that resistance 
conferring mutations impose biological costs on bacterial fitness in the absence of 
antimicrobial selective pressures (Levin et al.,1997).  This is particularly relevant 
where mutations result in drug target alterations, in cellular components key to 
biological functions such as protein biosynthesis within the bacterial ribosome 
(Springer et al.,2001; Paulander, Maisnier-Patin and Andersson, 2009).  
Consequently, this resulted in strategies to reduce antimicrobial therapy following 
resistance development, as an approach to combat antimicrobial resistance (Hall, 
2004). Founded upon the principal that sensitive genotypes would outcompete the 
‘less fit’ resistance mutants within a bacterial population, leading to the reversion to 
sensitivity (Lenski, 1998; Johnsen et al.,2009; Melnyk, Wong and Kassen, 2014). This 
provided incentives for an alternative approach to drug design, through the 
identification of antimicrobial targets which had the most detrimental effects on 
bacterial fitness (Andersson and Levin, 1999; Andersson, 2006).  
However, while antimicrobial suppression has the potential to revert resistance, this 
cannot explain the persistence of resistant bacteria in the absence of antibiotics 
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(Andersson, 2003). There is growing evidence to suggest that bacterial adaptation 
successfully facilitates the maintenance of resistance and alleviation of the associated 
fitness costs through three key mechanisms (Andersson and Hughes, 2010). 
Compensatory adaptation can counteract the fitness costs associated with resistance, 
through mutations at secondary sites which restore bacterial fitness (Levin, Perrot 
and Walker, 2000; Kugelberg et al.,2005; Besier et al.,2005). In addition, resistance 
mutations may arise within bacterial populations which encounter no fitness costs in 
the absence of selective pressures (Ramadhan and Hegedus, 2005). The final 
mechanism is genetic co-selection, where genetic linkages are formed between 
resistance markers, enhancing host fitness (Enne et al.,2004; Andersson, 2006).  
The assessment of bacterial fitness is relatively complex, as contributory elements 
such as in host competition, transmission and clearance have proven difficult to 
measure (Andersson and Levin, 1999). Subsequently, bacterial fitness has been 
experimentally determined through the comparative assessment of bacterial growth, 
virulence and competitiveness (Schrag, Perrot and Levin, 1997; Björkman, Hughes 
and Andersson,1998; Björkman et al.,1999).  
This chapter aims to experimentally determine the fitness costs associated with the 
acquisition of gentamicin resistance, through bacterial growth and virulence assays. 
Further bacterial assessments will include biofilm formation, dose response and 
morphological analysis. It is hypothesised that there will be fitness cost associated 
with resistance development, which could result in reductions in both bacterial growth 
and virulence. Nevertheless, an assumption can be made that subsequent evolution 
of the resistant population could have compensated for any observed fitness costs.  
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8.2 Materials and methods  
 
 
8.2.1 Manual growth curves  
The initial assessment of bacterial fitness was conducted through a direct comparison 
of bacterial growth using a manual growth curve over a 12-hour period, to obtain 
quantifiable bacterial colony counts.  Details of the manual growth curve protocol can 
be found in section (2.13.1).  
 
8.2.2 Automated growth curves 
In addition to the manual growth curve described section (2.13.1), an automated 
growth curve was conducted using the TECAN Infinite M200 Pro. Here bacterial 
cultures were prepared as stated in section (2.3), and standardised to an OD600 of 
0.08 OD units within falcon tubes. Subsequently, 50μL of each bacterial culture in 
triplicate was added to wells of a 96-well microtiter plate containing 150μL MH broth, 
to achieve a starting OD600 of 0.002 OD units. Negative controls containing 200μL of 
MH broth were included. Plates were sealed and placed in the plate TECAN plate 
reader under the conditions specified in table (8.1).  
 
Table 8.1 TECAN Infinite M200 Pro plate reader conditions. Displaying the plate 
reader conditions utilised in the automated analysis of bacterial growth.  
 
 
 
 
 
 
 
 
Temperature 37ºC 
Absorbance 600nm 
Shaking 5 seconds (prior to OD600) 
Kinetic cycles 12 
Duration of each cycle 30 minutes 
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8.2.3 Dose response analysis   
In addition to the analysis of fitness by assessing the growth of sensitive and resistant 
strains of E. coli, grown within identical conditions in MH broth. It was of interest to 
see how bacterial growth deviates in the presence of the antimicrobial agents at two 
given does; the MIC and x10 the MIC.  The dose response analysis was conducted 
by manual and automated methods as stated above in sections (8.2.1 and 8.2.2). The 
only modification made here was the addition of antimicrobial agents at the selected 
concentrations to the MH broth prior to inoculation. Positive controls were included for 
the comparative analysis of growth in the absence of the antimicrobial selective 
pressures.  
 
8.2.4 Galleria mellonella virulence model  
Furthermore, the bacterial fitness of the sensitive and resistant strains of E. coli 
MG1655 were analysed by assessing bacterial virulence using the G. mellonella 
toxicity model. The details of the protocol used in Galleria toxicity model are provided 
in section (2.13.2).  
 
8.2.5 Scanning electron microscopy 
The final bacterial comparison of the sensitive and resistant strains of E. coli, was a 
morphological assessment using SEM. Details of the SEM protocol are described 
previously in section (2.13.3).  
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8.3 Experimental results  
Several assays were conducted to determine the costs associated with the 
acquisition of gentamicin resistance, through a comparative assessment of fitness of 
sensitive and resistant strains of E. coli MG1655. For convenience, the sensitive 
strain of E. coli MG1655 was referred to as the WT, and the resistant strains were 
denoted MIC and x10 MIC, reflecting the selected antimicrobial concentration. The 
statistical analysis and graphical visualisation of data was completed using the 
software programme RStudio.  
 
8.3.1 Automated bacterial growth analysis 
Following the confirmation of phenotypic resistance and the identification of mutations 
related specifically to the aminoglycoside mechanism of action, it was of interest to 
determine any alterations in the growth of resistant strains when placed in a medium 
in the absence of the antimicrobial selective pressure.  Considering the colony 
variation amongst bacterial populations, growth analysis was conducted on five 
individual colonies from the WT, MIC and x10 MIC strains in triplicate within a 96-well 
plate format. To assist in the graphical interpretation of results, the triplicates of the 
five individual colonies from each strain were presented in the same colour.  
 
Prior to the comparative analysis of the sensitive and resistant strains, the growth of 
each strain will be discussed independently. The growth analysis of E. coli MG1665 
WT, revealed similar growth trajectories for all 15 cultures over a period of 12 hours. 
The greatest fluctuations between colonies appeared between 3-12 hours, with 
replicate two of colony five attaining an OD600 value of 0.2166 OD units after 12 hours 
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of growth, compared to the remaining WT cultures achieving OD600 values closer to 
0.3 OD units. Looking more broadly at the individual colonies, all colony triplicates 
followed similar growth trajectories except for C5 where disparities were observed 
(Figure 8.1). However, there was no significant difference in the growth of five 
colonies from the WT strain of E. coli MG1655 after 12 hours of growth (P=0.4279). 
This indicated reduced inter-colony variation between the WT population.  
 
 
 
Figure 8.1 Automated growth analysis of E. coli MG1655 WT strain. Graph 
showing the growth curve of the E. coli MG1655 WT strain in MH broth at 37ºC. All 
five colonies (C1-C5) were grown in triplicate in 96-well plates and the OD600 values 
were measured every 30minutes for 12 hours in the Infinite M200 PRO plate reader. 
The colony triplicates were presented in colour: C1 (red), C2 (Khaki green), C3 
(green), C4 (blue) and C5 (magenta). The triplicate values per colony were then 
averaged and the standard error was calculated. The error bars represent standard 
deviation. There was no significant difference in the growth rates between all 
replicates of the E. coli MG1655 WT strain (P=0.4279).    
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For the E. coli MG1655 resistant strain selected at the MIC of gentamicin. Again, 
similar phenotypic trajectories were observed after 12 hours of growth (Figure 8.2). 
However, variations were identified relatively early in the growth of replicate two of 
colony two and for all three replicates of colony four. Further deviations in growth 
were observed at the end of the growth curve for replicates one and two of colony 
five.  In comparison to the growth of the WT population, the gradient of the initial 
phase of growth over the first 300 minutes, was less steep for the MIC cultures. In 
addition, the maximum growth for the MIC cultures did not exceed 0.25 OD units. 
There was no significant difference in the growth of the five individual colonies of the 
MIC strain of E. coli MG1655 after 12 hours of growth (P= 0.4456). However, 
although statistically insignificant, in comparison to the WT strain there was greater 
inter-colony variation observed with the MIC cultures.  
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Figure 8.2 Automated growth analysis of E. coli MG1655 MIC strain. Graph 
showing the growth curve of the E. coli MG1655 MIC strain in MH broth at 37ºC. All 
five colonies (C1-C5) were grown in triplicate in 96-well plates and the OD600 values 
were measured every 30 minutes for 12 hours in the Infinite M200 PRO plate reader. 
The colony triplicates were presented in colour: C1 (red), C2 (Khaki green), C3 
(green), C4 (blue) and C5 (magenta).  The triplicate values per colony were averaged 
and the standard error was calculated. The error bars represent standard deviation. 
There was no significant difference in the growth rates between all replicates of the E. 
coli MG1655 MIC strain (P=0.4456).    
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For the E. coli MG1655 resistant strain selected at x10 the MIC of gentamicin. The 
overall trend of growth was similar for all 15 resistant cultures (Figure 8.3). Direct 
comparisons could be drawn between the growth of the two resistant strains, as 
fluctuations appeared in a subset of colonies or replicates which diverged from the 
overall trend of growth. This was observed within the x10 MIC resistant strain for all 
replicates of colony five between 90-480 minutes of growth and between individual 
replicates of colonies three and four after 60-420 minutes of growth.    
 
However, dissimilar to the MIC resistant strain, the maximum OD600 value achieved 
for the x10 MIC cultures was less than that of the WT and MIC strains, with the final 
OD600 values ranging from 0.15-0.2 OD units after 12 hours of growth. There was no 
significant difference in the growth of the x10 MIC strain of E. coli MG1655 after 12 
hours of growth (P=0.4781).  Again, although statistically insignificant, in comparison 
to the WT and MIC strains there was greater inter-colony variation observed with the 
x10 MIC cultures.  These results proposed that as the level of resistance increases, 
there is greater variation amongst bacterial colonies.  
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Figure 8.3 Automated growth analysis of E. coli MG1655 x10 MIC strain. Graph 
showing the growth curve of the E. coli MG1655 x10 MIC strain in MH broth at 37ºC. 
All five colonies (C1-C5) were grown in triplicate in 96-well plates and the OD600 
values were measured every 30 minutes for 12 hours in the Infinite M200 PRO plate 
reader. The colony triplicates were presented in colour: C1 (red), C2 (Khaki green), 
C3 (green), C4 (blue) and C5 (magenta). The triplicate values per colony were 
averaged and the standard error was calculated. The error bars represent standard 
deviation. There was no significant difference in the growth rates between all 
replicates of the E. coli MG1655 MIC strain (P=0.4781).    
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Successively, the OD600 values of the sensitive and resistant strains were averaged to 
comparatively asses the growth of the WT, MIC and x10MIC strains over 12 hours 
(Figure 8.4). Looking more briefly at the overall trend of growth between the strains, it 
was evident that the growth rate was higher for the WT in comparison to the two 
resistant strains, which shared more closely related growth profiles. The greatest 
disparities in growth amid the sensitive and resistant strains were observed over the 
initial 400 minutes. After which, the growth of the resistant strains started to diverge, 
with the MIC strain increasing more rapidly in growth, than its highly resistant 
counterpart. These preliminary growth results, suggest compromised growth following 
the acquisition of resistance.  
 
There were significant differences in growth observed between the sensitive and 
resistant strains over the 12-hour growth curve (P=1.1e-09). The greatest significant 
difference in growth was observed when comparing the growth of the  
WT with the two resistant strains independently. The bacterial growth of the WT strain 
differed most significantly to the x10MIC strain (P=3.094e-1) followed by the MIC 
strain (P=1.609e-05). Unsurprisingly, there was no significant difference between the 
growth of the two resistant strains (P=0.06019). 
 
The shaded ribbons surrounding the lines on the graph (Figure 8.4), represent the 
standard error of the triplicate OD600 values from each strain. The error values were 
relatively small for all three strains, yet the degree of error in the x10MIC strain 
appeared larger than that of the WT and MIC.  
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Figure 8.4 Automated growth analysis of gentamicin sensitive and resistant 
strains of E. coli MG1655. Graph showing the growth curve of the E. coli MG1655 
WT, MIC and x10 MIC strains in MH broth at 37ºC. Five colonies (C1-C5) per strain 
were grown in triplicate in 96-well plates and the OD600 values were measured every 
30 minutes for 12 hours in the Infinite M200 PRO plate reader. The colony triplicates 
per strain were averaged and the standard error was calculated. The error ribbons 
represent the standard error of the mean. There was a significant difference in the 
growth rates of the sensitive and resistant strains of E. coli MG1655 (P= 1.1e-09).  
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Prior to the statistical analysis, the data was assessed to determine the correct 
statistical approach. The normality tests for the statistical analysis revealed the 
automated growth curve data did not follow normal distribution, illustrated via 
histograms and the QQ plots. The histogram graphics suggested highly variable 
distribution between with the WT and resistant strains (Figure 8.5 A).  This was 
validated using QQ plots, where the quantiles for each strain did not form a straight 
line (Figure 8.5 B). As normality was desired, the data was transformed using various 
functions in RStudio (Figure 8.5 C), however this was unsuccessful. Therefore, a non-
parametric approach to an annova was conducted in the form of a Kruskal–Wallis 
test, to determine significance.  
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8.3.1.1 Automated exponential phase growth analysis 
 
Following the growth curve analysis of the sensitive and resistant strains over a 
duration of 12 hours, it was of interest to further analyse the bacterial growth in 
relation to the specific phases of growth. The exponential phase of growth was 
selected, as it is the phase in which bacterial cells are most rapidly dividing. 
The exponential growth analysis of the WT strain, revealed highly similar phenotypic 
trajectories for all five colonies (Figure 8.6). The exponential phase of the WT strain, 
was initiated following 60 minutes of growth in MH broth, which followed a rapid 
increase in OD600 values to between 0.188 and 0.208 OD units after 270 minutes for 
all selected colonies.  
Figure 8.6 Automated exponential growth analysis of E. coli MG1655 WT strain. 
Graphs showing the exponential growth curve of the E. coli MG1655 WT strain in MH 
broth at 37ºC. All five colonies (C1-C5) were grown in triplicate in 96-well plates and 
the OD600 values were measured in the Infinite M200 PRO plate reader. The triplicate 
values per colony were averaged and the standard error was calculated. The error 
bars represent standard deviation. There was no significant difference in the 
exponential growth rates between WT colonies of E. coli MG1655.  
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In comparison to the WT strain, the exponential phase of growth of the MIC strain, 
followed very similar trajectories in all but one colony (Figure 8.7). The slope of the is 
less steep than that seen with the WT cultures, and this is further demonstrated by 
the significantly lower OD600 values attained after 270 minutes of growth, ranging from 
0.106 to 0.145 OD units for all five colonies. The substantial difference in exponential 
growth identified within colony C4, inferred greater colony variation of resistant 
cultures as described previously.  
Figure 8.7 Automated exponential growth analysis of E. coli MG1655 MIC strain. 
Graphs showing the exponential growth curve of the E. coli MG1655 MIC strain in MH 
broth at 37ºC. All five colonies (C1-C5) were grown in triplicate in 96-well plates and 
the OD600 values were measured in the Infinite M200 PRO plate reader. The triplicate 
values per colony were averaged and the standard error was calculated. The error 
bars represent standard deviation.  
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The fluctuations observed between colonies was further demonstrated when looking 
at the exponential growth of the x10MIC resistant strain (Figure 8.8). Similarities can 
be drawn when looking at the overall trend in colony growth however, the inter-colony 
variation was more pronounced, excluding colonies C2 and C3. The exponential 
growth analysis further supported the findings of an extended lag phase within the 
X10 MIC resistant cultures, where the most pronounced increase in OD600 was 
observed following 120 minutes. Equivalent, OD600 values were achieved after 270 
minutes of growth for the two resistant strains, which ranged between 0.081 to 0.142 
OD units.  
Figure 8.8 Automated exponential growth analysis of E. coli MG1655 x10 MIC 
strain. Graphs showing the exponential growth curve of the E. coli MG1655 x10 MIC 
strain in MH broth at 37ºC. All five colonies (C1-C5) were grown in triplicate in 96-well 
plates and the OD600 values were measured in the Infinite M200 PRO plate reader. 
The triplicate values per colony were averaged and the standard error was calculated. 
The error bars represent standard deviation.  
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In addition to independently assessing the growth of the five individual colonies per 
strain, the OD600 values were averaged to directly compare the exponential growth of 
WT with the MIC and x10MIC resistant strains (Figure 8.9).  There were pronounced 
differences in the exponential growth of the WT strain, compared to the growth 
between 60-270 minutes for the resistant strains. This was most evident at 270 
minutes where the OD600 achieved for WT strain was 0.199 OD units compared to 
OD600 value of 0.122 and 0.115 OD units for the MIC and x10 MIC resistant strains 
respectively. As described previously (Section 8.3.1), the two resistant strains 
displayed similar profiles over the defined growth phase. Nevertheless, the MIC 
growth was marginally faster than the x10MIC strain, suggesting an indirect 
relationship between the level of resistance and the proficiency of bacterial growth.  
 
The statistical analysis revealed there was again a significant difference in the 
bacterial growth of all three strains over the exponential phase of growth (P=1.667e-
05). Comparably, the greatest difference in exponential growth was observed 
between the WT and x10 MIC strain (P= 2.368e-05) and there was no significant 
difference between the exponential growth of the two gentamicin resistant strains 
(P=0.2655).  
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Figure 8.9 Automated exponential growth analysis of gentamicin sensitive and 
resistant strains of E. coli MG1655. Graph showing the exponential growth curve of 
the E. coli MG1655 WT, MIC and x10 MIC strains in MH broth at 37ºC. Five colonies 
(C1-C5) per strain were grown in triplicate in 96-well plates and the OD600 values were 
measured using the Infinite M200 PRO plate reader. The colony triplicates per strain 
were averaged and the standard error was calculated. The error ribbons represent 
the standard error of the mean. There was a significant difference in the growth rates 
of the sensitive and resistant strains of E. coli MG1655 (P= 1.677e-05).  
 
 
 
 
 
 
 
 
 
 
  
 
 
333 
8.3.2 Manual assessment of bacterial growth  
 
To determine the reproducibility of the automated growth curve findings, the 
experiment was repeated manually with the inclusions of 5 individual colonies from 
each strain, as opposed to the 15 cultures per strain tested in the automated 96-well 
plate format. The growth of strains will be discussed independently, prior to the 
comparative assessments of growth between strains. As seen previously, the five 
colonies of E. coli MG1665 WT revealed similar phenotypic trajectories of growth 
(Figure 8.10). However, there appeared to be an extended lag period over the first 2.5 
hours of growth, which was not evident in the automated method. Another clear 
discrepancy between the growth of the WT cultures, was the significantly higher 
maximal OD600 achieved following 12 hours of growth within the manual method.  
There was no significant difference in the growth of the WT strain of E. coli MG1655 
after 12 hours of growth (P=0.3068).  
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Figure 8.10 Manual growth analysis of E. coli MG1655 WT strain. Displaying the 
growth curve of the E. coli MG1655 WT strain in MH broth at 37ºC. All five colonies 
(C1-C5) were grown within conical flasks and the OD600 values were measured every 
hour for 12 hours manually using a spectrophotometer. There was no significant 
difference in the growth rates between all colonies of the E. coli MG1655 WT strain 
(P=0.3068).    
 
 
When comparing this to the resistant strain selected at the MIC of gentamicin, similar 
phenotypic trajectories were observed for all MIC cultures, except for C2 which 
displayed a rapid increase in OD600 ensuing three hours of growth (Figure 8.11). 
Additionally, a primary lag phase of growth over the first 2.5 hours was detected, 
which parallels that seen with the WT cultures. A clear distinction in the growth of the 
MIC compared to the WT cultures, is reflected in the maximum OD600 achieved after 
12 hours of growth, which was 0.448 and 0.795 OD units respectively. Overall, there 
was no significant difference in the growth of the five MIC cultures (0.2495). 
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Figure 8.11 Manual growth analysis of E. coli MG1655 MIC strain. Displaying the 
growth curve of the E. coli MG1655 WT strain in MH broth at 37ºC. All five colonies 
(C1-C5) were grown within conical flasks and the OD600 values were measured every 
hour for 12 hours manually using a spectrophotometer. There was no significant 
difference in the growth rates between all colonies of the E. coli MG1655 MIC strain 
(P=0.2495).  
 
 
Similar trends in growth were observed for the E. coli MG1655 resistant strain 
selected at x10 the MIC of gentamicin (Figure 8.12). The growth of all five cultures 
was highly comparable, with no major colony discrepancies as seen above with the 
MIC strain (Figure 8.11). This resemblance was further justified following statistical 
analysis, where there was found to be no significant difference in the growth of the 
x10 MIC resistant strain of E. coli MG1655 after 12 hours of growth (P=0.0782). There 
appeared to be a trend emerging, whereby the maximum OD600 achieved following 12 
hours of growth, is lowest for the more highly resistant strain of E. coli MG1655.  
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Figure 8.12 Manual growth analysis of E. coli MG1655 x10MIC strain. Displaying 
the growth curve of the E. coli MG1655 x10MIC strain in MH broth at 37ºC. All five 
colonies (C1-C5) were grown within conical flasks and the OD600 values were 
measured every hour for 12 hours manually using a spectrophotometer. There was 
no significant difference in the growth rates between all colonies of the E. coli 
MG1655 X10MIC strain (P=0.0782). 
 
 
To assess the growth of the sensitive and resistant strains collectively, the OD600 
values were averaged per time point (Figure 8.13).  When comparing the manual and 
automated growth curves the general trends of the graphs are analogous, however 
variations were identifiable in terms of the OD600 values achieved, and the steepness 
of the gradient obtained within the manual method for the WT strain. There was a 
significant difference in the bacterial growth between the sensitive and resistant 
strains succeeding the lag phase (P=5.044e-06). However, there was no significant 
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difference in the growth between the two resistant strains (P=0.07526). Again, as 
seen with the automated bacterial analysis, the greatest difference in growth was 
observed between the WT and x10MIC resistant strain of E. coli MG1655 (P=6.849e-
06).  
 
Figure 8.13 Manual growth analysis of gentamicin sensitive and resistant 
strains of E. coli MG1655. Graph showing the growth curve of the E. coli MG1655 
WT, MIC and x10 MIC strains in MH broth at 37ºC. All five colonies (C1-C5) per strain 
were grown within conical flasks and the OD600 values were measured every hour for 
12 hours manually using a spectrophotometer. The OD600 values obtained from each 
colony per strain were averaged and the standard error was calculated. The error 
ribbons represent the standard error of the mean. There was a significant difference 
in the growth rates of the sensitive and resistant strains of E. coli MG1655 (P= 
5.044e-06). 
 
 
As above, prior to the statistical analysis, it was necessary to determine the correct 
statistical approach based on the manual growth curve data set. Comparable to the 
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previous data set, the normality tests established that the data did not follow normal 
distribution, even following transformation. The graphical normality and transformation 
plots can be found in the appendix (Figure A.24).  Consequently, the non-parametric 
Kruskal–Wallis test was applied.   
 
8.3.2.1 Manual exponential phase growth analysis 
 
As with the automated growth curve, the exponential phase of growth was examined 
more thoroughly. The duration of the exponential phase was determined for the WT 
strain before a comparative analysis of growth within the selected period of the  
two resistant strains. The exponential growth of the WT strain was initiated after 3 
hours of growth and progressed for a further five hours, during which the OD600 values 
increased progressively from a minimum of 0.017 OD units to a maximum of 0.722 
OD units. The independent exponential growth analysis plots for the E. coli MG1655 
WT, MIC and x10 MIC strains can be found in the appendix (Figure A.25-A.27).  
 
To directly compare the exponential growth of the sensitive and resistant strains 
collectively, the OD600 values for each colony were averaged (Figure 8.14).  There 
was a significant difference in the exponential growth of the sensitive and resistant 
strains of E. coli MG1655 (P=2.852e-05). The greatest difference in exponential 
growth of the three strains was seen after 8 hours, with an OD600 value of 0.686 OD 
units achieved for the WT compared to 0.261 and 0.221 OD units for the MIC and 
x10MIC resistant strains respectively. Correspondingly, the greatest difference in 
exponential growth was observed between the WT and x10MIC strain (P=3.705e-05) 
and there was no significant difference amongst the two resistant strains (P=0.1353).   
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Figure 8.14 Manual exponential growth analysis of gentamicin sensitive and 
resistant strains of E. coli MG1655. Graph showing the exponential growth curve of 
the E. coli MG1655 WT, MIC and x10 MIC strains in MH broth at 37ºC. All five 
colonies (C1-C5) per strain were grown within conical flasks and the OD600 values 
were measured manually using a spectrophotometer. The OD600 values obtained from 
each colony per strain were averaged and the standard error was calculated. The 
error ribbons represent the standard error of the mean. There was a significant 
difference in the growth rates of the sensitive and resistant strains of E. coli MG1655 
(P=2.852e-05). 
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8.3.3 Manual bacterial growth analysis bacterial enumeration  
To compare the OD600 values obtained from both the automated and manual turbidity 
methods, viable cell counts of the sensitive and resistant strains were performed and 
the logarithm of the number of CFU/mL was calculated. Again, the viable cell counts 
of the sensitive and resistant strains will be discussed independently before a direct 
comparative analysis.  
 
Following the enumeration of bacterial counts, the WT growth curve did not follow a 
smooth trajectory as seen with the two turbidity methods, however the growth of the 
five independent WT cultures proceeded in a comparable trend (Figure 8.15). This 
was supported through the statistical analysis of the WT cultures, where there was no 
significant difference observed in the log10 CFU/mL counts of the WT strain over the 
duration of the bacterial growth curve (P= 0.2573). The E. coli WT strain cultures 
appeared to reach the stationary phase of growth after approximately 6 hours of 
growth in MH broth.  The maximum bacterial count obtained within the growth 
analysis was 8.27875 log10 CFU/mL which was enumerated following 690 minutes of 
growth.  
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Figure 8.15 Manual growth analysis of E. coli MG1655 WT strain by bacterial 
enumeration. Displaying the growth curve of the E. coli MG1655 WT strain in MH 
broth at 37ºC. All five colonies (C1-C5) were grown within conical flasks and samples 
were taken every hour for 12 hours. The bacterial samples were used to perform 
serial dilutions which were plated on MH plates and incubated O/N at 37ºC. Following 
incubation, the log10 CFU/mL was determined. There was no significant difference in 
the bacterial counts between all colonies of the E. coli MG1655 WT strain (P=0.2573).  
 
 
Comparable growth profiles were seen for the MIC cultures, with similar overall 
trajectories for all five cultures (Figure 8.16).  The stationary phase of growth 
emerged approximately at the same time point as the WT, however the initial gradient 
during the exponential phase of growth was steeper for the WT cultures. Additionally, 
the maximum bacterial count obtained within the growth analysis of the MIC cultures 
was 7.77085 log10 CFU/mL. There was no significant difference detected in the 
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bacterial counts of the MIC cultures over the 12-hour duration of the growth curve 
(P=0.08545). Though the p-value implied borderline significance.  
Figure 8.16 Manual growth analysis of E. coli MG1655 MIC strain by bacterial 
enumeration. Displaying the growth curve of the E. coli MG1655 MIC strain in MH 
broth at 37ºC. All five colonies (C1-C5) were grown within conical flasks and samples 
were taken every hour for 12 hours. The bacterial samples were used to perform 
serial dilutions which were plated on MH plates and incubated O/N at 37ºC. Following 
incubation, the log10 CFU/mL was determined. There was no significant difference in 
the bacterial counts between all colonies of the E. coli MG1655 MIC strain 
(P=0.08545).  
 
The manual growth curve of the x10 MIC strain (Figure 8.17), displayed similar 
trajectories with no significant difference in the bacterial counts of the five 
independent cultures during the 12-hour growth analysis (P=0.09198).  However, 
again the obtained p-value suggested borderline significance. In contrast to the rapid 
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onset of bacterial growth over the first 2 hours observed for the WT and MIC strains, 
the x10 MIC cultures appeared to have an extended lag phase where bacterial counts 
remained low for the first 2.5 hours. Here, unlike the turbidity results, the maximal 
bacterial count obtained for the x10MIC cultures was comparable to the MIC strain, 
with a bacterial count of 7.57978 log10 CFU/mL after 9 hours of growth.  
Figure 8.17 Manual growth analysis of E. coli MG1655 X10MIC strain by 
bacterial enumeration. Displaying the growth curve of the E. coli MG1655 X10MIC 
strain in MH broth at 37ºC. All five colonies (C1-C5) were grown within conical flasks 
and samples were taken every hour for 12 hours. The bacterial samples were used to 
perform serial dilutions which were plated on MH plates and incubated O/N at 37ºC. 
Following incubation, the log10 CFU/mL was determined. There was no significant 
difference in the bacterial counts between all colonies of the E. coli MG1655 X10MIC 
strain (P=0.09198). 
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When analysing the averaged log10 CFU/mL growth collectively for the sensitive and 
resistant strains (Figure 8.18). There were similarities in the growth over the first 
hours for the WT and MIC strains, which was dissimilar to the extended two-hour lag 
phase recognised with the x10 MIC cultures. As previously discussed all strains 
appeared to plateau after approximately 6 hours of growth, with almost identical 
stationary phase profiles for the two resistant strains of E. coli MG1655. Despite this 
over the 12-hour growth analysis there was a significant difference in the bacterial 
counts for the sensitive and resistant strains (P=5.02e-06). The greatest variation in 
bacterial counts was observed independently between all the WT and X10MIC 
resistant strain (P=1.177e-05). There was no significant difference in the bacterial 
counts of the two resistant strains (P=0.2519) consistent with the OD600 findings. 
These results indicated compensated bacterial growth due to the acquisition of 
gentamicin resistance. 
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Figure 8.18 Manual growth analysis of gentamicin sensitive and resistant 
strains of E. coli MG1655 by bacterial enumeration. Graph showing the growth 
curve of the E. coli MG1655 WT, MIC and x10 MIC strains in MH broth at 37ºC. The 
five colonies (C1-C5) per strain were grown within conical flasks and samples were 
taken every hour for 12 hours. The bacterial samples were used to perform serial 
dilutions which were plated on MH plates and incubated O/N at 37ºC. Following 
incubation, the log10 CFU/mL was determined. The bacterial counts (log10 CFU/mL) 
per colony for each strain were averaged and the standard error was calculated. The 
error ribbons represent the standard error of the mean. There was a significant 
difference in the growth rates of the sensitive and resistant strains of E. coli MG1655 
(P=5.02e-06).  
 
 
Comparable to the previous data sets, the normality tests for the statistical analysis 
revealed the bacterial enumeration data did not follow normal distribution even 
following transformation. The graphical normality and transformation plots can be 
found in the appendix (Figure A.28).  Thus, the non-parametric Kruskal–Wallis test 
was applied to determine significance.  
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8.3.3.1 Manual exponential growth analysis bacterial enumeration  
As described previously with the turbidity methods, a supplementary analysis was 
performed on the viable bacterial counts of the sensitive and resistant strains during 
the exponential phase of growth. The bacterial enumeration of the E. coli MG1655 
WT strain, revealed an earlier initiation of exponential growth when compared to the 
turbidity methods. The exponential phase followed one hour of growth and extended 
for a further five. The independent exponential growth analysis plots for the E. coli 
MG1655 WT, MIC and x10 MIC strains can be found in the appendix (Figure A.29-
A.31).  
 
To summarise and directly compare the exponential growth of the three strains, the 
averaged bacterial counts were determined. This revealed clear distinctions in the 
exponential growth of the WT strain compared the two resistant strains (Figure 8.19). 
The bacterial counts achieved by the WT strain during the exponential growth 
extended from 5.3305 log10 CFU/mL at beginning of the phase to 7.8202 log10 
CFU/mL after six hours of growth. The bacterial counts obtained by the MIC strain 
were lower than that of the WT at the start of the exponential phase 4.9974 log10 
CFU/mL and this was maintained throughout the duration of the phase. Following this 
trend, the x10MIC strain had an even further reduced bacterial count after 1 hour of 
4.4261 log10 CFU/mL, which was sustained for a further hour. Despite this after three 
hours of exponential, the x10MIC strain rapidly increased in bacterial number to 
achieve almost identical averaged log10 CFU/mL values to that of the MIC, which 
were 7.1440 log10 CFU/mL and 7.1470 log10 CFU/mL for the MIC and x10MIC 
strains respectively.  
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There were significant differences in the exponential growth counts between the 
sensitive and resistant strains of E. coli (P=0.001568). Comparable to the previous 
bacterial growth analysis findings, the greatest difference in exponential counts was 
observed between the WT and X10MIC strain (P=0.0009513). There was no 
significant difference in the exponential counts between the two resistant strains 
(P=0.01836).  
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Figure 8.19 Manual exponential growth analysis of gentamicin sensitive and 
resistant strains of E. coli MG1655 by bacterial enumeration. Graph showing the 
exponential growth curve of the E. coli MG1655 WT, MIC and x10 MIC strains in MH 
broth at 37ºC. The five colonies (C1-C5) per strain were grown within conical flasks 
and samples were taken every hour for 12 hours. The bacterial samples were used to 
perform serial dilutions which were plated on MH plates and incubated O/N at 37ºC. 
Following incubation, the log10 CFU/mL was determined. The bacterial counts (log10 
CFU/mL) per colony for each strain were averaged and the standard error was 
calculated. The error ribbons represent the standard error of the mean. There was a 
significant difference in the growth rates of the sensitive and resistant strains of E. coli 
MG1655 (P=0.001568). 
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8.3.4 Bacterial dose response analysis 
A comparative dose response analysis was then conducted on the resistant strains  
in the presence of the selective concentrations of the antimicrobial agents.  This was 
then directly compared to the growth of the WT population in a non-selective 
environment. Owing to the previously determined accuracy of OD600 measurements, it 
was decided that the dose response analysis will be conducted manually using OD600 
measurements. As with the growth curve analysis, the response of each strain will be 
discussed individually, prior to a comparative analysis.  
 
As seen with the growth curve analysis, the five colonies of E. coli MG1665 WT 
revealed similar phenotypic trajectories of growth (Figure 8.20). Comparable to the 
manual growth curve turbidity analysis, a lag phase was observed over the first 200 
minutes and the maximal OD600 value attained ranged between 0.6 and 0.8 OD units. 
The discrepancies between the five cultures emerged following the exponential phase 
of growth, nevertheless there was no significant difference in the growth of the WT 
strain of E. coli MG1655 after 12 hours of growth (P=0.08049). 
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Figure 8.20 Manual dose response analysis of E. coli MG1655 WT strain. 
Displaying the growth curve of the E. coli MG1655 WT strain in MH broth at 37ºC. All 
five colonies (C1-C5) were grown within conical flasks and the OD600 values were 
measured every hour for 12 hours manually using a spectrophotometer. There was 
no significant difference in the growth rates between all colonies of the E. coli 
MG1655 WT strain (P=0.08049).   
 
In comparison to the growth curve analysis of the resistant strain selected at the MIC 
of gentamicin in a non-selective environment, there appeared to be an extended lag 
phase of growth for four of the five MIC cultures lasting approximately 300 minutes 
(Figure 8.21). Succeeding this prolonged lag phase, there was a rapid growth 
response for all five cultures, surpassing the optimal OD600 of the MIC strain in the 
absence of the antimicrobial selective pressures. This result suggests, providing there 
is a genotypic adaptation within the MIC cultures, there is increased growth in the 
presence of antimicrobial agents. There was a significant difference in the growth of 
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the MIC cultures in the presence of the antimicrobial selective pressure (2mg/L 
gentamicin) over 12 hours (P=0.007877). 
Figure 8.21 Manual dose response analysis of E. coli MG1655 MIC strain. 
Displaying the growth curve of the E. coli MG1655 MIC strain in MH broth 
supplemented with the MIC of gentamicin (2mg/L) at 37ºC. All five colonies (C1-C5) 
were grown within conical flasks and the OD600 values were measured every hour for 
12 hours manually using a spectrophotometer. There was no significant difference in 
the growth rates between all colonies of the E. coli MG1655 MIC strain (P=0.007877).   
 
 
Conversely, this was not observed for the x10 MIC strain (Figure 8.22). Following, the 
inoculation into a medium containing the high dose antimicrobial agent, there was a 
rapid reduction in the OD600 values which was not recovered within the 12-hour growth 
analysis. The data here revealed rapid bacterial decline upon the initial introduction to 
media containing x10MIC of gentamicin. This suggested that selection strength is an 
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important parameter which affects the phenotypic diversity of evolving bacterial 
populations, such that under strong selective pressures bacterial survival takes 
immediate priority over the presence of resistance-conferring mutations (Oz et al., 
2014).  This trend in dose response was seen for all five cultures of the X10 MIC 
strain and therefore unsurprisingly, there was no statistical significance difference in 
the dose response of the x10 MIC strain (P>0.9). Further, this suggested that for an 
accelerated response to occur in the presence of an antimicrobial agent, the bacterial 
populations must adapt to the selective pressure, and failing this the bacterial 
response is inhibited.  
Figure 8.22 Manual dose response analysis of E. coli MG1655 X10MIC strain. 
Displaying the growth curve of the E. coli MG1655 X10MIC strain in MH broth 
supplemented with X10 the MIC of gentamicin (20mg/L) at 37ºC. All five colonies (C1-
C5) were grown within conical flasks and the OD600 values were measured every hour 
for 12 hours manually using a spectrophotometer. There was no significant difference 
in the growth rates between all colonies of the E. coli MG1655 X10MIC strain.  
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When examining the averaged dose response of the three strains directly, the 
extended lag phase displayed within the resistant cultures is accentuated (Figure 
8.23). There were clear discrepancies between gradients of the WT and MIC strains, 
where there appears to be a right shift in the positive slope of the MIC strain.  This 
result also highlighted how rapidly the MIC cultures responded once adapted to the 
antimicrobial selective pressure. Here, there was a significant difference in the 
bacterial growth in response to presence of antimicrobial agents between the 
sensitive and resistant strains of E. coli MG1655 (P=2.2e-16).  
Figure 8.23 Manual dose response analysis of gentamicin sensitive and 
resistant strains of E. coli MG1655. Graph showing the growth curve of the E. coli 
MG1655 WT, MIC and x10 MIC strains in MH broth supplemented with 0, 2 and 
20mg/L respectively at 37ºC. All five colonies (C1-C5) per strain were grown within 
conical flasks and the OD600 values were measured manually using a 
spectrophotometer. The OD600 values obtained from each colony per strain were 
averaged and the standard error was calculated. The error ribbons represent the 
standard error of the mean. There was a significant difference in the growth rates of 
the sensitive and resistant strains of E. coli MG1655 (P= 2.2e-16). 
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Similarly, to the previous bacterial growth data, the dose response data set was not 
normally distributed and therefore the non-parametric Kruskal–Wallis test was used to 
determine significance. The graphical normality and transformation plots can be found 
in the appendix (Figure A.32).  
 
 
8.3.5 Bacterial virulence analysis  
 
The microbial virulence using the G. mellonella toxicity model was assessed over 
seven days. Twenty G. mellonella were inoculated with five cultures taken from the  
sensitive and resistant strains of E. coli MG1655 cultivated in a non-selective 
environment, to determine the fitness costs associated with resistance development. 
The larvae were assessed daily using four key observations: survival, activity, cocoon 
formation and melanisation. As with the bacterial growth analysis, the statistics and 
graphical visualisation of data was completed using RStudio using the non-parametric 
Kruskal–Wallis test. The graphical normality and transformation plots for the virulence 
data can be found in the appendix (A.33).  
 
The virulence of the sensitive and resistant strains will be discussed independently, 
prior to a comparative analysis. To assist in the interpretation of survival plots, a 
supplementary table has been included within the figure displaying the daily 
accumulated G. mellonella post-infection. Furthermore, an image has been added of 
the G. mellonella following the 7-day experimentation period.   
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Five bacterial WT cultures were each individually inoculated into twenty G. mellonella 
larvae at time point zero and the percentage knockdown was monitored daily over a 
period of 7 days (Figure 8.24). Following inoculation, the initial death of larvae was 
observed after 1 day for WT cultures C4 and C5. The survival deteriorated thereafter 
for larvae inoculated with all five WT cultures.  After day seven, the % knockdown of 
larvae inoculated with all five bacterial WT cultures was between 25% and 45%. 
Although there was significant variability in the virulence profiles of the five WT 
cultures, the overall trend depicts increased virulence after one-day post-inoculation. 
There was 100% survival for the non-injected and PBS controls after 7 days. 
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Figure 8.24 Survival analysis of G. mellonella after E. coli MG1655 WT infection. 
A total of twenty G. mellonella larvae were injected with five independent culture of 
the E. coli MG1655 WT (WT C1-C5) and incubated at 37ºC for a period of seven 
days, and mortality (% Knockdown) was monitored daily. The two experimental 
controls correspond to the non-infected G. mellonella (WTNI) and larvae injected with 
sterile PBS (WT PBS). The accumulative G. mellonella deaths over time post-
infection were represented within a tabular format, to stipulate the individual larvae 
deaths per WT colony which was difficult to interpret from the survival curve.  
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This was then compared to the virulence profiles of the larvae inoculated with the five 
bacterial resistant cultures selected at the MIC of gentamicin (Figure 8.25). The initial 
knockdown of a single larvae in MIC cultures 2C1 and 2C3, was observed 96 hours 
post-inoculation. This 5% knockdown of larvae was only apparent in galleria 
inoculated with two of the five MIC cultures, and the remaining larvae inoculated with 
the three remaining MIC bacterial cultures exhibited 100% survival. The 5% reduction 
in survival, is difficult to identify within the survival plot owing to the identical virulence 
profiles of MIC cultures 2C1 and 2C3, though evident within the table (Figure 8.25). 
There was 100% survival for the non-injected and PBS controls after 7 days. This 
result suggested a reduced virulence of resistant cultures.   
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Figure 8.25 Survival analysis of G. mellonella after E. coli MG1655 MIC 
infection. A total of twenty G. mellonella larvae were injected with five independent 
cultures of the E. coli MG1655 MIC (2mg/L) strain (2 C1-C5) and incubated at 37ºC 
for a period of seven days, and mortality (% Knockdown) was monitored daily. The 
two experimental controls correspond to the non-infected G. mellonella (2 NI) and 
larvae injected with sterile PBS (2 PBS). The accumulative G. mellonella deaths over 
time post-infection were represented within a tabular format, to stipulate the individual 
larvae deaths per MIC colony which was difficult to interpret from the survival curve. 
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Similar virulence profiles were observed for larvae inoculated with the five bacterial 
resistant cultures selected at the x10 MIC of gentamicin (Figure 8.26). As with the 
larvae inoculated with the MIC cultures, the initial knockdown of a single larvae was 
observed 96 hours post-inoculation for the x10 MIC culture 20C5. The later reduction 
in galleria survival occurred six days post-infection for the x10 MIC cultures 20C1 and 
20C4. There was 100% survival for the non-injected and PBS controls after 7 days. 
These results correspond to the virulence profiles of the MIC strains and further 
suggest reduced virulence of resistant cultures.  
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Figure 8.26 Survival analysis of G. mellonella after E. coli MG1655 X10MIC 
infection. A total of twenty G. mellonella larvae were injected with five independent 
cultures of the E. coli MG1655 X10MIC (20mg/L) strain (20 C1-C5) and incubated at 
37ºC for a period of seven days, and mortality (% Knockdown) was monitored daily. 
The two experimental controls correspond to the non-infected G. mellonella (20 NI) 
and larvae injected with sterile PBS (20 PBS). The accumulative G. mellonella deaths 
over time post-infection were represented within a tabular format, to stipulate the 
individual larvae deaths per X10MIC colony which was difficult to interpret from the 
survival curve.  
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To provide a direct comparison of the virulence profiles of the sensitive and resistant 
strains, the percentage knockdown values were averaged for all five bacterial cultures 
per strain (Figure 8.27).  The survival graph accentuated the substantial differences in 
virulence of the sensitive and resistant strains of E. coli MG1655. The two resistant 
strains displayed highly similar virulence profiles. Following one-day post-infection, 
there was a significant difference in the virulence of the WT compared to both 
gentamicin resistant strains (P= 3.928e-09). Unsurprisingly, there was no significant 
difference between the virulence of the MIC and X10 MIC resistant cultures 
(P>0.999).  The bacterial virulence results indicated a direct relationship between 
galleria survival and time post inoculation and more significantly a reduction in the 
virulence of resistant strains. This suggested a fitness cost in virulence associated 
with the acquisition of gentamicin resistance.  
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Figure 8.27 Survival analysis of G. mellonella after infection with sensitive and 
resistant strains of E. coli MG1655. A total of twenty G. mellonella larvae were 
injected with five independent cultures of E. coli MG1655 WT, MIC and X10MIC 
strains and incubated at 37ºC for a period of seven days, and mortality was monitored 
daily. The survival graph displays the averaged G. mellonella deaths over time post-
infection. There were statistically significant differences in the virulence of the E. coli 
MG1655 WT when compared to the two resistant strains (P=3.928e-09).  
 
 
As indicated previously an image has been included showing all galleria larvae 
seven-days post-inoculation (Figure 8.28). Unfortunately, the lighting within the 
microbiology laboratory had compensated the image quality, making it difficult to 
visualise the larvae inoculated with cultures C4 and C5 for all three bacterial strains.  
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Taking into consideration the four key observations, and the knowledge that 
melanisation typically begins with distinct black spots on the larvae, which progresses 
to the larvae turning black when they die. It was evident that there were detrimental 
consequences on the physical state of the galleria seven days post WT infection, as 
seen with the increased number of black larvae when compared to the larvae groups 
infected with the resistant cultures.  
 
Interestingly, it was concluded that all four-observations should be considered when 
assessing the physical conditions of the G. mellonella larvae. This was more evident 
when evaluating the virulence of the resistant strains than their sensitive WT 
counterpart. Looking at the graph in figure (8.25), there was 100% survival observed 
for all larvae inoculated with the MIC cultures 2C2 and 2C3. Nevertheless, when 
looking at the image below some of the galleria within these groups appeared to be 
melanised. Despite this, a physical assessment identified that the larvae were either 
reactive post-stimulation or had partial cocoon formation. An additional observation 
not included in this image, was the visualisation of increased silk production within the 
larvae injected with PBS in the experimental control group.  
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8.3.6 SEM bacterial morphology analysis 
In addition to an assessment of fitness, a preliminary study was conducted to 
examine the morphophysiological changes in the bacterial cells induced by 
antimicrobial therapy. Through high resolution SEM valuable information was 
obtained regarding the surface morphology, shape and spatial organisation of 
sensitive and antibiotic treated E. coli MG1655.  
 
 
 
8.3.6.1 SEM morphological analysis of E. coli MG1655 WT Strain  
 
The sensitive WT strain of E. coli MG1655, was prepared for SEM in MH medium. At 
a low magnification, the distribution of WT bacterial cells appeared uniform across the 
SEM micrograph (Figure 8.29 A). At a higher magnification, the length of the WT 
bacterial cells was determined to be approximately 2μm, and most WT bacterial cells 
displayed smooth intact surfaces with little surface topology (Figure 8.29 B). In 
addition, ruptured WT bacterial cells were detected infrequently across the SEM film, 
indicated by the black arrows in figure (8.29 B).  This disruption of WT bacterial cells 
could have occurred during the process of sample preparation and fixation. 
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8.3.6.2 SEM morphological analysis of the gentamicin resistant E. coli MG1655 
strain  
 
 
The resistant strain of E. coli MG1655 was selected at 2mg/L of gentamicin, which 
was the predetermined MIC value. The resistant bacterial cells were prepared for 
SEM analogously to the sensitive cells in MH medium. At the lowest magnification, 
the resistant bacterial cells displayed significant changes in their spatial distribution. 
The bacterial cells appeared to aggregate, and this clustering was consistent across 
the entire SEM film (Figure 8.30 A).  In addition, a matrix like substance appeared 
concealing some of the resistant bacterial cells, notably reducing the bacterial surface 
topology as indicated by the black arrow in figure (8.30 A).  
 
At a higher magnification, the average length of the resistant bacterial cells was 
significantly reduced to approximately 1μm (Figure 8.30 B).  At this magnification, 
there was a distinct increase in the bacterial compactness of resistant cells in 
comparison to the sensitive WT in figure (8.29 B). Comparable to that seen at a lower 
magnification, there appears to be a layer over the resistant bacterial cells reducing 
the surface topology. In addition, although relatively infrequent, cell surface 
protrusions were identified on several resistant bacterial cells on the SEM film, as 
indicted by the black arrow (Figure 8.30 B), discussed further in the discussion.   
 
The preliminary results derived from SEM, indicated a reduced ability of the 
gentamicin resistant strain of E. coli MG1655 to grow to maximum lengths, which 
supported the findings from the bacterial fitness assessments, where reduced growth 
was observed within the resistant strains (Sections 8.3.1-8.3.3).  
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8.4 Discussion 
 
8.4.1 Fitness costs of antimicrobial resistance  
 
The aim of this chapter described in section (8.1), was completed as follows. The 
fitness costs associated with the acquisition of gentamicin resistance were 
determined through the experimental assessment of both bacterial growth and 
virulence. As hypothesised there was a substantial reduction in fitness observed 
within the resistant isolates of E. coli MG1655. A further morphological assessment of 
the resistant isolates using SEM revealed alterations in the size and spatial 
organisation of resistant colonies. In accordance with the WGS data, compensatory 
evolution had not occurred within the resistant isolates to alleviate the fitness cost of 
antibiotic resistance. 
 
The acquisition of drug resistant mutations within bacterial populations is frequently 
associated with biological costs which alter the fitness of organisms (Spratt, 1996). 
Predominantly, as resistant conferring mutations target fundamental biological 
processes within the bacterial cell, which in the absence of antibiotics can impose 
substantial costs (Lenski, 1998). Therefore, it is unsurprising that the mutations 
identified in both the rrn and fusA genes confer fitness costs due to their essential 
involvement in ribosomal protein synthesis. In addition, it is likely that the fitness costs 
associated with the acquisition of gentamicin resistance were accentuated, as no 
secondary site compensatory mutations were identified during experimental evolution 
to alleviate such costs (Björkman et al., 2000).  
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The substantial reduction in fitness within the experimentally evolved resistant strains 
of E. coli MG1655, reaffirmed the findings from the phylogenetic analysis where the 
resistant mutations discovered in the laboratory, were not identified within natural 
environments. Since natural selection acts to eliminate resistant mutants with 
elevated fitness costs, it might be presumed that under natural conditions the evolved 
resistant mutants, impaired in both growth and virulence would be outcompeted by 
mutants which do not confer these substantial fitness costs (Andersson and Hughes, 
2011). Furthermore, the selection of aminoglycoside resistant mutants, relies heavily 
upon the fitness costs associated with the nature of the resistance mechanisms 
(Beceiro, Tomás and Bou, 2013).  As demonstrated by the acquisition of 
aminoglycoside resistance by aminoglycoside modifying enzymes, such as Rmt 
methyltransferases, which confer no fitness costs (Gutierrez et al.,2012). Hence, it 
could be predicted that the acquisition of aminoglycoside resistance through 
ribosomal mutagenesis of the fusA and rrn genes would not be detected in a clinical 
setting, when alternative mechanisms exist which confer no fitness costs.  
 
8.4.2 The fitness costs associated with chromosomal mutations  
The fitness costs associated with antimicrobial resistance have been found to be 
dependent upon the precise mutations which mediate resistance to a given 
antimicrobial agent (Bottger, Pletschette and Andersson, 2005). A well-established 
model used to explore the relationship between chromosomal mutations and bacterial 
fitness, is through mutagenesis of the rpsL gene, which is renowned to confer 
streptomycin resistance (Nair et al.,1993). In streptomycin, resistant strains of E. coli, 
the replacement of the lysine residue at position 42, with the amino acids arginine, 
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asparagine and threonine, caused apparent discrepancies in bacterial fitness due to 
the restrictiveness of the mutations (Funatsu and Wittmann, 1972). This is extremely 
pertinent as resistant strains with restrictive ribosomal mutations have been shown to 
exhibit slower rates of translation compared to strains with non-restrictive mutants 
(Sander et al.,2002). Therefore, an assumption can be made that the reduced growth 
displayed by the gentamicin resistant strains of E. coli MG1655, may be enhanced by 
the replacement of a proline residue with the restrictive amino acid threonine within 
the ribosomal protein EF-G, which has been correlated with slower growing, less fit 
bacterial strains (Chiou and Jones, 1995). 
 
8.4.3 The fitness costs associated with rRNA mutations  
Ribosomal RNA mutations in antibiotic resistant bacteria, are frequently associated 
with structural alterations within the 70s-ribosomal complex and reduced translation 
efficiency, therefore rRNA mutations would be predicted to confer substantial fitness 
costs (Binet and Maurelli, 2005). However, the extent in which rRNA mutations 
contribute to bacterial fitness was found to vary significantly depending on the degree 
of conservation at the mutation position, and the level of resistance conferred 
(Shcherbakov et al.,2010). Several studies have reported that rrn mutations which 
confer high levels of antibiotic resistance, have little or no effect on bacterial fitness 
within the mycobacterial species (Sander et al.,2002; Shcherbakov et al.,2010; 
Nessar et al.,2011). In addition, a frequently detected laboratory rrn mutation  
linked to streptomycin resistance, exhibits high fitness costs and has yet to be 
identified within clinical strains (Springer et al.,2001). Therefore, owing to the 
variability in fitness costs of resistant rrn mutations, it is extremely difficult to make 
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any definitive conclusions regarding the contribution of these mutations to the 
observed reduction in bacterial fitness of the experimentally evolved gentamicin 
resistant strains.  
 
8.4.4 Bacterial virulence and antimicrobial resistance 
As previously described the larvae of G. mellonella are being used increasingly in the 
study of bacterial pathogenicity and virulence (Ramarao, Neilsen-Leroux and 
Lereclus, 2012; Cook and McArthur, 2013; Li et al.,2018). To date, very few studies 
report using G. mellonella to explore the fitness costs in bacterial virulence associated 
with antimicrobial resistance. Nevertheless, mice models have formerly been 
implemented to study the fitness costs in bacterial virulence of antibiotic resistant 
Salmonella typhimurium, where resistant mutants were avirulent in mice (Bjorkman, 
Hughes and Andersson, 1998). A comparative study using mice and G. mellonella as 
models to study the virulence of Pseudomonas aeruginosa mutants disclosed highly 
comparable virulence findings (Jander, Rahme and Ausubel, 2000; Norville et 
al.,2014).  
 
Therefore, as non-human primate models are not used in research at Kingston 
University, Galleria was utilised as an alternative model within this study. The results 
from the virulence analysis were comparable to the findings of Bjorkman et al. (1998), 
as antibiotic resistant strains of bacteria exhibited substantial fitness costs in bacterial 
virulence. In addition, the observed reduction in bacterial virulence, provides an 
explanation for the persistence of resistant bacteria in animals long after the 
termination of antimicrobial treatment (Smith, 1975). 
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8.4.5 Morphological assessments using SEM  
Scanning electron microscopy has been used to explore the detrimental effects on 
the bacterial cell envelope induced by antimicrobial agents (Hartmann et al.,2010).  
SEM analysis revealed the aminoglycoside gentamicin used within this study, 
severely reduces the integrity of the P. aeruginosa cell envelope, which manifest as 
holes due to the displacement of critical metal ions in the membrane of bacterial cells 
(Martin and Beveridge, 1986). This is the first report, of SEM being utilised to 
visualise the structural morphology of resistant strains in the absence of antimicrobial 
selective pressures. The SEM analysis exposed a reduction in the size of resistant 
colonies of E. coli MG1665, which supports the observation of reduced growth of 
resistant strains. Despite these preliminary observations, the preparation of bacterial 
samples for SEM generally requires a dehydration phase which is associated with the 
collapse and shrinking of bacterial cells (Golding et al.,2016).  Therefore, before any 
conclusions can be made, SEM must be repeated with an increased number of 
replicates.  
 
8.4.6 Conclusion  
The observed fitness costs associated with the acquisition of gentamicin resistance, 
are most likely due to the restrictive mutation in the fusA gene. The contribution of the 
16s rRNA mutations in the reduction of bacterial fitness, is yet to be elucidated. As 
the resistant mutations are costly to the growth and virulence of E. coli MG1655, it 
would be expected that the gentamicin resistant strains would be outcompeted in the 
natural environment.  
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Chapter 9: General discussion and conclusions   
The aims of the work outlined within this thesis were developed to produce an 
experimental tool to explore the evolution of antimicrobial resistance in vitro. Detailed 
bioinformatic and phylogenetic analysis, was used to determine the significance of the 
genotypic findings and finally the fitness of the resistant evolved strains were 
determined. In the following chapter, the individual aims outlined within each chapter 
will be addressed and any future work will be stipulated.  
 
9.1 The ARGP experimental evolution model  
Chapter 3, describes the extensive method development of the adaptive laboratory 
evolution tool, the ARGP, which facilitates the direct visualisation of resistance 
evolution across an antibiotic spatial concentration gradient. The application of spatial 
antibiotic concentration gradients in the study of microbial evolution has been 
previously described by Baym et al. (2016) and more recently by Ghaddar et al. 
(2018).  The direct visualisation of the evolutionary progress of bacterial populations 
within the ARGP, enables researchers to determine the exact point in which 
resistance emerges across the antimicrobial gradient. Through subsequent 
mutational analysis of resistant isolates selected from the ARGP, using the 
indispensable tool of WGS, the underlying genotypic mutational pathways to 
resistance could be predicted (Baym et al., 2017; Spicknall et al., 2013). 
 
The ARGP is a well-established model to monitor the evolution of antimicrobial 
resistance in vitro. The simplicity of the ARGP, suggests scope for its application 
within an educational setting, where it can be installed in teaching laboratories to 
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demonstrate the rapid rates of resistance evolution amongst bacterial species (Krist 
and Showsh, 2007; Kawecki et al., 2012).   
 
The ARGP holds potential for other areas of antimicrobial resistance research. In 
modern medicine, combinational therapy has been highly successful, however its 
effect on the evolution of antibiotic resistance is unclear (Hegreness et al., 2008; 
Torella, Chait and Kishony, 2010). It has been suggested that synergistic 
combinations which are preferred clinically, may favour resistance evolution while 
antagonistic interactions can suppress the evolution of resistance (Michel et al., 2008; 
Yeh et al., 2010). There is also opportunity for investigating the effects of sub-lethal 
antibiotic concentrations on resistance evolution within the ARGP (Andersson and 
Hughes, 2012; Hughes and Andersson, 2012).  
 
An interesting prospective application of the ARGP is within diagnostic experimental 
evolution during complex cases, where bacterial stains are removed from patients, 
evolved in real-time against a range of antimicrobial agents, and the information 
generated can be used to advise clinical decisions (Wood and Read, 2015). If 
successful, in incidences of chronic bacterial infections, treatment regimes could be 
selected based on evolutionary risk management (Palmer and Kishony, 2013). It is 
hoped that the ARGP will assist therapeutic strategies, in informing the design of 
novel antimicrobials and manipulating current antimicrobial agents to restrict or 
reverse the evolution of antimicrobial resistance (Baym, Stone and Kishony, 2016a). 
Finally, the ARGP could be applied to other areas of applied microbiology, including 
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the evolution of biocide resistance which is essential from an infection control 
perspective (Webber et al., 2015).   
 
9.2 Comparative genomic analysis through WGS 
The WGS analysis described within chapter 4 revealed that the SNPs identified within 
the fusA and 16s rRNA genes, are the genotypic adaptations most likely associated 
with the acquisition of the gentamicin resistance. These findings in support of Toprak 
et al. (2011), suggest WGS should be routinely applied within laboratory evolution 
experiments, due to the discovery of resistance conferring mutations which would 
have been previously missed by the conventional sequencing of primary antimicrobial 
targets (Köser et al., 2014; Baym et al., 2015). These observations suggest 
adaptation to the aminoglycoside gentamicin, is not exclusive to mutations of the 16s 
rRNA target, and can occur more broadly through mutations in genes such as fusA, 
encoding proteins directly involved in the underlying biological process of ribosomal 
protein synthesis (Rodnina et al., 1997). The genomic conclusions reached within this 
chapter, provided the grounds for subsequent investigations into the functional 
consequences of these adaptive mutations.   
9.3 Bioinformatic analysis: the functional consequences of mutagenesis 
Chapter 5 describes the identification of structural and physiochemical variations 
within the mutated 16s rRNA and fusA genes, which related specifically to the 
functional activity of gentamicin. The mutagenesis of the fusA gene, resulted in an 
amino substitution within a highly conserved region of EF-G between the boundary of 
domains 4 and 5, which plays an essential role in the conformational changes 
required during the ribosomal translocation stage of protein synthesis (Munro et al., 
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2010). The replacement of a flexible proline residue at the molecular hinge of domain 
four, produced apparent alterations in the protein compressibility and tertiary structure 
of EF-G (Sansom and Weinstein, 2000). Furthermore, the identification of the fusA 
mutation in resequenced isolates obtained from the ARGP and serial passage 
system, suggested repeatability in the emergence of a resistant genotype in 
independently evolving populations of E. coli MG1655 conferring resistance to 
gentamicin (Weinreich et al., 2006; Toprak et al., 2013; Furusawa, Horinouchi and 
Maeda, 2018).   
The functional analysis of the 16s rRNA mutations, was complicated by the presence 
of several copies of the rRNA operon in E. coli MG1655 (Kiss, Sain and Venetianer, 
1977). Therefore, despite the observed structural alterations in the secondary 
structures of rna123 and rna154, it was impossible to determine whether gentamicin 
resistance was mediated by the mutations within the 16s rRNA genes (Springer et al., 
2001).  
 
9.4 Molecular docking analysis of gentamicin  
The data presented in chapter 6, employed atomic resolution crystal structures of EF-
G bound to the 70s-ribosomal complex, to examine whether the binding of gentamicin 
was disrupted through ribosomal mutagenesis of the fusA gene (Lin et al., 2015). 
Significantly, the in silico molecular docking analysis revealed that gentamicin was 
unable to bind to the decoding region of the 70s-ribosomal complex in its pre-
translocational state, following the ribosomal mutagenesis of EF-G. Together with the 
findings from previous chapters, this undoubtedly suggested that fusA mutagenesis is 
the primary mechanism driving the evolution of gentamicin resistance in vitro.  
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9.5 Phylogenetic analysis of the fusA gene  
Chapter 7 describes the phylogenetic analysis of the fusA gene. Reconstruction of the 
fusA phylogeny revealed evolutionary conservation across the Escherichia taxa and 
Enterobacteriaceae family. The phylogenetic analysis of the fusA mutant distribution 
within the Enterobacteriaceae family, showed no evidence of convergent evolution, as 
the mutant appeared independently and was not distributed across multiple branches 
of the phylogenetic tree (Hazbon et al., 2008). The protein conservation analysis of 
EF-G, exposed positional conservation of the proline residue at codon 610 across the 
Enterobacteriaceae family, indicative of functional and structural significance 
(Ashkenazy et al., 2010). Chapter 7 was concluded, by the unsuccessful identification 
of the experimentally evolved fusA mutant genotype within the PHE collection of 
carbapenemase and ESBL producing strains of E. coli.  
The fusA mutant genotype has so far only been identified in vitro, which suggests that 
the genotype may be unable to thrive in natural and clinical settings owing to the 
presence of increased selective pressures, which were not incorporated within the 
experimental evolution model. Thus, it is likely that the resistant mutant may be 
eliminated from the population before reaching detectable limits. The work presented 
within this chapter, paved way for the investigation into the fitness costs associated 
with the mutagenesis of the fusA gene.   
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9.6 The bacterial fitness costs of gentamicin resistance 
Chapter 8 describes the fitness costs associated with the acquisition of gentamicin 
resistance. The bacterial fitness investigations confirmed biological costs associated 
with gentamicin resistance development, which were reflected in reduced growth and 
virulence of the experimentally evolved resistant strain of E. coli MG1655. 
Interestingly, it has been reported that restrictive ribosomal mutations have 
detrimental impacts on bacterial growth, colonisation and pathogenesis (Bohman et 
al., 1984; Chiou and Jones, 1995; Sander et al., 2002; Chen et al., 2013).  
Therefore, the fitness costs inferred by the resistant strain of E. coli MG1655, could 
be directly linked to the restrictive substitution of the amino acid proline within EF-G. 
The large fitness costs associated with the fusA resistant genotype, suggest bacterial 
populations carrying this mutation are likely to be outcompeted within the natural 
environment (Melnyk, Wong and Kassen, 2014).  
 
9.7 Future work  
Future work will include the study of a wide variety of antimicrobial agents with 
differing mechanisms and spectrums of activity. In addition, a more diverse range of 
microorganisms will be incorporated within the ARGP model, including clinically 
significant pathogens which appear on the antimicrobial resistance threat list 
(Ventola, 2015).  
 
To demonstrate the importance of the single amino acid alteration in EF-G in the 
generation of gentamicin resistance in E. coli, site directed mutagenesis will be 
applied to generate fusA 610T mutants which will be introduced by plasmids into 
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gentamicin-susceptible strains of E. coli (Heermann, Zeppenfeld and Jung, 2008).  
Subsequent expression analysis of the fusA mutants in the recombinant strains of E. 
coli, will determine whether the 610T mutation in the fusA gene results in gentamicin 
resistance (Besier et al., 2003). In addition, gene-inactivation techniques will be 
employed to determine whether rrn deletion strains of rna123 and rna154, can 
maintain a gentamicin resistant phenotype in E. coli MG1655 (Asai et al.,1999). 
To further enhance the computational docking, it would be of interest to determine the 
crystal structures of EF-G bound to the ribosome in complex with gentamicin (Gagnon 
et al., 2012; Lin et al., 2015). Supplementary to the structural investigations, smFRET 
could provide insights into the conformational dynamics during ribosomal 
translocation following aminoglycoside binding and fusA mutagenesis (Ha, 2001; 
Feldman et al., 2010; Petrov et al., 2012; Shebl et al., 2016). 
 
To augment the bacterial fitness analysis and to further explore the evolutionary fate 
of the fusA resistant genotype, in vitro competition assays will be conducted to 
determine the relative fitness of the resistant and sensitive strains of E. coli MG1655 
(Wiser and Lenski, 2015). 
 
9.8 Concluding remarks  
The ARGP experiments are conducted in a highly controlled laboratory environment, 
with minimal selective pressures acting on the evolving bacterial populations, which 
facilitates the identification of the core adaptive mutations governing resistance 
development in vitro. The aim of this thesis have been met as described above, 
however unfortunately due to time constraints mathematical modelling was not 
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performed. The findings presented here provide a grounded platform for the in depth 
analysis of the evolution of antimicrobial resistance. The research approach outlined 
within this thesis, will be utilised in a future CARA funded research project at Kingston 
University for the continued exploration of the evolutionary pathways to antimicrobial 
resistance in Klebsiella, Pseudomonas and Mycoplasma spp. under various 
environmental stress conditions.   
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Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1 The triphasic circle plate experiment: E. coli under trimethoprim 
selection.  Image of the preliminary triphasic circle plate experiment within a petri 
dish displaying E. coli under trimethoprim selection following three days incubation at 
37C. The image clearly demonstrates the agar dehydration between the two outer 
antimicrobial phases. The lines drawn on the triphasic plates indicate the daily 
bacterial migration.  
 
 
 
Figure A.2 The triphasic circle plate experiment: P. mirabilis under trimethoprim 
selection. The enlarged triphasic circle plate experiment within glass petri dishes. 
Displaying the daily images of P. mirabilis under trimethoprim selection over a period 
of three days (1-3) incubation at 37C. The image demonstrates the rapid resistance 
evolution in the motile organism P. mirabilis. This was apparent by the decolourisation 
in the MH media after 3 days incubation (3). The lines drawn on the triphasic plates 
indicate the daily bacterial migration.  
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Figure A.3 The triphasic circle plate experiment: E. coli under trimethoprim 
selection over 2 weeks. The enlarged triphasic circle plate experiment within glass 
petri dishes. Displaying E. coli under trimethoprim selection following one day (1) and 
14 days (14) incubation at 37C. The image demonstrates the slow migration of E. 
coli after two weeks incubation.  The growth of E. coli also appears sporadic within 
the initial phase contain no antimicrobial agent (14). The lines drawn on the triphasic 
plates indicate the daily bacterial migration. The decolourisation of the MH media was 
evident after 14 days incubation. 
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Figure A.4 The triphasic circle plate experiment: E. coli and P. mirabilis under 
trimethoprim selection in MH and M9 minimal media. The image displays a 
comparative analysis of the triphasic circle plate experiment for E. coli and P. mirabilis 
under trimethoprim selection following two days incubation at 37C within two 
different growth medium M9 minimal media (A) and MH (B). The lines drawn on the 
triphasic plates indicate the daily bacterial migration. The M9 minimal media did not 
enable the growth of the two organisms. The MH triphasic circle plates facilitated the 
growth of the two organisms, but resistance evolution proceeded at faster rates for 
the motile organism P. mirabilis.   
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Figure A.5 Gel electrophoresis image of the genomic analysis of bacterial 
motility. The gel electrophoresis image displaying the PCR reactions of the five 
strains of E. coli: MG1655, UTI89, CFT073, TPA2743 and TPA4792 (wells 2-6). The 
gel electrophoresis image indicated apparent flhDC expression in E. coli strains:  
CFT073, TPA2743 and TPA4792.  
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Figure A.6 The 0.3% 6-well plate motility assay. The phenotypic motility assay of 
the five E. coli strains (UTI89, TPA2743, CFT073, TPA4792 and MG1655) using a 
motility layer formed by MH broth solidified with 3% bacteriological agar [wt/vol]. 
Following O/N incubation at 37C the bacterial motility can be observed on the 
surface of the motility layer within the each well. 
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Figure A.7 LC-MS chromatogram 4mg/L gentamicin agar extraction. Image 
displaying the LC-MS chromatogram output of the 4mg/L Gentamicin agar extract for 
all three Gentamicin components: 1 (464.292/322.300), 2 (450.317/322.200) and 3 
(478.325/322.200) presenting LC-MS intensity over time. 
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Figure A.8 LC-MS chromatogram 8mg/L gentamicin agar extraction. Image 
displaying the LC-MS chromatogram output of the 8mg/L Gentamicin agar extract for 
all three Gentamicin components: 1 (464.292/322.300), 2 (450.317/322.200) and 3 
(478.325/322.200) presenting LC-MS intensity over time. 
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Figure A.9 LC-MS chromatogram 10mg/L gentamicin agar extraction. Image 
displaying the LC-MS chromatogram output of the 10mg/L Gentamicin agar extract 
for all three Gentamicin components: 1 (464.292/322.300), 2 (450.317/322.200) and 3 
(478.325/322.200) presenting LC-MS intensity over time. 
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Figure A.10 LC-MS chromatogram 20mg/L gentamicin agar extraction. Image 
displaying the LC-MS chromatogram output of the 20mg/L Gentamicin agar extract 
for all three Gentamicin components: 1 (464.292/322.300), 2 (450.317/322.200) and 3 
(478.325/322.200) presenting LC-MS intensity over time. 
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Figure A.11 LC-MS chromatogram 40mg/L gentamicin agar extraction. Image 
displaying the LC-MS chromatogram output of the 40mg/L Gentamicin agar extract 
for all three Gentamicin components: 1 (464.292/322.300), 2 (450.317/322.200) and 3 
(478.325/322.200) presenting LC-MS intensity over time. 
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Table A.1 MAUVE SNP export. Table displaying the nodal information of all SNPs 
within the coding regions of the sensitive and resistant genomes obtained using 
Mauve SNP export.  
 
SNP 
patter
n 
Sensitiv
e 
Contig 
Sensitiv
e 
Position 
Contig 
Sensitive 
Genome 
Wide 
Position 
Resista
nt 
Contig 
Resistant 
Position in 
Contig 
Resistant 
Genome 
Wide 
Position 
ac NODE_1
4 
1746 1062759 NODE_1
6 
1746 1060305 
tc NODE_1
4 
1786 1062799 NODE_1
6 
1786 1060345 
tc NODE_1
4 
99500 1160513 NODE_1
6 
99500 1158059 
ga NODE_1
4 
112605 1173618 NODE_6
2 
222 1171144 
ct NODE_1
4 
112609 1173622 NODE_6
2 
226 1171148 
ga NODE_1
4 
112611 1173624 NODE_6
2 
228 1171150 
ac NODE_1
4 
112613 1173626 NODE_6
2 
230 1171152 
tg NODE_1
4 
112614 1173627 NODE_6
2 
231 1171153 
tc NODE_1
4 
112615 1173628 NODE_6
2 
232 1171154 
at NODE_1
4 
112619 1173632 NODE_6
2 
236 1171158 
ga NODE_1
4 
112620 1173633 NODE_6
2 
237 1171159 
ct NODE_1
4 
112621 1173634 NODE_6
2 
238 1171160 
ca NODE_1
4 
112623 1173636 NODE_6
2 
240 1171162 
ca NODE_1
4 
112624 1173637 NODE_6
2 
241 1171163 
gt NODE_1
4 
112625 1173638 NODE_6
2 
242 1171164 
tc NODE_1
4 
112628 1173641 NODE_6
2 
244 1171166 
ta NODE_1
4 
112629 1173642 NODE_6
2 
245 1171167 
ag NODE_1
4 
112630 1173643 NODE_6
2 
246 1171168 
ac NODE_1
4 
112634 1173647 NODE_6
2 
250 1171172 
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ca NODE_1
4 
112636 1173649 NODE_6
2 
252 1171174 
tg NODE_1
4 
112638 1173651 NODE_6
2 
254 1171176 
tg NODE_1
4 
112639 1173652 NODE_6
2 
255 1171177 
tg NODE_1
4 
112640 1173653 NODE_6
2 
256 1171178 
ag NODE_1
4 
112641 1173654 NODE_6
2 
257 1171179 
ag NODE_1
4 
112642 1173655 NODE_6
2 
258 1171180 
ag NODE_1
4 
112643 1173656 NODE_6
2 
259 1171181 
ct NODE_1
4 
112645 1173658 NODE_6
2 
261 1171183 
tc NODE_1
4 
112649 1173662 NODE_6
2 
265 1171187 
ac NODE_1
4 
112652 1173665 NODE_6
2 
268 1171190 
ac NODE_1
4 
112655 1173668 NODE_6
2 
271 1171193 
ct NODE_1
4 
112657 1173670 NODE_6
2 
273 1171195 
ac NODE_1
4 
112658 1173671 NODE_6
2 
274 1171196 
gt NODE_1
4 
112661 1173674 NODE_6
2 
277 1171199 
gt NODE_1
4 
112662 1173675 NODE_6
2 
278 1171200 
gt NODE_1
4 
112665 1173678 NODE_6
2 
280 1171202 
ga NODE_1
4 
112666 1173679 NODE_6
2 
281 1171203 
ta NODE_1
4 
112669 1173682 NODE_6
2 
284 1171206 
ac NODE_1
4 
112670 1173683 NODE_6
2 
285 1171207 
ga NODE_1
4 
112686 1173699 NODE_6
2 
299 1171221 
cg NODE_1
4 
112698 1173711 NODE_6
2 
303 1171225 
ag NODE_1
4 
112702 1173715 NODE_6
2 
307 1171229 
at NODE_1
4 
112704 1173717 NODE_6
2 
309 1171231 
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ta NODE_1
4 
112705 1173718 NODE_6
2 
310 1171232 
gt NODE_1
4 
112707 1173720 NODE_6
2 
312 1171234 
ca NODE_1
4 
112708 1173721 NODE_6
2 
313 1171235 
ac NODE_1
4 
112709 1173722 NODE_6
2 
314 1171236 
ta NODE_1
4 
112711 1173724 NODE_6
2 
316 1171238 
ag NODE_1
4 
112717 1173730 NODE_6
2 
322 1171244 
tg NODE_1
4 
112718 1173731 NODE_6
2 
323 1171245 
ct NODE_1
4 
112721 1173734 NODE_6
2 
326 1171248 
tc NODE_1
4 
112723 1173736 NODE_6
2 
328 1171250 
gt NODE_1
4 
112724 1173737 NODE_6
2 
329 1171251 
ct NODE_1
4 
112729 1173742 NODE_6
2 
336 1171258 
gt NODE_1
4 
112731 1173744 NODE_6
2 
338 1171260 
ct NODE_1
4 
112732 1173745 NODE_6
2 
339 1171261 
ca NODE_1
4 
112733 1173746 NODE_6
2 
340 1171262 
ta NODE_1
4 
112734 1173747 NODE_6
2 
341 1171263 
ca NODE_1
4 
112739 1173752 NODE_6
2 
346 1171268 
at NODE_1
4 
112744 1173757 NODE_6
2 
350 1171272 
ga NODE_1
4 
112745 1173758 NODE_6
2 
351 1171273 
ct NODE_1
4 
112746 1173759 NODE_6
2 
352 1171274 
ac NODE_1
4 
112748 1173761 NODE_6
2 
354 1171276 
ag NODE_1
4 
112750 1173763 NODE_6
2 
356 1171278 
ag NODE_1
4 
112753 1173766 NODE_6
2 
359 1171281 
ac NODE_1
4 
112754 1173767 NODE_6
2 
360 1171282 
  
 
 
395 
at NODE_1
4 
112755 1173768 NODE_6
2 
361 1171283 
ga NODE_1
4 
112758 1173771 NODE_6
2 
364 1171286 
ta NODE_1
4 
112759 1173772 NODE_6
2 
365 1171287 
gt NODE_1
4 
112760 1173773 NODE_6
2 
366 1171288 
at NODE_1
4 
112766 1173779 NODE_6
2 
377 1171299 
gt NODE_1
4 
112769 1173782 NODE_6
2 
380 1171302 
ct NODE_1
4 
112770 1173783 NODE_6
2 
381 1171303 
at NODE_1
4 
112772 1173785 NODE_6
2 
383 1171305 
cg NODE_1
4 
112773 1173786 NODE_6
2 
384 1171306 
ag NODE_1
4 
112774 1173787 NODE_6
2 
385 1171307 
at NODE_1
4 
112776 1173789 NODE_6
2 
387 1171309 
at NODE_1
4 
112780 1173793 NODE_6
2 
391 1171313 
gt NODE_1
4 
112782 1173795 NODE_6
2 
393 1171315 
gt NODE_1
4 
112787 1173800 NODE_6
2 
402 1171324 
tc NODE_1
4 
112788 1173801 NODE_6
2 
403 1171325 
tc NODE_1
4 
112789 1173802 NODE_6
2 
404 1171326 
ag NODE_1
4 
112790 1173803 NODE_6
2 
405 1171327 
ga NODE_1
4 
112793 1173806 NODE_6
2 
408 1171330 
tc NODE_1
4 
112795 1173808 NODE_6
2 
413 1171335 
ta NODE_1
4 
112798 1173811 NODE_6
2 
416 1171338 
ag NODE_1
4 
112800 1173813 NODE_6
2 
418 1171340 
ca NODE_1
4 
112801 1173814 NODE_6
2 
419 1171341 
ta NODE_1
4 
112802 1173815 NODE_6
2 
420 1171342 
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ct NODE_1
4 
112804 1173817 NODE_6
2 
422 1171344 
ga NODE_1
4 
112805 1173818 NODE_6
2 
423 1171345 
tc NODE_1
4 
112807 1173820 NODE_6
2 
425 1171347 
tc NODE_1
4 
112810 1173823 NODE_6
2 
428 1171350 
ga NODE_1
4 
112811 1173824 NODE_6
2 
429 1171351 
ag NODE_1
4 
112812 1173825 NODE_6
2 
430 1171352 
gt NODE_1
4 
112818 1173831 NODE_6
2 
436 1171358 
ac NODE_1
4 
112821 1173834 NODE_6
2 
439 1171361 
ga NODE_2
0 
59648 1234726 NODE_2
0 
59759 1232510 
tg NODE_2
0 
59719 1234797 NODE_2
0 
59830 1232581 
tc NODE_2
0 
59848 1234926 NODE_2
0 
59959 1232710 
tg NODE_2
0 
59849 1234927 NODE_2
0 
59960 1232711 
ta NODE_2
0 
59872 1234950 NODE_2
0 
59983 1232734 
ag NODE_2
0 
59912 1234990 NODE_2
0 
60023 1232774 
ag NODE_2
0 
59919 1234997 NODE_2
0 
60030 1232781 
ct NODE_2
0 
59928 1235006 NODE_2
0 
60039 1232790 
ga NODE_2
0 
59944 1235022 NODE_2
0 
60055 1232806 
ga NODE_2
0 
59950 1235028 NODE_2
0 
60061 1232812 
tg NODE_2
0 
59972 1235050 NODE_2
0 
60083 1232834 
at NODE_2
0 
60010 1235088 NODE_2
0 
60121 1232872 
ag NODE_2
0 
60446 1235524 NODE_2
0 
60557 1233308 
gt NODE_1
5 
620 3406523 NODE_1
5 
620 3404619 
tg NODE_2 113054 4232928 NODE_2 113254  4229015 
gc NODE_5
5 
91 4562477 NODE_5
5 
91 4558564 
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gc NODE_5
5 
1277 4563663 NODE_5
5 
1277 4559750 
ga NODE_5
5 
1278 4563664 NODE_5
5 
1278 4559751 
ct NODE_5
5 
1285 4563671 NODE_5
5 
1285 4559758 
ct NODE_5
5 
1285 4563671 NODE_5
5 
1285 4559758 
gt NODE_5
7 
31 4565444 NODE_5
8 
224 4561724 
at NODE_5
7 
90 4565503 NODE_5
8 
283 4561783 
at NODE_5
7 
1891 4567304 NODE_5
8 
2084 4563584 
tc NODE_5
7 
1893 4567306 NODE_5
8 
2086 4563586 
tc NODE_5
7 
1894 4567307 NODE_5
8 
2087 4563587 
ac NODE_5
7 
1898 4567311 NODE_5
8 
2091 4563591 
ta NODE_5
7 
1907 4567320 NODE_5
8 
2100 4563600 
tc NODE_5
7 
1909 4567322 NODE_5
8 
2102 4563602 
ta NODE_5
7 
1910 4567323 NODE_5
8 
2103 4563603 
ga NODE_5
9 
680 4568505 NODE_5
9 
680 4564289 
tg NODE_5
9 
975 4568800 NODE_5
9 
975 4564584 
tg NODE_6
1 
1 4569899 NODE_6
0 
1 4565683 
cg NODE_6
1 
2 4569900 NODE_6
0 
2 4565684 
ct NODE_6
1 
3 4569901 NODE_6
0 
3 4565685 
ac NODE_6
1 
8 4569906 NODE_6
0 
8 4565690 
gc NODE_6
1 
9 4569907 NODE_6
0 
9 4565691 
cg NODE_6
1 
10 4569908 NODE_6
0 
10 4565692 
ga NODE_6
1 
21 4569919 NODE_6
0 
15 4565697 
ga NODE_6
1 
23 4569921 NODE_6
0 
17 4565699 
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ta NODE_6
1 
25 4569923 NODE_6
0 
19 4565701 
tc NODE_6
1 
30 4569928 NODE_6
0 
25 4565707 
ag NODE_6
1 
31 4569929 NODE_6
0 
26 4565708 
tc NODE_6
1 
33 4569931 NODE_6
0 
28 4565710 
cg NODE_6
1 
38 4569936 NODE_6
0 
33 4565715 
tc NODE_6
1 
39 4569937 NODE_6
0 
34 4565716 
tc NODE_6
1 
44 4569942 NODE_6
0 
39 4565721 
cg NODE_7
0 
319 4580401 NODE_6
3 
1375 4569052 
ca NODE_7
0 
345 4580427 NODE_6
3 
1401 4569078 
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Table A.2 CD-Hit export non-identical proteins in the sensitive strain. The CD-Hit 
analysis export displaying the protein sequences of the non-identical proteins within 
the sensitive strain of E. coli MG1655. 
 
CD-Hit Non-Identical Proteins Sensitive Strain 
>sensitive_hypothetical protein 
MDEQWGYVGAKSRQRWLFYAYDRLRKTVVAHVFGERTMATLGRLMSLLSPFDV
VIWMTDGWPLYESRLKGKLHVISKRYTQRIERYNLNLRQHLARLGRKSLSFSKSV
ELHDKVIGHYLNIKHYQ 
>sensitive_hypothetical protein 
MASVSISCPSCSATDGVVRNGKSTAGHQRYLCSHCRKTWQLQFTYTASQPGTH
QKIIDMAMNGVGCRATARIMGVGLNTIFRHLKNSGRSR 
> sensitive_hypothetical protein 
MWPDNRIARDAHYLYRYDRHGRLTEKTDLIPEGVIRTDDERTHRYHYDSQHRLVH
YTRTQYAEPLVESRYLYDPLGRRVAKRVWRRERDLTGWMSLSRKPQVTWYGWD
GDRLTTIQNDRTRIQTIYQPGSFTPLIRVETATGELAKTQRRSLADTLQQSGGEDG
GSVVFPPVLVQMLDRLESEILADRVSEESRRWLASCGLTVEQMQNQMDPVYTPA
RKIHLYHCDHRGLPLALVSTEGATEWCAEYDEWGNLLNEENPHQLQQLIRLPGQ
QYDEESGLYYNRHRYYDPLQGRYITQDPIGLKGGWNFYQYPLNPVQYIDSMGLA
SKYGHLNNGGYGARPNKPPTPDPSKLPDIAKQLRLPYPIDQASSAPNVFKTFFRAL
SPYDYTLYCRKWVKPNLTCTPQDDSQYPGMDTKTASDYLPQTNWPTTQLPPGYT
CAEPYLFPDINKPDGPATAGIDDLGEILAKMKQRTSRGIRK 
>sensitive_putative deoxyribonuclease RhsB 
MVAHRHTGRPEICYRYDSDGRVTEQLNPAGLSYTYQYEKDRITITDSLNRREVLHT
QGEGGLKRVVKKEHADGSVTQSQFDAVGRLRAQTDAAGRTTEYSPDVVTGLITRI
TTPDGRASAFYYNHHSQLTSATGPDGLEIRREYDEWGRLIQETAPDGDITRYRYD
NPHSDLPCATEDATGSRKTMTWSRYGQLLSFTDCSGYVTRYDHDRFGQVTAVH
REEGLSQYRAYDSRGQLIAVKDTQGHETRYEYNAAGDLTTVIAPDGSRNGTQYD
AWGKAICTTQGGLTRSMEYDAAGRVIRLTSENGSHTTFRYDVLDRLIQETGFDGR
TQRYHHDLTGKLIRSEDEGLVTHWHYDEADRLTHRTVNGETAERWQYDERGWL
TDISHISEGHRVTVHYGYDSKGRLASEHLTVHHPQTNELLWQHETRHAYNAQGLA
NRCIPDSLPAVEWLTYGSGWLSGMKLGDTPLVEYTRDRLHRETLRSFGRYELTTA
YTPAGQLQSQHLNSLLSDRDYTWNDNGELIRISSPRQTRSYSYSTTGRLTGVHTT
AANLDIRIPYTTDPAGNRLPDPELHPDSALSMWPDNRIARDAHYLYRYDRHGRLT
EKTDLIPEGVIRTDDERTHRYHYDSQHRLVHYTRTQYAEPLVESRYLYDPLGRRV
AKRVWRRERDLTGWMSLSRKPQVTWYGWDGDRLTTIQNDRTRIQTIYQPGSFTP
LIRVETATGELAKTQRRSLADTLQQSGGEDGGSVVFPPVLVQMLDRLESEILADR
VSEESRRWLASCGLTVAQMQSQMDPVYTPARKIHLYHCDHRGLPLALISTEGTTA
WYAEYDEWGNLLNEENPHQLQQLIRLPGQQYDEESGLYYNRHRYYDPLQGRYIT
QDPIGLKGGWNFYQYPLNPISNIDPLGLETLKCIKPLHSMGGTGERSGPDIWGNPF
YHQYLCVPDGKGDYTCGGQDQRGESKGDGLWGPGKASNDTKEAAGRCDLVET
DNSCVENCLKGKFKEVRPRYSVLPDIFTPINLGLFKNCQDWSNDSLETCKMKCSG
NNIGRFIRFVFTGVM 
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>sensitive_Putative deoxyribonuclease RhsC 
MVAHRHTGRPEIRYRYDSDGRVTEQLNPAGLSYTYQYEKDRITITDSLDRREVLHT
QGEAGLKRVVKKEHADGSVTQSQFDAVGRLRAQTDAAGRTTEYSPDVVTGLITRI
TTPDGRASAFYYNHHNQLTSATGPDGLELRREYDELGRLIQETAPDGDITRYRYD
NPHSDLPCATEDATGSRKTMTWSRYGQLLSFTDCSGYVTRYDHDRFGQMTAVH
REEGLSQYRAYDSRGQLIAVKDTQGHETRYEYNIAGDLTAVIAPDGSRNGTQYDA
WGKAVRTTQGGLTRSMEYDAAGRVIRLTSENGSHTTFRYDVLDRLIQETGFDGRT
QRYHHDLTGKLIRSEDEGLVTHWHYDEADRLTHRTVKGETAERWQYDERGWLT
DISHISEGHRVAVHYRYDEKGRLTGERQTVHHPQTEALLWQHETRHAYNAQGLA
NRCIPDSLPAVEWLTYGSGYLAGMKLGDTPLVEYTRDRLHRETLRSFGRYELTTA
YTPAGQLQSQHLNSLLSDRDYTWNDNGELIRISSPRQTRSYSYSTTGRLTGVHTT
AANLDIRIPYATDPAGNRLPDPELHPDSTLSMWPDNRIARDAHYLYRYDRHGRLT
EKTDLIPEGVIRTDDERTHRYHYDSQHRLVHYTRTQYEEPLVESRYLYDPLGRRV
AKRVWRRERDLTGWMSLSRKPQVTWYGWDGDRLTTIQNDRTRIQTIYQPGSFTP
LIRVETATGELAKTQRRSLADALQQSGGEDGGSVVFPPVLVQMLDRLESEILADR
VSEESRRWLASCGLTVEQMQNQMDPVYTPARKIHLYHCDHRGLPLALISKEGTTE
WCAEYDEWGNLLNEENPHQLQQLIRLPGQQYDEESGLYYNRHRYYDPLQGRYIT
QDPIGLKGGWNFYQYPLNPVTNTDPLGLEVFPRPFPLPIPWPKSPAQQQADDNA
AKALTKWWNDTASQRIFDSLILNNPGLALDITMIASRGNVADTGITDRVNDIINDRF
WSDGKKPDRCDVLQELIDCGDISAKDAKSTQKAWNCRHSRQSNDKKR 
>sensitive_ATP synthase gamma chain 
MAGAKEIRSKIASVQNTQKITKAMEMVAASKMRKSQDRMAASRPYAETMRKVIGH
LAHGNLEYKHPYLEDRDVKRVGYLVVSTDRGLCGGLNINLFKKLLAEMKTWTDKG
VQCDLAMIGSKGVSFFNSVGGNVVAQVTGMGDNPSLSELIGPVKVMLQAYDEGR
LDKLYIVSNKFINTMSQVPTISQLLPLPASDDDDLKHKSWDYLYEPDPKALLDTLLR
RYVESQVYQGVVENLASEQAARMVAMKAATDNGGSLIKELQLVYNKARQASITQ
ELTEIVSGAAAV 
>sensitive_putative major fimbrial subunit LpfA 
MFALAGNKWNTTLPGGNMQFQGVIIAETCRIEAGDKQMTVNMGQISSNRFHAVG
EDSAPVPFVIHLRECSTVVSERVGVAFHGVADGKNPDVLSVGEGPGIATNIGVALF
DDEGNLVPINRPPANWKRLYSGSTSLHFIAKYRATGRRVTGGIANAQAWFSLTYQ 
>sensitive_hypothetical protein 
MHRIDTKTAQKDKFGAGKNGFTRGNPQTGTPATDLDDDYFDMLQEELCSVVEAS
GASLEKGRHDQLLTALRALLLSRKNPFGDIKSDGTVQTALENLGLGEGSALPVGV
PVPWPSATPPTGWLKCNGAAFSAEEYPELAKAYPTNKLPDLRGEFIRGWDDGRG
IDTGRSILSIQGYATEDHAHGLPSRSTIVTDATINFYFDEIWVNSGTDIIKRGNTNDA
GLPAPDYGTFKTYKQSVDGLGAAASETRPRNIAFNYIVRAA 
>sensitive_Small toxic polypeptide LdrD 
MTLAQFAMTFWHDLAAPILAGIITAAIVSWWRNRK 
>sensitive_hypothetical protein 
MASVSISCPSCSATDGVVRNGKSTAGHQRYLCSHCRKTWQLQFTYTASQPGTH
QKIIDMAMNGVGCRATARIMGVGLNTIFRHLKNSGRSR 
>sensitive_hypothetical protein 
MDEQWGYVGAKSRQRWLFYAYDRLRKTVVAHVFGERTMATLGRLMSLLSPFDV
VIWMTDGWPLYESRLKGKLHVISKRYTQRIERHNLNLRQHLARLGRKSLSFSKSV
EQHDKVIGHYLNIKHYQ 
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>sensitive_hypothetical protein 
MDEQWGYVGAKSRQRWLFYAYDSLRKTVVAHVFGERTMATLGRLMSLLSPFDV
VIWMTDGWPLYESRLKGKLHVISKRYTQRIERHNLNLRQHLARLGRKSLSFSKSV
ELHDKVIGHYLNIKHYQ 
>sensitive_HTH-type transcriptional regulator ArcR 
MKLFSLLSETQCQHIEYNMALTSKLAKERVTKILRYLCQTVGYDHDEFYEIKHFMTI
QLLSDMAGISRETTSHIINELREEKILFKNSKNWLVSKDL 
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Table A.3 CD-Hit export non-identical proteins in the resistant strain. The CD-Hit 
analysis export displaying the protein sequences of the non-identical proteins within 
the resistant strain of E. coli MG1655. 
 
CD-Hit Non-Identical Proteins Resistant Strain 
>resistant_Putative deoxyribonuclease RhsC 
MVFPPVLVQMLDRLESEILADRVSEESRRWLASCGLTVEQMQNQMDPVYTPARK
IHLYHCDHRGLPLALVSTEGATEWCAEYDEWGNLLNEENPHQLQQLIRLPGQQY
DEESGLYYNRHRYYDPLQGRYITQDPIGLKGGWNFYQYPLNPVQYIDSMGLASKY
GHLNNGGYGARPNKPPTPDPSKLPDIAKQLRLPYPIDQASSAPNVFKTFFRALSPY
DYTLYCRKWVKPNLTCTPQDDSQYPGMDTKTASDYLPQTNWPTTQLPPGYTCAE
PYLFPDINKPDGPATAGIDDLGEILAKMKQRTSRGIRK 
>resistant_Ethanolamine utilization protein EutM 
MNGPVLDPDKEESTMEALGMIETRGLVALIEASDAMVKAARVKLVGVKQIGGGLC
TAMVRGDVAACKAATDAGAAAAQRIGELVSVHVIPRPHGDLEEVFPIGLKGDSSN
L 
>resistant_Putative deoxyribonuclease RhsC 
MVFPPVLVQMLDRLESEILADRVSEESRRWLASCGLTVEQMQNQMDPVYTPARK
IHLYHCDHRGLPLALISKEGTTEWCAEYDEWGNLLNEENPHQLQQLIRLPGQQYD
EESGLYYNRHRYYDPLQGRYITQDPIGLKGGWNFYQYPLNPVTNTDPLGLEVFPR
PFPLPIPWPKSPAQQQADDNAAKALTKWWNDTASQRIFDSLILNNPGLALDITMIA
SRGNVADTGITDRVNDIINDRFWSDGKKPDRCDVLQELIDCGDISAKDAKSTQKA
WNCRHSRQSNDKKR 
>resistant_ATP synthase gamma chain 
MAGAKEIRSKIASVQNTQKITKAMEMVAASKMRKSQDRMAASRPYAETMRKVIGH
LAHGNLEYKHPYLEDRDVKRVGYLVVSTDRGLCGGLNINLFKKLLAEMKTWTDKG
VQCDLAMIGSKGVSFFNSVGGNVVAQVTGMGDNPSLSELIGPVKVMLQAYDEGR
LDKLYIVSNKFINTMSQVPTISQLLPLPASDDDDLKHKSWDYLYEPDPKALLDTLLR
RYVESQVYQGVVENLASEQAARYGGDESRDRQWRQPD 
>resistant_Maltodextrin glucosidase 
MMLNAWHLPVPPFVKQSKDQLLITLWLTGEDPPQRIMLRTEHDNEEMSVPMHKQ
RSQPQPGVTAWRAAIDLSSGQPRRRYSFKLLWHDRQRWFTPQGFSRMPPARLE
QFAVDVPDIGPQWAADQIFYQIFPDRFARSLPREAEQDHVYYHHAAGQEIILRDW
DEPVTAQAGGSTFYGGDLDGISEKLPYLKKLGVTALYLNPVFKAPSVHKYDTEDY
RHVDPQFGGDGALLRLRHNTQQLGMRLVLDGVFNHSGDSHAWFDRHNRGTGG
ACHNPESPWRDWYSFSDDGTALDWLGYASLPKLDYQSESLVNEIYRGEDSIVRH
WLKAPWNMDGWRLDVVHMLGEAGGARNNMQHVAGITEAAKETQPEAYIVGEHF
GDARQWLQADVEDAAMNYRGFTFPLWGFLANTDISYDPQQIDAQTCMAWMDNY
RAGLSHQQQLRMFNQLDSHDTARFKTLLGRDIARLPLAVVWLFTWPGVPCIYYGD
EVGLDGKNDPFCRKPFPWQVEKQDTALFALYQRMIALRKKSQALRHGGCQVLYA
EDNVVVFVRVLNQQRVLVAINRGEACEVVLPASPFLNAVQWQCKEGHGQLTDGIL
ALPAISATVWMN 
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>resistant_Elongation factor G 
MARTTPIARYRNIGISAHIDAGKTTTTERILFYTGVNHKIGEVHDGAATMDWMEQE
QERGITITSAATTAFWSGMAKQYEPHRINIIDTPGHVDFTIEVERSMRVLDGAVMV
YCAVGGVQPQSETVWRQANKYKVPRIAFVNKMDRMGANFLKVVNQIKTRLGANP
VPLQLAIGAEEHFTGVVDLVKMKAINWNDADQGVTFEYEDIPADMVELANEWHQN
LIESAAEASEELMEKYLGGEELTEAEIKGALRQRVLNNEIILVTCGSAFKNKGVQAM
LDAVIDYLPSPVDVPAINGILDDGKDTPAERHASDDEPFSALAFKIATDPFVGNLTF
FRVYSGVVNSGDTVLNSVKAARERFGRIVQMHANKREEIKEVRAGDIAAAIGLKDV
TTGDTLCDPDAPIILERMEFPEPVISIAVEPKTKADQEKMGLALGRLAKEDPSFRV
WTDEESNQTIIAGMGELHLDIIVDRMKREFNVEANVGKPQVAYRETIRQKVTDVEG
KHAKQSGGRGQYGHVVIDMYPLEPGSNPKGYEFINDIKGGVIPGEYIPAVDKGIQE
QLKAGPLAGYPVVDMGIRLHFGSYHDVDSSELAFKLAASIAFKEGFKKAKTVLLEPI
MKVEVETPEENTGDVIGDLSRRRGMLKGQESEVTGVKIHAEVPLSEMFGYATQLR
SLTKGRASYTMEFLKYDEAPSNVAQAVIEARGK 
>resistant_DNA-binding transcriptional repressor YiaJ 
MIFYCALSIGRVFSATIKTCPNVHQVHHVVLTIEMSINMQNNEQTEYKTVRGLTRGL
MLLNMLNKLDGGASVGLLAELSGLHRTTVRRLLETLQEEGYVRRSPSDDSFRLTIK
VRQLSEGFRDEQWISALAAPLLGDLLREVVWPTDVSTLDVDAMVVRETTHRFSRL
SFHRAMVGRRLPLLKTASGLTWLAFCPEQDRKELIEMLASRPGDDYQLAREPLKL
EAILARARKEGYGQNYRGWDQEEKIASIAVPLRSEQRVIGCLNLVYMASAMTIEQA
AEKHLPALQRVAKQIEEGVESQAILVAGRRSGMHLR 
>resistant_Galactoside O-acetyltransferase 
MNMPMTERIRAGKLFTDMCEGLPEKRLRGKTLMYEFNHSHPSEVEKRESLIKEMF
ATVGENAWVEPPVYFSYGSNIHIGRNFYANFNLTIVDDYTVTIGDNVLIAPNVTLSV
TGHPVHHELRKNGEMYSFPITIGNNVWIGSHVVINPGVTIGDNSVIGAGSIVTKDIP
PNVVAAGVPCRVIREINDRDKHYYFKDYKVESSV 
>resistant_hypothetical protein 
MLYFSGLGLSVSDSANPVHHYGHVQGGYSVPLIITASDITSHQPVSRKISARHFAGI
FQWMTGICTENIPPFNPLTDEDN 
>resistant_Putative deoxyribonuclease RhsC 
MVFPPVLVQMLDRLESEILADRVSEESRRWLASCGLTVEQMQNQMDPVYTPARK
IHLYHCDHRGLPLALISTEGATAWCAEYDEWGNLLNEENPHQLQQLIRLPGQQYD
EESGLYYNRHRYYDPLQGRYITQDPIGLKGGWNLYGYQLNPISDIDPLGLSMWED
AKSGACTNGLCGTLSAMIGPDKFDSIDSTAYDALNKINSQSICEDKEFAGLICKDNS
GRYFSTAPNRGERKGSYPFNSPCPNGTEKVSAYHTHGADSHGEYWDEIFSGKDE
KIVKSKDNNIKSFYLGTPSGNFKAIDNHGKEITNRKGLPNVCRVHGNM 
>resistant_DNA translocase SpoIIIE 
MELSKTPHMLISGLTGSGKSYSMYYLMYSLILKGHEVFVIDRKQVLTKFGTVIGND
HVADENPNESEQIFELIERVNNIMLKRQKILKNDDRFKKDIEAGFQNANWNNICLVI
DELGALTQDLAMMKKAERDRFYSALGNIAMKGRNTGVSLMISLQQANAQSFNGT
GIRDQLSFKMVLGNSDRQTREVLFSSQDISDVKLKPGQAFYTKADTRNKPGFLFM
PTFDFELTIPNLEKLIELQNRDKRSFMPRKFIEVEKNP 
>resistant_Serine recombinase PinR 
MSQIFAYCRISTLDQTTENQRREIESAGFKIKPQQIIEEHISGSAATSERPGFNRLLA
RLKCGDQLIVTKLDRLGCNAMDIRKTVEQLTETGIRVHCLALGGIDLTSPTGKMMM
QVISAVAEFERDLLLERTHSGIVRARGAGKRFGRPPVLNEEQKQVVFERIKSGVSI
SAIAREFKTSRQTILRAKAKLQTPDI 
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>resistant_hypothetical protein 
MLPEQCFRLRVMHRLTLTGQPAFLIIPVMHRHPVPFADMADVCQPATFVILPPLCG
FTLHGAVREAVCFVIVPVGDQTLILAADKFAGQVVVITLCAAVKAGFLYQPVKYIVT
EGGVAAVFTGQADDPSGSIVFHTAR 
>resistant_hypothetical protein 
MEEYYSIKDVANICNKNKSSVSRKLTNLCFEIMNDDFDMHFKKQKGYNNIEQFFFN
EYAVKYIISLFYKDLDYNIIKDMPLNQVLKKINTTKINTKLSNIEILIDLVSNPNSDTIDIL
NTISNIKSDFNKLNDEINLLKSLENEHKKDLAHMDFWIDKQNEEIDFLKNEILKRLKK
D 
>resistant_hypothetical protein 
MSFRLSDNQLKNMLNATHSEIYELMNSQCNDISHFDLEVISNIELPIDYRKNLSLLF
ELLKFEKSLIEIYLKLVNVYSQNDDLFNYDLKNNRRELKGQLEKIDLRISELSKGYIQ
FLEYENGV 
>resistant_hypothetical protein 
MCEENYEDNIYESEKFINIENVDDIKKEVIIFFIQLGKYFENEQNEAFKNLSDENKMN
IFDVLNVIYPNIKKLFDNVNNITVCLLYTSPSPRDRTRSRMPSSA 
>resistant_hypothetical protein 
MLPEQFIRLRMMHRQVFTGEAAFTVITIVHRHPVPFADMADVCQPAAFVILPPLCG
FAIHGAVREAVCFVIVPVGDQPLILAADKFAGQVVVITLCAAVKAGFLYQPVEYIVT
EGGVAAVFTGQADDPSGSIVFHTARQTALRGTDGFSPRIVLCPVSAAVRGNDGG
QVTGGVVFIPRFMALRVFHGN 
>resistant_Putative deoxyribonuclease RhsC 
MVFPPVLVQMLDRLESEILADRVSEESRRWLASCGLTVAQMQSQMDPVYTPARK
IHLYHCDHRGLPLALISTEGTTAWYAEYDEWGNLLNEENPHQLQQLIRLPGQQYD
EESGLYYNRHRYYDPLQGRYITQDPIGLKGGWNFYQYPLNPISNIDPLGLETLKCI
KPLHSMGGTGERSGPDIWGNPFYHQYLCVPDGKGDYTCGGQDQRGESKGDGL
WGPGKASNDTKEAAGRCDLVETDNSCVENCLKGKFKEVRPRYSVLPDIFTPINLG
LFKNCQDWSNDSLETCKMKCSGNNIGRFIRFVFTGVM 
>resistant_hypothetical protein 
MPGLKGLDNFVKFDVKSFLEKKELVFISCEKNYEKKLDEEGRKVPDINKPRGLKFE
INIDKDDTIYSIYDFNSKERKEEKGSNFRKSITVWINNPKLEPEKFDNFAPGDKIFLK
GVDEVETMQMTSHLIIVADNIVKVEKNEQQLPKQ 
>resistant_hypothetical protein 
MLQRPADAPPEMQTQPMASVLRDLDIYSVRLEALRGHFWGCMDRCKALALLERP
ARSPEVNTHAGREYDLWVWMPQLSVGTLVEP 
>resistant_hypothetical protein 
MRAHQHRDITRLHRAPTQHRFARTRLDQGLVDRSDAGLGRCLTRGIGTPRLVTPA
AQHAQGECLGGVAVVQIVLIGAHATGTHPLELDVRLEEGVLTPVVVQRLKRAQH 
>resistant_hypothetical protein 
MSFEVLLASFGLDGNHGLARLGAVVHALDVGGTTVPEAGGFVAILAGARKRLADD
DALLTEIGSVLDSLYAHFSGSRKPS 
>resistant_hypothetical protein 
MLLTQPFFKQFTTKPIADARSQTEVITCLSADSRKAVDVMVDKALAAGASEPQPAR
DYGFMYQRGFQDLDGHLWEIAHMDGEPG 
>resistant_hypothetical protein 
MPSSRFFAGAYPCCGWRGARTNLLLQVSLDAEQRAPAIVQLGTLLQWQLEPLDY
LEQVLAGVPEPVLLDRVLQILASDVPDGARCGVP 
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>resistant_PTS system fructose-specific EIIB component 
MSLNLAKPAGVTLDIATVEQAAEKLNSGKLDHKKVMVVLGNTAETLALVEKVPGIS
AINYGGLPQKEGARQFGKAIYLTEEEIAHSRALKEKGIRLEMRQVPAHSAELLNDQ
L 
>resistant_UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
MALNCVADGVGVINETIFENRFMHVNELLRLGADIQVEGHTAIVRGSEHLSGAPVM
ATDLRASASLILAGLMASGETTIDRIYHLDRGYENIEEKLSSLGATIRRVP 
>resistant_hypothetical protein 
MAVTERQQFGDFFQAEAQRLGAADEAQPAQVLLTEDAVAPGRACRRGQQLLAF
VVAHRIDRHAGLACQLTNVHGGFLRMLPLIVKP 
>resistant_hypothetical protein 
MNIESIEMISITIIFVILISLATFIIDKMNWWGGVKKTLFIMWNIVCAIFILLGTLVSLIFIV
FTAMLFASGD 
>resistant_NADP-dependent alcohol dehydrogenase C 
MRRSLAGSNIGGIAETQEMLNFCAEHGVTPEIELIEPDYINDAYERVLASDVRYRFV
IDISL 
>resistant_hypothetical protein 
MHLVDGQAERVAVQVLAGIGEAVGQVDEVRDGFLQHLEVGNPRDLAQRLCCHP
HGTVELADGGQPRFQAPVEAFVLEEEARLFNLDQRESLTIHALADPEEGVV 
>resistant_Lactose operon repressor 
MPGEKSVIGYDDTYESSFFYPALSTVSLDLDLQGKEAVRRILASTSGAPHTSSILPA
RLVIRHSSGARIEQGKDLQAIAEQLRAIAHRLAP 
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Figure A.12 Mountain plot representation of the rRNA secondary structure 
analysis using RNA fold.  Displaying the base pair probabilities based on the 
genomic position for the sensitive (A) and resistant (B) 16s rRNA genes rna 123and 
154 secondary structures predicted using RNA fold. There were apparent differences 
in the centroid secondary structure predictions between the sensitive and resistant 
strains of E. coli MG1655.  
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Figure A.13 Secondary structure analysis of rRNA 86 using RNA fold. Displaying 
the centroid structure image of the rRNA 86 gene in gentamicin sensitive (A) and 
resistant (B) strains of E. coli MG1655.There was no apparent difference in the 
centroid secondary structure predictions between the sensitive and resistant strains.  
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Figure A.14 Secondary structure analysis of rRNA 3 using RNA fold. Displaying 
the centroid structure image of the rRNA 3 gene in gentamicin sensitive (A) and 
resistant (B) strains of E. coli MG1655. There was no apparent difference in the 
centroid secondary structure predictions between the sensitive and resistant strains. 
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Figure A.15 Secondary structure analysis of rRNA 134 using RNA fold. 
Displaying the centroid structure image of the rRNA 134 gene in gentamicin sensitive 
(A) and resistant (B) strains of E. coli MG1655. There was no apparent difference in 
the centroid secondary structure predictions between the sensitive and resistant 
strains. 
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Figure A.16 Secondary structure analysis of rRNA 146 using RNA fold. 
Displaying the centroid structure image of the rRNA 146 gene in gentamicin sensitive 
(A) and resistant (B) strains of E. coli MG1655. There was no apparent difference in 
the centroid secondary structure predictions between the sensitive and resistant 
strains. 
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Figure A.17 Secondary structure analysis of rRNA 156 using RNA fold. 
Displaying the centroid structure image of the rRNA 156 gene in gentamicin sensitive 
(A) and resistant (B) strains of E. coli MG1655. There was no apparent difference in 
the centroid secondary structure predictions between the sensitive and resistant 
strains. 
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Figure A.18 Gel electrophoresis image of the genomic analysis of genes with 
mutations. 2% w/v Top Vision Agarose gel electrophoresis image displaying the EF-
G (1.), rRNA 123 (2.) and rRNA 154 (3.) PCR reactions. Five colonies were selected 
at three antibiotic concentrations (0, MIC, X10MIC) for each of the mutated genes 
(lanes 1-15 respectively). 2Kb DNA ladder (lane M) was used as standard. All 
colonies were successfully amplified for the three genes selected at the three 
antimicrobial concentrations.   
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Figure A.21 Phylogenetic analysis of fusA within the Escherichia genus. iTOL 
image displaying the ML tree of the fusA gene within the Escherichia genus 
constructed using PhyML with a bootstrap of 1000. The E. coli MG1655 sensitive and 
resistant strains have been highlighted in yellow. 
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Figure A.25 Manual exponential growth analysis of E. coli MG1655 WT strain. 
Displaying the exponential growth curve of the E. coli MG1655 WT strain in MH broth 
at 37ºC. All five colonies (C1-C5) were grown within conical flasks and the OD600 
values were measured using a spectrophotometer. 
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Figure A.26 Manual exponential growth analysis of E. coli MG1655 MIC strain. 
Displaying the exponential growth curve of the E. coli MG1655 MIC strain in MH broth 
at 37ºC. All five colonies (C1-C5) were grown within conical flasks and the OD600 
values were measured using a spectrophotometer. 
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Figure A.27 Manual exponential growth analysis of E. coli MG1655 x10MIC 
strain. Displaying the exponential growth curve of the E. coli MG1655 x10MIC strain 
in MH broth at 37ºC. All five colonies (C1-C5) were grown within conical flasks and 
the OD600 values were measured using a spectrophotometer. 
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Figure A.29 Manual exponential growth analysis of E. coli MG1655 WT strain by 
bacterial enumeration. Displaying the exponential growth curve of the E. coli 
MG1655 WT strain in MH broth at 37ºC. All five colonies (C1-C5) were grown within 
conical flasks and samples were taken every hour for 12 hours. The bacterial 
samples were used to perform serial dilutions which were plated on MH plates and 
incubated O/N at 37ºC. Following incubation, the log10 CFU/mL was determined.  
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Figure A.30 Manual exponential growth analysis of E. coli MG1655 MIC strain by 
bacterial enumeration. Displaying the exponential growth curve of the E. coli 
MG1655 MIC strain in MH broth at 37ºC. All five colonies (C1-C5) were grown within 
conical flasks and samples were taken every hour for 12 hours. The bacterial 
samples were used to perform serial dilutions which were plated on MH plates and 
incubated O/N at 37ºC. Following incubation, the log10 CFU/mL was determined.  
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Figure A.31 Manual exponential growth analysis of E. coli MG1655 X10MIC 
strain by bacterial enumeration. Displaying the exponential growth curve of the E. 
coli MG1655 X10MIC strain in MH broth at 37ºC. All five colonies (C1-C5) were grown 
within conical flasks and samples were taken every hour for 12 hours. The bacterial 
samples were used to perform serial dilutions which were plated on MH plates and 
incubated O/N at 37ºC. Following incubation, the log10 CFU/mL was determined.  
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